Prostate specific Ag [Mass/volume] in Serum or Plasma

    
          Number of people
          
128 027 (0.30% female)
          
          People with ≥2 records
          75.62%

          Median duration from first to last measurement
          5.64 years

Coding

Definition

OMOP Concept ID: 3013603— open in OHDSI Athena.
Part of collection: Prostate specific Ag with 0 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3013603	p-psa	ug/l (ug/l)	78346	342446	0.26%
3013603	p-psa	— (—)	39653	146918	100.00%	Distribution not available
3013603	s-psa	ug/l (ug/l)	31743	63298	0.00%
3013603	s-psa	µg/l (ug/l)	14210	23767	0.00%
3013603	s-psa-t	ug/l (ug/l)	8700	35843	0.00%
3013603	s-psa	— (—)	3916	7946	100.00%	Distribution not available
3013603	p-prostataspesifinenantigeeni	ug/l______ (ug/l)	3319	5084	0.00%
3013603	p-psa	ug/l______ (ug/l)	3096	9251	0.00%
3013603	s-prostataspesifinenantigeeni,kokonais	ug/l (ug/l)	3014	5061	0.00%
3013603	prostataspesifinenantigeeni	ug/l (ug/l)	2498	2897	0.00%
3013603	p-psa-t	ug/l (ug/l)	2276	11084	0.00%
3013603	s-psa-t	— (—)	1582	5768	100.00%	Distribution not available
3013603	p-psa	µg/l (ug/l)	1354	2443	0.00%
3013603	s-psa	ug/l______ (ug/l)	649	1115	0.00%
3013603	p-prostataspesifinenantigeeni	ug/l (ug/l)	612	790	0.00%
3013603	p-prostataspesifinenantigeeni,kokonais	ug/l (ug/l)	569	725	0.00%
3013603	s-prostataspesifinenantigeeni,kokonais	— (—)	470	922	100.00%	Distribution not available
3013603	p-psaleik	— (—)	400	2015	100.00%	Distribution not available
3013603	p-psagen	— (—)	357	1271	100.00%	Distribution not available
3013603	p-prostataspesifinenantigeeni	— (—)	337	607	100.00%	Distribution not available
3013603	p-psasäde	ug/l (ug/l)	327	1491	0.00%
3013603	p-psa	µg/L (ug/l)	214	276	0.00%
3013603	p-psasäde	— (—)	207	875	100.00%	Distribution not available
3013603	s-psa	UG/L (ug/l)	201	241	0.00%
3013603	s-prostataspesifinenantigeeni	— (—)	173	195	100.00%	Distribution not available
3013603	prostataspesifinenantigeeni	— (—)	156	220	100.00%	Distribution not available
3013603	p-psaleik	ug/l (ug/l)	147	163	0.00%
3013603	p-psa-suh	ug/l (ug/l)	132	251	0.00%
3013603	prostataspesifinenantigeeni,kokonais	ug/l (ug/l)	122	174	0.00%
3013603	p-psamob	ug/L______ (ug/l)	105	427	0.00%
3013603	s-psa/oma	ug/l (ug/l)	100	183	0.00%
3013603	p-psamob	— (—)	81	287	100.00%	Distribution not available
3013603	s-prostataspesifinenantigeeni	ug/l (ug/l)	80	97	0.00%
3013603	s-psa-suh	ug/l (ug/l)	77	111	0.00%
3013603	prostataspesifinenantigeeni,totaali	ug/l (ug/l)	72	109	0.00%
3013603	p-prostataspesifinenantigeeni	µg/l (ug/l)	70	79	0.00%
3013603	p-psamob	ug/L (ug/l)	66	125	0.00%
3013603	p-prostataspesifinenantigeeni(pi)	ug/l (ug/l)	54	78	0.00%
3013603	prostataspesifinenantigeeni	µg/l (ug/l)	48	72	0.00%
3013603	s-psa-suh,s-psa	ug/l (ug/l)	46	66	0.00%
3013603	p-psagen	ug/l (ug/l)	31	36	0.00%
3013603	p-psa-t	— (—)	22	22	100.00%	Distribution not available
3013603	s-psa-t	ug/l______ (ug/l)	19	31	0.00%
3013603	p-psamob	ug/l______ (ug/l)	17	23	0.00%
3013603	p-psa	UG/L (ug/l)	11	11	0.00%	Distribution not available
3013603	p-psa	µg7l (ug/l)	10	11	0.00%
3013603	s-psa	mg/l (ug/l)	7	7	0.00%	Distribution not available

Cohort

Number of people: 128 027 (0.30% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

People with ≥2 records: 75.62%
Median number of measurements per person: 3.0
Median duration from first to last measurement: 5.64 years

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Reference range

N people

N records

—

123691

561231

<6.2/Myli67V

4087

15883

<6.5/miehetyli70

3876

13998

0.0-6.5

3799

14073

0.0-4.5

2077

7115

<6.5/miehetyli70v

1852

5509

<4.5/miehet60-70v

1792

5476

<6.9/miehetyli70v

1785

3928

alle6.5/myli69v

1640

5048

<6.5/yli69v

1634

4576

<4.5/miehet60-69v

1483

3259

<4.8/miehet60-70v

1239

2861

alle4.5/m60-69v

1161

3463

mies

1104

1928

<5.8/M64-67V

1054

3237

<6.5/Miehet70-79v

856

2440

<4.5/60-69v

837

2133

0.0-3.5

771

2082

<4.8/M60-63V

731

1966

<3.3/Malle56V

687

1363

<4.5/Miehet60v-69v

590

1738

<3.5/miehet50-60v

586

1415

alle6.5/m70-79v

524

1304

<3.8/M56-59V

494

1235

alle3.5/m50-59v

483

1225

<3.5/miehet50-59v

438

859

<6.7/Miehet70-79v

433

993

<3.7/miehet50-60v

324

648

0.0-2.5

309

558

<3.5/50-59v

284

541

<5.5/Miehet65-69v

256

524

<3.5/Miehet50-59v

216

467

<4.9/Miehet60-64v

172

365

<2.5/miehet40-50v

152

247

<2.5/miehetalle50v

129

191

<2.6/miehetalle50v

121

151

<3.8/Miehet55-59v

100

190

alle2.5/malle50v

150

Yleiset

<2.5/alle50v

102

<2.5/Miehet40-49v

118

<2.8/Miehet50-54v

alle2.5/m40-49v

<2.5/miehet40-49v

yli69v

60-69v

Value range per person

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Intracranial trauma

11163

52973

1.60

321.75

5.0

5.1

2.86

3.08

ug/l

0.33

10049

48511

Inflammatory diseases of prostate (prostatitis)

4959

34546

3.74

319.79

7.1

4.8

3.09

2.86

ug/l

0.13

4649

30846

832

20791

0.24

319.07

3.3

5.6

2.05

3.39

ug/l

4.49

677

18873

Artrosis, including avohilmo

18372

77173

1.46

315.30

5.5

5.0

3.00

3.32

ug/l

0.47

16735

70072

Retention of urine

10716

64582

1.81

314.61

7.1

5.7

5.86

3.47

ug/l

3.46

9879

57534

Metabolic disorders

19453

90215

1.43

312.97

5.3

5.1

2.75

3.30

ug/l

1.60

17669

82048

Injuries to the head

22157

103038

1.39

312.31

5.2

5.3

3.16

3.15

ug/l

0.01

19811

93929

Pain in throat and chest

17544

74650

1.57

307.65

5.3

5.1

2.54

3.36

ug/l

3.04

15870

68120

malignant neoplasm of male genital organs, including Hilmo

12902

58912

2.96

307.65

13.4

4.2

9.61

1.96

ug/l

22.98

11747

53749

Inguinal hernia

18678

89939

1.80

307.65

5.6

5.0

3.03

3.13

ug/l

0.12

17047

81948

Any death

9123

89483

0.60

307.65

5.2

5.9

7.30

2.22

ug/l

14.77

7918

82107

Malignant neoplasm of prostate, including Hilmo

12653

57272

3.10

307.65

13.7

4.2

9.87

1.99

ug/l

23.30

11517

52212

Malignant neoplasm of prostate

12389

56266

3.09

307.65

14.0

4.3

9.54

2.00

ug/l

27.21

11245

51249

Sensorineural hearing loss

17023

86499

1.50

307.65

6.2

5.4

3.26

3.44

ug/l

0.28

15272

78506

Sleep apnoea, including avohilmo

20846

93560

1.52

307.65

5.6

5.2

2.51

3.24

ug/l

1.89

18842

85139

Genitourinary diseases

15413

57244

1.58

307.65

5.4

4.0

2.99

2.51

ug/l

0.83

14330

51656

malignant neoplasm of male genital organs

12631

57872

2.96

307.65

13.7

4.2

9.34

1.97

ug/l

27.01

11469

52770

Conductive and sensorineural hearing loss

17596

88780

1.50

307.65

6.1

5.4

3.21

3.38

ug/l

0.28

15810

80663

Other disorders of ear

19544

94953

1.50

307.65

5.9

5.2

3.09

3.24

ug/l

0.21

17654

86436

Abnormal findings on examination of blood, without diagnosis

13839

93066

1.77

307.65

10.1

5.2

5.89

3.05

ug/l

14.10

12829

84022

All kidney diseases

19369

97284

1.48

307.65

5.5

5.2

3.76

2.85

ug/l

2.19

17620

88489

Sleep apnoea

20896

95082

1.60

307.65

5.5

5.3

2.50

3.20

ug/l

1.79

18879

86602

Hernia

19975

90621

1.70

307.65

5.4

5.0

2.63

3.12

ug/l

1.23

18182

82401

Diseases of male genital organs

20168

74652

2.06

307.65

5.9

4.3

3.10

2.88

ug/l

0.38

18810

67252

Hyperplasia of prostate

16517

65098

3.73

307.65

7.2

4.6

3.71

3.17

ug/l

0.98

15637

58409

Symptoms and signs involving the urinary system

19733

92790

2.06

307.65

6.8

5.0

4.04

2.96

ug/l

3.18

18245

83804

Abnormal serum enzyme levels

10907

80305

2.20

307.65

11.4

5.4

6.72

3.04

ug/l

16.69

10211

72365

Unspecified haematuria

13014

73936

1.99

307.65

7.3

5.5

4.36

3.28

ug/l

2.34

11884

66220

Disorders of lipoprotein metabolism and other lipidaemias

18684

88552

1.45

297.50

5.5

5.2

2.55

3.31

ug/l

4.28

17053

80568

Dental operations

14259

54813

1.53

293.96

5.8

5.2

3.61

3.60

ug/l

0.01

12886

49411

Pure hypercholesterolaemia

17508

86511

1.46

290.45

5.7

5.3

2.59

3.34

ug/l

4.06

16059

78692

Renal tubulo-interstitial diseases

16949

95696

1.43

285.54

5.7

5.5

4.82

2.99

ug/l

4.12

15353

86754

Abnormalities of breathing

17070

74657

1.43

283.38

5.2

5.1

2.65

3.37

ug/l

1.99

15422

68120

Other diseases of hard tissues of teeth

12975

49923

1.54

279.00

6.1

5.2

3.30

3.50

ug/l

0.21

11739

45115

Injuries to the shoulder and upper arm

17973

108818

1.41

271.84

5.4

5.3

2.34

3.23

ug/l

7.83

16386

98881

Parasetamol

15306

58612

1.45

268.30

5.1

4.8

3.05

2.93

ug/l

0.13

13879

53537

Codeine

18089

76239

1.40

259.37

5.4

5.0

2.93

2.63

ug/l

0.54

16375

69475

Coxibs

6245

21407

1.81

256.52

5.7

5.0

2.79

4.84

ug/l

3.88

5621

19153

Chronic periodontitis, including avohilmo

20121

102479

1.38

255.82

5.7

5.2

2.78

3.01

ug/l

0.77

18102

93519

Codeine or tramadol medication

22216

96888

1.35

253.67

5.5

5.2

2.89

3.25

ug/l

0.77

20119

88060

Periodontitis

20116

102484

1.37

252.42

5.7

5.2

2.78

3.01

ug/l

0.78

18098

93517

Diseases of oral cavity, salivary glands and jaws

13068

50716

1.50

251.81

5.8

5.2

3.53

3.61

ug/l

0.08

11801

45732

Abnormal spermatozoa

4787

36836

5.52

243.84

12.0

5.8

8.25

3.32

ug/l

6.94

4488

33298

Other diseases of intestines

20412

90743

1.35

243.24

5.6

5.0

2.97

3.10

ug/l

0.18

18623

82470

Spondylopathies

17030

79389

1.41

241.69

5.7

5.2

2.91

3.38

ug/l

1.05

15516

71917

Erysipelas, including avohilmo

16443

96585

1.41

236.44

5.3

3.03

2.82

ug/l

0.36

14857

88019

Statin medication

10937

44994

1.49

235.72

4.6

2.49

3.28

ug/l

3.10

9957

41066

Other bacterial diseases, including avohilmo

19536

97586

1.36

234.42

5.2

3.91

2.79

ug/l

2.63

17708

88871

Artificial joint operation, meniscal resection

19934

103299

1.37

232.98

5.8

5.3

2.52

3.26

ug/l

2.46

18227

93846

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

18459

92808

1.36

230.84

5.5

5.2

2.65

3.31

ug/l

2.52

16613

84701

Diseases of pulp and periapical tissues and dental caries

14049

55476

1.44

227.98

5.7

5.3

3.38

3.49

ug/l

0.18

12662

50140

Shoulder lesions

16448

78105

1.40

225.84

5.6

5.2

2.28

3.37

ug/l

8.36

15179

70861

Dental caries, including avohilmo

15518

62128

1.41

224.71

5.7

5.3

3.60

3.47

ug/l

0.16

13996

56212

Arthrosis

15701

67781

1.41

221.21

5.5

5.1

3.02

3.39

ug/l

0.49

14311

61586

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

17627

95067

1.36

219.01

5.2

2.73

3.03

ug/l

0.79

15899

86736

Persons encountering health services for specific procedures and health care

20145

95951

1.33

219.00

5.5

5.0

4.55

2.56

ug/l

6.82

18300

87323

Finngen Rheumatological endpoints

18623

84738

1.35

215.35

5.3

5.1

2.92

3.24

ug/l

0.48

16946

77106

Rotator cuff syndrome

13920

75345

1.44

215.20

5.7

5.3

2.21

3.39

ug/l

10.59

12907

68378

Injuries to the wrist and hand

19428

104211

1.34

213.93

5.3

2.74

3.02

ug/l

0.39

17662

94791

Gonarthrosis

14649

65191

1.43

213.51

5.7

5.3

2.83

3.49

ug/l

1.28

13352

59171

Dipeptidyl peptidase 4 (DPP-4) inhibitors

12852

79379

1.47

212.69

5.5

5.7

2.78

3.54

ug/l

2.22

11461

72296

Benign neoplasms

20837

92360

1.33

212.48

5.5

5.0

2.72

3.29

ug/l

1.83

19007

83912

Caries of dentine, including avohilmo

16136

65251

1.39

210.50

5.7

5.3

3.47

3.42

ug/l

0.06

14542

59111

Tramadol

15864

75497

1.38

210.45

5.5

5.1

2.83

2.67

ug/l

0.32

14298

68778

Hypothyreosis and Thyroxine purchase for inclusion criteria

10142

87989

0.70

206.13

5.6

2.68

3.47

ug/l

1.73

9011

79602

Oter anti-inflammatory and antirheumatic agents, non-steroids

5450

20383

1.81

202.43

6.2

5.2

3.09

5.05

ug/l

2.96

4840

18242

Emergency coronary revascularization (for ACS)

17942

87898

1.36

202.11

5.1

5.3

2.53

3.37

ug/l

3.42

16251

80055

Oxicams

5432

20909

1.77

199.65

5.9

5.1

2.47

4.93

ug/l

5.54

4899

18722

Other soft tissue disorders, not elsewhere classified

17728

81270

1.34

194.97

5.5

5.1

2.67

3.44

ug/l

3.13

16129

73639

Concussion

9193

52889

1.48

194.95

5.0

5.1

2.59

3.08

ug/l

1.29

8267

48432

Hypothyroidism, other/unspecified

10097

87200

0.71

194.55

5.6

2.65

3.46

ug/l

1.81

8976

78914

Sleep disorders (combined)

20777

88864

1.31

194.16

5.6

5.3

2.59

3.42

ug/l

2.22

18794

80720

Other heart diseases, wide

16040

77368

1.35

192.85

4.9

5.0

2.35

3.03

ug/l

3.41

14594

70940

Gonarthrosis [arthrosis of knee](FG)

16915

78929

1.36

192.16

5.8

5.3

2.73

3.41

ug/l

1.64

15434

71780

Excessive earwax

13526

97864

1.40

190.34

6.2

5.5

2.55

3.26

ug/l

3.57

12309

88753

Other bacterial diseases

18812

101968

1.32

190.09

5.4

5.2

4.35

2.78

ug/l

4.02

16986

92918

Other intervertebral disc disorders

16756

80634

1.35

189.23

5.5

5.2

2.86

3.27

ug/l

0.77

15444

73098

Chronic apical periodontitis

21058

97279

1.30

188.77

5.6

5.2

3.05

3.02

ug/l

0.03

18955

88625

Biguanides

18572

91494

1.32

188.14

5.1

5.3

2.64

3.33

ug/l

3.45

16668

83544

Disease of hard tissues of teeth, NOS

11804

47981

1.45

186.86

6.1

5.2

2.15

3.26

ug/l

8.21

10794

43491

Other dorsopathies, not elsewhere classified

19302

81874

1.31

184.43

5.4

5.1

2.85

3.30

ug/l

1.04

17615

74145

Symptoms and signs involving cognition, perception, emotional state and behaviour

18824

103214

1.31

182.83

5.6

5.3

3.09

3.23

ug/l

0.21

16948

93872

Dorsalgia

18918

81852

1.31

181.57

5.4

5.1

2.83

3.30

ug/l

1.05

17217

74128

Meniscus derangement

12402

65157

1.42

180.54

5.7

5.2

2.40

3.17

ug/l

4.05

11372

59320

Cardiac arrhythmias

9374

44980

1.45

177.39

4.7

4.8

2.23

2.92

ug/l

2.36

8580

41591

Polyarthropathies

13301

67793

1.38

175.06

5.2

5.1

2.88

3.39

ug/l

1.60

11973

61551

Other special examinations and investigations of persons without complaint or reported diagnosis

13933

56052

1.37

174.79

5.2

4.9

3.00

3.17

ug/l

0.18

12773

50810

Diseases of oesophagus, stomach and duodenum

20540

100813

1.29

170.51

5.6

5.2

2.79

3.26

ug/l

1.25

18650

91693

Other arrhythmias

11740

68836

1.39

169.70

5.8

5.3

2.96

3.26

ug/l

0.39

10597

62963

Medical observation and evaluation for suspected diseases and conditions

13769

56036

1.37

169.32

5.5

4.9

2.72

3.12

ug/l

1.24

12421

50799

Testicular dysfunction

1520

9307

7.04

166.93

5.5

4.2

1.37

1.88

ug/l

10.88

1445

8613

Benign neoplasm of colon, rectum, anus and anal canal

13863

95461

1.37

165.86

6.3

5.7

2.95

3.49

ug/l

1.09

12613

86318

Disorders of choroid and retina

17146

99218

1.32

165.74

6.0

5.4

3.22

3.36

ug/l

0.21

15394

90063

Percutaneous Coronary Intervention

16188

80753

1.34

165.43

5.0

5.3

2.25

3.19

ug/l

8.30

14715

73854

Paracetamol or NSAID medication

3384

10497

1.85

164.93

5.3

4.5

4.25

3.91

ug/l

0.10

3020

9433

Diverticular disease of intestine

15826

80907

1.34

162.71

6.2

5.3

3.07

3.35

ug/l

0.44

14387

73372

Hypothyroidism, strict autoimmune

8356

72202

0.71

162.62

5.5

5.7

2.80

3.75

ug/l

1.72

7396

65284

Acetic acid derivatives and related substances

5849

21349

1.61

162.25

5.7

5.0

2.80

4.98

ug/l

4.08

5248

19105

All chronic kidney diseases

12087

77489

1.39

158.67

5.5

5.7

4.40

3.16

ug/l

2.50

10898

69972

Soft tissue disorders

19278

81908

1.28

156.10

5.3

5.1

2.55

3.51

ug/l

5.21

17586

74147

Other joint disorders

16447

70028

1.31

155.96

5.3

5.0

2.51

3.27

ug/l

3.69

14913

63588

Testicular hypofunction

1351

8223

7.72

153.08

5.6

4.2

1.37

1.88

ug/l

9.62

1288

7611

Gonarthrosis,primary

19229

97638

1.29

151.54

6.0

5.5

2.87

3.39

ug/l

1.10

17497

88601

Hypothyroidism, strict autoimmune, 3 medication purchases required

8253

72632

0.72

150.24

5.5

5.7

2.51

3.49

ug/l

3.74

7298

65569

Disorders of the thyroid gland

12511

100391

0.76

149.56

5.8

5.5

2.78

3.43

ug/l

1.61

11162

91035

Polyuria

5644

42427

1.68

148.59

7.0

5.7

2.32

3.33

ug/l

3.33

5238

37868

Hypertension, essential

14064

64430

1.33

148.34

4.9

4.8

2.42

3.26

ug/l

3.44

12860

58900

Fitting and adjustment of other devices

8100

55431

1.48

145.68

6.4

6.0

3.40

3.19

ug/l

0.22

7458

49578

Coronary revascularization (ANGIO or CABG)

16023

80766

1.32

145.24

5.0

5.3

2.21

3.19

ug/l

8.99

14584

73865

Pneumonias (Asthma/COPD co-morbidities)

18311

99895

1.27

144.19

4.9

5.3

3.00

3.01

ug/l

0.01

16598

91209

Implicit Sepsis, including avohilmo

16495

98047

1.30

143.95

5.3

5.4

3.11

3.10

ug/l

0.01

14762

89348

All pneumoniae

18380

99789

1.27

143.85

4.9

5.3

2.99

3.01

ug/l

0.03

16661

91119

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

18048

100550

1.27

140.54

4.9

5.3

3.11

3.00

ug/l

0.22

16323

91825

Condition for Implicit Sepsis (Organ dysfunction codes)

16850

97485

1.29

139.61

5.2

5.3

3.00

3.06

ug/l

0.07

15101

88933

Other (not insulin) diabetes medications

18332

90148

1.27

139.54

5.0

5.3

2.50

3.34

ug/l

5.03

16460

82319

Exposure to unspecified factor

18886

108096

1.26

138.91

5.2

5.3

2.44

3.16

ug/l

4.06

16851

98573

Pneumonia, organism unspecified

16999

97260

1.28

138.33

5.0

5.3

3.16

3.02

ug/l

0.29

15311

88805

Disorders of lens

14599

75162

1.33

137.11

5.9

5.4

2.76

3.41

ug/l

2.79

13132

68688

Type 2 diabetes, definitions combined, including avohilmo

17456

84241

1.28

137.07

5.1

5.3

2.51

3.38

ug/l

4.89

15699

77022

Hypogonadotropic hypogonadism

1085

6191

6.29

136.95

5.6

3.9

1.19

1.70

ug/l

10.50

1010

5750

Gingivitis and periodontal diseases

19555

85207

1.27

136.45

5.7

5.2

3.07

3.28

ug/l

0.39

17683

77478

Coxarthrosis

11539

60463

1.38

135.87

6.1

5.5

3.64

3.62

ug/l

0.01

10467

54751

Diseases of the ear and mastoid process

21064

89355

1.25

135.77

5.4

5.0

2.78

3.18

ug/l

0.89

19160

81378

Hypertension

14030

64684

1.31

135.23

4.9

4.8

2.41

3.25

ug/l

3.26

12858

59132

Hypertensive diseases

14025

64689

1.31

134.80

4.9

4.8

2.42

3.25

ug/l

3.24

12853

59137

Type 2 diabetes, strict (exclude DM1)

17586

85642

1.27

134.73

5.1

5.3

2.50

3.37

ug/l

4.98

15821

78263

Episodal and paroxysmal disorders

19434

82848

1.26

134.71

5.3

5.2

2.62

3.47

ug/l

2.64

17552

75270

Type 2 diabetes, definitions combined

17524

85355

1.27

133.93

5.1

5.3

2.50

3.37

ug/l

4.94

15763

78008

Influenza and pneumonia

18777

97699

1.26

130.93

4.8

5.3

2.88

3.01

ug/l

0.29

17051

89192

Other heart diseases

7448

36711

1.43

130.92

4.3

4.4

2.06

2.60

ug/l

1.78

6818

33924

Symptoms and signs involving the circulatory and respiratory systems

17853

74799

1.26

130.44

5.1

5.0

2.45

3.36

ug/l

5.00

16179

68250

Opioids

17733

76610

1.27

130.28

5.3

5.0

3.50

2.68

ug/l

1.97

16027

69757

Other antidepressants

21155

92175

1.25

129.71

5.4

5.3

2.78

3.33

ug/l

1.54

18865

84197

Diabetes, insulin treatment (Kela reimbursement)

18944

95839

1.25

122.85

5.0

5.3

2.53

3.33

ug/l

4.41

17005

87437

Diabetes medication

18541

91673

1.25

122.79

4.9

5.3

2.45

3.29

ug/l

5.34

16652

83688

Diseases of pulp and periapical tissues, including avohilmo

19080

83627

1.25

122.78

5.7

5.2

3.20

3.22

ug/l

0.02

17181

76001

Basal cell carcinoma

9056

49327

1.40

121.80

6.6

4.3

3.22

2.05

ug/l

10.18

8065

44590

L02BX Other hormone antagonists and related agents

2084

15892

9.04

121.31

21.6

6.1

32.94

2.78

ug/l

18.31

2033

14252

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

17327

86782

1.26

120.76

4.9

5.2

2.46

3.33

ug/l

5.00

15559

79296

Type 2 diabetes

17649

86292

1.25

120.63

5.0

5.3

2.46

3.34

ug/l

5.19

15876

78854

Basal cell carcinoma, including Hilmo

9392

51098

1.39

119.90

6.6

4.3

3.16

2.03

ug/l

10.16

8381

46243

Diabetes, varying definitions

17777

87075

1.25

119.66

4.9

5.2

2.45

3.32

ug/l

5.12

15989

79556

Non-invasive ventilation

4548

28382

1.56

119.53

5.6

5.2

2.23

3.19

ug/l

3.47

4281

26385

Type 2 diabetes, wide definition

15626

82952

1.28

119.23

5.1

5.4

2.49

3.41

ug/l

6.23

14068

75794

Fall on same level

21383

97859

1.23

118.32

5.2

2.99

3.10

ug/l

0.17

19195

89350

Senile cataract

13623

69395

1.32

117.57

6.1

5.6

2.85

3.58

ug/l

2.99

12210

63250

Pain (limb, back, neck, head abdominally)

15377

64544

1.28

116.00

5.2

5.1

2.61

3.57

ug/l

4.28

13981

58514

Presence of cardiac and vascular implants and grafts

11460

70599

1.37

115.59

5.7

5.8

2.76

3.87

ug/l

6.05

10231

63949

Actinic keratosis

7883

57325

1.43

115.46

6.9

6.3

3.75

4.17

ug/l

0.26

7012

51086

Propionic acid derivatives

5740

21455

1.49

114.73

5.6

5.0

3.95

4.96

ug/l

0.55

5148

19194

Presence of other functional implants

12301

69904

1.32

114.63

6.4

5.8

3.60

3.89

ug/l

0.36

10736

63223

Provisional assignment of new diseases of uncertain etiology

9512

76159

1.35

114.38

5.5

5.6

2.81

3.31

ug/l

1.29

8745

68701

Codes for special purposes

9517

76218

1.34

114.06

5.5

5.6

2.81

3.31

ug/l

1.29

8750

68756

Diabetes mellitus

17781

87101

1.24

114.01

4.9

5.2

2.45

3.32

ug/l

5.12

15993

79576

Malignant neoplasm of skin, including Hilmo

10611

58108

1.35

113.91

6.4

4.2

2.93

1.96

ug/l

9.19

9531

52847

Malignant neoplasm of skin

10122

55801

1.35

113.31

6.4

4.2

3.04

1.98

ug/l

9.52

9077

50669

Skin changes due to chronic exposure to nonionizing radiation

8000

58118

1.41

112.42

6.9

6.3

3.73

4.16

ug/l

0.28

7118

51807

Gout

7721

53915

1.48

112.17

5.5

5.7

3.35

3.85

ug/l

0.86

6932

48671

Other malignant neoplasms of skin (=non-melanoma skin cancer)

9270

50863

1.37

112.11

6.5

4.3

3.12

2.03

ug/l

9.20

8269

46018

Malignant neoplasm of bronchus and lung

2499

30252

0.58

111.68

4.8

4.5

2.42

2.23

ug/l

1.05

2161

27110

Neoplasms

13797

60019

1.28

111.53

5.7

3.5

3.19

1.72

ug/l

5.07

12666

54968

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

9638

52876

1.36

110.31

6.5

4.3

2.99

2.01

ug/l

8.88

8612

47916

Bleeding

16945

101668

1.25

109.84

5.6

5.4

3.90

3.09

ug/l

1.09

15187

92578

Lumbar disc prolapse

12430

76617

1.29

108.50

5.3

5.2

2.83

2.96

ug/l

0.15

11498

69679

Dorsopathies

18913

81914

1.23

107.87

5.3

5.1

2.90

3.30

ug/l

0.85

17244

74180

Persons encountering health services for examination and investigation

13430

56053

1.29

107.78

5.2

4.9

3.18

3.17

ug/l

0.02

12207

50811

Diseases of the eye and adnexa

14636

61329

1.27

107.75

5.0

4.7

2.60

3.05

ug/l

0.74

13347

56220

Conduction disorders

6784

43010

1.46

107.63

6.0

6.1

3.22

3.95

ug/l

1.25

5933

38832

Hypertensive diseases (excluding secondary)

8030

36662

1.37

107.24

4.3

4.4

2.05

2.60

ug/l

1.85

7399

33892

Acute tubulo-interstitial nephritis

10717

74119

1.31

107.19

6.2

5.9

5.97

3.32

ug/l

4.42

9684

66540

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6548

25003

1.41

106.19

4.7

3.6

2.41

2.21

ug/l

0.31

5991

22887

Fever of other and unknown origin

10821

77180

1.31

105.88

5.7

5.4

4.14

2.96

ug/l

1.71

9781

70135

GASTRO-related operations

12811

52954

1.28

105.50

5.1

4.2

3.26

2.38

ug/l

1.71

11592

48524

Any gastric operation

12811

52954

1.28

105.50

5.1

4.2

3.26

2.38

ug/l

1.71

11592

48524

Covid-19 confirmed case

7386

58926

1.40

104.96

5.6

5.9

2.99

3.64

ug/l

1.38

6744

52983

Redundant prepuce, phimosis and paraphimosis

6373

50943

1.55

104.33

5.2

4.1

2.47

2.46

ug/l

0.02

5808

45994

8321

60776

1.38

104.01

6.8

6.3

3.79

4.12

ug/l

0.22

7406

54228

Arthropathies

16364

70056

1.24

103.84

5.1

5.0

2.97

3.31

ug/l

0.44

14836

63613

Dislocation, sprain and strain of joints and ligaments of knee

10561

78481

1.30

103.47

4.9

2.06

2.54

ug/l

2.46

9761

72072

Dyspnoea

16909

104615

1.24

102.56

5.6

5.4

3.08

3.30

ug/l

0.39

15108

95161

Malignant neoplasm of respiratory system and intrathoracic organs

3033

34597

0.62

101.16

4.9

4.5

2.47

2.20

ug/l

1.96

2633

31030

Bacterial infection, other or unspecified, including avohilmo

12235

84372

1.29

100.66

5.9

5.7

5.86

3.03

ug/l

6.04

10996

76425

L02BB Anti-androgens

3210

25336

2.36

100.49

20.7

5.8

25.91

3.06

ug/l

19.39

3071

22520

Malaise and fatigue

10103

65486

1.31

98.65

5.5

5.6

4.72

3.17

ug/l

1.56

9000

59190

Haemorrhage from respiratory passages

7800

55979

1.38

98.46

5.8

5.7

3.55

3.93

ug/l

0.31

6966

50649

AV-block

4653

30672

1.58

98.03

6.1

6.4

3.44

4.52

ug/l

1.33

4046

27510

Dermatophytosis, including avohilmo

12714

105290

1.27

97.82

5.4

5.3

2.53

2.90

ug/l

0.99

11557

95978

ILD medications: prednisolone, methylprednisolone, prednisone

20372

98357

1.21

97.80

5.6

5.2

3.92

2.92

ug/l

3.21

18486

89462

Abdominal and pelvic pain

20498

89524

1.21

97.29

5.3

5.2

2.69

3.35

ug/l

2.09

18661

81407

Benign neoplasm: Colon

11534

91456

1.30

97.05

6.3

5.8

2.91

3.51

ug/l

1.08

10486

82574

Hypopituitarism

1636

10496

2.14

95.12

5.8

4.4

1.37

2.16

ug/l

8.64

1510

9662

Depression

12080

96181

0.80

95.03

4.7

5.1

2.16

2.81

ug/l

3.07

10804

88137

Malignant neoplasm of bronchus and lung, including Hilmo

2957

33715

0.63

93.92

4.9

4.5

2.40

2.21

ug/l

1.27

2564

30208

Anti-inflammatory and antirheumatic products, non-steroids

5594

21455

1.44

93.67

5.5

5.0

3.80

4.96

ug/l

0.68

5030

19194

Presence of other devices

5022

38227

1.48

93.62

6.5

6.3

2.67

4.72

ug/l

8.30

4693

34191

Dizziness and giddiness

13622

89970

1.25

93.14

5.9

5.6

3.09

3.49

ug/l

0.66

12296

81402

Cardiovascular diseases (excluding rheumatic etc)

8307

37853

1.32

93.01

4.2

4.3

1.77

2.55

ug/l

5.42

7636

34941

Other disorders of penis

3090

23670

1.97

92.82

6.1

4.5

2.33

2.63

ug/l

0.41

2790

21223

Continuous positive airway pressure

4300

27264

1.55

92.49

5.6

5.3

2.37

3.46

ug/l

2.77

3730

25315

Diseases of the musculoskeletal system and connective tissue

9512

38723

1.31

92.13

4.9

4.8

2.99

3.51

ug/l

0.49

8659

35113

Mood [affective] disorders

13588

102321

0.81

92.04

4.7

5.2

2.17

2.90

ug/l

4.26

12154

93527

Coxarthrosis [arthrosis of hip](FG)

12046

70253

1.28

91.01

6.2

5.6

3.60

3.62

ug/l

0.02

10927

63634

Pain in limb

14749

79940

1.24

90.95

5.6

5.2

2.78

3.46

ug/l

2.15

13382

72454

Myocardial infarction, unclassifiable

3413

40427

0.65

90.87

5.0

6.1

6.31

4.42

ug/l

0.58

2986

35957

Inflammatory bowel disease treatment related agents

21086

102332

1.20

90.84

5.5

5.2

3.62

3.01

ug/l

1.73

19115

93042

Mood disorders

13649

102437

0.81

90.63

4.7

5.2

2.16

2.90

ug/l

4.33

12212

93627

Neurological diseases

14528

61817

1.24

90.46

5.0

5.1

2.67

3.33

ug/l

1.29

13163

56397

COPD, hospital admissions 1, only main diagnosis

5953

63081

0.71

90.40

5.2

6.2

3.70

4.15

ug/l

0.30

5141

56553

Impotence

1956

14558

2.92

90.19

7.0

4.6

2.09

2.33

ug/l

0.86

1780

13049

Factors influencing health status and contact with health services

7618

30798

1.37

89.69

5.0

4.6

3.28

2.56

ug/l

0.67

6921

28236

ILD medications

20928

98691

1.20

89.52

5.4

5.2

3.61

2.91

ug/l

2.12

18977

89761

Implicit Sepsis

15261

96955

1.24

89.41

5.3

5.5

3.31

3.15

ug/l

0.23

13594

88265

Persons encountering health services in other circumstances, wide

22040

99537

1.19

89.16

5.3

5.2

3.02

3.17

ug/l

0.22

20143

90250

Other retinal disorders

13095

85064

1.26

88.29

6.0

5.7

3.36

3.55

ug/l

0.25

11682

76778

Other symptoms and signs involving the urinary system

2557

18478

1.83

88.25

8.0

5.5

4.01

3.02

ug/l

0.95

2449

16557

Major coronary heart disease event

16396

84979

1.23

87.89

5.0

5.3

2.27

3.25

ug/l

8.49

14901

77574

Other cataract

9114

56206

1.33

87.81

6.1

5.7

2.63

3.74

ug/l

5.46

8160

50942

Constipation

16690

97993

1.22

87.26

6.3

5.4

4.22

3.22

ug/l

1.67

14939

88872

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

10251

82971

1.29

86.65

5.4

5.2

2.27

2.97

ug/l

3.08

9353

75652

Mycoses, including avohilmo

16438

108355

1.22

86.39

5.4

5.3

2.63

2.99

ug/l

0.81

14928

98637

Lung cancer and mesothelioma

3013

34179

0.64

86.07

5.0

6.5

2.36

4.30

ug/l

7.21

2610

30831

General examination and investigation of persons without complaint and reported diagnosis

12711

55897

1.26

84.73

5.0

4.9

2.90

3.09

ug/l

0.24

11648

50700

Spermatocele

2542

19605

2.21

83.77

6.0

4.9

3.28

3.00

ug/l

0.20

2350

17417

Hydrocele

3722

29557

1.76

83.70

5.8

4.9

2.79

3.51

ug/l

1.19

3388

26094

Malignant neoplasm, wide definition

15325

76875

1.22

82.72

7.3

3.8

4.35

1.77

ug/l

13.73

13956

70474

Malignant neoplasm, including Hilmo

15293

76748

1.22

82.66

7.3

3.8

4.36

1.77

ug/l

13.71

13924

70366

Valvular heart disease excluding rheumatic fever

9987

60099

1.30

82.32

5.7

5.6

2.63

3.52

ug/l

4.52

8865

54800

COPD, hospital admissions 3, with asthma pneumonia sepsis

4818

51403

0.70

82.19

4.9

6.3

3.11

4.35

ug/l

2.85

4161

45983

Non-rheumatic valve diseases

9961

59924

1.30

81.82

5.7

5.6

2.63

3.53

ug/l

4.53

8844

54637

Orchitis and epididymitis

2895

22368

1.90

81.07

6.2

4.7

2.88

2.97

ug/l

0.07

2674

19946

Follow-up examination after treatment for conditions other than malignant neoplasms

4742

40894

0.72

80.56

5.4

5.2

4.12

3.09

ug/l

0.50

4386

36990

Ischemic heart diseases

15724

81330

1.22

80.31

4.9

5.3

2.22

3.18

ug/l

8.01

14301

74386

Antihypertensive medication - note that there are other indications

7474

31163

1.31

79.87

4.3

2.13

2.88

ug/l

2.24

6821

28703

Atrial fibrillation and flutter

6349

32951

1.38

79.51

4.7

2.25

2.79

ug/l

1.33

5830

30483

Symptoms and signs involving the digestive system and abdomen

20269

89524

1.19

79.04

5.2

2.73

3.35

ug/l

1.94

18425

81407

Alcoholic liver disease

1550

22039

0.54

78.67

4.2

5.4

2.98

2.97

ug/l

0.00

1338

20130

Presbycusis

2700

19255

1.62

77.89

6.9

6.3

6.38

4.60

ug/l

0.37

2231

16977

Varicose veins

7258

66905

0.77

77.22

5.9

4.71

3.67

ug/l

0.53

6469

60113

Solid cancers, including Hilmo

15109

76235

1.22

76.77

7.5

3.8

4.46

1.77

ug/l

14.31

13747

69883

COPD, hospital admission 2, with asthma infections

5769

60342

0.73

76.66

4.9

6.2

2.93

4.13

ug/l

3.59

4998

54182

Migraine, single triptan purchase ok & required. ICD-code if available is included

5979

51048

0.76

76.11

4.5

4.3

1.78

2.08

ug/l

2.98

5522

46979

Triptan medication for migraine, single purchase ok

5979

51048

0.76

76.11

4.5

4.3

1.78

2.08

ug/l

2.98

5522

46979

Hyperlipidaemia, other/unspecified

8912

67861

1.32

75.88

5.9

5.8

2.88

3.59

ug/l

1.83

7974

61247

Any operation in hilmo

873

2299

2.27

75.35

3.9

2.2

1.84

1.39

ug/l

2.05

791

2182

Use of hypnotics and sedatives

20494

103825

1.18

74.93

5.7

5.2

2.69

3.25

ug/l

2.32

18386

94677

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

17725

104980

1.19

74.46

5.5

5.3

4.10

3.04

ug/l

2.79

15846

95603

Disorders of other endocrine glands

5799

45404

1.34

73.64

5.6

5.1

2.19

3.02

ug/l

2.04

5308

41288

Oral corticosteroids

19621

101721

1.18

73.13

5.7

5.2

3.91

3.02

ug/l

2.79

17746

92499

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

3534

37430

0.68

73.03

5.0

4.5

2.42

2.17

ug/l

2.23

3075

33610

Spinal stenosis

10831

68454

1.27

72.54

6.1

5.7

2.53

3.65

ug/l

6.02

9849

61692

Any event in cancer register

15485

78700

1.20

72.08

7.5

3.8

4.33

1.95

ug/l

11.46

14065

72151

Neurological diseases, wide definition

4160

15672

1.42

71.69

4.4

4.6

2.00

3.30

ug/l

2.81

3777

14476

Exposure to other specified factors

13975

104178

1.21

71.58

5.1

5.2

2.39

2.87

ug/l

1.20

12691

95041

Any prescribed medicine buy

120

10.41

70.99

5.6

1.6

2.85

1.29

ug/l

2.67

113

Hard cardiovascular diseases

15233

78613

1.21

70.97

4.9

5.3

2.35

3.13

ug/l

4.43

13873

71931

Nerve, nerve root and plexus disorders

19974

106505

1.18

70.86

5.5

5.3

2.35

3.31

ug/l

5.70

18263

96654

Malignant neoplasm

14940

76183

1.21

70.56

7.6

3.8

4.38

1.77

ug/l

13.53

13566

69831

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2804

20850

1.62

70.36

6.3

4.6

3.72

2.38

ug/l

2.01

2498

18560

Malignant neoplasm

14913

76094

1.21

69.72

7.6

3.8

4.39

1.78

ug/l

13.55

13538

69750

Anxiety disorders, excluding more controls

10383

77994

0.81

69.66

4.6

5.2

2.80

2.74

ug/l

0.05

9369

71846

In situ neoplasms

5766

46434

1.33

68.87

6.6

6.3

3.03

3.92

ug/l

2.26

5133

41406

Mood disorders, excluding more controls

13387

90552

0.83

68.82

4.8

5.4

2.19

2.96

ug/l

4.22

11979

82937

Infections, IBD-co-morbidities

2679

13563

1.55

68.75

5.2

5.1

2.48

3.67

ug/l

1.85

2452

12523

Diseases of the skin and subcutaneous tissue

18739

83110

1.18

68.29

5.3

5.2

2.53

3.42

ug/l

5.55

16956

75543

Other medical care

9435

67339

1.27

68.04

7.2

5.8

10.94

2.98

ug/l

13.56

8351

60597

Acute alcohol intoxication

4498

55377

0.72

67.45

4.7

5.4

2.67

3.13

ug/l

1.05

3981

50504

Syncope and collapse

9254

65664

1.27

66.86

5.7

5.6

3.59

3.15

ug/l

0.42

8254

59385

First line medication for Crohn's disease

20161

96462

1.17

66.73

5.5

5.1

3.97

2.75

ug/l

3.56

18313

87757

Conjunctivitis (acute, non atopic), including avohilmo

14971

102880

0.84

66.33

5.3

2.61

2.95

ug/l

0.67

13673

93696

Other hearing loss

5424

42639

1.36

66.24

6.4

5.9

4.57

4.43

ug/l

0.05

4741

38068

Endocrine, nutritional and metabolic diseases

13591

59318

1.21

66.13

4.8

4.9

2.23

3.42

ug/l

7.07

12339

54396

Other disorders of prostate

1166

8244

2.99

65.36

8.6

5.0

7.06

2.87

ug/l

1.14

1090

7274

Other external causes of accidental injury

14102

61359

1.20

65.11

5.3

5.2

2.73

3.41

ug/l

2.71

12687

56043

Contraceptive management

3629

33117

0.72

65.07

3.8

3.7

1.63

1.70

ug/l

0.34

3431

30838

Other diseases of upper respiratory tract

20422

94931

1.17

64.48

5.6

5.3

2.55

3.40

ug/l

4.74

18554

86016

Alcohol dependence

5132

61665

0.73

64.39

4.5

5.3

2.73

3.00

ug/l

0.35

4536

56431

Solid cancers

14663

75244

1.20

64.29

7.9

3.8

4.55

1.79

ug/l

14.52

13312

68957

Later onset COPD

5162

49851

0.73

63.75

5.5

6.7

3.35

4.68

ug/l

2.85

4473

44303

Complications of surgical and medical care, not elsewhere classified

17988

106614

1.17

63.65

5.8

5.3

3.12

3.18

ug/l

0.07

16188

96948

Bacterial infection, other or unspecified

11114

81373

1.24

63.54

5.9

5.7

6.13

3.09

ug/l

5.84

9945

73601

Non-small cell lung cancer, including Hilmo

2083

26464

0.64

62.83

5.1

4.5

2.38

2.26

ug/l

0.53

1806

23692

Degeneration of macula and posterior pole

9590

63581

1.26

62.74

6.6

6.2

3.74

4.05

ug/l

0.31

8554

56801

Other and unspecified tonsillitis

5829

39459

1.32

62.55

4.0

4.1

1.89

1.98

ug/l

0.24

5438

36682

Other neurological diseases

13914

94889

1.20

62.55

5.7

2.96

3.54

ug/l

2.04

12630

85679

Accidents

14047

61359

1.20

61.40

5.3

5.2

2.75

3.41

ug/l

2.58

12652

56043

14875

76283

1.19

60.91

5.0

5.6

3.08

3.30

ug/l

0.42

13432

69396

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

14875

76283

1.19

60.91

5.0

5.6

3.08

3.30

ug/l

0.42

13432

69396

Mental and behavioural disorders due to alcohol, excluding acute intoxication

8910

101536

0.79

60.79

4.5

5.3

2.77

2.98

ug/l

0.36

7876

92880

Atrial fibrillation and flutter with reimbursement

5529

28643

1.36

59.52

5.0

2.37

3.03

ug/l

1.49

5069

26443

Anxiety disorders

10614

84425

0.83

59.01

4.6

4.9

2.76

2.57

ug/l

0.17

9576

77571

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2335

30246

0.65

58.90

4.3

5.5

2.62

2.98

ug/l

0.21

2041

27564

Certain infectious and parasitic diseases, including avohilmo

13188

57603

1.20

58.43

5.2

5.3

2.78

3.15

ug/l

0.99

12013

52314

Cardiovascular diseases

7440

32600

1.26

58.34

4.1

4.2

1.73

2.45

ug/l

5.57

6841

30115

Pacemaker

8244

66099

1.29

58.23

5.7

6.2

3.21

4.01

ug/l

1.77

7290

59235

Squamous cell neoplasms and carcinomas of the skin

2231

16677

1.64

58.20

6.2

4.6

4.01

2.40

ug/l

1.90

1988

14828

Renal failure

10958

81985

1.24

57.66

5.2

6.0

3.76

3.66

ug/l

0.09

9833

73731

Alcohol use disorder, ICD-based

8150

93960

0.79

57.58

4.5

5.3

2.82

2.96

ug/l

0.20

7202

85993

Neurotic, stress-related and somatoform disorders

10446

83289

0.83

56.70

4.6

4.9

2.77

2.57

ug/l

0.18

9419

76556

Persons encountering health services in circumstances related to reproduction

6434

51827

0.79

56.02

4.0

1.63

1.89

ug/l

2.66

6033

48046

General symptoms and signs

19141

85819

1.16

55.95

5.1

3.17

2.81

ug/l

0.59

17369

78240

Other disorders of bladder

2962

23568

1.56

55.04

7.1

5.8

3.52

3.37

ug/l

0.04

2630

21197

Falls/tendency to fall

18974

85095

1.16

55.00

5.2

3.21

3.10

ug/l

0.12

17117

77714

Ischaemic heart disease, wide definition

15384

84589

1.18

53.98

5.1

5.4

2.33

3.19

ug/l

6.62

13953

77359

COPD related to multimorbidity

7551

73531

0.79

53.94

5.1

6.2

3.15

3.94

ug/l

0.89

6539

66094

Abnormalities of heart beat

5556

44320

1.29

53.71

5.9

5.6

2.55

3.77

ug/l

3.82

4990

40056

Coronary atherosclerosis

13614

76359

1.20

53.66

5.2

5.5

2.33

3.32

ug/l

7.32

12342

69772

Chronic kidney disease

7427

61607

1.29

53.08

5.2

6.1

3.13

4.07

ug/l

1.67

6689

55151

Depression medications

3841

14988

1.36

51.92

3.8

2.9

1.44

1.59

ug/l

3.77

3482

14126

Persons encountering health services for other counselling and medical advice, not elsewhere classified

20586

98916

1.15

51.21

5.4

5.2

2.69

3.13

ug/l

2.22

19032

89760

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6445

33857

1.26

50.14

4.8

4.6

3.69

2.74

ug/l

0.72

5907

31305

Sub-endpoint used in defining T1D endpoints

3545

43431

0.75

48.45

4.0

5.1

2.01

3.22

ug/l

6.27

3183

39382

Exclusions for E4_PCOS_BROAD

2523

19212

1.45

48.27

5.7

4.9

2.25

2.67

ug/l

0.36

2311

17556

Deviated nasal septum

7981

69763

1.27

48.22

5.5

5.2

2.55

2.92

ug/l

0.51

7304

63812

Liquid cancers, including Hilmo

6855

51718

1.26

47.68

6.7

4.2

5.91

1.99

ug/l

4.34

6205

46853

Complications of medical and surgical care

12468

99384

1.18

47.28

5.8

5.6

3.44

3.32

ug/l

0.09

11201

90015

Hypothyroidism (congenital or acquired)

3340

14483

1.36

47.18

4.4

2.9

1.49

1.62

ug/l

2.18

3053

13662

Other disorders of male genital organs

1130

8126

2.13

47.14

5.1

4.1

1.98

2.14

ug/l

0.28

1047

7312

Chronic diseases of tonsils and adenoids

9395

68183

0.84

46.79

4.6

4.9

1.86

2.68

ug/l

8.22

8717

62543

Gastro-oesophageal reflux disease

12478

93527

1.18

46.74

6.0

5.4

2.52

3.25

ug/l

3.16

11284

85057

Non-small cell lung cancer, squamous, helper endpoint

607

9629

0.50

46.64

4.7

6.1

2.36

4.62

ug/l

4.67

522

8487

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

12669

98313

1.18

46.41

5.7

2.61

3.54

ug/l

6.87

11332

89019

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3865

30950

1.32

46.34

5.8

5.2

2.02

2.71

ug/l

3.08

3495

28127

Hypothyroidism, levothyroxine purchases

3318

14447

1.36

45.82

4.4

2.9

1.50

1.62

ug/l

2.17

3038

13628

Hypothyroidism and >3 levothyroxin purchases

3318

14447

1.36

45.82

4.4

2.9

1.50

1.62

ug/l

2.17

3038

13628

Mouth breathing

8375

73347

1.24

45.79

5.5

5.2

2.18

2.78

ug/l

2.56

7709

67195

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2083

10940

1.53

45.53

5.2

5.7

2.89

4.20

ug/l

0.93

1844

10040

Caries of enamel

13318

97583

0.86

45.27

5.3

5.1

1.94

2.74

ug/l

12.38

12134

89337

Other headache syndromes

4681

38137

1.28

45.08

5.4

5.1

2.04

2.96

ug/l

4.40

4256

34749

Disorders of conjunctiva

9453

83923

0.84

44.82

5.4

5.1

2.28

2.86

ug/l

2.84

8631

76397

Angina pectoris

12002

71155

1.20

44.82

5.5

5.7

2.38

3.46

ug/l

8.12

10873

64866

Malignant neoplasm of bladder, including Hilmo

3197

26083

1.49

44.76

6.2

4.5

3.22

2.28

ug/l

2.03

2803

23374

Gastrointestinal diseases

8930

38596

1.20

43.65

4.9

4.6

2.84

3.18

ug/l

0.28

8101

35208

Examination and observation for other reasons

11110

55317

1.19

43.26

5.4

4.9

2.63

3.05

ug/l

0.58

10174

50221

Urethral stricture

1726

13684

1.88

43.08

7.7

5.7

2.99

3.27

ug/l

0.26

1556

12318

Diseases of arteries, arterioles and capillaries

14224

94307

1.17

42.71

5.4

5.7

3.10

3.45

ug/l

0.42

12650

85655

Internal derangement of knee

6932

59129

1.24

42.71

5.2

5.1

2.79

3.16

ug/l

0.57

6219

53883

Early onset COPD

3631

43561

0.74

42.57

4.7

5.6

3.20

3.23

ug/l

0.01

3166

39713

Mental and behavioural disorders due to alcohol

10223

108812

0.84

42.44

4.6

5.3

2.73

3.13

ug/l

1.00

9046

99448

Heart failure and antihypertensive medication

4559

24579

1.31

42.28

4.6

5.0

2.73

3.37

ug/l

1.00

4069

22660

Excessive attrition of teeth

9209

79837

1.19

41.78

5.6

5.1

2.41

2.71

ug/l

0.58

8387

73058

Insulin medication

11867

88063

1.18

41.45

4.8

5.4

2.66

3.38

ug/l

2.40

10566

80340

Symptoms and signs involving the skin and subcutaneous tissue

11757

98898

1.17

41.28

5.8

5.5

2.40

3.23

ug/l

5.53

10720

89588

Hernia of abdominal wall, postoperative

3830

31411

1.34

41.16

6.0

4.8

2.38

2.52

ug/l

0.17

3445

28713

STROKE

10038

59672

1.19

41.16

5.2

5.4

3.08

3.04

ug/l

0.04

9172

54849

Care involving use of rehabilitation procedures

11134

89025

1.17

40.89

5.3

5.2

3.14

2.61

ug/l

0.53

10205

80969

COPD, early/later onset

8690

81841

0.83

40.15

5.2

6.1

3.18

3.77

ug/l

0.70

7553

73750

COPD, hospital admissions

8606

81388

0.83

40.09

5.2

6.1

3.20

3.78

ug/l

0.67

7481

73325

Non-small cell lung cancer

1465

19272

0.65

40.03

4.9

4.5

2.33

2.27

ug/l

0.24

1269

17214

Acute sinusitis

7356

57665

1.21

39.93

4.7

4.9

2.08

2.65

ug/l

2.11

6727

52803

Anaemias

2801

13944

1.36

39.78

4.1

3.0

2.25

1.64

ug/l

1.96

2570

13158

Chronic rhinitis, nasopharyngitis and pharyngitis

4399

36416

1.28

39.65

5.6

5.1

2.06

2.96

ug/l

3.32

4000

33210

Persons encountering health services in other circumstances

6354

53860

1.23

39.44

5.6

5.4

3.63

3.05

ug/l

0.29

5621

48758

Exclusions for E4_PCOS_CONSORTIUM

2980

23764

0.77

39.28

5.2

4.6

1.57

2.49

ug/l

5.31

2632

21613

Diaphragmatic hernia

5540

47174

1.25

38.90

6.0

5.7

2.48

3.52

ug/l

5.48

5021

42496

Other diseases of anus and rectum

5309

44961

1.26

38.71

7.5

5.6

3.69

3.56

ug/l

0.10

4751

40403

Injury of muscle and tendon at shoulder and upper arm level

8628

77127

1.23

38.65

5.7

5.5

2.28

3.05

ug/l

4.50

7947

70352

Seborrhoeic keratosis

4109

34210

1.30

38.54

6.6

6.0

2.84

3.60

ug/l

1.68

3788

30819

Urolithiasis

7721

68586

1.24

38.12

6.1

5.7

3.34

3.38

ug/l

0.03

6984

61976

Cerebrovascular diseases (FINNGEN)

5318

31598

1.26

37.55

4.6

4.8

2.83

2.86

ug/l

0.03

4886

29197

Chronic periodontitis, complicated

11131

97591

1.18

37.26

5.7

5.5

2.79

2.95

ug/l

0.39

9923

89162

Spondylosis

10522

73509

1.18

36.82

5.8

5.4

2.97

3.23

ug/l

0.26

9581

66629

3683

28452

1.31

36.59

6.8

6.4

4.32

4.59

ug/l

0.11

3202

25177

Other skin changes

3390

27905

1.33

36.47

6.2

6.0

2.59

3.61

ug/l

2.77

3079

25093

Visual disturbances and blindness

8016

70295

1.19

36.12

5.7

5.6

2.86

3.20

ug/l

0.53

7203

63583

Irritable bowel syndrome

2814

22285

1.32

36.08

5.6

5.0

2.02

2.77

ug/l

2.65

2583

20202

Diseases of arteries, arterioles and capillaries (FINNGEN)

4970

29247

1.28

35.98

4.7

5.0

2.31

2.99

ug/l

1.54

4490

26991

Inguinal hernia, bilateral

3156

27128

1.51

35.54

6.0

5.8

2.58

3.43

ug/l

2.54

2871

24538

Other specific joint derangements/joint disorders

12010

67082

1.15

35.25

5.2

5.0

2.55

3.01

ug/l

0.89

11003

61119

Pain associated with micturition

1569

11655

1.48

35.06

6.8

5.4

2.14

3.15

ug/l

1.65

1440

10403

Inguinal or femoral hernia, bilateral

3176

27303

1.49

35.06

6.0

5.8

2.58

3.55

ug/l

2.82

2888

24696

Missing teeth due to accident, extraction or parodontitis

11608

93592

1.16

34.96

6.1

5.6

2.95

3.12

ug/l

0.21

10296

85191

Haemorrhoids and perianal venous thrombosis

6021

51819

1.22

34.19

6.2

5.5

3.56

3.53

ug/l

0.01

5499

46664

Other functional intestinal disorders

7235

57495

1.19

33.58

6.0

5.6

4.24

3.75

ug/l

0.29

6536

51556

Complications of procedures, not elsewhere classified

14048

102892

1.14

33.54

5.9

5.4

2.87

3.23

ug/l

0.68

12649

93507

Wet age-related macular degeneration

2907

22915

1.34

33.08

6.7

6.4

4.98

4.48

ug/l

0.16

2576

20245

Small cell lung cancer, helper endpoint

223

4280

0.40

32.73

4.1

6.0

1.88

4.59

ug/l

2.10

193

3775

Cystitis

11001

72875

0.87

32.66

6.9

5.7

3.59

3.44

ug/l

0.17

10026

65341

Erectile dysfunction

2477

21481

1.71

32.60

10.4

6.0

4.22

3.35

ug/l

0.87

1968

19437

Hypotension

3526

29715

1.32

32.26

6.0

6.2

4.18

4.03

ug/l

0.07

3112

26453

Other inflammation of eyelid, including avohilmo

5149

43884

1.22

31.95

5.4

4.9

2.82

2.62

ug/l

0.12

4724

39974

Visual disturbances

7320

64458

1.19

31.61

5.7

5.6

2.87

3.15

ug/l

0.35

6613

58383

Erysipelas

12110

95105

1.15

31.57

5.3

5.4

3.19

2.87

ug/l

0.47

10875

86583

Tinnitus

3737

31399

1.28

31.55

6.0

5.4

1.97

3.03

ug/l

5.58

3430

28590

Early onset COPD, excluding more controls

3631

42440

0.78

31.36

4.7

5.7

3.20

3.60

ug/l

0.17

3166

38798

Other diseases of urinary system

18315

94726

1.12

31.23

6.7

5.3

4.22

3.18

ug/l

1.54

16620

85789

Primary coxarthrosis, bilateral

5022

43468

1.24

31.02

6.3

6.0

3.09

3.49

ug/l

0.65

4562

39005

Open wound of head

11644

99532

1.15

30.70

5.3

3.32

3.12

ug/l

0.15

10279

90802

Acute alcohol intoxication, ICD10

3264

38586

0.77

30.70

4.5

5.0

2.38

2.71

ug/l

0.59

2883

35414

Sulfonylureas

6019

54135

0.82

30.68

5.4

6.4

3.33

4.31

ug/l

1.60

5214

48523

Bacterial pneumonia (organism specified)

7181

73201

0.84

30.57

5.0

5.8

3.29

3.76

ug/l

0.79

6474

65923

Carcinoma in situ of skin of other and unspecified parts of face

1512

11655

1.51

30.45

6.7

6.5

2.74

4.41

ug/l

3.34

1318

10319

Adjustment and management of implanted device

3854

32986

1.30

30.35

5.8

6.1

3.13

ug/l

0.01

3365

29440

Type 1 diabetes, wide definition, subgroup 2

1670

0.16

30.13

2.8

5.9

3.39

3.73

ug/l

0.08

1460

Vocal cord dysfunction

2011

13859

1.37

30.01

5.8

5.4

2.69

3.86

ug/l

1.12

1804

12835

Tonsillectomy and adenotomy

4677

38301

0.83

29.94

4.0

4.1

1.48

1.96

ug/l

12.00

4319

35345

Calculus of kidney and ureter

6922

61944

1.22

29.91

5.9

5.7

3.17

3.31

ug/l

0.11

6263

56035

Impingement syndrome of shoulder

4396

37830

1.26

29.86

5.9

5.5

2.20

3.12

ug/l

3.83

4055

34439

Paroxysmal tachycardia

3499

24257

1.28

29.67

5.3

5.2

3.10

3.25

ug/l

0.10

3177

22211

Low back pain

13108

80508

1.13

29.54

5.5

5.2

2.48

3.19

ug/l

2.94

11955

72988

Disorders of lacrimal system

4993

42088

1.21

29.21

6.1

5.6

2.63

3.14

ug/l

1.07

4548

37970

Other disorders of lacrimal gland

4011

33794

1.24

28.93

6.1

5.5

2.43

2.99

ug/l

1.15

3646

30514

Transport accidents

7729

57060

1.17

28.65

4.9

5.2

2.36

3.10

ug/l

3.39

7041

52337

Used for control exclusion in common control thyroid runs

20281

94869

1.11

28.62

5.1

5.3

2.26

3.37

ug/l

11.30

18321

86383

Non-small cell lung cancer, squamous

607

8797

0.58

28.58

4.7

4.4

2.36

2.34

ug/l

0.03

522

7807

Myalgia

2711

22023

1.29

28.54

5.7

5.2

2.05

2.89

ug/l

2.91

2464

19955

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10094

89448

1.15

28.27

5.8

5.7

2.97

3.23

ug/l

0.32

9059

80860

Other CVD

3901

33494

1.27

27.98

6.0

6.1

4.17

3.95

ug/l

0.11

3454

29866

Blepharochalasis

3727

31466

1.25

27.95

6.7

6.1

2.81

3.34

ug/l

1.04

3345

28221

Retinal detachments and breaks

6934

61894

1.19

27.79

6.2

5.8

3.08

3.42

ug/l

0.55

6277

55904

Other degenerative diseases of the nervous system

5071

32061

1.22

27.66

5.3

6.1

3.36

3.89

ug/l

0.68

4464

28904

Other diseases of lip and oral mucosa

5668

49438

1.20

27.66

5.7

5.4

2.99

2.97

ug/l

0.01

5159

44995

Implicit viral Sepsis, including avohilmo

5473

47867

1.21

27.45

5.5

5.9

2.57

3.47

ug/l

3.16

4964

43139

Melanocytic naevi

4073

34672

1.23

27.31

6.0

5.4

2.38

2.86

ug/l

1.22

3730

31484

Carcinoma in situ, bladder

1008

7960

1.95

26.98

6.6

6.2

3.07

3.79

ug/l

0.45

924

7128

5449

41115

1.21

26.68

6.8

6.4

4.13

4.67

ug/l

0.35

4795

36465

Cough

6185

50749

1.18

26.66

5.9

5.6

2.70

3.55

ug/l

2.08

5625

46044

Chronic sinusitis

6101

53563

1.18

26.57

5.5

5.1

2.55

3.03

ug/l

0.67

5564

48785

Disorders of vestibular function (Vertigo)

6633

57145

1.18

26.46

6.0

5.8

2.58

3.38

ug/l

3.64

5998

51560

External causes of morbidity and mortality

10490

47396

1.14

26.41

5.2

5.3

3.11

3.42

ug/l

0.29

9472

43239

Injury, poisoning and certain other consequences of external causes

8359

37293

1.16

26.26

5.2

5.3

3.06

3.52

ug/l

0.39

7525

33907

Status post-ami

5566

47129

0.82

26.24

5.6

6.4

3.67

4.07

ug/l

0.27

4914

42372

Dysphagia

4442

38508

1.23

26.07

6.0

5.9

2.36

3.78

ug/l

8.21

3977

34616

Other disorders of eyelid

7062

59358

1.17

25.94

6.4

6.1

3.92

3.68

ug/l

0.13

6340

53152

Cervical disc disorders

6552

58341

1.19

25.86

5.6

5.4

2.57

3.12

ug/l

1.25

5997

52994

Other CVD (FINNGEN)

2349

14792

1.36

25.72

5.8

6.0

4.51

3.89

ug/l

0.20

2088

13352

Other benign neoplasms of skin

5567

48897

1.19

25.60

6.2

5.8

3.61

3.43

ug/l

0.18

5011

44046

Diseases of external ear

6125

54309

1.19

25.54

6.2

5.6

2.74

3.28

ug/l

1.09

5402

49260

Necrosis of pulp, including avohilmo

9429

84313

1.14

25.51

5.2

4.9

2.18

2.63

ug/l

2.85

8547

77471

Other arthrosis

10338

63048

1.15

25.41

5.7

5.3

2.46

3.21

ug/l

2.46

9446

57372

Benign paroxysmal vertigo

3613

30652

1.24

25.27

6.1

5.8

2.49

3.32

ug/l

2.16

3260

27655

Umbilical hernia

6149

55118

1.21

25.25

5.5

5.3

2.42

2.79

ug/l

0.65

5613

50440

Transient ischemic attack

10213

74253

1.15

25.23

5.9

6.0

3.06

3.70

ug/l

1.72

9266

66825

Acute upper respiratory infections of multiple and unspecified sites

11914

79279

1.13

25.20

4.8

5.3

2.51

3.18

ug/l

2.45

10876

72086

Zoster [herpes zoster], including avohilmo

8039

69700

1.16

25.00

5.9

5.8

2.47

3.41

ug/l

6.53

7302

62761

Carcinoma in situ of other and unspecified sites

1060

8462

1.81

24.84

6.5

6.2

3.05

3.81

ug/l

0.52

970

7576

Coxarthrosis, primary, with hip surgery

8605

72370

1.16

24.65

6.2

6.0

3.92

3.52

ug/l

0.28

7798

64994

Macular pucker

2967

25292

1.30

24.57

6.8

6.4

3.01

3.90

ug/l

1.46

2681

22706

Obesity related asthma

5527

48741

1.19

24.44

5.3

5.4

2.44

2.95

ug/l

0.77

5023

44425

Other/unspecified dorsalgia

5313

45949

1.19

24.29

5.3

5.2

3.63

3.15

ug/l

0.30

4797

41576

Symptoms and signs involving the nervous and musculoskeletal systems

9402

85338

1.14

24.23

5.4

5.7

2.72

3.36

ug/l

0.90

8555

77069

Small cell lung cancer

223

3950

0.46

24.10

4.1

4.3

1.88

2.29

ug/l

1.87

193

3498

Small cell lung cancer, including Hilmo

223

3950

0.46

24.10

4.1

4.3

1.88

2.29

ug/l

1.87

193

3498

Pain, not elsewhere classified

4035

34708

1.22

23.94

5.7

5.4

2.28

2.90

ug/l

2.12

3691

31535

Diabetic retinopathy, strict definition

2111

22554

0.76

23.69

4.3

5.3

2.05

2.67

ug/l

2.63

1845

20302

Coxarthrosis, primary

11418

87179

1.13

23.65

6.2

5.9

3.64

3.53

ug/l

0.08

10358

78513

Functional dyspepsia

3259

27535

1.24

23.50

6.0

5.4

1.88

3.22

ug/l

6.03

2953

24931

Enthesopathies of lower limb, excluding foot

3188

26973

1.25

23.45

5.7

5.1

2.83

2.71

ug/l

0.09

2927

24578

Fibroblastic disorders

4750

41908

1.22

23.44

6.1

5.8

3.10

3.88

ug/l

1.64

4269

37631

Other and unspecified nerve root and plexus disorders, also in other diseases

3416

29267

1.25

23.31

5.6

5.1

2.25

2.66

ug/l

0.51

3163

26816

Neuromuscular dysfunction of bladder

1654

13347

1.40

23.20

6.0

5.6

2.02

2.98

ug/l

5.03

1547

12037

Abrasion of teeth

4341

37582

1.20

23.14

5.8

5.3

2.15

2.67

ug/l

2.07

3992

34241

Dermatitis and eczema

17326

110049

0.91

23.02

5.2

5.3

2.32

3.22

ug/l

7.89

15746

99996

Other specified/unspecified arthritis

4029

34850

1.22

22.86

5.3

5.4

2.61

3.32

ug/l

1.96

3637

31657

Primary open-angle glaucoma, strict

4230

36815

1.22

22.74

6.4

6.2

4.56

4.05

ug/l

0.17

3717

32896

Disturbances of skin sensation

3293

27926

1.23

22.67

5.5

5.1

1.85

2.60

ug/l

4.50

3008

25489

Heart failure, not strict

14422

90008

1.12

22.67

5.3

5.6

2.95

3.27

ug/l

0.88

12943

82156

Soft tissue disorders related to use, overuse and pressure

4300

37468

1.21

22.50

5.5

5.3

2.29

3.16

ug/l

3.39

3938

34035

Complications of internal orthopaedic prosthetic devices, implants and grafts

3580

30875

1.24

22.47

6.0

2.64

3.50

ug/l

2.56

3227

27787

Bacterial pneumonia, not elsewhere classified

6262

61279

0.86

22.44

5.0

5.9

3.11

3.58

ug/l

0.80

5667

55411

Substance abuse

11148

112016

0.89

22.29

4.5

5.3

2.70

3.13

ug/l

1.13

9847

102274

Open wound of wrist and hand

9444

83586

1.14

22.24

5.3

5.1

2.91

2.79

ug/l

0.08

8579

76624

Lower back pain or/and sciatica

18629

108135

1.10

22.21

5.4

5.3

2.37

3.23

ug/l

6.16

17022

98180

Cholelithiasis

11948

88546

0.90

22.12

5.9

5.7

2.95

3.62

ug/l

2.51

10739

79916

Oedema, not elsewhere classified

5529

47919

1.18

22.08

6.1

5.8

4.79

3.22

ug/l

0.80

4930

43203

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

5707

51003

1.19

22.03

5.0

5.3

2.06

2.66

ug/l

0.64

5163

47018

Glucagon-like peptide-1 (GLP-1) analogues

5707

51003

1.19

22.03

5.0

5.3

2.06

2.66

ug/l

0.64

5163

47018

Subjective visual disturbances

3214

27335

1.23

21.94

5.8

5.5

2.10

2.88

ug/l

3.55

2919

24812

Voice disturbances

3248

27670

1.23

21.69

6.4

5.8

3.41

3.16

ug/l

0.09

2965

24922

Alcohol use disorder, Swedish definition

11463

112177

0.89

21.68

4.6

5.4

2.73

3.15

ug/l

0.93

10160

102407

Other extrapyramidal and movement disorders in other diseases

3634

31393

1.23

21.64

6.0

5.8

2.33

3.34

ug/l

3.31

3264

28355

Benign neoplasm: Rectum

3425

29826

1.26

21.45

6.3

5.9

2.66

3.35

ug/l

1.62

3132

26948

Injuries to the knee and lower leg

20282

102734

1.09

21.30

5.4

5.3

2.68

3.18

ug/l

1.04

18437

93291

Peripheral artery operations in Hilmo

2144

25312

0.76

21.28

4.6

6.1

7.62

3.87

ug/l

0.54

1870

22717

Certain infectious and parasitic diseases

16309

75924

1.10

21.18

5.1

5.3

3.02

2.93

ug/l

0.17

14791

69074

Other and unspecified dermatitis

7753

70077

1.14

21.18

5.4

5.5

2.43

3.16

ug/l

3.75

7036

63502

Impacted cerumen

1986

16461

1.34

21.16

6.9

6.0

2.77

3.56

ug/l

0.86

1677

14843

Alcohol withdrawal state with delirium

1255

15222

0.68

21.10

4.6

5.1

2.40

2.72

ug/l

0.37

1102

13954

Gout, idiopatic and unspecified

6593

60451

1.20

20.98

5.6

6.0

3.26

3.58

ug/l

0.49

5919

54498

Examination and encounter for administrative purposes

1868

15623

1.38

20.89

6.1

5.6

2.19

3.24

ug/l

2.47

1764

14081

Benign neoplasm: Rectum, anus and anal canal

3766

33040

1.24

20.73

6.4

5.9

2.87

3.42

ug/l

0.99

3440

29816

Disorders of sclera, cornea, iris and ciliary body

8702

79324

1.13

20.65

5.2

2.57

2.91

ug/l

0.65

7929

72251

Glaucoma suspect

5346

47515

1.18

20.55

6.2

5.9

2.62

3.54

ug/l

3.88

4764

42828

Diseases of inner ear

8448

73582

1.14

20.50

6.0

5.7

2.95

3.27

ug/l

0.58

7671

66506

Palmar fascial fibromatosis [Dupuytren]

3801

33784

1.26

20.35

6.3

6.0

3.38

4.11

ug/l

1.13

3381

30281

Symptoms and signs involving speech and voice

4500

39544

1.19

20.21

6.2

5.9

3.49

3.45

ug/l

0.02

4066

35585

Appendicitis, broad definition

12505

103900

1.11

20.12

5.1

5.2

2.39

2.93

ug/l

2.90

11428

94731

Behavioural syndromes associated with physiological disturbances and physical factors

12736

93057

0.90

20.11

5.1

2.10

2.85

ug/l

4.50

11682

84902

Bacterial pneumoniae

6688

64804

0.87

19.97

5.0

5.9

3.06

3.49

ug/l

0.79

6045

58655

11884

113835

0.89

19.82

4.6

5.4

2.75

3.18

ug/l

1.04

10518

103884

Gout, strict definition

4851

44079

1.24

19.77

5.5

6.1

3.25

3.57

ug/l

0.38

4358

39756

Atopic dermatitis

5652

50639

0.87

19.77

4.7

2.11

2.53

ug/l

1.55

5186

46415

Degenerative macular diseases

1841

15178

1.32

19.75

6.2

6.0

4.95

3.86

ug/l

0.26

1640

13572

Diseases of appendix

12571

104170

1.11

19.74

5.1

5.2

2.39

2.94

ug/l

2.94

11492

94961

Alzheimer’s disease (Atypical or mixed), excluding more controls

1799

11068

1.35

19.70

5.3

6.9

6.27

5.60

ug/l

0.08

1520

9775

Other enthesopathies

4025

35112

1.19

19.65

5.3

5.1

2.06

3.08

ug/l

4.48

3703

31998

Malignant melanoma, including Hilmo

3162

27465

1.25

19.51

6.6

4.4

3.19

2.10

ug/l

2.81

2823

24778

Acute appendicitis

11744

100859

1.11

19.38

5.0

5.1

2.38

2.89

ug/l

2.49

10748

92066

Aplastic and other anaemias

8861

74454

1.14

19.32

5.9

6.0

5.51

3.65

ug/l

2.57

7862

66827

Other and unspecified disorders of vitreous body

5960

52297

1.16

19.22

6.7

6.0

2.33

3.29

ug/l

5.40

5416

47229

Liquid cancers

5333

45248

1.18

19.10

5.3

4.3

3.57

2.04

ug/l

1.76

4776

40842

Dilated cardiomyopathy

2179

25168

0.76

19.07

4.5

5.8

2.65

3.13

ug/l

0.87

1944

22801

Special screening examination for neoplasms

1427

11668

1.41

19.03

6.8

5.2

3.29

3.10

ug/l

0.30

1262

10580

Cervicalgia

2759

23473

1.24

18.99

5.8

5.3

2.35

2.98

ug/l

1.29

2527

21273

Nonorganic sleeping disorders, excluding more controls

2483

20875

1.24

18.93

5.2

5.0

1.80

2.66

ug/l

3.37

2278

19212

Nonorganic sleeping disorders

2483

20879

1.24

18.90

5.2

4.8

1.80

2.57

ug/l

2.80

2278

19053

Intracranial injury

10397

89377

1.12

18.83

5.3

5.4

3.30

3.26

ug/l

0.05

9287

81187

Other spirochaetal diseases, including avohilmo

4798

42596

1.17

18.69

6.1

5.5

2.29

3.03

ug/l

3.36

4299

38791

Implicit bacterial Sepsis, including avohilmo

9799

75372

1.13

18.64

5.3

5.9

3.54

3.45

ug/l

0.12

8747

68064

Carcinoma in situ of skin

1361

10993

1.39

18.60

6.4

6.2

2.88

3.69

ug/l

0.73

1205

9830

Degeneration of nervous system due to alcohol

346

4815

0.52

18.47

4.1

5.6

3.37

2.62

ug/l

0.28

305

4369

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9193

84269

1.12

18.41

5.8

5.7

2.98

3.33

ug/l

0.42

8265

76114

Other spirochaetal diseases

4739

42095

1.17

18.32

6.1

5.5

2.30

3.04

ug/l

3.30

4245

38336

Carcinoma in situ of skin of ear and external auricular canal

438

3239

2.32

18.32

6.7

6.4

2.47

4.03

ug/l

2.85

392

2839

Non-small cell lung cancer, adenocarcinoma, helper endpoint

808

10442

0.68

18.32

5.2

6.2

2.34

4.03

ug/l

3.49

702

9293

Other arthritis (FG)

4658

41332

1.18

18.31

5.3

5.4

2.54

3.20

ug/l

2.24

4212

37556

Spirochaetal infections, other/unspecified, including avohilmo

4729

42010

1.17

18.26

6.1

5.5

2.30

3.02

ug/l

3.15

4235

38258

Primary open-angle glaucoma

5209

44924

1.17

18.18

6.5

6.2

4.50

4.10

ug/l

0.15

4588

40104

Asthma (diagnoses ohter than nonallergic)

12423

107892

0.91

18.16

5.3

5.4

2.50

3.31

ug/l

4.33

11268

97764

Lyme disease

4697

41729

1.17

18.13

6.1

5.5

2.31

3.03

ug/l

3.12

4207

37997

Lyme disease, including avohilmo

4697

41729

1.17

18.13

6.1

5.5

2.31

3.03

ug/l

3.12

4207

37997

Gout, unspecified

5336

48822

1.21

18.06

5.6

6.1

3.37

3.58

ug/l

0.23

4765

43995

Diarrhoea and gastroenteritis of presumed infectious origin

11573

95720

1.11

18.05

4.7

5.1

2.46

3.21

ug/l

2.21

10539

87021

Other and unspecified anaemias

8232

70982

1.14

18.02

6.0

5.54

3.72

ug/l

2.22

7293

63657

Benign neoplasm: Colon, unspecified

4966

44746

1.19

17.98

6.3

6.0

2.82

3.59

ug/l

1.49

4451

40337

Pain in thoracic spine

1797

14742

1.28

17.90

5.3

4.9

1.98

2.68

ug/l

1.59

1667

13420

Atherosclerosis, excluding cerebral and coronary sclerosis

8087

68768

0.88

17.88

5.2

6.3

4.49

3.92

ug/l

0.26

7078

61785

Conjunctivitis

7560

67007

0.89

17.88

5.2

4.9

2.03

2.69

ug/l

4.70

6926

61160

Glaucoma, exfoliation

1503

12213

1.33

17.80

6.7

6.3

3.77

4.67

ug/l

0.60

1333

10814

Other anaemias

8284

71291

1.13

17.70

6.0

5.52

3.72

ug/l

2.22

7339

63934

Cardiac arrest

1155

12033

0.71

17.69

4.7

6.1

2.47

3.92

ug/l

2.40

1023

10840

Ectropion of eyelid

822

6356

1.55

17.67

5.9

6.3

5.96

4.09

ug/l

0.59

720

5612

Injuries to the abdomen, lower back, lumbar spine and pelvis

6512

58164

1.14

17.59

5.4

5.5

3.07

3.26

ug/l

0.25

5833

52628

Colorectal cancer, including Hilmo

5089

42684

1.18

17.58

5.5

4.3

2.95

2.08

ug/l

4.33

4520

38485

Fissure and fistula of anal and rectal regions

4072

36047

1.19

17.56

5.9

5.2

2.16

3.05

ug/l

4.01

3687

32760

Degeneration of the brain due to alcohol

346

4780

0.53

17.53

4.1

5.7

3.37

2.86

ug/l

0.18

305

4332

Autoimmune diseases excluding thyroid diseases, strict definition

19017

97451

1.08

17.43

4.9

5.3

2.43

3.36

ug/l

7.15

17284

88736

Testicular dysfunction, other/unspecified

172

1064

4.74

17.40

4.7

4.3

1.36

1.60

ug/l

1.27

165

970

Headache

8450

71288

0.89

17.39

5.3

5.1

2.32

2.70

ug/l

1.04

7700

65043

Calculus of lower urinary tract

1347

11357

1.49

17.30

7.1

6.0

3.92

3.72

ug/l

0.12

1215

10197

Fall on same level involving ice and snow

8597

78842

1.12

17.26

5.3

2.53

2.97

ug/l

1.25

7782

71674

Malignant melanoma

2812

24464

1.24

17.17

6.6

4.4

3.30

2.10

ug/l

2.72

2502

22089

Temporomandibular joint disorders, including avohilmo

3250

27057

1.19

17.16

5.5

4.8

2.78

2.33

ug/l

0.22

2934

24670

Unspecific neurodegenerative disorder

8107

51034

1.14

17.15

5.6

6.7

4.60

4.37

ug/l

0.11

7010

45346

Autoimmune diseases excluding thyroid diseases

19339

98843

1.08

17.10

5.0

5.3

2.42

3.34

ug/l

7.16

17567

89995

COPD-related respiratory insufficiency

1975

22988

0.77

17.00

4.8

6.2

2.79

3.89

ug/l

1.28

1680

20572

Deforming dorsopathies

3358

29178

1.19

16.98

5.5

5.2

1.93

2.97

ug/l

4.42

3060

26483

Erosion of teeth , including avohilmo

3277

28460

1.20

16.93

5.4

4.8

1.78

2.29

ug/l

7.58

3002

26065

Other symptoms and signs involving cognitive functions and awareness

8798

71935

1.13

16.93

5.6

5.8

3.14

3.68

ug/l

0.86

7878

64768

Other symptoms and signs involving the circulatory and respiratory systems

1044

8211

1.41

16.87

6.1

5.4

4.11

3.44

ug/l

0.14

959

7447

Extrapyramidal and movement disorders

6423

58458

1.14

16.77

5.7

6.0

3.21

3.55

ug/l

0.33

5763

52580

Other systemic involvement of connective tissue (FG)

2686

22505

1.21

16.74

5.9

2.28

3.75

ug/l

5.41

2405

20139

Calcific aortic valvular stenosis, operated

6343

55926

1.16

16.69

5.8

6.3

2.73

4.36

ug/l

9.15

5635

49910

Calcific aortic valvular stenosis

6343

55926

1.16

16.69

5.8

6.3

2.73

4.36

ug/l

9.15

5635

49910

Operations 2 for CAVS

6339

55889

1.16

16.68

5.8

6.3

2.73

4.36

ug/l

9.16

5631

49877

Calcific aortic valvular stenosis, diagnosis (helper)

6339

55889

1.16

16.68

5.8

6.3

2.73

4.36

ug/l

9.16

5631

49877

Viral warts, including avohilmo

2788

23984

1.22

16.64

5.2

4.9

1.85

2.54

ug/l

3.12

2584

21923

Localized swelling, mass and lump of skin and subcutaneous tissue

4864

43562

1.16

16.64

5.8

5.6

2.67

3.29

ug/l

1.19

4443

39488

Insulin, fast-acting (human)

1399

17153

0.77

16.40

3.7

4.7

1.74

2.67

ug/l

2.50

1262

15636

Heartburn

1578

12970

1.30

16.39

5.8

5.3

2.17

2.69

ug/l

1.46

1451

11818

Familial hypercholesterolemia

3046

26858

1.24

16.33

5.8

6.1

3.36

3.99

ug/l

0.47

2756

24090

Hernia of abdominal wall

9301

86423

1.12

16.33

5.6

5.5

2.57

3.05

ug/l

1.25

8405

78792

Mixed conductive and sensorineural hearing loss

1905

16063

1.28

16.31

6.0

5.8

2.75

3.21

ug/l

0.78

1682

14416

Covid-19 suspected case

2382

20212

1.23

16.30

5.2

4.9

2.60

2.66

ug/l

0.04

2235

18409

Bacterial Sepsis

10008

76950

1.12

16.30

5.3

5.9

4.10

3.45

ug/l

0.54

8911

69506

Disorders of thyroid, IBD co-morbidities

2164

12392

1.24

16.26

5.8

5.3

2.66

3.86

ug/l

1.47

1922

11415

Calcific aortic valvular stenosis, including rheumatic fever

6354

56031

1.16

16.25

5.8

6.3

2.73

4.36

ug/l

9.21

5645

50009

Striking against or struck by other objects

6005

54495

1.15

16.21

5.1

4.9

2.41

2.58

ug/l

0.27

5394

49989

Combinations of oral blood glucose lowering drugs

6475

59675

1.16

16.20

5.3

5.8

2.38

3.30

ug/l

3.08

5880

54499

Respiratory insufficiency

1172

14317

0.74

16.18

4.3

6.4

2.59

5.29

ug/l

3.45

972

12862

Migraine with aura

1484

11907

1.27

16.17

5.0

4.6

1.94

2.37

ug/l

1.86

1372

10890

Traumatic subdural haemorrhage

2982

24566

1.24

16.06

5.8

6.1

4.53

4.15

ug/l

0.16

2647

22142

Gout, FINNGEN

7721

71432

1.15

16.00

5.5

6.1

3.35

3.72

ug/l

0.59

6932

64304

Sleep disorders

12020

88814

0.91

16.00

5.1

5.0

2.10

2.82

ug/l

3.90

11033

81087

Restless leg syndrome

1671

13812

1.28

15.94

6.1

5.5

2.14

2.81

ug/l

2.55

1526

12505

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

5401

48930

1.16

15.92

5.1

5.0

2.29

2.72

ug/l

1.12

4944

44753

Male infertility

960

7672

1.46

15.91

3.7

2.9

1.50

1.35

ug/l

0.56

901

7053

Benign lipomatous neoplasm

4500

40323

1.17

15.74

5.9

5.5

3.60

3.07

ug/l

0.30

4124

36619

Benign neoplasm: Sigmoid colon

3510

31230

1.21

15.73

6.3

5.8

2.62

3.12

ug/l

1.01

3215

28225

Dementia, including avohilmo

9004

56926

1.12

15.67

5.6

6.6

3.56

4.13

ug/l

0.82

7854

50818

Carcinoma in situ of skin of trunk

667

5148

1.62

15.66

6.7

6.5

2.70

4.57

ug/l

1.34

589

4565

Implicit viral Sepsis

3743

33286

1.19

15.62

5.2

5.9

2.61

3.63

ug/l

2.23

3383

30006

Use of other anti-dementia drugs

5042

36662

1.17

15.59

5.5

6.6

3.97

5.12

ug/l

1.57

4340

32321

Use of memantine

5042

36662

1.17

15.59

5.5

6.6

3.97

5.12

ug/l

1.57

4340

32321

Type of accident

4482

40116

1.17

15.59

5.3

5.2

2.60

3.00

ug/l

0.75

4072

36556

Viral Sepsis

3748

33341

1.19

15.56

5.2

5.9

2.61

3.63

ug/l

2.22

3388

30057

Anxiety (asthma-related co-morbidities)

6451

54015

0.89

15.56

4.3

4.5

2.88

2.26

ug/l

0.43

5799

50015

Polymyalgia rheumatica

1987

16862

1.27

15.54

6.3

6.2

2.44

3.74

ug/l

4.50

1780

15078

Type 1 diabetes

3263

37000

0.84

15.47

4.0

5.1

1.81

3.19

ug/l

7.15

2944

33854

Other disorders of veins

4925

43433

1.15

15.40

5.8

5.6

2.89

3.15

ug/l

0.26

4434

39344

Trigger finger

1860

15600

1.26

15.32

5.9

5.3

2.02

3.06

ug/l

3.16

1710

14189

Diseases of liver

5274

58033

0.87

15.17

4.9

5.5

2.49

3.05

ug/l

0.93

4714

52852

Benign neoplasm: Ascending colon

2544

22242

1.25

15.12

6.9

6.0

2.69

3.25

ug/l

0.95

2338

20052

Superficial injury of head

3461

30479

1.18

15.00

5.1

5.3

4.12

3.04

ug/l

0.31

3080

27722

Other sleep disorders

1906

16197

1.27

14.99

5.7

5.4

2.18

3.02

ug/l

3.63

1742

14749

Dermatitis

9999

90856

1.10

14.97

5.4

5.6

2.44

3.25

ug/l

4.25

9059

82329

Autoimmune diseases

20570

98990

1.07

14.92

5.0

5.3

2.44

3.34

ug/l

4.87

18526

90122

Vasomotor and allergic rhinitis

4143

35902

1.16

14.92

5.0

4.6

1.90

2.61

ug/l

4.87

3784

32846

Alzheimer disease, excluding more controls

3499

20074

1.20

14.77

5.5

6.7

3.48

4.55

ug/l

1.26

3066

17951

Insomnia

11309

84377

0.91

14.76

5.1

5.0

2.07

2.77

ug/l

3.43

10400

77094

Chronic gastritis

4186

37495

1.17

14.69

6.2

6.0

2.79

3.91

ug/l

3.25

3735

33506

Mental and behavioural disorders due to psychoactive substance use

11545

112517

0.91

14.67

4.5

5.3

2.71

3.12

ug/l

1.12

10197

102722

Viral infections characterized by skin and mucous membrane lesions

6668

61026

1.13

14.61

5.0

5.1

2.06

2.85

ug/l

6.98

6120

55779

Hallux valgus (acquired)

2341

19631

0.83

14.60

5.9

5.8

2.46

3.51

ug/l

2.83

2092

17662

Other symptoms and signs involving the nervous and musculoskeletal systems

5898

53656

1.13

14.45

5.3

5.5

2.45

3.19

ug/l

1.99

5407

48566

Other respiratory disorders and diseases

3187

35820

0.84

14.44

5.0

6.0

3.40

4.01

ug/l

0.69

2739

32062

Other diseases of the respiratory system

3187

35820

0.84

14.44

5.0

6.0

3.40

4.01

ug/l

0.69

2739

32062

Injuries to the elbow and forearm

8362

77622

0.90

14.34

5.3

5.1

2.74

2.89

ug/l

0.29

7581

70606

Ptosis of eyelid

1668

14058

1.28

14.33

6.5

6.0

3.32

3.20

ug/l

0.04

1528

12650

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4853

43839

1.15

14.31

5.3

5.2

2.57

2.96

ug/l

0.81

4408

39951

Alzheimer’s disease (Atypical or mixed)

1799

15073

1.27

14.31

5.3

6.6

6.27

5.08

ug/l

0.15

1520

13248

Carcinoma in situ of skin of scalp and neck

643

5093

1.67

14.24

6.8

6.5

2.49

4.53

ug/l

1.52

557

4518

Nasal polyp

4022

36363

1.19

14.17

5.7

5.4

3.09

3.38

ug/l

0.20

3687

33062

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

4056

36226

1.16

14.06

4.7

2.01

2.38

ug/l

1.63

3719

33280

Hallux rigidus

1781

15026

1.26

14.06

6.1

5.7

2.02

3.11

ug/l

12.40

1594

13573

Keratitis

5390

48960

1.14

14.03

5.2

2.51

2.86

ug/l

0.42

4907

44606

Other and unspecified polyneuropathies, also in other diseases

3998

36213

1.19

14.01

5.9

2.61

3.60

ug/l

1.66

3646

32713

Malignant neoplasm of oesophagus, including Hilmo

573

7288

0.65

14.00

4.5

4.3

2.27

2.01

ug/l

1.35

512

6600

Cervicobrachial syndrome

2665

23133

1.20

14.00

5.3

5.1

3.25

2.77

ug/l

0.19

2496

21046

Myocardial infarction, with ST-elevation

3486

38522

0.84

13.86

5.3

6.0

3.16

3.67

ug/l

0.67

3083

34622

Spondylolisthesis/Spondylolysis

2385

20611

1.21

13.85

5.6

5.3

1.91

2.81

ug/l

3.89

2188

18738

Panic disorder

1226

9870

1.29

13.76

4.1

1.50

1.94

ug/l

3.14

1099

9098

Candidiasis, including avohilmo

2975

25972

1.18

13.76

5.6

5.5

2.41

2.91

ug/l

1.20

2682

23486

Retinal vascular occlusion

2122

18410

1.25

13.74

6.1

3.22

3.78

ug/l

0.49

1903

16461

Other chronic obstructive pulmonary disease

8532

74649

0.90

13.46

5.2

6.1

3.16

3.82

ug/l

0.78

7421

67290

Entropion and trichiasis of eyelid

1524

12909

1.30

13.42

6.2

6.3

3.66

3.87

ug/l

0.10

1363

11451

Cholelithiasis, broad definition with cholecystitis

12915

91332

0.92

13.40

5.8

5.7

2.92

3.59

ug/l

2.72

11612

82535

Ganglion

2247

19281

1.21

13.36

5.1

5.0

2.60

2.80

ug/l

0.18

2047

17532

Other diseases of intestine

2894

25677

1.21

13.25

5.9

5.5

2.60

3.17

ug/l

1.23

2652

23273

Asthma, hospital admissions , main diagnosis only

11117

103187

0.92

13.20

5.2

5.3

2.55

3.22

ug/l

2.32

10098

93561

Acute alcohol intoxication ICD-9

487

6324

0.64

13.19

5.2

5.5

2.07

2.88

ug/l

2.09

444

5724

Other inflammation of eyelid

1758

14877

1.24

13.19

6.2

5.6

4.13

2.86

ug/l

0.31

1588

13448

All anxiety disorders

6458

54765

0.90

13.19

4.3

4.4

2.88

2.23

ug/l

0.45

5805

50487

Cardiodefibrillation

8187

76552

1.13

13.18

5.9

6.0

2.78

3.47

ug/l

2.28

7368

69093

Cardiomyopathy (excluding other)

2423

27228

0.81

13.16

4.7

5.9

2.61

3.80

ug/l

2.65

2151

24718

Leisure time condition

2575

22509

1.20

13.14

5.6

5.3

2.61

3.04

ug/l

0.69

2301

20415

Other disorders of patella

2033

17379

1.22

13.13

4.9

4.6

2.64

2.35

ug/l

0.24

1872

16060

Retinal vascular disorders

2150

18742

1.24

12.98

6.1

3.22

3.80

ug/l

0.53

1927

16747

Fracture of rib(s), sternum and thoracic spine

6459

59804

1.13

12.98

5.6

3.51

3.24

ug/l

0.20

5777

54258

Malignant melanoma of skin, including Hilmo

2599

22944

1.22

12.96

6.6

4.4

3.33

2.10

ug/l

2.59

2338

20721

Other specified/unspecified hearing loss

1373

11483

1.30

12.89

5.9

5.7

3.13

3.34

ug/l

0.13

1286

10314

Other shoulder lesions

1228

10080

1.30

12.89

5.1

4.9

1.60

2.66

ug/l

7.57

1113

9171

Fracture of lumbar spine and pelvis

3313

29411

1.17

12.85

5.6

5.7

3.67

3.50

ug/l

0.11

2947

26432

Alcoholic cardiomyopathy

1231

0.33

12.83

4.0

5.2

2.19

2.55

ug/l

0.34

1121

Injury of muscle and tendon at lower leg level

3192

28712

1.20

12.70

5.5

5.1

2.70

ug/l

0.00

2936

26358

Injuries to the thorax

9427

88304

1.10

12.68

5.5

5.4

3.16

3.23

ug/l

0.07

8436

80241

Contact with and exposure to communicable diseases

2559

22085

1.18

12.62

4.6

4.1

2.32

1.94

ug/l

0.46

2317

20299

Diseases of salivary glands

3993

35825

1.15

12.61

5.5

5.3

2.48

2.79

ug/l

0.68

3627

32589

Oesophageal varices

554

7084

0.67

12.61

3.8

5.5

1.52

2.92

ug/l

6.82

477

6458

Amputation

1682

19371

0.79

12.54

4.4

6.1

6.05

3.80

ug/l

0.31

1479

17401

Transplanted organ and tissue status

1719

14794

1.27

12.52

4.0

5.0

1.79

2.42

ug/l

5.19

1620

13610

Malignant neoplasm of pancreas

875

10775

0.74

12.45

4.4

4.3

2.52

2.10

ug/l

1.32

743

9681

Other viral diseases, including avohilmo

4539

40575

1.14

12.37

4.5

4.6

1.94

2.39

ug/l

2.59

4220

37228

Recurrent or chronic depression

4636

35562

0.88

12.37

4.5

1.70

2.35

ug/l

4.71

4184

33106

Other and unspecified vascular occlusions

1568

13386

1.28

12.32

6.2

6.1

2.85

4.00

ug/l

1.66

1412

11996

Cyst of kidney

1347

11452

1.32

12.32

6.3

5.9

2.21

3.46

ug/l

2.59

1223

10330

Herpesviral [herpes simplex] infections, including avohilmo

2270

19573

1.19

12.31

5.3

5.0

2.06

2.73

ug/l

2.07

2084

17780

Acute appendicitis, no complications

8709

80659

1.10

12.26

5.0

4.9

2.17

2.63

ug/l

2.05

8017

74022

Any reimbursement code in KELA

7757

35814

1.11

12.25

4.5

3.9

1.97

2.01

ug/l

0.09

7081

33163

Use of pramipexole

2967

26308

1.18

12.24

6.1

5.8

2.78

3.21

ug/l

0.52

2689

23705

Organic, including symptomatic, mental disorders

10162

67156

1.10

12.24

5.5

6.3

3.46

3.81

ug/l

0.49

8899

60269

Hypertensive heart and/or renal disease

5649

38030

1.14

12.17

5.4

5.9

3.17

4.37

ug/l

1.62

4963

34151

Major coronary heart disease event excluding revascularizations

12493

77957

1.09

12.13

5.2

5.6

2.63

3.44

ug/l

4.46

11230

71025

Bronchitis

18157

103496

1.07

12.11

5.0

5.4

2.83

3.31

ug/l

1.60

16423

93815

Nontraumatic intracranial haemmorrhage

2942

32926

0.85

12.06

5.3

6.0

6.89

3.86

ug/l

0.63

2638

29490

Sequelae with surgical and medical care as external cause

3122

27868

1.18

12.05

5.8

2.17

3.16

ug/l

6.09

2824

25206

Obesity due to excess calories

6383

58740

1.11

12.03

5.0

5.3

2.21

2.77

ug/l

1.15

5712

53758

Other systemic involvement of connective tissue

2746

24100

1.17

12.01

5.9

2.27

3.41

ug/l

6.18

2459

21617

Lichen ruber planus, wide definition including periferal and oral lichen planus

2578

22603

1.19

12.00

5.8

5.4

1.96

2.80

ug/l

3.02

2336

20535

Ill-defined and unknown causes of mortality

1564

18087

0.79

11.99

4.7

6.0

4.09

3.85

ug/l

0.13

1324

16246

Other and unspecified iron deficiency

4796

43547

1.13

11.93

5.6

6.0

3.51

3.69

ug/l

0.17

4217

39052

Other symptoms and signs involving the digestive system and abdomen

1308

10766

1.25

11.91

6.3

5.7

1.90

3.37

ug/l

3.23

1162

9689

Disorders of ocular muscles, binocular movement, accommodation and refraction

6046

54978

1.11

11.88

5.3

5.1

2.86

2.82

ug/l

0.04

5509

50169

Triptan medication for migraine, min. 3 purchases

2811

24015

0.86

11.85

4.3

4.1

1.64

1.86

ug/l

2.37

2604

22075

Colorectal cancer

4577

40146

1.15

11.84

5.5

4.4

3.01

2.11

ug/l

3.89

4054

36154

Adenocarcinoma of pancreas

276

3960

0.61

11.75

3.9

4.3

2.74

2.12

ug/l

0.75

221

3547

Polyneuropathies and other disorders of the peripheral nervous system

4478

41101

1.16

11.73

5.8

5.9

2.70

3.49

ug/l

1.30

4080

37138

Retinal breaks without detachment

2609

23144

1.20

11.65

6.4

5.7

2.96

2.95

ug/l

0.01

2374

21034

Hyperkinetic disorders, excluding more controls

709

5046

1.34

11.63

2.7

2.5

0.98

1.19

ug/l

3.99

632

4698

Persons with potential health hazards related to communicable diseases

3763

33384

1.14

11.61

4.8

4.5

3.12

2.26

ug/l

0.48

3424

30650

Parkinson's disease, strict definition, excluding more controls

2633

21903

1.21

11.58

5.7

6.5

4.51

4.32

ug/l

0.06

2360

19734

Any event in hilmo or specialist outpatient

231

2.61

11.58

5.0

1.8

2.06

1.53

ug/l

1.06

215

Adenocarcinoma and ductal carcinoma of pancreas

376

5098

0.65

11.55

3.9

4.3

2.58

2.11

ug/l

0.78

312

4578

Selective serotonin reuptake inhibitors

18623

92226

1.07

11.55

5.2

5.3

2.66

3.36

ug/l

2.01

16558

84233

Anoxic brain damage

155

2395

0.50

11.54

4.2

5.7

2.08

3.47

ug/l

1.85

131

2133

Zoster [herpes zoster]

2593

22888

1.19

11.54

5.7

5.9

2.36

3.37

ug/l

4.44

2346

20572

Generalized anxiety disorder

1229

10060

1.25

11.54

4.4

4.1

4.04

1.85

ug/l

0.38

1093

9230

Contact with machinery

2847

25972

1.24

11.50

5.4

5.3

2.15

2.58

ug/l

2.34

2627

23785

Achilles tendinitis

1687

14522

1.25

11.46

6.0

5.2

3.33

2.53

ug/l

0.43

1563

13238

Melanocytic naevi of trunk

1722

14792

1.24

11.44

6.3

5.5

2.86

2.77

ug/l

0.07

1571

13414

Malignant neoplasm of bladder

1634

14271

1.29

11.43

5.5

4.5

2.71

2.29

ug/l

1.87

1395

12732

Alzheimer disease, including avohilmo

6804

43702

1.12

11.43

5.5

6.7

5.54

4.69

ug/l

0.37

5909

38628

Benign neoplasm: Skin of other and unspecified parts of face

1425

12060

1.26

11.35

6.4

5.8

4.37

3.75

ug/l

0.29

1268

10813

Malignant neoplasm of pancreas, including Hilmo

1119

13335

0.77

11.34

4.8

4.4

2.59

2.14

ug/l

1.71

967

12014

Superficial injury of wrist and hand

2487

21819

1.18

11.28

5.0

4.7

1.95

2.38

ug/l

2.14

2273

19978

Kidney transplant status

907

7469

1.38

11.26

3.7

5.0

1.76

2.11

ug/l

2.66

870

6848

Dentofacial anomalies [including malocclusion]

6785

57501

0.91

11.25

5.2

4.6

2.36

ug/l

0.00

6159

52727

Other disorders of kidney and ureter

2320

20565

1.21

11.22

5.5

5.8

2.25

3.20

ug/l

3.40

2129

18612

Asthma/COPD (KELA code 203)

14617

102908

0.93

11.21

5.2

5.3

2.49

3.23

ug/l

3.69

13217

93704

Pleural plaque

2582

23568

1.27

11.20

6.7

6.6

3.46

4.37

ug/l

0.98

2236

21032

Varicose veins of other sites

1216

10311

1.32

11.16

5.7

4.9

1.88

2.33

ug/l

1.91

1123

9436

Dementia

8426

53964

1.11

11.16

5.5

6.6

3.66

4.18

ug/l

0.66

7343

48124

Hydronephrosis

1998

17500

1.23

11.11

8.0

6.0

11.45

3.11

ug/l

4.24

1813

15702

Recurrent aphthous stomatitis , including avohilmo

1562

13254

1.23

11.11

5.6

5.5

2.01

3.07

ug/l

2.22

1426

11972

Systemic connective tissue disorders

3772

33934

1.14

11.09

5.7

5.9

2.54

3.51

ug/l

2.29

3382

30507

Melanoma in situ

745

6014

1.42

11.06

7.0

6.1

4.29

3.35

ug/l

0.29

637

5394

Parkinson's disease, excluding more controls

2793

23044

1.19

11.04

5.6

6.4

4.59

4.24

ug/l

0.13

2502

20787

Conjunctivitis (acute, non atopic)

3459

30884

1.15

11.01

5.3

5.0

2.36

2.70

ug/l

0.80

3172

28201

Non-small cell lung cancer, adenocarcinoma

808

9864

0.74

10.99

5.2

4.5

2.34

2.16

ug/l

0.93

702

8847

Diseases of middle ear and mastoid

6727

59353

0.91

10.98

4.9

2.11

2.85

ug/l

4.46

6075

54129

Thoracic aortic aneurysm

3817

35352

1.20

10.90

6.1

2.33

3.31

ug/l

5.25

3380

32072

Other viral diseases, not elsewhere classified, including avohilmo

3093

27388

1.16

10.82

4.6

1.91

2.52

ug/l

2.71

2871

25060

L04AD Calcineurin inhibitors

1654

14293

1.24

10.80

3.7

4.9

1.75

2.03

ug/l

2.28

1559

13120

Dental caries

4562

39396

1.14

10.80

5.0

3.70

3.10

ug/l

0.89

4143

36009

Abnormal findings on diagnostic imaging of other body structures

1807

15607

1.22

10.80

6.4

5.7

2.88

2.81

ug/l

0.08

1674

14144

Symptoms and signs concerning food and fluid intake

1631

14000

1.24

10.76

5.6

5.9

2.34

2.89

ug/l

0.97

1462

12580

Benign neoplasm: Transverse colon

2038

18038

1.23

10.75

6.4

6.0

2.64

3.33

ug/l

0.90

1876

16312

Transient global amnesia

1179

9874

1.28

10.73

6.6

6.1

2.55

3.15

ug/l

1.48

1070

8897

Peripheral artery disease

8688

72762

0.91

10.72

5.2

6.2

4.33

3.81

ug/l

0.25

7637

65503

Benzodiazepine use

15738

111517

0.94

10.71

5.4

5.3

3.19

3.17

ug/l

0.02

13874

101684

Abnormal findings on diagnostic imaging of lung

9601

85766

1.10

10.70

5.6

5.9

2.56

3.74

ug/l

8.77

8547

77309

Ascites

854

10418

0.76

10.68

4.4

5.7

4.49

3.30

ug/l

0.43

758

9428

Disorders of vitreous body

7680

68189

1.10

10.60

6.4

5.9

2.47

3.22

ug/l

3.62

6966

61637

Benign neoplasm: Skin of eyelid, including canthus

1946

16943

1.21

10.55

6.3

5.9

4.54

3.43

ug/l

0.59

1749

15242

Benign neoplasm: Caecum

1800

15752

1.24

10.55

6.9

6.1

4.11

3.39

ug/l

0.16

1652

14165

Cervicocranial syndrome

1122

9274

1.27

10.53

6.0

5.3

2.65

3.13

ug/l

0.30

1044

8361

Other bursopathies

2068

18163

1.21

10.51

5.7

5.4

2.66

3.14

ug/l

0.37

1903

16433

Disorders of skin appendages

6333

58245

1.10

10.44

5.2

5.1

2.56

2.81

ug/l

0.22

5769

53098

Intentional self-harm by hanging, strangulation and suffocation

1139

0.37

10.42

3.4

4.7

1.70

2.24

ug/l

0.80

1031

Malignant neoplasm of oesophagus

422

5360

0.65

10.41

4.2

4.3

2.25

2.01

ug/l

0.98

373

4843

Sudden idiopathic hearing loss

1580

13659

1.24

10.39

6.3

5.6

2.73

2.93

ug/l

0.21

1431

12356

Trochanteric bursitis

965

7802

1.27

10.39

6.0

5.5

1.95

3.61

ug/l

2.33

884

6965

Malignant melanoma of skin

2144

18999

1.21

10.31

6.6

4.4

3.55

2.06

ug/l

2.64

1923

17166

Lateral epicondylitis

1753

15166

1.21

10.29

5.0

4.8

1.81

2.48

ug/l

5.39

1637

13917

Left bundle-branch block

1262

10746

1.28

10.28

6.1

6.0

2.94

3.96

ug/l

1.12

1098

9709

Benign neoplasm of male genital organs

579

4852

1.73

10.27

7.0

5.7

2.64

2.88

ug/l

0.20

513

4375

Type 1 diabetes, wide definition

2665

29851

0.86

10.26

3.8

4.9

1.88

2.91

ug/l

3.89

2409

27365

Infections of the skin and subcutaneous tissue

10399

96585

1.08

10.21

4.8

5.1

2.42

2.84

ug/l

0.80

9423

88245

Superficial injury of lower leg

3005

26831

1.15

10.20

5.2

5.1

2.04

2.84

ug/l

3.59

2723

24441

Other mental disorders due to brain damage and dysfunction and to physical disease

1961

17258

1.21

10.14

5.9

6.2

2.85

3.81

ug/l

1.28

1735

15539

Follow-up examination after treatment for malignant neoplasms

1475

12641

1.24

10.11

8.0

6.0

4.07

4.00

ug/l

0.03

1308

11204

Other superficial mycoses, including avohilmo

1276

10751

1.25

10.07

4.9

4.6

1.80

2.17

ug/l

1.68

1165

9841

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

847

7014

1.37

10.06

5.8

4.4

2.35

2.11

ug/l

0.78

750

6296

Disorders of refraction and accommodation

3123

27859

1.15

9.98

5.2

4.8

2.37

2.54

ug/l

0.19

2852

25509

Unspecified kidney failure

2052

18228

1.22

9.94

5.0

6.1

5.36

4.00

ug/l

0.45

1861

16301

Disturbance of activity and attention

657

4955

1.32

9.92

2.7

2.5

0.98

1.13

ug/l

2.44

585

4545

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1831

15989

1.21

9.85

5.9

5.2

3.04

2.53

ug/l

0.42

1684

14584

Lichen planus, including avohilmo

2226

19616

1.18

9.84

5.8

5.5

2.01

2.91

ug/l

2.68

2018

17808

Cardiomyopathies, Primary/intrinsic

2365

26165

0.83

9.81

4.7

5.9

2.62

3.75

ug/l

2.48

2106

23772

Progressive vascular leukoencephalopathy

586

4627

1.42

9.78

5.6

6.6

3.30

5.18

ug/l

0.97

530

4076

Migraine without aura

879

7044

1.27

9.77

4.4

4.1

1.49

1.94

ug/l

4.96

821

6455

All influenza

4707

43398

1.13

9.67

5.0

5.5

3.14

3.31

ug/l

0.13

4253

39475

Other viral diseases

3647

32930

1.13

9.66

4.6

2.02

2.49

ug/l

2.07

3374

30227

Pleural plaque with presence of asbestos

2018

18464

1.31

9.57

6.7

6.6

3.42

3.86

ug/l

0.35

1727

16461

Accidental poisoning by and exposure to alcohol

125

2057

0.53

9.56

3.4

4.8

1.93

2.18

ug/l

0.34

107

1863

Explicit Sepsis, including avohilmo

8526

72758

1.09

9.55

5.6

5.9

4.88

3.45

ug/l

1.30

7611

65609

Alzheimer’s disease (Late onset), excluding more controls

2796

16320

1.17

9.55

5.6

6.9

4.25

4.99

ug/l

0.47

2455

14514

Colonic or urogenital fistula

4250

39015

1.13

9.50

5.9

5.4

2.18

2.98

ug/l

3.35

3841

35497

Asthma, unspecified (mode), excluding more controls

8293

55587

1.09

9.50

5.6

5.4

2.48

3.31

ug/l

2.84

7545

51047

Hyperkinetic disorders

709

5429

1.30

9.48

2.7

2.5

0.98

1.12

ug/l

2.65

632

4967

Abdominal aortic aneurysm (AAA)

2182

23923

0.83

9.48

5.3

6.4

2.92

4.93

ug/l

5.43

1890

21191

Benign neoplasm of other and unspecified endocrine glands

1845

16182

1.20

9.45

6.3

5.6

1.95

2.78

ug/l

8.16

1707

14692

Caries of dentine

4067

35963

1.14

9.41

5.0

3.89

3.15

ug/l

1.06

3682

32903

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

726

8775

0.74

9.41

4.5

4.4

2.16

2.19

ug/l

0.08

611

7896

Mycoses

4252

39017

1.13

9.36

5.3

5.5

3.46

3.05

ug/l

0.24

3858

35381

Dislocation, sprain and strain of joints and ligaments at neck level

1699

14716

1.20

9.36

5.3

4.7

2.06

2.26

ug/l

0.54

1559

13458

Memory loss

1332

11456

1.25

9.35

6.0

6.3

3.88

3.91

ug/l

0.01

1185

10288

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1331

11215

1.21

9.35

4.0

3.7

3.71

1.66

ug/l

0.50

1207

10292

Invasive ventilation

931

11053

0.77

9.32

4.2

5.6

3.18

2.97

ug/l

0.08

794

10009

Other disorders of conjunctiva

2181

19411

1.19

9.18

6.3

5.9

3.09

3.39

ug/l

0.21

1969

17525

Unspecified fall

8253

76145

1.09

9.16

5.3

5.4

3.65

3.16

ug/l

0.33

7335

68993

Seborrhoeic dermatitis

1828

16187

1.22

9.09

5.5

5.6

2.12

3.17

ug/l

3.31

1636

14689

Otitis externa

3244

29413

1.14

9.06

5.7

5.3

2.54

2.92

ug/l

0.46

2897

26789

Sequelae of external causes of morbidity and mortality

3962

36337

1.13

9.00

5.7

2.32

3.21

ug/l

3.49

3585

32881

Superficial injury of shoulder and upper arm

1722

15067

1.20

8.97

5.4

5.2

2.01

2.98

ug/l

2.57

1574

13724

Brain glioblastoma, helper endpoint

147

2203

0.55

8.89

3.6

5.3

2.01

2.28

ug/l

0.38

126

1994

Unspecified urinary incontinence

558

4313

1.34

8.89

7.1

5.6

3.38

2.90

ug/l

0.34

490

3776

Implicit bacterial Sepsis

8815

71511

1.09

8.88

5.2

6.0

3.70

3.52

ug/l

0.23

7852

64465

Cerebrovascular diseases

14288

94702

1.07

8.86

5.5

5.7

3.45

3.24

ug/l

0.29

12803

86060

Fracture at wrist and hand level

5859

54440

1.10

8.77

4.9

4.8

2.63

2.69

ug/l

0.03

5339

49936

Injuries to the neck

3264

29645

1.14

8.74

5.3

5.1

2.38

2.72

ug/l

0.63

2976

27033

Use of galantamine

1182

10118

1.25

8.72

5.7

6.5

2.67

4.72

ug/l

4.15

1036

8876

Dermatophytosis

2531

22895

1.18

8.68

5.3

5.5

2.84

2.99

ug/l

0.13

2305

20820

Speech therapy

3527

32184

1.13

8.67

5.8

5.7

4.36

3.09

ug/l

0.41

3337

29096

Chronic laryngitis and laryngotracheitis

1931

17061

1.19

8.66

6.3

5.6

2.21

3.42

ug/l

3.93

1691

15425

Diplopia

1961

17393

1.19

8.63

5.8

5.6

3.58

3.23

ug/l

0.13

1743

15760

5712

52599

1.10

8.61

4.8

5.0

2.81

2.93

ug/l

0.12

5197

47841

Disorders of vitreous body and globe

7902

70318

1.09

8.60

6.4

5.9

2.58

3.28

ug/l

2.96

7167

63555

Injury of eye and orbit

2511

22637

1.17

8.60

4.7

4.8

2.27

2.51

ug/l

0.30

2309

20836

Barrett oesophagus

1071

9296

1.32

8.59

6.3

5.6

2.43

2.94

ug/l

0.50

966

8462

Disorders of muscles

1516

13219

1.21

8.44

5.1

3.00

3.08

ug/l

0.04

1388

11996

Ethmoidectomy

1901

16853

1.19

8.42

5.7

5.0

2.03

2.38

ug/l

1.75

1717

15439

Visual impairment including blindness (binocular or monocular)

884

7361

1.28

8.40

5.9

5.7

2.61

3.82

ug/l

1.16

761

6605

Adenocarcinoma and papillary adenocarcinoma of stomach

348

4525

0.68

8.38

4.7

4.2

2.24

2.15

ug/l

0.22

310

4052

Noise effects on inner ear

1069

9444

1.37

8.36

5.7

5.3

4.45

2.51

ug/l

0.78

1009

8618

Plantar fascial fibromatosis

957

7982

1.25

8.24

5.6

5.2

2.34

2.86

ug/l

0.60

892

7217

Stomatitis and related lesions

2304

20573

1.16

8.15

5.3

5.2

3.38

2.78

ug/l

0.21

2086

18718

Acute upper respiratory infections

15742

98457

0.94

8.15

5.2

5.5

2.60

3.46

ug/l

4.41

14272

89001

Adhesive capsulitis of shoulder

2327

20868

1.16

8.13

5.4

5.5

2.53

3.12

ug/l

1.03

2149

18873

Normotensive glaucoma

1065

9058

1.25

8.13

6.4

6.2

8.86

3.69

ug/l

0.54

916

8087

Other pulmonary diagnosis

13311

63540

1.07

8.13

5.0

5.3

2.60

3.22

ug/l

2.08

12108

58288

Abnormal involuntary movements

1926

17115

1.18

8.07

5.6

1.94

3.15

ug/l

4.77

1746

15484

Somatoform disorder

1591

13849

1.19

8.07

5.3

5.0

2.10

2.51

ug/l

0.51

1438

12628

Sciatica+with lumbago

8254

68931

1.08

8.06

5.3

5.2

2.26

2.94

ug/l

2.29

7595

62754

Explicit Sepsis

8324

71743

1.08

7.92

5.6

5.9

4.71

3.50

ug/l

1.04

7426

64665

Other and unspecified visual disturbances

1264

10893

1.22

7.89

5.7

5.4

2.89

2.74

ug/l

0.08

1170

9868

Olecranon bursitis

1530

13751

1.26

7.85

5.2

5.3

2.34

3.15

ug/l

1.26

1408

12509

Allergic rhinitis

2673

23700

1.13

7.85

4.7

4.3

1.73

2.04

ug/l

2.11

2437

21751

Abnormal weight loss

1376

12015

1.22

7.85

5.7

5.9

2.42

3.40

ug/l

1.19

1232

10822

Superficial injury of hip and thigh

2180

19510

1.16

7.84

5.6

5.7

2.80

3.52

ug/l

0.96

1960

17567

Migraine with aura and triptan purchases

579

4539

1.30

7.84

4.4

4.1

1.63

1.81

ug/l

0.66

540

4106

Vascular dementia

1539

13036

1.20

7.80

5.2

6.5

4.95

5.93

ug/l

0.25

1326

11451

Misadventures to patients during surgical and medical care

2012

17961

1.17

7.75

5.9

5.8

3.44

3.00

ug/l

0.28

1825

16252

Cardiomyopathy

3306

35717

0.88

7.72

4.7

5.9

2.56

3.66

ug/l

3.67

2940

32437

FESS (DNB20)

1808

16070

1.18

7.70

5.7

5.0

2.05

2.34

ug/l

1.35

1629

14746

Asthma, excluding more controls

12060

58920

1.07

7.69

5.1

5.3

2.39

3.20

ug/l

2.67

11039

54191

Panhypopituitarism

324

2492

1.57

7.68

6.8

5.4

1.67

2.46

ug/l

3.19

301

2243

Suppurative and necrotic conditions of lower respiratory tract

888

10289

0.78

7.66

5.0

5.7

2.58

3.42

ug/l

0.86

789

9318

Chalazion

1487

13016

1.20

7.65

5.8

5.2

3.21

2.58

ug/l

0.45

1356

11835

Open wound of lower leg

2156

19323

1.16

7.65

5.2

2.32

2.95

ug/l

1.42

1909

17596

Vascular dementia (subcortical)

540

4358

1.37

7.65

5.2

6.6

2.56

5.81

ug/l

2.51

492

3837

Undetermined asthma

1724

15195

1.18

7.65

5.9

5.8

2.36

3.08

ug/l

1.38

1570

13844

Undetermined asthma, excluding more controls

1724

15198

1.18

7.63

5.9

5.8

2.36

3.86

ug/l

2.32

1570

13870

Benign neoplasm of eye and adnexa

1379

12032

1.21

7.62

6.5

5.7

3.15

3.25

ug/l

0.06

1237

10839

Vestibular neuronitis

1257

10934

1.22

7.56

5.8

5.5

2.46

2.78

ug/l

0.59

1141

9914

Ventral hernia

3649

33619

1.12

7.53

5.9

5.6

3.03

3.39

ug/l

0.34

3250

30403

Malignant neoplasm of liver and intrahepatic bile ducts

473

5776

0.72

7.52

4.5

4.4

2.10

2.15

ug/l

0.10

396

5201

Glucosamine medication

5692

48555

0.91

7.52

6.6

6.2

3.02

3.81

ug/l

2.10

5037

43428

Brain glioblastoma and astrocytoma

174

2478

0.61

7.48

3.5

4.0

2.14

1.79

ug/l

0.57

151

2245

Carcinoma in situ of prostate

154

1219

5.32

7.44

9.9

5.8

5.89

2.44

ug/l

12.95

149

1100

1319

11388

1.19

7.43

5.0

4.8

2.08

2.40

ug/l

0.77

1192

10371

Other enthesopathy of foot (+metatarsalgia)

898

7507

1.24

7.41

5.5

5.1

2.26

2.80

ug/l

0.90

822

6748

Superficial injury of abdomen, lower back and pelvis

2096

18763

1.16

7.41

5.4

5.2

1.99

3.02

ug/l

3.72

1884

17064

12569

113828

0.94

7.36

4.6

5.4

2.71

3.18

ug/l

1.24

11142

103852

Open wound of forearm

1554

13751

1.20

7.35

5.2

5.1

3.00

2.91

ug/l

0.04

1390

12509

COPD

8979

76433

0.93

7.34

5.2

6.0

3.17

3.78

ug/l

0.75

7815

68947

Weight loss

1428

12547

1.20

7.30

5.7

5.9

2.43

3.36

ug/l

1.19

1279

11294

Benign neoplasm: Descending colon

1264

11138

1.24

7.30

6.2

5.8

2.70

3.31

ug/l

0.47

1161

10047

Other disorders of the musculoskeletal system and connective tissue

2113

19011

1.16

7.28

5.7

5.5

2.24

3.04

ug/l

2.38

1920

17255

Other ill-defined and unspecified causes of mortality

1457

16346

0.83

7.25

4.8

6.0

3.88

3.97

ug/l

0.04

1230

14663

Diseases of tongue

668

5469

1.29

7.25

6.2

5.1

2.05

2.74

ug/l

2.26

607

4938

Septicaemia

8243

71329

1.08

7.25

5.6

5.9

4.69

3.17

ug/l

1.46

7351

64248

Metatarsalgia

825

6861

1.25

7.22

5.6

5.2

2.31

2.73

ug/l

0.61

757

6154

conjunctival haemorrhage

1125

9757

1.23

7.20

6.6

5.9

2.63

3.15

ug/l

0.93

1009

8786

Retinal detachment with retinal break

2476

22643

1.16

7.20

6.1

5.7

2.95

3.14

ug/l

0.18

2248

20540

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4146

37746

1.10

7.19

4.6

4.4

2.02

2.23

ug/l

0.39

3772

34738

Diabetic maculopathy

1608

16992

0.84

7.19

4.1

5.3

1.77

2.62

ug/l

6.41

1440

15315

Insulin, intermediate and long-acting

11188

103324

1.07

7.18

4.8

5.6

2.59

3.21

ug/l

2.12

9980

93958

Polyarthrosis

2003

16044

1.15

7.17

6.2

5.8

2.76

3.19

ug/l

0.46

1791

14417

Brain glioblastoma

147

2116

0.58

7.13

3.6

4.0

2.01

1.81

ug/l

0.33

126

1915

Abnormalities of gait and mobility

2114

19149

1.17

7.13

5.6

6.1

3.91

3.50

ug/l

0.09

1887

17167

Schizophrenia

1960

21824

0.86

7.10

3.3

4.4

2.14

2.09

ug/l

0.04

1766

20127

Effects of foreign body entering through natural orifice

4719

44204

1.11

7.03

4.9

5.0

2.71

2.56

ug/l

0.17

4322

40534

Subarachnoid haemorrhage

1202

13758

0.83

7.01

5.3

5.8

6.72

3.50

ug/l

0.34

1095

12366

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

4526

41032

1.11

7.00

11.8

4.4

22.63

2.06

ug/l

19.96

4121

37038

Stenosis and insufficiency of lacrimal passages

852

7145

1.24

7.00

6.1

5.7

3.08

3.09

ug/l

0.01

774

6399

Other viral diseases, not elsewhere classified

2292

20598

1.15

7.00

4.8

2.01

2.62

ug/l

1.84

2114

18824

Corneal ulcer

2612

23762

1.14

7.00

5.0

4.9

2.89

2.69

ug/l

0.10

2360

21708

Unstable angina pectoris

7997

59792

1.09

6.99

5.7

6.1

3.81

3.87

ug/l

0.03

7187

53941

Malignant neoplasm of stomach

728

8578

0.78

6.98

5.0

4.3

3.31

2.13

ug/l

1.02

643

7718

Injury of muscle and tendon at hip and thigh level

1670

14916

1.19

6.95

5.5

5.2

2.21

2.53

ug/l

0.65

1518

13677

Use of rivastigmine

2374

21485

1.15

6.95

5.6

6.4

5.39

4.50

ug/l

0.15

2059

18934

Ménière disease

1069

9196

1.22

6.95

6.1

5.8

3.58

3.49

ug/l

0.03

985

8252

Alzheimer’s disease (undefined)

869

0.42

6.95

3.2

6.2

27.30

10.66

ug/l

0.35

752

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

15977

106462

0.95

6.94

4.9

5.3

2.60

3.24

ug/l

1.48

14561

96604

Psychiatric diseases

17610

84922

1.05

6.88

5.0

5.4

2.79

3.15

ug/l

0.76

15815

77695

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

989

11340

0.80

6.86

4.6

4.4

2.15

2.14

ug/l

0.02

848

10196

Melanocytic naevi, other sites/unspecified

1032

8876

1.22

6.81

5.9

5.3

2.14

2.61

ug/l

1.37

950

8072

Type 1 diabetes, strict (exclude DM2)

690

8306

0.80

6.78

3.3

3.6

1.56

1.78

ug/l

0.42

620

7673

COPD differential diagnosis

13217

63377

1.06

6.77

5.0

5.3

2.60

3.24

ug/l

2.18

12015

58126

Phlebitis and thrombophlebitis (not including DVT)

3246

29883

1.12

6.76

5.6

5.5

3.85

2.78

ug/l

0.75

2935

27172

Unattended death

103

1549

0.53

6.74

3.8

5.6

5.71

2.49

ug/l

0.67

1386

Abnormal results of function studies

1198

10446

1.21

6.74

5.3

5.2

2.37

2.70

ug/l

0.58

1069

9502

Malignant neoplasm of stomach, including Hilmo

837

9731

0.80

6.74

5.1

4.3

3.28

2.10

ug/l

1.21

740

8742

Alcohol abuse, main dg

2545

27736

0.88

6.73

4.7

5.0

2.35

2.60

ug/l

0.32

2280

25493

Cardiomyopathies, Secondary/extrinsic

1243

0.49

6.72

3.8

5.2

1.91

2.49

ug/l

0.73

1131

Alcohol abuse, main dg, excluding more controls

2545

27732

0.88

6.71

4.7

5.1

2.35

2.55

ug/l

0.25

2280

25616

Fall on and from ladder

1780

16270

1.22

6.71

6.0

5.6

2.59

3.02

ug/l

0.58

1635

14799

Lesion of ulnar nerve

2448

22374

1.15

6.70

5.3

5.1

2.04

2.89

ug/l

3.34

2252

20504

Exposure to excessive natural cold

114

1697

0.56

6.70

4.4

5.3

2.08

2.40

ug/l

0.27

103

1533

Carcinoma in situ of skin of upper limb, including shoulder

441

3585

1.42

6.66

6.4

2.66

3.33

ug/l

0.82

386

3178

Sexual dysfunction

384

3094

1.48

6.64

5.0

4.7

2.18

2.10

ug/l

0.05

357

2835

Periapical abscess

7921

75259

1.08

6.61

5.3

5.1

2.67

2.64

ug/l

0.04

7171

69032

Other bacterial intestinal infections, including avohilmo

3399

31365

1.12

6.60

5.5

5.6

2.96

3.36

ug/l

0.44

3086

28335

Macular hole

771

6530

1.27

6.59

6.5

6.2

2.51

3.35

ug/l

2.05

695

5818

Type 1 diabetes, definitions combined

704

8433

0.80

6.59

3.3

3.6

1.55

1.78

ug/l

0.45

634

7790

Urticaria

2669

24223

1.12

6.58

5.4

5.0

2.03

2.62

ug/l

2.21

2440

22070

Right bundle-branch block

738

6311

1.31

6.57

6.1

4.65

3.83

ug/l

0.18

645

5724

Amputation of ankle bones

299

3783

0.68

6.56

3.9

5.9

1.76

3.05

ug/l

3.27

256

3383

Other disorders of the genitourinary system

725

5990

1.24

6.55

8.3

6.1

2.85

4.30

ug/l

1.05

610

5279

Need for other prophylactic measures

774

6552

1.27

6.55

5.6

5.1

2.56

2.40

ug/l

0.19

721

5964

Iron deficiency anaemia

6211

57379

1.08

6.55

5.6

6.0

3.68

3.89

ug/l

0.22

5490

51428

Excluding asthma or asthma-COPD overlap

13241

63540

1.06

6.54

5.0

5.3

2.59

3.22

ug/l

2.14

12032

58288

Otalgia

671

5525

1.26

6.54

5.9

5.2

2.07

2.68

ug/l

1.44

593

4994

Migraine without aura and triptan purchases

558

4457

1.27

6.53

4.2

3.8

1.48

1.76

ug/l

1.60

521

4061

Primary hyperparathyroidism

836

7032

1.23

6.52

6.2

5.8

3.23

2.99

ug/l

0.09

750

6292

ILD differential diagnosis

13203

63361

1.06

6.52

5.0

5.3

2.60

3.24

ug/l

2.18

12001

58112

Myocardial infarction, without ST-elevation

9141

78970

1.08

6.51

5.4

6.1

3.34

3.79

ug/l

0.68

8139

71024

Spontaneous rupture of synovium and tendon

1183

10350

1.21

6.51

5.6

5.5

2.06

2.95

ug/l

4.88

1051

9352

Spirochaetal infections, other/unspecified

1161

10137

1.21

6.51

6.5

5.6

2.42

2.81

ug/l

0.84

1032

9206

Anogenital herpesviral [herpes simplex] infection, including avohilmo

694

5710

1.25

6.50

4.7

4.3

1.68

1.81

ug/l

0.47

633

5232

Iridocyclitis

3168

29182

1.12

6.48

5.4

5.3

2.74

2.82

ug/l

0.09

2897

26533

Benign neoplasm: Pituitary gland, craniopharyngeal duct

673

5629

1.28

6.45

6.2

5.3

1.71

2.46

ug/l

3.25

619

5103

Malignant neoplasm of brain, including Hilmo

515

6273

0.76

6.44

4.2

3.9

2.67

1.87

ug/l

1.23

461

5686

Other/unspecified synovitis and tenosynovitis

1378

12125

1.18

6.43

5.1

5.2

2.91

3.22

ug/l

0.24

1241

10973

Urticaria and erythema

3532

32518

1.10

6.43

5.4

5.1

2.11

2.75

ug/l

3.39

3217

29550

Moderate visual impairment, binocular

350

2709

1.40

6.40

5.8

5.9

2.96

5.45

ug/l

0.84

279

2391

Tuberculosis

743

8727

0.80

6.40

5.1

5.9

4.11

4.55

ug/l

0.14

655

7696

Malignant neoplasm of urinary organs, including Hilmo

2289

21009

1.16

6.36

5.9

4.4

3.16

2.08

ug/l

2.78

2037

18987

Vascular dementia (mixed)

336

2639

1.46

6.36

5.3

6.8

9.11

6.20

ug/l

0.17

285

2324

Other/unspecified enthesopathies of lower limb, excluding foot

729

6096

1.25

6.32

5.2

4.7

2.60

2.29

ug/l

0.27

666

5547

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

778

8982

0.79

6.30

4.5

4.3

2.17

2.10

ug/l

0.20

663

8088

Intracerebral haemorrhage

1919

21142

0.86

6.29

5.3

6.1

6.62

4.05

ug/l

0.44

1707

18834

L01XE Protein kinase inhibitors

573

6847

0.77

6.27

4.1

6.0

2.48

2.95

ug/l

0.99

502

6166

Diabetic retinopathy

5803

34003

1.09

6.24

5.4

2.55

2.89

ug/l

0.58

5124

30575

Other disorders of nervous system

1091

9583

1.23

6.23

5.4

5.6

2.13

2.81

ug/l

2.10

995

8687

Other peripheral vertigo

1069

9282

1.21

6.23

6.3

5.8

2.62

2.99

ug/l

0.62

964

8341

Asthma

12737

62938

1.06

6.22

5.1

5.3

2.47

3.23

ug/l

2.54

11641

57731

Oxycodone

7652

62227

1.08

6.21

7.2

5.6

10.39

2.92

ug/l

15.05

6783

56401

Pyothorax

701

8106

0.78

6.20

5.1

5.6

2.64

3.10

ug/l

0.43

633

7339

Ocular pain

740

6196

1.24

6.18

5.5

5.1

2.09

2.54

ug/l

0.54

674

5588

Respiratory tuberculosis

645

7633

0.79

6.17

5.1

5.9

4.10

4.33

ug/l

0.06

565

6753

Other specified disorders of external ear

829

7288

1.32

6.16

7.0

5.8

3.00

3.03

ug/l

0.02

740

6604

Respiratory tuberculosis, confirmed and not-confirmed

645

7632

0.79

6.16

5.1

5.9

4.10

4.33

ug/l

0.06

565

6751

Asthma (only as main-diagnosis)

10766

62938

0.94

6.16

5.2

5.3

2.46

3.23

ug/l

2.35

9794

57731

Vasomotor rhinitis (mode)

826

7036

1.24

6.15

6.2

5.5

2.13

2.79

ug/l

1.85

747

6365

Urinary track infection

195

1.95

6.15

1.1

0.39

0.96

ug/l

—

COPD (mode)

6556

48534

1.09

6.15

5.1

6.0

3.10

3.79

ug/l

0.59

5728

44182

Lichen planus

1414

12502

1.17

6.14

5.8

5.5

2.16

2.80

ug/l

1.37

1279

11296

Colorectal adenocarcinoma

3884

35864

1.11

6.10

5.5

4.4

3.08

2.14

ug/l

3.26

3444

32295

Hypertensive Renal Disease

726

6233

1.29

6.09

5.1

6.2

2.60

4.97

ug/l

2.06

670

5548

Faecal incontinence

515

4137

1.28

6.07

7.7

5.9

3.87

3.18

ug/l

0.28

462

3656

Secondary hypertension

1329

11627

1.19

6.07

4.3

5.5

2.24

3.24

ug/l

1.92

1218

10536

Radiculopathy

2361

21554

1.14

6.06

5.6

3.17

3.43

ug/l

0.14

2104

19359

Other disorders of eye and adnexa

1380

12156

1.17

6.06

5.6

5.1

2.08

2.89

ug/l

1.28

1248

11012

Idiopathic gout

2299

21356

1.18

6.05

5.5

6.0

2.81

3.25

ug/l

0.73

2082

19303

Fibromyalgia

262

1911

1.39

5.98

4.4

4.3

1.57

2.10

ug/l

1.27

232

1717

Nontoxic goitre/thyroid nodule

1791

15983

1.14

5.90

6.6

5.9

2.95

3.54

ug/l

0.51

1613

14243

Benign neoplasm: Skin of ear and external auricular canal

599

5038

1.30

5.89

6.7

6.0

3.68

4.12

ug/l

0.14

522

4486

Benign neoplasm: Prostate

203

1655

2.27

5.85

9.1

6.2

2.96

2.89

ug/l

0.03

174

1468

Early lumbar disc prolapse, operated

1171

10256

1.19

5.84

3.3

3.1

1.44

1.47

ug/l

0.15

1111

9653

Pleural plaque without asbestos

763

6676

1.31

5.84

6.6

6.5

4.82

4.67

ug/l

0.04

664

5901

Infections with a predominantly sexual mode of transmission

2247

20275

1.12

5.83

4.3

4.1

3.13

1.85

ug/l

0.53

2020

18606

Carcinoma in situ of skin of lower limb, including hip

286

2209

1.45

5.81

6.8

6.5

3.13

3.54

ug/l

0.25

256

1943

Malignant neoplasm of brain

363

4522

0.74

5.81

3.7

3.8

2.31

1.81

ug/l

1.08

323

4117

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

4111

36543

1.09

5.77

5.2

4.6

1.79

2.49

ug/l

5.29

3758

33297

Other and unspecified injuries of head

1007

8784

1.21

5.71

5.3

2.97

2.80

ug/l

0.07

910

7981

Cholecystitis

2392

21983

1.14

5.69

5.7

6.0

3.39

3.78

ug/l

0.29

2156

19641

Benign neoplasm of other and ill-defined parts of digestive system

2346

21471

1.13

5.69

6.4

5.9

2.66

3.24

ug/l

1.10

2129

19368

Bicipital tendinitis

818

7098

1.25

5.69

5.3

5.1

2.32

2.74

ug/l

0.35

769

6448

Asthma, unspecified (mode)

8620

59276

1.07

5.68

5.6

5.5

2.58

3.36

ug/l

2.50

7817

54282

Benign neoplasm: Choroid

836

7208

1.23

5.68

6.6

5.8

2.55

2.80

ug/l

0.39

751

6499

Flat foot [pes planus] (acquired)

748

6308

1.22

5.67

5.7

5.1

2.89

2.68

ug/l

0.09

675

5681

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

532

4388

1.29

5.61

5.1

4.6

1.75

2.40

ug/l

1.78

499

3982

Pruritus

988

8538

1.19

5.61

5.7

5.6

2.32

3.67

ug/l

1.75

895

7650

Hypertensive Heart Disease

5024

36010

1.10

5.60

5.5

6.0

3.29

4.48

ug/l

1.38

4393

32280

Diabetic nephropathy

2630

27939

0.88

5.59

4.4

5.6

2.24

3.05

ug/l

2.42

2416

24922

Other predominantly sexually transmitted diseases, not elsewhere classified

1069

9259

1.18

5.59

4.1

3.8

4.28

1.70

ug/l

0.51

968

8515

Intestinal adhesions without obstruction

1271

11304

1.18

5.58

5.7

2.76

3.37

ug/l

0.96

1114

10168

Residual foreign body in soft tissue

844

7331

1.24

5.54

5.3

4.7

2.04

2.45

ug/l

0.95

781

6686

Amputation of thigh

364

4474

0.74

5.54

4.0

6.2

4.67

4.72

ug/l

0.01

314

3945

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

923

8010

1.21

5.52

6.2

5.3

2.26

2.44

ug/l

0.39

836

7266

Chronic lower respiratory diseases

20189

102991

1.04

5.50

5.0

5.3

2.66

3.23

ug/l

1.69

18288

93783

Rheumatoid arthritis

3620

34431

0.91

5.49

5.2

5.7

2.49

3.62

ug/l

4.70

3255

31016

Volume depletion

1597

14426

1.16

5.44

5.2

5.9

5.25

3.93

ug/l

0.28

1381

12902

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

1092

9709

1.21

5.38

5.7

5.4

2.78

2.65

ug/l

0.12

1003

8834

Allergic conjunctivitis

4314

38703

1.08

5.37

5.1

4.6

1.77

2.45

ug/l

5.56

3944

35270

Artificial joint re-operation

856

7429

1.22

5.33

6.1

6.0

2.26

3.09

ug/l

1.82

775

6690

Injuries to unspecified part of trunk, limb or body region

1419

12717

1.17

5.33

5.2

5.4

3.13

3.16

ug/l

0.02

1265

11505

Delirium, not induced by alcohol and other psychoactive substances

2185

20043

1.14

5.32

5.3

6.1

5.03

4.03

ug/l

0.52

1899

17944

Synovial cyst of popliteal space [Baker]

863

7472

1.21

5.27

5.8

5.5

2.49

3.18

ug/l

0.76

785

6684

Malignant neoplasm of eye, brain and central nervous system

486

5816

0.78

5.25

4.1

3.9

2.37

1.85

ug/l

1.66

436

5282

Melanocytic naevi of other and unspecified parts of face

537

4448

1.26

5.23

6.1

5.3

2.32

2.53

ug/l

0.29

482

4009

Malignant neoplasm of testis

343

2821

1.45

5.22

4.7

3.5

2.32

1.58

ug/l

0.58

306

2580

Other noninfective gastroenteritis and colitis

2988

27636

1.10

5.21

5.8

5.4

2.84

3.03

ug/l

0.23

2691

25016

Acute and subacute iridocyclitis

2626

24252

1.12

5.19

5.3

5.2

2.86

2.83

ug/l

0.03

2408

22090

Pneumonitis due to solids and liquids

1342

14848

0.85

5.18

4.6

5.8

3.41

3.99

ug/l

0.52

1130

13321

Myocardial infarction

10492

70634

1.06

5.17

5.3

5.7

2.88

3.47

ug/l

2.11

9408

64377

Insulin, fast-acting or short human

6025

63288

0.93

5.14

4.6

5.4

2.40

3.12

ug/l

2.06

5397

57438

Alcohol-induced chronic pancreatitis

1243

13628

0.83

5.12

4.7

5.0

3.54

2.21

ug/l

0.51

1119

12528

Hepatocellular carcinoma

376

4476

0.73

5.12

4.6

4.4

2.11

2.15

ug/l

0.07

312

4016

Care involving dialysis

1550

14143

1.18

5.12

4.0

5.5

2.46

2.39

ug/l

0.07

1455

12826

Alzheimer’s disease (undefined), excluding more controls

753

0.47

5.12

3.2

6.3

27.30

7.13

ug/l

0.46

645

Cardiac murmurs and other cardiac sounds

754

6345

1.21

5.11

5.7

5.4

2.46

3.67

ug/l

1.06

685

5715

Nausea and vomiting

3162

28591

1.10

5.08

5.3

5.6

3.59

3.64

ug/l

0.03

2808

25674

Foreign body on external eye

3296

31025

1.12

5.07

4.7

2.49

2.22

ug/l

0.40

3051

28645

Adult respiratory distress syndrome

143

1940

0.63

5.06

4.3

5.9

1.69

2.78

ug/l

3.51

122

1733

Melanoma in situ of trunk

307

2508

1.48

5.03

7.2

6.1

6.83

2.77

ug/l

0.64

265

2238

Hepatic failure, not elsewhere classified

442

5283

0.77

5.03

4.5

5.6

2.39

2.80

ug/l

0.41

400

4772

Other and unspecified injuries of shoulder and upper arm

447

3698

1.31

5.00

5.4

5.1

1.92

2.48

ug/l

1.15

402

3357

Spondylopathies (FG)

1785

16215

1.14

4.99

4.9

4.8

3.12

2.50

ug/l

0.56

1628

14837

Nontoxic multinodular goitre

1102

9649

1.16

4.98

6.8

6.0

3.27

3.85

ug/l

0.27

984

8568

Nonalcoholic fatty liver disease

1297

11604

1.17

4.97

4.8

4.7

1.72

2.06

ug/l

1.44

1185

10639

Brachial plexus disorders

815

7021

1.20

4.95

4.9

4.6

5.34

2.07

ug/l

0.51

768

6462

Malignant neoplasm of testis, including Hilmo

392

3289

1.40

4.95

4.9

3.6

2.77

1.67

ug/l

0.86

348

3003

Hepatocellular carcinoma, including Hilmo

503

5830

0.76

4.94

4.6

4.4

1.99

2.11

ug/l

0.28

429

5265

Use of antiglaucoma preparations and miotics

1010

8907

1.19

4.93

6.3

6.1

3.86

4.46

ug/l

0.28

891

7901

Type1 diabetes, definitions combined, early onset

263

3414

0.74

4.93

2.3

2.4

1.10

1.08

ug/l

0.06

239

3147

Tuberculosis, wide

867

9875

0.83

4.92

5.1

5.8

3.91

4.31

ug/l

0.15

763

8732

Disorder of lipoprotein metabolism, unspecified

2500

23255

1.13

4.91

5.6

6.0

2.56

3.84

ug/l

3.12

2210

20907

Malignant neoplasm of colon, including Hilmo

3209

29897

1.11

4.91

5.7

4.4

3.18

2.17

ug/l

2.85

2862

26899

Ankylosing spondylitis

1344

12098

1.17

4.89

5.1

4.9

3.57

2.46

ug/l

0.86

1215

11034

Rosacea

1170

10350

1.16

4.88

5.6

5.5

1.97

2.75

ug/l

4.22

1048

9375

Melanoma in situ of other and unspecified parts of face

194

1477

1.55

4.85

7.1

6.3

2.93

4.17

ug/l

0.71

163

1311

Fracture of forearm

5172

49198

0.93

4.83

5.4

5.2

2.95

2.97

ug/l

0.02

4677

44608

Amputation of toe

1217

13410

0.84

4.82

4.6

6.0

6.82

3.75

ug/l

0.31

1079

12062

Amputation of foot

431

5035

0.75

4.81

3.9

6.0

1.93

3.00

ug/l

3.26

379

4526

Thyrotoxicosis, other and/or unspecified

1552

13937

1.13

4.81

5.5

5.4

2.32

2.83

ug/l

1.29

1358

12597

Malignant neoplasm of urinary organs

1914

17664

1.15

4.80

5.7

4.4

3.16

2.06

ug/l

2.25

1718

15980

Diseases of the respiratory system

10002

48054

1.06

4.80

5.3

5.6

2.78

3.51

ug/l

1.93

9039

43739

Neuralgia and neuritis, unspecified

595

5044

1.24

4.78

5.9

5.1

2.66

2.98

ug/l

0.24

551

4544

Postprocedural musculoskeletal disorders, not elsewhere classified

949

8378

1.20

4.76

6.0

5.7

2.39

3.34

ug/l

1.02

865

7551

Tuberculosis, IBD comorbidity

851

9677

0.83

4.76

5.1

5.8

3.95

4.33

ug/l

0.14

748

8551

Use of entacapone

1083

0.55

4.75

5.2

5.9

5.14

3.70

ug/l

0.28

947

Type 1 diabetes, strict definition

471

5681

0.80

4.74

2.6

2.9

1.18

1.36

ug/l

1.36

430

5284

L04AA Selective immunosuppressants

2721

25230

1.11

4.72

4.1

5.1

1.89

2.62

ug/l

3.62

2507

23072

Oral lichen planus, including avohilmo , including avohilmo

539

4503

1.24

4.71

5.9

5.2

1.60

2.21

ug/l

4.34

493

4091

Otitis externa, unspecified

1405

12647

1.15

4.71

5.8

5.1

2.00

2.63

ug/l

3.26

1282

11537

Pollen allergy

1205

10503

1.15

4.71

4.2

3.8

1.63

1.71

ug/l

0.17

1069

9633

Exposure to other and unspecified inanimate mechanical forces

1117

9968

1.18

4.70

4.8

2.32

2.22

ug/l

0.12

1016

9119

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

802

9156

0.83

4.70

4.8

4.0

2.91

1.93

ug/l

1.79

714

8300

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1202

10768

1.17

4.69

5.5

5.3

2.81

2.60

ug/l

0.10

1079

9794

Use of donepezil

3274

29233

1.10

4.68

5.4

6.5

6.69

4.62

ug/l

0.49

2808

25781

Glaucoma-related operations

724

6279

1.22

4.68

7.2

6.1

4.76

4.05

ug/l

0.19

647

5598

Cholecystectomy

9462

83602

0.95

4.67

5.8

2.75

3.55

ug/l

3.18

8563

75292

Other fall from one level to another

3758

35350

1.09

4.65

5.3

2.78

2.77

ug/l

0.01

3453

32207

Injury of unspecified body region

1002

8872

1.18

4.65

5.3

5.5

2.45

3.19

ug/l

0.65

892

8011

Presbyopia

968

8544

1.18

4.64

5.0

4.7

2.78

2.15

ug/l

0.33

905

7866

Pulmonary oedema

188

2449

0.69

4.63

4.0

6.1

3.62

3.64

ug/l

0.01

162

2168

Paralytic ileus and intestinal obstruction

4391

41474

1.08

4.62

5.5

5.6

3.08

3.68

ug/l

1.05

3885

37245

Colitis due to radiation

221

1770

1.58

4.59

12.6

6.2

6.73

3.81

ug/l

0.56

202

1544

Complications following myocardial infarction

1344

0.59

4.58

4.9

6.4

2.63

3.58

ug/l

0.89

1181

Vascular dementia (undefined)

595

5024

1.24

4.58

5.1

6.5

5.21

6.33

ug/l

0.30

499

4391

Conductive hearing loss, unspecified

996

8810

1.18

4.57

5.6

5.3

2.46

2.79

ug/l

0.30

896

7978

Herpesviral [herpes simplex] infections

1220

10894

1.15

4.54

5.3

5.4

2.31

3.17

ug/l

1.22

1113

9864

Clear cell adenocarcinoma of kidney

905

8104

1.23

4.53

5.7

4.3

2.50

1.95

ug/l

4.31

815

7359

Atypical facial pain

394

3204

1.28

4.53

5.8

5.3

1.93

2.70

ug/l

1.15

355

2901

Unspecified jaundice

666

7642

0.82

4.52

4.5

5.7

2.40

3.77

ug/l

1.59

571

6869

Fall on and from stairs and steps

3580

33593

1.09

4.52

5.3

5.4

2.94

2.92

ug/l

0.02

3226

30549

Small fibre neuropathy

518

4449

1.30

4.51

5.9

5.6

1.90

2.65

ug/l

1.65

466

4018

Viral warts

1128

10047

1.16

4.50

5.1

1.82

2.40

ug/l

3.10

1048

9153

Aneurysms, operations, SAH

1966

21372

0.89

4.49

5.2

5.7

4.90

3.17

ug/l

0.29

1806

19314

Benign neoplasm: Stomach

1134

10130

1.17

4.48

6.5

5.9

3.05

3.09

ug/l

0.03

1032

9078

Tuberculosis, wide, including avohilmo

884

9989

0.84

4.47

5.1

5.8

3.87

4.33

ug/l

0.17

779

8832

Post-traumatic stress disorder

406

3290

1.26

4.46

4.0

1.45

1.73

ug/l

1.19

362

3029

Other otitis externa (chronic)

842

7392

1.20

4.45

5.9

5.4

3.92

3.35

ug/l

0.15

724

6705

Anterior Iridocyclitis

2741

25524

1.10

4.43

5.4

5.2

2.83

2.84

ug/l

0.01

2509

23266

Pediculosis, acariasis and other infestations, including avohilmo

1988

18224

1.12

4.42

4.5

4.6

3.02

2.23

ug/l

0.49

1806

16711

Other disorders of cornea

1191

10674

1.16

4.41

5.2

2.10

2.71

ug/l

2.02

1091

9677

Gluteal tendinitis

312

2475

1.31

4.41

6.4

5.5

1.73

2.56

ug/l

3.56

278

2202

Thyrotoxicosis

1842

16769

1.12

4.38

5.7

5.5

2.40

3.07

ug/l

1.36

1617

15108

Papulosquamous disorders

5888

56121

1.07

4.38

5.2

5.4

2.10

3.01

ug/l

5.38

5329

51122

Perforation of tympanic membrane

1254

11282

1.15

4.38

5.8

5.5

2.69

3.22

ug/l

0.53

1109

10226

Superficial injury of forearm

1138

10151

1.16

4.37

5.2

5.0

1.88

2.88

ug/l

1.70

1050

9210

Carcinoma in situ of skin, other sites/unspecified

255

2048

1.44

4.37

6.3

6.4

4.85

3.43

ug/l

0.25

221

1806

Other and unspecified injuries of lower leg

762

6611

1.19

4.37

5.0

4.8

1.82

2.38

ug/l

1.95

699

6025

Respiratory tuberculosis, not confirmed

467

5498

0.79

4.34

5.2

6.0

2.87

4.54

ug/l

1.30

408

4863

Cellulitis

3742

35303

1.09

4.34

4.9

5.3

2.19

2.99

ug/l

2.85

3378

32228

Other gastritis (incl. Duodenitis)

3661

34517

1.09

4.33

5.6

5.7

2.84

3.58

ug/l

0.93

3342

31101

Viral and other specified intestinal infections, including avohilmo

2926

26179

1.09

4.32

4.4

4.3

2.01

2.52

ug/l

0.96

2722

23861

Struck by thrown, projected or falling objec

876

7783

1.20

4.32

5.1

4.8

1.99

2.22

ug/l

0.54

823

7149

Carbimazole or st.post thyroidectomy, condition for graves disease

1469

13234

1.13

4.31

5.6

5.3

2.04

2.58

ug/l

2.73

1306

11977

Personal history of other diseases and conditions

493

4070

1.23

4.29

5.5

4.7

2.63

2.09

ug/l

0.33

436

3691

Hypertrophy of breast in women and men

887

7728

1.16

4.27

6.2

5.2

2.17

2.75

ug/l

1.16

814

6928

Phobic anxiety disorders

1063

9385

1.15

4.26

4.0

3.8

1.69

1.70

ug/l

0.03

949

8675

Systemic atrophies primarily affecting the central nervous system

516

5995

0.80

4.25

5.0

5.8

8.48

3.66

ug/l

0.88

455

5393

Other crystal arthropathies

312

2560

1.37

4.24

6.2

5.8

2.71

3.41

ug/l

0.54

272

2262

Other and unspecified glaucoma

923

8190

1.18

4.24

6.2

6.0

3.07

4.09

ug/l

0.90

799

7306

Malignant neoplasm of colon

2611

24395

1.11

4.24

5.7

4.4

3.35

2.16

ug/l

2.73

2320

21959

Noninfective enteritis and colitis

6634

63313

1.06

4.23

5.4

5.2

2.56

3.02

ug/l

1.20

6033

57534

Dislocation of lens

232

1830

1.42

4.22

5.9

5.8

7.00

6.94

ug/l

0.00

207

1622

Other and unspecified follicular disorders

630

5476

1.24

4.21

5.0

5.1

2.00

2.39

ug/l

0.66

578

4988

Calcific tendinitis of shoulder

593

5074

1.22

4.20

5.4

5.1

3.62

2.59

ug/l

0.21

545

4573

Disorders of mineral metabolism

1196

10783

1.16

4.19

5.3

5.5

4.11

3.29

ug/l

0.62

1076

9759

Hyperparathyroidism

1546

13855

1.13

4.19

5.6

5.7

2.74

3.67

ug/l

0.79

1374

12380

Sequelae of injuries, of poisoning and of other consequences of external causes

3707

34982

1.09

4.19

4.8

4.9

1.96

2.56

ug/l

2.82

3338

32119

Respiratory tuberculosis, not confirmed, including avohilmo

472

5534

0.80

4.18

5.1

6.0

2.85

4.53

ug/l

1.32

413

4896

Procreative management

3032

26756

0.92

4.17

4.2

3.8

1.62

1.76

ug/l

0.74

2816

24639

DVT of lower extremities

3004

28186

1.10

4.17

5.8

5.7

4.12

3.08

ug/l

0.64

2725

25516

Collagenous colitis

933

8249

1.17

4.16

5.8

5.5

2.12

3.34

ug/l

1.54

844

7432

Status epilepticus

394

4698

0.78

4.16

4.4

5.4

3.66

2.95

ug/l

0.25

353

4263

Other congenital malformations, including avohilmo

1046

9274

1.15

4.16

4.9

2.27

ug/l

0.00

962

8445

Implicit fungal Sepsis, including avohilmo

937

8330

1.18

4.14

5.7

6.0

2.47

2.98

ug/l

1.08

848

7508

Focal epilepsy

2822

30132

0.91

4.14

4.8

5.5

3.28

3.02

ug/l

0.24

2517

27312

Mixed disorders of conduct and emotions, excluding more controls

407

1.72

4.13

2.1

1.8

1.14

0.90

ug/l

0.20

359

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2580

27433

0.91

4.13

4.0

4.7

2.54

2.56

ug/l

0.02

2248

25405

Nummular dermatitis

1457

13351

1.15

4.12

5.7

5.8

2.74

3.31

ug/l

0.33

1321

12076

Disorders of parathyroid gland

1707

15371

1.12

4.11

5.6

5.7

2.80

3.57

ug/l

0.69

1515

13763

Malignant neoplasm of renal pelvis, including Hilmo

237

1927

1.48

4.10

5.2

4.4

2.51

2.10

ug/l

0.64

192

1714

Disorders of male genital organs in diseases classified elsewhere

165

1314

1.72

4.10

6.0

4.1

7.68

1.85

ug/l

0.55

151

1174

Prepatellar bursitis

999

9075

1.21

4.09

5.4

5.0

2.46

2.64

ug/l

0.23

912

8269

Dependence on enabling machines and devices, not elsewhere classified

1304

0.62

4.09

2.6

5.4

1.66

2.51

ug/l

1.80

1155

Schizophrenia or delusion

3735

39622

0.93

4.08

3.7

4.6

2.40

2.46

ug/l

0.05

3335

36412

Retinoschisis and retinal cysts

380

3201

1.33

4.08

6.4

5.9

3.38

2.73

ug/l

0.37

337

2877

Other and unspecified urticaria

1681

15319

1.12

4.07

5.4

5.0

2.04

2.45

ug/l

2.37

1532

13941

Strabismus

3044

28397

1.09

4.06

5.3

5.2

3.11

2.83

ug/l

0.18

2760

25848

Special screening examination for other diseases and disorders

1774

16283

1.12

4.05

5.3

5.4

4.27

3.13

ug/l

0.34

1697

14680

Human immunodeficiency virus [HIV] disease resulting in other conditions

240

2928

0.72

4.05

3.4

3.9

1.80

1.65

ug/l

0.18

226

2724

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

238

2932

0.72

4.04

5.4

4.5

2.48

2.19

ug/l

0.74

203

2615

Congenital malformations of the urinary system, including avohilmo

696

6065

1.20

4.04

5.1

5.2

2.02

2.57

ug/l

1.70

639

5491

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

240

2928

0.72

4.04

3.4

3.9

1.80

1.65

ug/l

0.18

226

2724

Other reaction to severe stress, and adjustment disorders

3374

31576

1.08

4.03

4.5

4.3

2.56

2.12

ug/l

0.41

3059

29114

Additional codes for the location of defect, injury or illness

694

6056

1.20

4.02

5.4

3.56

2.66

ug/l

0.28

651

5498

Cutaneous abscess, furuncle and carbuncle

4147

39291

1.08

4.02

4.8

5.1

2.13

2.84

ug/l

3.09

3776

35939

Convulsions, not elsewhere classified

3561

37266

0.92

4.02

4.8

5.2

2.70

2.85

ug/l

0.18

3142

33950

Open wound of ankle and foot

1680

15462

1.13

4.02

4.8

5.2

2.03

2.60

ug/l

2.44

1501

14113

Schizophrenia, schizotypal and delusional disorders

3758

39837

0.93

4.02

3.7

4.6

2.40

2.46

ug/l

0.05

3354

36591

Suggestive for eosinophilic asthma

1461

13381

1.14

4.01

5.7

5.5

3.04

3.11

ug/l

0.03

1340

12169

Reactive arthropathies

1165

10502

1.15

4.01

5.3

5.1

2.66

2.79

ug/l

0.11

1071

9586

Type 1 diabetes, wide definition, subgroup 1

2613

27963

0.91

4.00

3.9

4.9

1.87

2.84

ug/l

3.29

2363

25674

Crystal arthropathies, rheuma endpoint

312

2578

1.35

4.00

6.2

5.9

2.71

3.26

ug/l

0.39

272

2276

Budesonide

1696

15530

1.12

4.00

5.8

5.0

2.81

2.65

ug/l

0.10

1553

14141

Sleep disorders, other/unspecified

291

2324

1.31

3.99

4.3

1.46

1.88

ug/l

1.54

263

2125

Disorders of eyelid, lacrimal system and orbit

14083

100046

1.04

3.99

6.1

5.5

3.54

3.29

ug/l

0.25

12742

90594

Fenamates

1400

10527

0.89

3.97

5.5

5.0

2.69

3.72

ug/l

0.74

1264

9463

Schizophrenia or delusion, excluding more controls

3735

39081

0.93

3.97

3.7

4.7

2.40

2.39

ug/l

0.01

3335

36145

Postprocedural endocrine and metabolic disorders, not elsewhere classified

749

6504

1.17

3.94

5.5

5.0

1.96

2.55

ug/l

1.89

676

5868

Lung transplant status

140

1064

1.63

3.94

3.4

4.9

1.41

1.90

ug/l

2.06

116

970

Gingival hyperplasia

494

4229

1.25

3.94

5.8

5.4

3.08

2.54

ug/l

0.41

463

3833

Lung transplantation

140

1064

1.63

3.93

3.4

4.9

1.41

1.90

ug/l

2.06

116

970

Medial epicondylitis

421

3529

1.26

3.92

5.1

4.8

1.97

2.31

ug/l

0.79

387

3212

Other metabolic disorders

888

7812

1.16

3.92

5.4

5.1

1.89

2.66

ug/l

2.73

805

7057

Other complications of surgical and medical care, not elsewhere classified

1068

9564

1.15

3.91

5.6

5.4

6.92

2.85

ug/l

0.54

962

8672

Benign neoplasm of urinary organs

636

5550

1.22

3.91

6.6

6.0

2.49

3.14

ug/l

1.21

582

4971

Traumatic amputation of wrist and hand

985

9017

1.22

3.90

5.6

5.3

2.73

2.74

ug/l

0.01

919

8245

Alzheimer disease

5764

39392

1.07

3.90

5.3

6.6

6.12

4.76

ug/l

0.55

4979

34756

Dislocation, sprain and strain of joint and ligaments of hip

499

4276

1.25

3.87

5.4

5.7

3.45

3.02

ug/l

0.18

455

3837

Alcohol induced polyneuropathy

166

2055

0.66

3.87

4.8

5.5

1.73

2.42

ug/l

1.67

151

1859

Injury of muscle and tendon at wrist and hand level

2464

23097

1.11

3.87

5.2

5.0

1.82

2.44

ug/l

7.15

2277

21243

Congenital malformations of the urinary system

641

5573

1.20

3.85

5.0

5.2

2.04

2.58

ug/l

1.47

593

5043

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1396

12756

1.14

3.85

5.8

5.7

2.70

3.25

ug/l

0.75

1243

11527

Familial hypercholesterolemia, with ischemic heart disease

1909

17840

1.14

3.85

5.6

6.4

2.53

3.96

ug/l

4.25

1715

16020

Obsessive-compulsive disorder

474

3979

1.22

3.84

3.8

3.9

1.31

1.73

ug/l

2.04

422

3677

Acute pharyngitis

1985

18150

1.11

3.84

4.3

4.1

1.87

1.94

ug/l

0.13

1838

16844

Monoarthritis, not elsewhere classified

528

4535

1.23

3.84

4.9

5.2

2.17

2.78

ug/l

1.39

480

4095

Lung diseases due to external agents

2371

25282

0.90

3.81

5.2

5.9

3.69

3.86

ug/l

0.12

2030

22592

Anaemia in chronic diseases classified elsewhere

433

3725

1.30

3.81

5.7

5.9

8.60

2.99

ug/l

2.37

399

3337

Type 1 diabetes, strict definition, subgroup 1

436

5183

0.82

3.80

2.6

2.8

1.18

1.33

ug/l

0.91

398

4817

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

844

7460

1.17

3.80

4.3

4.0

1.78

2.15

ug/l

0.75

776

6868

Other and unspecified disorders of skin and subcutaneous tissue

727

6388

1.19

3.80

6.3

5.7

2.19

2.86

ug/l

1.51

641

5744

Infectious mononucleosis

631

5440

1.19

3.79

3.7

3.5

2.02

1.59

ug/l

0.69

580

5023

Infectious mononucleosis, including avohilmo

631

5440

1.19

3.79

3.7

3.5

2.02

1.59

ug/l

0.69

580

5023

Other specified and unspecified retinal disorders

482

4133

1.25

3.79

5.6

5.5

2.36

2.61

ug/l

0.28

440

3732

Suicide or other Intentional self-harm

2575

27585

0.92

3.79

4.0

4.6

2.54

2.36

ug/l

0.13

2247

25389

Social phobias

686

5950

1.18

3.78

4.0

3.7

1.68

1.66

ug/l

0.02

605

5508

Haemangioma, any site

923

8222

1.16

3.78

5.9

5.4

2.28

2.71

ug/l

1.17

848

7456

Separation of retinal layers (serosa)

776

6948

1.21

3.77

5.3

4.8

2.17

2.10

ug/l

0.22

715

6390

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

381

3178

1.27

3.76

5.4

4.7

1.75

2.05

ug/l

0.88

351

2920

Other follicular disorders

922

8228

1.17

3.75

4.6

4.9

1.74

2.31

ug/l

1.90

843

7542

Chromosomal abnormalities, not elsewhere classified

139

1006

1.45

3.75

3.5

3.7

1.04

1.76

ug/l

1.57

121

921

Other hammer toe(s) (acquired)

1382

11384

1.12

3.74

5.8

2.35

3.38

ug/l

2.59

1207

10211

Muscle strain

401

3368

1.26

3.74

5.0

4.8

2.74

2.56

ug/l

0.08

363

3044

Seminoma of testis, including Hilmo

210

1717

1.51

3.74

4.4

3.5

1.66

1.57

ug/l

0.24

186

1570

Diabetic retinopathy, excluding more controls

4207

22346

1.08

3.74

5.2

5.5

2.43

2.74

ug/l

0.41

3733

20118

Benign neoplasm: Kidney

444

3780

1.26

3.74

6.6

6.1

2.58

2.91

ug/l

0.37

405

3384

Kela-code for severe mental illness

4525

47606

0.94

3.74

4.1

4.7

2.57

2.48

ug/l

0.08

4045

43655

18544

91510

1.04

3.73

5.3

5.5

2.87

3.46

ug/l

2.21

16683

82831

Fentanyl

1385

15107

0.88

3.73

7.0

5.7

7.84

3.14

ug/l

4.98

1196

13535

Colon adenocarcinoma

2103

19616

1.11

3.72

5.7

4.4

3.50

2.14

ug/l

2.47

1875

17629

Human immunodeficiency virus [HIV] disease

266

3187

0.74

3.72

3.7

4.0

1.75

1.71

ug/l

0.05

251

2967

Other condition

1987

18428

1.11

3.70

5.0

4.9

2.55

2.44

ug/l

0.12

1846

16860

Human immunodeficiency virus [HIV] disease, including avohilmo

270

3229

0.74

3.70

3.7

4.0

1.77

1.71

ug/l

0.07

255

3005

Intermittent heterotropia

423

3531

1.23

3.69

5.6

4.8

2.30

2.15

ug/l

0.14

383

3206

Recurrent dislocation and subluxation of joint

718

6293

1.18

3.68

4.1

3.9

1.76

2.15

ug/l

0.64

661

5803

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2016

18725

1.11

3.66

5.4

5.7

2.78

3.30

ug/l

0.42

1796

16898

Haemorrhage, not elsewhere classified

629

5534

1.22

3.66

5.8

6.1

2.45

3.17

ug/l

1.77

554

4938

Alcoholic gastritis

240

2865

0.72

3.65

5.3

5.2

2.23

2.33

ug/l

0.12

219

2588

Malignant neoplasm of hypopharynx

852

0.52

3.65

3.8

4.3

1.77

2.00

ug/l

0.45

768

Focal epilepsy, strict definition

2661

28329

0.92

3.64

4.9

5.5

3.38

3.04

ug/l

0.30

2370

25686

Other/unspecified enthesopathies, not elsewhere classified

1098

9920

1.15

3.64

5.5

5.3

2.21

3.44

ug/l

1.69

978

8936

Other vitreous opacities

531

4594

1.23

3.63

6.3

5.8

2.60

2.83

ug/l

0.30

491

4138

Coeliac disease

1195

10802

1.14

3.63

5.1

5.4

2.20

2.75

ug/l

1.28

1096

9785

Superficial injury of ankle and foot

1305

11849

1.13

3.60

4.8

4.7

2.25

2.14

ug/l

0.08

1202

10824

Overexertion and strenuous or repetitive movements

1401

12842

1.13

3.60

4.8

2.33

2.25

ug/l

0.12

1285

11774

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

847

7536

1.17

3.60

5.6

5.9

3.25

3.13

ug/l

0.04

764

6763

Other sexually transmitted chlamydial diseases, including avohilmo

568

4863

1.19

3.59

3.1

2.8

1.53

1.31

ug/l

0.73

509

4495

Atrophic disorders of skin

750

6551

1.16

3.59

5.5

5.0

2.17

2.37

ug/l

0.27

679

5885

Other congenital malformations of skin, including avohilmo

707

6192

1.18

3.59

5.2

5.1

2.09

2.34

ug/l

0.60

651

5620

Viral pneumonia (known virus, not influenza)

417

3563

1.27

3.58

5.2

5.7

2.14

2.96

ug/l

1.41

378

3206

Orthopaedic devices associated with adverse incidents

243

1971

1.37

3.57

7.8

6.3

3.39

2.76

ug/l

0.24

213

1756

Cluster headache, wide

457

3899

1.23

3.56

4.7

4.6

1.73

2.28

ug/l

2.64

411

3597

Superficial injury of thorax

2400

22482

1.10

3.55

5.4

5.2

2.75

3.00

ug/l

0.23

2147

20461

Abnormal blood-pressure reading, without diagnosis

452

3838

1.23

3.53

5.6

5.1

1.93

2.47

ug/l

2.21

409

3475

Benign neoplasm of mouth and pharynx

1480

13610

1.13

3.53

5.6

5.5

2.38

3.12

ug/l

1.03

1323

12330

Viral pneumonia

2125

19840

1.11

3.53

4.9

5.6

2.51

3.28

ug/l

0.93

1926

18001

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2580

27608

0.92

3.52

4.0

4.6

2.54

2.36

ug/l

0.13

2248

25391

Patellar tendinitis

236

1901

1.35

3.51

4.3

3.8

1.65

1.77

ug/l

0.22

214

1751

Malignant neoplasm of other and unspecified parts of biliary tract

169

2139

0.71

3.50

4.5

4.4

2.11

2.03

ug/l

0.18

146

1915

N06DA Anticholinesterases

6190

45848

1.06

3.50

5.5

6.6

4.94

4.64

ug/l

0.10

5346

40584

Use of anticholinesterases

6190

45848

1.06

3.50

5.5

6.6

4.94

4.64

ug/l

0.10

5346

40584

Unspecified acute lower respiratory infection

2714

25575

1.09

3.49

4.4

5.0

2.47

2.80

ug/l

0.41

2512

23432

Preparatory care for dialysis

808

7307

1.20

3.49

4.2

5.5

2.50

2.66

ug/l

0.16

765

6634

Pyogenic arthritis

1104

10055

1.15

3.49

5.1

5.4

7.53

3.11

ug/l

0.46

999

9130

Other specified and unspecified disorders of lens

588

1.62

3.48

8.5

6.1

8.29

2.83

ug/l

0.77

504

Scleritis and episcleritis

568

4917

1.20

3.48

5.0

4.9

1.76

2.11

ug/l

1.90

535

4480

Arterial embolism and thrombosis

825

9159

0.85

3.48

4.7

6.0

3.08

4.13

ug/l

0.47

721

8187

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1904

17806

1.12

3.46

5.9

4.3

3.18

2.05

ug/l

2.42

1720

16143

Other disorders of pigmentation

462

3948

1.22

3.45

6.1

5.6

2.27

2.68

ug/l

0.62

416

3543

Peripheral retinal degeneration

368

3100

1.27

3.45

5.7

5.3

2.02

2.59

ug/l

1.09

332

2805

Infective bursitis

582

5179

1.25

3.45

5.3

5.1

3.74

2.60

ug/l

0.27

532

4683

Benign neoplasm: Adrenal gland

1070

9719

1.15

3.44

6.3

5.7

2.07

2.76

ug/l

3.49

998

8806

Follicular cysts of skin and subcutaneous tissue

2784

26224

1.09

3.44

5.6

5.2

3.24

2.80

ug/l

0.18

2541

23936

Urethritis and urethral syndrome

227

1810

1.34

3.43

5.6

4.7

1.97

2.11

ug/l

0.16

202

1637

Use of riluzole

566

0.48

3.43

3.4

5.7

14.56

2.29

ug/l

0.46

510

DVT of lower extremities and pulmonary embolism

7010

67227

1.06

3.42

5.7

5.8

3.57

3.67

ug/l

0.08

6288

60571

Abnormal findings on examination of urine, without diagnosis

667

5920

1.20

3.42

5.5

5.7

2.11

3.00

ug/l

2.31

604

5349

Embedded and impacted teeth

1622

14368

0.91

3.42

3.9

3.7

2.09

1.75

ug/l

0.33

1501

13135

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

17315

106690

1.04

3.41

5.7

5.3

3.89

3.12

ug/l

0.93

15589

97018

Disorders of calcium metabolism

827

7392

1.17

3.41

5.6

5.7

5.08

3.59

ug/l

0.86

748

6673

Monoamine oxidase A inhibitors

1475

13557

1.12

3.41

5.5

5.4

1.85

2.72

ug/l

6.67

1321

12430

Polypectomy (DHB20)

1315

12176

1.15

3.41

5.5

5.3

4.72

2.65

ug/l

0.66

1209

11089

Psoriatic arthropathies

1376

12622

1.13

3.40

4.8

5.0

1.96

2.70

ug/l

4.32

1238

11574

Use of levodopa decarboxylase inhibitor

2578

24349

1.10

3.39

5.7

6.3

4.35

3.80

ug/l

0.21

2306

21758

Thiazolidinediones

2141

20138

1.11

3.37

5.4

6.1

2.60

3.69

ug/l

1.50

1899

18298

Macular cyst

444

3835

1.25

3.37

6.4

6.0

2.51

3.24

ug/l

0.95

399

3435

Acute peritonitis

843

9346

0.86

3.37

4.6

5.6

2.23

3.45

ug/l

1.79

774

8422

Complications of other internal prosthetic devices, implants and grafts

498

4306

1.22

3.36

5.4

5.8

2.16

3.17

ug/l

2.41

441

3859

Secondary polycythaemia

438

3817

1.27

3.35

5.3

5.1

1.81

2.26

ug/l

1.75

398

3464

Diffuse large B-cell lymphoma, including Hilmo

798

7188

1.19

3.34

5.1

4.3

3.32

2.03

ug/l

1.22

710

6484

Diffuse large B-cell lymphoma

798

7188

1.19

3.34

5.1

4.3

3.32

2.03

ug/l

1.22

710

6484

Diffuse large B-cell lymphoma, helper endpoint

798

7188

1.19

3.34

5.1

4.3

3.32

2.03

ug/l

1.22

710

6484

Cerebral cysts

549

6292

0.84

3.34

4.2

5.3

1.70

2.67

ug/l

4.84

487

5692

Lichen sclerosus et atrophicus

429

3606

1.21

3.34

5.3

4.9

2.23

2.05

ug/l

0.16

383

3245

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

2713

25634

1.09

3.33

8.8

4.3

9.54

2.03

ug/l

3.55

2505

23210

Benign neoplasm of bone and articular cartilage

956

8608

1.15

3.33

5.5

5.0

1.92

2.36

ug/l

1.97

884

7857

Malignant neoplasm of larynx

264

3108

0.74

3.33

4.8

4.3

2.55

2.12

ug/l

0.52

230

2793

Other diseases of gallbladder

491

4236

1.21

3.33

5.6

5.8

2.22

4.04

ug/l

1.12

440

3780

Inflammatory disorders of male genital organs, not elsewhere classified

324

2805

1.38

3.32

5.2

4.5

2.66

2.29

ug/l

0.24

297

2481

Other/unspecified soft tissue disorders related to use, overuse and pressure

305

2521

1.28

3.31

5.7

4.9

1.68

2.39

ug/l

2.51

266

2277

Cluster headache, strict

422

3601

1.23

3.31

4.7

4.5

1.73

2.23

ug/l

2.02

380

3335

Asthma-related infections

8509

80068

1.05

3.31

5.0

5.3

2.78

3.44

ug/l

1.52

7698

72397

Asthma, hospital admission 2, infections

8509

80068

1.05

3.31

5.0

5.3

2.78

3.44

ug/l

1.52

7698

72397

Tubulo-interstitial nephritis, not specified as acute or chronic

762

6770

1.17

3.30

5.4

5.9

4.67

3.34

ug/l

0.84

682

5996

Haemangioma and lymphangioma, any site

973

8767

1.15

3.29

5.9

5.4

2.26

2.69

ug/l

1.24

893

7959

Unspecified mental disorder

4901

51282

0.94

3.29

4.1

4.8

2.52

2.49

ug/l

0.03

4388

46985

Pathological resorption of teeth

485

4206

1.22

3.29

5.8

5.2

3.55

2.43

ug/l

0.53

445

3832

Dislocation, sprain and strain of joints and ligaments of thorax

469

4056

1.23

3.29

5.4

5.2

1.83

2.52

ug/l

1.88

433

3698

Sequelae of injuries of upper limb

1362

12523

1.13

3.28

4.8

4.7

2.04

2.27

ug/l

0.31

1235

11487

Crushed, pushed or stepped on by crowd or human stampede

815

7267

1.16

3.28

4.5

4.1

1.78

1.87

ug/l

0.14

760

6669

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

2655

25013

1.09

3.27

5.5

5.4

3.31

2.81

ug/l

0.25

2488

22782

Seminoma of testis

181

1481

1.51

3.27

4.4

3.5

1.74

1.56

ug/l

0.49

160

1346

Nontoxic single thyroid nodule

476

4069

1.20

3.26

6.4

5.7

2.59

2.80

ug/l

0.26

424

3647

Alzheimer’s disease (Early onset)

427

4977

0.82

3.23

4.3

6.0

3.51

4.71

ug/l

0.62

370

4402

Postprocedural disorders of nervous system

442

3755

1.21

3.22

4.9

4.3

1.85

2.11

ug/l

0.27

410

3454

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2831

29909

0.92

3.21

6.0

4.4

5.17

2.07

ug/l

7.80

2495

27005

Other specified/unspecified bacterial intestinal infections

834

7490

1.16

3.21

5.7

5.6

2.54

3.54

ug/l

0.84

779

6763

Benign neoplasm: Rectosigmoid junction

627

5582

1.20

3.19

6.5

5.9

2.12

2.95

ug/l

2.67

565

5019

Unspecified misadventure during surgical and medical care

811

7299

1.17

3.19

6.0

5.7

2.31

2.69

ug/l

0.89

737

6601

Disorders of eyelid in diseases classified elsewhere

305

2529

1.27

3.19

5.5

5.3

15.82

2.84

ug/l

0.50

281

2284

Xerosis cutis

262

2178

1.33

3.18

6.1

6.0

1.80

2.52

ug/l

2.81

242

1941

therapeutic use

409

3518

1.25

3.18

7.0

6.1

2.78

2.85

ug/l

0.03

368

3147

Paralytic strabismus

1042

9507

1.15

3.17

5.8

5.7

3.96

3.47

ug/l

0.12

930

8571

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1181

9305

1.12

3.17

2.8

1.79

1.32

ug/l

0.30

1050

8561

Occlusion and stenosis of arteries, not leading to stroke

144

1843

0.71

3.16

5.2

6.4

3.43

3.57

ug/l

0.04

131

1607

Bipolar affective disorders

2006

18669

1.09

3.16

4.4

4.5

1.95

2.21

ug/l

0.63

1808

17210

Tongue abnormality

609

5353

1.18

3.15

6.3

5.6

2.06

2.60

ug/l

1.45

551

4820

IgA nephropathy (IgA glomerulonephritis)

406

3529

1.27

3.15

4.5

5.1

1.95

2.24

ug/l

0.73

384

3215

Other diseases of oesophagus

1547

14358

1.12

3.15

5.9

5.7

2.65

3.67

ug/l

2.03

1407

12908

Scabies, including avohilmo

1542

14203

1.11

3.15

4.4

2.10

ug/l

0.00

1397

13051

Simple and mucopurulent chronic bronchitis

481

5507

0.83

3.14

6.1

5.9

2.71

4.26

ug/l

1.21

428

4890

Carcinoma in situ of other and unspecified digestive organs

781

7080

1.19

3.14

6.3

5.7

2.75

2.77

ug/l

0.01

713

6406

Enlarged lymph nodes

2325

21823

1.09

3.13

5.4

5.5

3.22

2.71

ug/l

0.35

2117

19802

Focal epilepsy, mode (most common among epilepsy diagnosis)

2485

26373

0.92

3.13

4.9

5.5

3.41

3.04

ug/l

0.32

2220

23920

Panniculitis affecting regions of neck and back

414

3546

1.23

3.12

5.6

5.1

4.85

2.51

ug/l

0.37

375

3205

Other benign neoplasms of connective and other soft tissue

1153

10525

1.13

3.12

5.8

5.4

2.14

3.16

ug/l

1.72

1045

9518

Malignant neoplasm of kidney, except renal pelvis

1702

15925

1.12

3.12

5.8

4.3

3.19

2.06

ug/l

2.07

1545

14442

Other disorders of bone

2499

23490

1.09

3.12

5.1

4.8

1.95

2.54

ug/l

2.37

2270

21585

Toxic effect of alcohol

270

3199

0.77

3.12

4.0

4.8

2.19

2.10

ug/l

0.10

244

2935

Herpesviral keratitis and keratoconjunctivitis

551

4840

1.20

3.11

5.7

5.5

2.32

2.61

ug/l

0.39

501

4378

Heterophoria

637

5593

1.17

3.11

5.7

5.0

1.89

2.38

ug/l

1.43

579

5072

Occupational exposure to risk-factors

665

6010

1.22

3.11

5.5

5.8

4.21

2.67

ug/l

0.48

596

5433

Other or ill-defined heart diseases

719

8016

0.86

3.11

4.3

5.3

1.84

3.24

ug/l

2.08

645

7329

Toxic effect of ethanol

423

4889

0.82

3.10

3.9

4.7

1.76

2.23

ug/l

1.11

383

4468

Family history of malignant neoplasm

590

5132

1.17

3.10

6.0

4.8

1.96

2.26

ug/l

0.64

537

4660

Erythema intertrigo

339

2877

1.27

3.10

5.5

5.6

2.19

2.77

ug/l

0.62

303

2593

Episcleritis

468

4031

1.20

3.10

5.0

4.8

1.72

2.07

ug/l

1.57

439

3672

Drowning and submersion while in natural water

816

0.57

3.08

5.7

2.02

2.48

ug/l

0.40

731

Mesothelioma, including Hilmo

179

2181

0.72

3.08

5.0

4.6

2.80

2.15

ug/l

1.23

148

1951

Other general symptoms and signs

437

3700

1.21

3.08

5.3

2.84

2.26

ug/l

0.24

389

3334

Cirrhosis of liver, NAS

848

9293

0.86

3.06

4.4

5.7

1.77

3.39

ug/l

2.63

747

8428

Chondropathies

1849

17219

1.10

3.06

5.1

4.8

1.86

2.38

ug/l

4.01

1677

15793

Other necrotizing vasculopathies (FG)

761

6823

1.16

3.05

5.5

5.9

3.63

3.12

ug/l

0.17

673

6107

Raynaud syndrome

783

6986

1.15

3.05

5.4

5.3

2.20

2.40

ug/l

0.31

710

6341

All influenza (not pneumonia)

2436

22961

1.09

3.04

4.7

5.1

2.54

2.80

ug/l

0.32

2225

21055

Anosmia

277

2193

1.28

3.04

6.7

4.0

1.87

2.18

ug/l

1.29

247

2025

Disorders of synovium and tendon in diseases classified elsewhere

343

2937

1.28

3.04

5.4

5.0

1.91

2.77

ug/l

1.57

323

2659

Astigmatism

663

5862

1.17

3.04

5.3

5.2

1.94

2.59

ug/l

1.45

601

5315

Other abnormal findings in urine

248

2064

1.34

3.04

6.7

6.0

2.31

3.60

ug/l

1.27

224

1819

Drug-induced neutropenia

639

7202

0.86

3.04

5.9

5.7

4.89

2.67

ug/l

1.94

560

6495

Other and unspecified rosacea

866

7779

1.14

3.04

5.6

5.5

1.88

2.78

ug/l

3.73

776

7051

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

2253

21165

1.09

3.03

5.5

5.4

3.54

2.63

ug/l

0.45

2109

19287

Asthma and allergy

851

7493

1.14

3.03

4.2

4.1

2.10

1.80

ug/l

0.26

776

6874

Ectopic pregnancy

2.26

3.02

1.2

1.1

—

1.53

—

Malignant neoplasm of head and neck

1404

15062

0.89

3.01

5.0

4.2

2.73

1.97

ug/l

1.36

1236

13665

Vertigo of central origin

191

1530

1.36

3.01

5.9

3.36

2.63

ug/l

0.39

167

1355

Rheumatic valve diseases

209

2564

0.76

3.00

4.7

5.8

2.82

3.70

ug/l

0.63

187

2260

Fracture of femur

3893

36773

0.94

2.99

5.4

5.9

4.59

4.32

ug/l

0.11

3416

32769

Elevated blood glucose level

1192

10953

1.13

2.99

5.1

4.9

2.16

2.84

ug/l

0.91

1060

9916

Dermatographic urticaria

425

3626

1.20

2.98

5.7

5.0

1.79

2.26

ug/l

2.02

386

3284

Mixed disorders of conduct and emotions

445

1.56

2.98

2.1

1.8

1.14

0.87

ug/l

0.22

396

Asthma and allergy, excluding more controls

851

7504

1.14

2.98

4.2

4.1

2.10

1.78

ug/l

0.28

776

6890

Duodenal ulcer

1966

20873

0.91

2.98

5.7

5.9

4.25

3.96

ug/l

0.14

1742

18687

Adenocarcinoma and Papillary adenocarcinoma of kidney

263

2270

1.41

2.98

6.1

4.3

2.19

1.90

ug/l

1.24

249

2046

Peritonsillar abscess

2854

26983

1.08

2.96

4.8

4.7

2.20

2.61

ug/l

0.86

2616

24795

Ulcerative proctitis

732

6548

1.16

2.96

5.5

5.0

3.26

2.11

ug/l

0.47

672

5964

Complications of genitourinary prosthetic devices, implants and grafts

265

2191

1.28

2.96

7.1

5.9

4.12

3.42

ug/l

0.26

235

1947

Valvular operations

3197

30557

1.09

2.96

5.3

6.0

2.67

3.89

ug/l

3.20

2876

27712

Ankylosing spondylitis, ICD10

1267

11689

1.13

2.95

5.0

4.8

3.48

2.29

ug/l

0.88

1146

10717

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

732

6454

1.15

2.95

4.7

4.5

1.85

1.96

ug/l

0.15

664

5893

Trigeminal neuralgia

517

4502

1.19

2.95

5.6

5.4

2.12

2.90

ug/l

1.51

459

4058

Other septicaemia, including avohilmo

7386

67068

1.05

2.95

5.6

5.9

5.15

3.26

ug/l

1.63

6598

60323

Acne

610

5310

1.16

2.95

3.7

1.66

ug/l

0.00

562

4874

Torsion of testis

280

2349

1.29

2.94

3.5

3.0

1.62

1.37

ug/l

0.86

260

2144

Other keratitis

1394

12864

1.11

2.94

4.9

2.04

2.74

ug/l

1.20

1275

11753

Pilonidal cyst

1295

11951

1.12

2.94

4.0

1.49

1.78

ug/l

2.32

1193

11058

Abscess of lung

208

2499

0.75

2.94

5.0

5.6

2.29

2.87

ug/l

0.75

177

2244

Embolic stroke

693

7672

0.85

2.93

5.4

6.3

3.43

4.54

ug/l

0.74

623

6800

Endovascular or surgical operations to intracerebral aneurysms

604

6801

0.85

2.92

4.9

5.5

2.00

2.67

ug/l

2.79

561

6166

Malignant neoplasm of larynx, including Hilmo

341

3898

0.78

2.92

5.0

4.3

2.50

2.11

ug/l

0.59

298

3498

Reactive arthropathies, FINNGEN

891

8069

1.14

2.92

5.1

5.0

2.28

2.54

ug/l

0.37

820

7348

Fracture of foot, except ankle

2996

28351

1.07

2.92

4.8

4.9

2.44

2.53

ug/l

0.11

2717

25993

Inguinal hernia, unilateral

334

2840

1.25

2.92

6.3

5.7

2.35

2.92

ug/l

0.69

305

2529

Femoral hernia, unilateral

334

2840

1.25

2.92

6.3

5.7

2.35

2.92

ug/l

0.69

305

2529

Inguinal of femoral hernia, unilateral

334

2840

1.25

2.92

6.3

5.7

2.35

2.92

ug/l

0.69

305

2529

Myopia

1041

9438

1.12

2.91

4.7

4.4

1.86

2.06

ug/l

0.80

943

8648

Dental pulpitis, including avohilmo

13689

89898

0.97

2.90

4.8

5.1

2.32

2.64

ug/l

0.95

12523

82460

Medicines for HER+ breast cancer

228

1689

1.26

2.90

5.1

4.1

1.63

2.01

ug/l

0.83

178

1293

Other deformities of toe(s)

275

2272

1.26

2.90

6.1

5.4

2.21

3.18

ug/l

0.87

226

2029

Viral hepatitis, IBD co-morbidity

697

6220

1.16

2.88

3.6

4.0

1.96

2.26

ug/l

0.24

610

5812

Bell's palsy

1593

14816

1.11

2.87

5.6

5.3

2.47

3.08

ug/l

1.02

1431

13481

Diabetic neuropathy

1868

19703

0.90

2.86

5.1

5.5

2.44

2.76

ug/l

0.19

1684

17671

Carcinoma in situ of rectum

254

2168

1.36

2.86

7.0

5.8

2.40

2.57

ug/l

0.23

235

1959

L02BG Aromatase inhibitors

125

908

1.36

2.84

3.6

2.9

1.31

1.44

ug/l

0.36

605

Nonischemic cardiomyopathy

1735

18436

0.90

2.83

4.8

5.8

2.80

3.55

ug/l

1.46

1547

16776

Postzoster neuralgia

205

1672

1.33

2.83

5.8

5.9

2.45

3.24

ug/l

0.64

179

1489

Melanocytic naevi of lower limb, including hip

413

3556

1.21

2.83

6.0

5.4

1.98

2.37

ug/l

1.36

377

3216

Other specified/unspecified inflammatory spondylopathies

403

3454

1.21

2.83

4.6

4.4

2.04

2.06

ug/l

0.01

379

3150

Nutritional anaemias

7486

68998

1.05

2.81

5.6

6.0

3.63

3.91

ug/l

0.39

6625

61849

Other or unspecified ileus, impaction or obstruction

3205

30519

1.07

2.80

5.4

5.6

3.00

3.61

ug/l

1.11

2836

27415

Cluster headache, strict, including avohilmo

532

4678

1.18

2.80

4.8

4.5

1.77

1.95

ug/l

0.61

485

4297

Undefined dementia

1520

15089

0.91

2.79

4.5

6.2

4.93

5.51

ug/l

0.15

1317

13174

Acute renal failure

4490

43206

1.07

2.78

5.0

6.0

3.88

3.66

ug/l

0.23

4019

38857

Spinal osteochondrosis

148

1167

1.40

2.77

4.8

4.3

1.55

2.18

ug/l

1.25

138

1061

Speech and linguistic disorders, excluding more controls

559

4589

1.16

2.77

4.0

4.3

2.30

2.11

ug/l

0.14

496

4180

Abnormal findings on diagnostic imaging of central nervous system

547

4825

1.18

2.77

5.0

5.2

3.43

2.69

ug/l

0.28

483

4390

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

472

4174

1.22

2.76

4.4

5.1

2.11

2.19

ug/l

0.13

442

3806

Adverse effects, not elsewhere classified

1711

15901

1.09

2.76

5.4

5.2

2.16

2.51

ug/l

0.63

1548

14434

Osteonecrosis

858

7805

1.15

2.76

8.5

5.5

6.27

2.61

ug/l

3.73

791

7100

Glaucoma

9473

78143

1.04

2.76

6.2

5.9

3.68

3.67

ug/l

0.01

8409

70250

Disorders of optic nerve and visual pathways

936

8497

1.13

2.75

5.3

3.55

2.72

ug/l

0.32

841

7680

Salpingitis and oophoritis

124

2.02

2.75

1.3

1.1

—

0.45

—

Vascular dementia (multiple infarctions)

133

1701

0.73

2.74

4.7

6.4

2.34

8.34

ug/l

1.61

111

1486

Other embolism and thrombosis

1809

16948

1.10

2.72

5.5

5.6

6.49

2.96

ug/l

0.92

1623

15352

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1963

18097

1.08

2.72

4.8

5.0

3.51

2.79

ug/l

0.39

1767

16445

Mesothelioma

154

1860

0.71

2.72

5.0

4.7

2.54

2.17

ug/l

0.71

128

1663

Laparoscopic right hemicolectomy

850

7762

1.15

2.71

6.4

6.1

3.57

3.08

ug/l

0.21

780

6967

Other disorders of optic [2nd] nerve and visual pathways

737

6636

1.15

2.71

5.4

5.5

3.91

2.69

ug/l

0.39

660

5986

Hyperprolactinaemia

189

1504

1.29

2.70

5.6

4.7

1.36

2.19

ug/l

2.32

177

1370

Cluster headache, wide,, including avohilmo

567

5021

1.17

2.70

4.8

4.5

1.77

1.99

ug/l

0.88

516

4608

Cramp and spasm

586

5219

1.17

2.69

5.4

5.3

1.86

2.42

ug/l

1.71

538

4730

Bullous disorders

782

7092

1.15

2.68

5.3

5.9

3.55

3.80

ug/l

0.06

708

6351

Acne vulgaris

462

3989

1.18

2.68

3.5

3.2

1.35

1.47

ug/l

0.51

426

3667

Other/unspecified disorders of vestibular function

455

3979

1.20

2.68

5.9

5.8

2.42

2.85

ug/l

0.44

418

3585

Senility

108

802

1.43

2.68

5.7

6.4

14.04

3.84

ug/l

0.64

692

Other obstructive and reflux uropathy

485

4258

1.19

2.66

6.4

5.6

7.24

2.80

ug/l

1.12

425

3794

Malignant neoplasm, without specification of site

375

4311

0.82

2.65

5.1

4.3

3.45

2.22

ug/l

0.89

330

3851

Hypo-osmolality and hyponatraemia

2478

23255

1.08

2.65

5.3

5.8

3.75

3.55

ug/l

0.13

2181

20953

Malignant neoplasm, without specification of site, including Hilmo

550

6171

0.85

2.65

5.1

4.2

3.19

2.19

ug/l

1.14

491

5515

Peripheral arterial reconstruction

3306

34467

0.93

2.65

5.1

6.3

6.14

3.94

ug/l

0.47

2879

30829

Early lumbar disc prolapse operation

1205

11100

1.11

2.64

3.3

3.2

1.44

1.45

ug/l

0.03

1143

10408

Other disorders starting during childhood or adolecense, excluding more controls

163

1210

1.31

2.64

3.0

2.8

1.04

1.36

ug/l

1.66

151

1094

Chronic pancreatitis

2330

24486

0.92

2.63

4.8

5.4

2.88

2.86

ug/l

0.01

2092

22321

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

14423

109599

1.03

2.62

5.4

5.3

2.17

3.08

ug/l

11.43

13222

99641

Any dementia

7214

48329

1.05

2.62

5.3

6.7

4.96

4.42

ug/l

0.25

6286

42928

Alzheimer’s disease (Early onset), excluding more controls

427

4611

0.84

2.62

4.3

5.8

3.51

5.51

ug/l

1.45

370

4089

Sequelae of cerebrovascular disease

6845

60273

0.95

2.61

5.4

6.1

4.65

3.82

ug/l

0.46

6060

54115

Acute laryngitis and tracheitis

968

8657

1.12

2.60

3.8

3.6

1.41

1.78

ug/l

2.14

870

7929

Other infective otitis externa

780

7072

1.15

2.60

5.8

5.5

2.07

2.95

ug/l

2.73

699

6421

Lesion of lateral popliteal nerve

789

7197

1.16

2.60

5.1

5.2

1.99

2.82

ug/l

2.72

712

6553

Hyperkalaemia

1040

9611

1.14

2.59

5.2

6.0

3.50

4.18

ug/l

0.49

933

8592

Hypotension due to drugs

249

2120

1.31

2.59

5.7

6.1

2.58

3.72

ug/l

0.85

220

1876

Insulin, fast-acting

6007

62072

0.95

2.58

4.6

5.5

2.40

3.07

ug/l

1.83

5384

56437

Noninfectious colitis NAS

1520

14139

1.10

2.58

5.0

5.2

2.77

3.01

ug/l

0.17

1374

12787

Injuries to the ankle and foot

9768

85761

0.96

2.58

4.8

4.9

2.28

2.64

ug/l

1.31

8881

78621

Retinal haemorrhage

335

2888

1.24

2.58

5.7

5.8

2.19

2.53

ug/l

0.45

296

2582

Other strabismus

2128

19913

1.08

2.58

5.1

4.9

2.63

2.61

ug/l

0.01

1947

18186

Anogenital herpesviral [herpes simplex] infection

417

3603

1.18

2.56

4.8

4.3

1.77

1.81

ug/l

0.09

378

3326

Fall involving bed

445

3918

1.20

2.55

5.1

6.2

7.70

3.62

ug/l

0.42

397

3466

556

6242

0.86

2.55

4.5

5.8

10.05

4.92

ug/l

0.46

497

5474

Unspecified chronic bronchitis

422

4795

0.84

2.55

5.9

5.7

2.42

4.47

ug/l

1.40

369

4264

Malignant neoplasm of endocrine gland

605

5382

1.15

2.54

6.0

4.0

2.32

1.83

ug/l

1.60

544

4874

Other and unspecified effects of external causes

2921

27718

1.07

2.54

4.9

2.31

2.59

ug/l

0.44

2624

25304

Disturbances of smell and taste

414

3605

1.20

2.53

6.4

5.4

1.81

2.67

ug/l

2.14

379

3267

Mixed and other personality disorders

820

7435

1.13

2.53

4.1

1.57

1.80

ug/l

0.52

737

6871

Disorders resulting from impaired renal tubular function

574

5167

1.19

2.53

3.9

5.4

2.10

2.50

ug/l

0.77

545

4679

Other congenital malformations of urinary system

439

1.62

2.52

5.1

4.8

1.62

1.83

ug/l

0.29

391

Thyrotoxicosis with diffuse goitre

756

6785

1.13

2.51

5.6

5.2

2.17

2.63

ug/l

1.12

665

6146

Rash and other nonspecific skin eruption

951

8686

1.12

2.50

5.4

5.5

2.26

3.50

ug/l

1.61

869

7798

Fibrosis and cirrhosis of liver

1040

11245

0.89

2.50

4.5

5.7

1.99

3.26

ug/l

1.94

923

10180

Diseases of the digestive system

8199

79065

1.04

2.50

5.5

5.8

3.52

3.64

ug/l

0.08

7296

71231

Respiratory tuberculosis, clinically confirmed

142

1756

0.73

2.50

4.4

5.9

2.23

3.90

ug/l

2.25

126

1537

Malignant neoplasm of head and neck, including Hilmo

1688

17889

0.91

2.50

5.1

4.2

2.85

2.01

ug/l

1.77

1496

16217

Rheumatic fever incl heart disease

303

3529

0.82

2.50

5.1

5.8

2.66

4.54

ug/l

0.85

274

3136

Arthropod-borne viral fevers and viral haemorrhagic fevers

1566

14709

1.11

2.49

5.3

5.2

2.03

2.59

ug/l

3.34

1474

13435

Other congenital malformations of the digestive system, including avohilmo

456

3963

1.18

2.49

5.2

5.4

2.17

2.56

ug/l

0.66

417

3564

Meralgia paraesthetica

416

3646

1.20

2.48

5.8

5.2

1.95

2.30

ug/l

0.56

384

3351

Sequelae of other accidents

175

2121

0.76

2.48

4.4

5.5

4.34

2.61

ug/l

0.30

149

1892

Foreign body entering into or through eye or natural orifice

1324

12362

1.11

2.47

5.0

4.9

2.80

2.32

ug/l

0.28

1221

11320

Hypermetropia

689

6187

1.14

2.47

5.9

5.2

2.65

2.41

ug/l

0.18

632

5599

Malignant neoplasm of heart, mediastinum and pleura

183

2182

0.75

2.47

5.3

4.5

2.53

2.12

ug/l

0.92

153

1954

Other disorders involving the immune mechanism, not elsewhere classified

494

4413

1.20

2.47

4.5

5.1

2.08

2.20

ug/l

0.20

461

4020

Other disorders starting during childhood or adolescence

163

1269

1.29

2.46

3.0

2.8

1.04

1.17

ug/l

0.81

151

1134

Autoimmune diseases related-to ILD

12991

110978

0.97

2.45

5.0

5.3

2.44

3.13

ug/l

3.98

11770

100967

Other specified/unspecified dorsopathies

350

3018

1.21

2.45

5.2

5.1

2.41

2.68

ug/l

0.21

310

2717

Anankastic personality disorder

322

2748

1.21

2.45

4.6

4.5

1.55

1.89

ug/l

1.06

297

2530

Other diseases of blood and blood-forming organs

1005

9275

1.13

2.45

5.3

5.5

2.67

3.19

ug/l

0.31

891

8391

Gastroduodenal ulcer

4717

48724

0.95

2.44

5.6

5.9

3.35

4.22

ug/l

1.40

4226

43587

Sacrococcygeal disorders, not elsewhere classified

197

1599

1.27

2.44

5.9

4.8

1.73

2.31

ug/l

1.30

182

1448

Asthma (only as main-diagnosis), excluding more controls

10377

58920

0.97

2.44

5.1

5.3

2.36

3.20

ug/l

2.63

9457

54191

Other and specified injuries of hip and thigh

300

2576

1.24

2.43

6.0

5.7

2.02

3.29

ug/l

1.78

262

2302

Bitten or struck by other mammals

985

9006

1.11

2.43

5.0

4.7

2.28

2.33

ug/l

0.05

886

8220

Benign lipomatous neoplasm of other sites/unspecified

1101

10178

1.12

2.43

5.9

5.7

5.87

3.44

ug/l

0.38

998

9148

Infections with a predominantly sexual mode of transmission, including avohilmo

2954

25617

1.06

2.43

4.2

4.0

2.74

1.89

ug/l

0.44

2663

23530

Fracture of neck

1097

10210

1.13

2.43

5.8

5.7

3.04

3.35

ug/l

0.17

990

9206

Femoral hernia

543

4850

1.17

2.42

6.3

5.8

2.62

3.38

ug/l

0.92

495

4341

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

970

8892

1.12

2.42

5.5

5.4

7.67

2.88

ug/l

0.58

861

8063

Arterial embolism and thrombosis of lower extremity artery

478

5341

0.84

2.41

4.6

6.1

2.08

4.03

ug/l

1.82

415

4770

Pterygium

519

4679

1.20

2.41

6.7

6.1

5.44

2.99

ug/l

0.55

462

4183

Personality and behavioural disorders due to brain disease, damage and dysfunction

178

2133

0.76

2.41

4.8

5.4

3.03

2.32

ug/l

0.39

140

1923

Other bacterial intestinal infections

2625

24955

1.07

2.41

5.5

5.7

3.24

3.48

ug/l

0.18

2384

22498

Hyperhidrosis

212

1737

1.26

2.40

5.9

4.9

1.98

2.20

ug/l

0.29

190

1579

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

271

2269

1.22

2.40

6.2

5.7

1.80

2.62

ug/l

1.82

228

2001

Cystic kidney disease, including avohilmo

454

4024

1.19

2.39

5.0

5.4

2.02

2.48

ug/l

1.25

421

3649

Other and unspecified local infections of skin and subcutaneous tissue

1405

13125

1.10

2.39

5.3

5.4

2.12

3.14

ug/l

2.16

1265

11914

Inflammation of lacrimal passages (chronic)

139

1097

1.35

2.38

5.7

3.10

2.82

ug/l

0.12

125

962

Disorders of acoustic nerve

337

2926

1.22

2.38

6.6

5.5

5.58

2.62

ug/l

0.59

310

2640

Aphakia

230

1938

1.28

2.37

5.8

5.5

7.17

3.94

ug/l

0.30

206

1735

Myositis

354

3091

1.22

2.37

5.2

5.4

3.22

2.59

ug/l

0.33

332

2779

Other disorders of Eustachian tube

325

2803

1.22

2.35

6.3

5.3

2.24

2.61

ug/l

0.44

303

2533

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1237

11549

1.11

2.35

5.3

5.2

2.02

2.58

ug/l

2.51

1163

10551

Injury of urinary and pelvic organs

352

3097

1.24

2.35

5.3

5.2

5.08

2.51

ug/l

0.52

315

2796

Other specified/unspecified spondylopathies

323

2799

1.23

2.35

6.3

5.7

2.42

4.42

ug/l

0.72

295

2488

Other septicaemia

7191

65856

1.04

2.33

5.5

6.0

4.96

3.28

ug/l

1.40

6415

59231

Unspecified privation

1435

13418

1.10

2.33

5.4

5.3

2.97

3.10

ug/l

0.06

1277

12169

Psoriatic and enteropathic arthropathies

1549

14512

1.09

2.33

4.9

5.0

2.03

2.53

ug/l

2.38

1397

13282

Other and unspecified mononeuropathies of upper limb

392

3446

1.20

2.32

5.3

4.9

1.56

2.19

ug/l

3.72

362

3159

Dissection of aorta

522

5756

0.84

2.32

5.4

5.9

2.62

3.90

ug/l

0.76

453

5154

Unspecified human immunodeficiency virus [HIV] disease

148

1771

0.73

2.32

3.7

4.0

1.85

1.73

ug/l

0.09

140

1645

Biomechanical lesions, not elsewhere classified

624

5634

1.15

2.31

5.7

5.6

2.13

2.79

ug/l

1.60

562

5099

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

337

0.47

2.31

7.8

4.6

3.14

2.41

ug/l

0.45

292

Malignant neoplasm of hypopharynx, including Hilmo

105

1291

0.68

2.31

3.9

4.3

3.00

2.01

ug/l

0.56

1151

Other secondary gonarthrosis

737

6727

1.14

2.31

5.7

5.4

1.94

2.72

ug/l

3.48

670

6084

Dronedarone medication

486

4375

1.20

2.30

6.5

6.2

3.11

2.91

ug/l

0.08

426

3963

Motor neuron disease ALS

256

2969

0.80

2.30

4.1

6.2

5.51

3.70

ug/l

0.35

222

2691

Certain disorders involving the immune mechanism

2581

24564

1.07

2.30

5.0

5.2

2.32

2.67

ug/l

0.77

2362

22425

Other disorders of urethra and urinary system

9344

66780

0.97

2.30

7.0

5.8

5.08

3.62

ug/l

1.32

8342

59759

Non-seminoma of testis, including Hilmo

102

800

1.49

2.29

3.8

2.9

1.14

1.34

ug/l

0.69

732

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

324

3714

0.82

2.29

5.5

6.0

3.16

4.93

ug/l

0.82

282

3269

Amyloidosis

355

3123

1.22

2.29

5.3

6.1

2.40

3.47

ug/l

1.63

318

2764

Discitis, unspecified

295

2574

1.26

2.29

5.4

5.6

2.09

2.66

ug/l

1.17

266

2305

Other postsurgical states

828

7579

1.13

2.29

5.6

5.4

2.31

2.88

ug/l

1.30

766

6871

Other and unspecified drugs and medicaments

910

8346

1.12

2.28

5.6

5.4

8.02

2.84

ug/l

0.60

814

7549

Kela-code for behavioural disturbances in mental retardation

973

0.67

2.28

4.4

5.3

1.83

2.28

ug/l

0.28

877

Other dialysis

526

4763

1.19

2.28

3.8

5.4

1.84

2.55

ug/l

2.30

508

4316

Respiratory tuberculosis, bacteriologically and histologically confirmed

219

2578

0.79

2.27

4.9

5.7

6.24

4.93

ug/l

0.13

195

2282

Hordeolum and other deep inflammation of eyelid

637

5742

1.14

2.27

5.2

5.0

2.48

2.26

ug/l

0.15

589

5217

Viral and other specified intestinal infections

2078

19111

1.07

2.27

4.3

4.2

2.16

2.63

ug/l

0.54

1917

17368

Other epidermal thickening

591

5330

1.16

2.27

5.5

5.7

3.15

3.18

ug/l

0.01

546

4788

Malignant neoplasm of endocrine gland, including Hilmo

695

6277

1.13

2.27

6.1

4.0

2.42

1.87

ug/l

2.07

622

5666

Malignant neoplasm of thyroid gland, including Hilmo

586

5241

1.14

2.27

6.1

4.0

2.30

1.83

ug/l

1.71

529

4749

Other local infections of skin and subcutaneous tissue

1515

14222

1.10

2.26

5.3

5.4

2.10

3.09

ug/l

2.33

1361

12926

Malignant neoplasm of thyroid gland

531

4723

1.15

2.26

6.0

4.0

2.28

1.83

ug/l

1.41

481

4285

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

156

1855

0.74

2.26

3.6

4.0

1.82

1.72

ug/l

0.08

148

1723

Injury of nerves at wrist and hand level

588

5326

1.16

2.25

4.9

4.7

1.75

2.09

ug/l

1.89

537

4892

Use of disulfiram, acamprosate or naltrexone

1658

15691

1.10

2.25

4.4

2.00

1.96

ug/l

0.05

1478

14546

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

182

1515

1.32

2.25

7.6

6.1

2.62

3.04

ug/l

0.32

157

1335

Other disorders of glucose regulation and pancreatic internal secretion

972

10521

0.90

2.24

4.4

5.3

2.00

3.24

ug/l

2.22

855

9513

Thyroiditis, ILD-related definition

636

5702

1.13

2.22

5.6

5.2

3.00

2.50

ug/l

0.29

578

5119

Osteopathies and chondropathies

7264

68352

0.96

2.21

5.7

5.3

3.47

3.09

ug/l

0.21

6495

62116

Candidiasis

1342

12495

1.09

2.21

5.5

3.06

3.12

ug/l

0.04

1205

11313

Traumatic subarachnoid haemorrhage

654

5974

1.16

2.20

5.4

5.7

5.62

3.77

ug/l

0.25

581

5411

Polycystic kidney disease

343

3007

1.21

2.20

4.3

5.2

1.92

2.55

ug/l

1.38

322

2728

Pneumothorax

1192

12703

0.90

2.19

5.4

5.7

4.64

3.42

ug/l

0.52

1069

11480

Vascular disorders of the intestines

1096

10201

1.11

2.19

6.0

5.9

3.24

3.78

ug/l

0.60

974

9109

Osteonecrosis due to drugs

223

1905

1.29

2.19

17.6

5.9

16.59

2.44

ug/l

4.53

213

1707

Other/unspecified seropositive rheumatoid arthritis

2395

25235

0.94

2.19

5.0

5.8

2.49

3.26

ug/l

2.09

2145

22754

Family history of certain disabilities and chronic diseases leading to disablement

342

2954

1.19

2.19

4.9

4.3

1.99

1.95

ug/l

0.07

309

2696

Gilbert syndrome

110

870

1.42

2.18

5.4

4.9

1.98

2.46

ug/l

0.41

102

792

Parkinson's disease, strict definition

2633

25215

1.08

2.18

5.7

6.3

4.51

3.73

ug/l

0.32

2360

22565

Contact with nonpowered hand tool

843

7836

1.15

2.17

5.7

5.0

2.00

2.28

ug/l

0.92

766

7185

Seropositive rheumatoid arthritis, wide

2433

25618

0.94

2.17

5.0

5.8

2.48

3.25

ug/l

2.12

2180

23109

Sequelae of other external causes

707

6442

1.14

2.17

5.4

2.54

2.60

ug/l

0.05

645

5820

Giant cell arteritis

490

4384

1.17

2.17

6.1

6.2

4.38

3.09

ug/l

0.31

436

3898

Cystic kidney disease

414

3676

1.19

2.16

4.9

5.3

2.03

2.49

ug/l

1.06

386

3330

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

723

0.61

2.16

6.7

5.3

2.90

1.93

ug/l

0.79

639

Failure and rejection of transplanted organs and tissues

210

1786

1.29

2.16

4.4

4.8

2.33

2.12

ug/l

0.16

196

1634

Caught, crushed, jammed or pinched in or between objects

789

7252

1.13

2.16

4.9

4.7

2.07

ug/l

0.01

734

6642

Persons encountering health services for specific procedures, not carried out

1115

10354

1.11

2.16

4.9

2.58

2.15

ug/l

0.25

987

9450

Lesion of plantar nerve

376

3275

1.17

2.16

6.4

5.5

1.96

2.81

ug/l

1.83

345

2946

Benign neoplasm: Conjunctiva

382

3367

1.19

2.15

6.2

5.6

4.61

2.71

ug/l

0.44

343

3033

Pemphigoid

391

3471

1.20

2.15

5.4

6.3

5.18

3.58

ug/l

0.25

355

3081

Personal history of malignant neoplasm

234

1948

1.21

2.14

5.4

5.1

2.05

2.28

ug/l

0.45

200

1697

Complications peculiar to reattachment and amputation

996

0.68

2.14

4.2

5.3

1.95

2.69

ug/l

0.64

901

Campylobacter enteritis

374

3304

1.20

2.14

5.5

5.1

1.78

2.29

ug/l

1.64

332

2992

Other chondrocalcinosis

209

1786

1.30

2.13

5.7

6.0

2.94

2.84

ug/l

0.05

181

1579

Congenital malformations of eye, ear, face and neck

513

4571

1.15

2.13

5.1

4.8

2.04

2.10

ug/l

0.14

461

4153

Hypertrophic disorders of skin

399

3494

1.17

2.13

5.5

4.9

2.25

2.43

ug/l

0.16

371

3174

Exposure to excessive heat of man-made origin

1200

0.71

2.13

4.5

5.4

3.50

2.40

ug/l

0.30

1055

Mandibular retrognathia

434

3812

1.16

2.11

4.9

4.4

1.66

1.84

ug/l

0.60

407

3505

Radial styloid tenosynovitis [de Quervain]

331

2857

1.18

2.10

5.8

4.6

1.69

2.30

ug/l

1.94

302

2578

Motor neuron disease (with DMD)

259

2982

0.81

2.10

4.1

6.1

5.45

3.69

ug/l

0.34

225

2702

Benign neoplasm: Epididymis

785

1.80

2.10

5.9

5.1

1.89

2.29

ug/l

0.40

709

Other rupture of muscle

730

1.44

2.10

6.1

5.1

1.63

2.67

ug/l

1.12

661

Crystalline deposits in vitreous body

165

1390

1.36

2.10

6.4

6.0

2.58

2.95

ug/l

0.26

146

1231

Hypothyroidism, drug reimbursement

1304

8457

1.09

2.09

5.4

3.5

1.91

1.90

ug/l

0.05

1171

7916

Hyperaldosteronism

388

3447

1.20

2.09

6.0

5.5

2.47

2.38

ug/l

0.10

360

3123

271

2330

1.22

2.09

4.8

4.3

1.51

1.96

ug/l

1.31

246

2152

Benign neoplasm of brain and other parts of central nervous system

777

7129

1.13

2.09

6.1

5.5

4.10

2.62

ug/l

0.68

709

6469

Other and unspecified erythematous conditions

313

2716

1.20

2.09

6.0

5.5

2.40

2.51

ug/l

0.11

283

2421

Malignant neoplasm of renal pelvis

118

965

1.45

2.08

4.8

4.5

1.99

2.14

ug/l

0.29

851

Spondyloarthritis

2522

24042

1.07

2.08

5.1

5.2

3.19

3.03

ug/l

0.13

2282

21855

Hypoglycaemia, other or unspecified

752

8198

0.89

2.08

4.3

5.3

1.94

3.39

ug/l

2.03

668

7424

Recurrent dislocation of patella

210

1740

1.23

2.08

3.4

3.5

1.33

1.84

ug/l

1.44

190

1592

Other diseases of stomach and duodenum

880

8128

1.12

2.08

5.8

5.7

2.13

3.67

ug/l

2.27

804

7319

Lactose intolerance

246

2086

1.22

2.07

5.1

5.0

1.52

2.77

ug/l

1.94

229

1883

Acute nasopharyngitis (common cold)

2362

22406

1.08

2.07

3.9

3.8

1.71

1.80

ug/l

0.43

2231

20965

Sacroiliitis, not elsewhere classified

318

2745

1.19

2.06

3.5

3.8

1.34

1.88

ug/l

2.49

295

2523

Scoliosis

458

4046

1.15

2.06

5.7

5.2

2.14

2.42

ug/l

0.35

405

3618

Primary angle-closure glaucoma

496

4451

1.16

2.06

6.5

5.9

2.57

4.26

ug/l

1.03

435

3967

Loose body in joint

408

3658

1.20

2.05

5.7

5.2

2.34

2.84

ug/l

0.65

380

3305

Respiratory tuberculosis, confirmed

212

2477

0.80

2.05

5.0

5.8

6.39

5.03

ug/l

0.13

189

2187

Generalized epilepsy, mode (most common among epilepsy diagnosis)

202

2406

0.81

2.04

3.6

4.7

1.39

2.17

ug/l

3.05

185

2191

Disorders of psychological development

769

6486

1.11

2.04

3.6

3.8

1.97

1.85

ug/l

0.13

682

5881

Iron deficiency

120

936

1.31

2.04

5.3

5.1

1.58

2.32

ug/l

1.31

107

848

Other erythematous conditions

341

2982

1.19

2.04

6.0

5.5

2.33

2.46

ug/l

0.16

309

2670

Bruxism

730

1.36

2.04

5.2

4.2

1.40

1.69

ug/l

1.01

663

Car occupant injured in other and unspecified transport accidents

2127

20174

1.07

2.03

4.9

4.8

2.83

2.69

ug/l

0.11

1934

18393

Diseases of peritoneum

1171

12533

0.91

2.03

4.9

5.6

2.26

3.54

ug/l

2.83

1070

11280

Rheumatism, unspecified

500

4438

1.14

2.03

5.6

5.2

2.19

2.69

ug/l

1.01

445

3934

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

254

2921

0.81

2.03

4.7

4.4

2.00

2.06

ug/l

0.16

221

2626

Non-Hodgkin lymphoma, all, including Hilmo

2221

21198

1.08

2.03

5.3

4.4

2.96

2.10

ug/l

2.21

1990

19160

Fourth [trochlear] nerve palsy

322

2839

1.22

2.02

5.9

6.0

2.04

2.94

ug/l

1.64

288

2548

Suppurative and unspecified otitis media

3483

32162

0.95

2.02

4.4

1.87

2.43

ug/l

2.27

3156

29420

Pulmonary heart disease

4679

45247

1.05

2.01

5.6

5.8

3.37

3.56

ug/l

0.24

4168

40786

Other symptoms and signs involving general sensations and perceptions

427

3793

1.16

2.01

5.2

5.5

1.88

3.14

ug/l

2.94

370

3421

Foreign body in respiratory tract

518

4656

1.15

2.00

5.5

5.4

5.18

2.52

ug/l

0.54

465

4217

Dermatitis due to substances taken internally

533

4793

1.14

2.00

5.7

5.4

2.31

2.99

ug/l

0.93

470

4313

Ankylosing hyperostosis [Forestier]

243

2122

1.27

1.99

6.4

5.4

2.13

2.53

ug/l

0.81

224

1904

Disorder of external ear, unspecified

461

4145

1.17

1.99

5.2

5.3

3.13

2.50

ug/l

0.32

412

3767

Epilepsy

4513

46553

0.95

1.99

4.7

5.4

3.19

3.43

ug/l

0.28

4035

42179

Pleural effusion

2834

29467

0.94

1.98

5.4

6.2

3.20

3.86

ug/l

1.12

2482

26427

Sequelae of injuries of lower limb

1197

11195

1.10

1.98

4.8

1.66

2.38

ug/l

4.64

1096

10258

Substance use, excluding alcohol

2584

27037

0.94

1.97

4.1

4.6

2.10

2.31

ug/l

0.24

2234

24931

Other nutritional deficiencies

8825

82603

0.97

1.97

5.0

5.3

2.12

2.83

ug/l

2.73

7903

75579

Speech and linguistic disorders

559

4808

1.13

1.96

4.0

4.1

2.30

2.01

ug/l

0.24

496

4341

Pulmonary embolism

4679

45272

1.05

1.96

5.6

5.8

3.37

3.56

ug/l

0.24

4168

40818

Benign neoplasm: Testis

108

905

1.57

1.96

5.7

5.6

3.55

2.73

ug/l

0.19

812

Other facial nerve disorders

281

2434

1.20

1.94

6.1

5.2

2.61

2.26

ug/l

0.26

259

2202

Other and unspecified iridocyclitis

525

4738

1.15

1.94

5.5

5.2

2.11

2.40

ug/l

0.51

487

4292

Melanocytic naevi of scalp and neck

256

2207

1.22

1.93

5.5

5.4

2.08

2.41

ug/l

0.60

233

1987

Malignant neoplasm of rectum, including Hilmo

2225

21286

1.08

1.93

5.3

4.4

2.59

2.06

ug/l

2.77

1963

19246

Oral lichen planus

200

1679

1.24

1.93

5.8

5.5

1.53

2.36

ug/l

2.72

182

1522

Pediculosis, acariasis and other infestations

908

8442

1.12

1.92

4.5

4.8

1.64

2.10

ug/l

3.01

821

7771

Crushing injury of wrist and hand

323

2904

1.25

1.92

4.9

5.2

2.05

2.67

ug/l

0.81

300

2654

Myocardial infarction, strict

9974

69109

1.04

1.92

5.3

5.8

3.08

3.52

ug/l

0.60

8923

62947

Allergic colitis

424

1.44

1.90

4.5

3.7

1.37

2.37

ug/l

0.65

372

Emotional disorders starting during childhood or adolecense, excluding more controls

120

913

1.29

1.90

2.3

0.81

1.08

ug/l

2.54

102

845

Bullous pemphigoid

326

2895

1.21

1.89

5.3

6.3

2.31

3.50

ug/l

1.93

296

2567

Other congenital malformations

586

5290

1.13

1.89

4.2

4.8

1.77

2.23

ug/l

1.36

546

4799

Seronegative rheumatoid arthritis

1100

10241

1.09

1.89

5.3

5.7

2.26

3.08

ug/l

3.98

980

9211

Other disorders of iris and ciliary body

383

3421

1.18

1.88

5.2

5.5

2.13

2.82

ug/l

1.24

334

3083

Allergic contact dermatitis

900

8293

1.10

1.88

5.0

5.1

2.06

2.63

ug/l

1.76

824

7521

Specific development disorders of scholastic skills

213

1753

1.21

1.88

2.7

1.00

1.20

ug/l

1.33

190

1604

Disorders of speech understanding and production

312

2664

1.18

1.87

4.9

5.2

3.30

2.67

ug/l

0.30

278

2374

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2140

19782

1.07

1.87

5.0

1.92

2.43

ug/l

4.67

1925

18071

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2357

24723

0.94

1.86

5.0

5.8

2.50

3.26

ug/l

2.00

2113

22297

Other and unspecified injuries of ankle and foot

392

3477

1.16

1.86

4.6

4.7

2.39

2.06

ug/l

0.20

357

3173

Other diseases of pleura

9441

80295

1.04

1.85

5.6

6.0

3.80

3.73

ug/l

0.06

8237

72291

Myocarditis

784

7260

1.12

1.85

4.2

4.9

2.36

2.46

ug/l

0.10

715

6657

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1917

18310

1.08

1.85

5.1

4.4

2.57

2.07

ug/l

2.04

1683

16573

Other congenital malformations of male genital organs, including avohilmo

568

1.43

1.85

4.3

4.2

1.74

1.54

ug/l

0.18

510

Other abnormal immunological findings in serum

157

1294

1.26

1.84

5.0

4.7

2.13

2.11

ug/l

0.01

142

1146

Contusion of other and unspecified parts of foot

478

4290

1.14

1.84

4.8

4.6

1.68

2.01

ug/l

1.16

445

3921

Other necrotizing vasculopathies

871

8081

1.11

1.84

5.4

5.8

3.41

3.15

ug/l

0.09

774

7263

Vitreous haemorrhage

1567

14856

1.08

1.84

5.4

5.6

2.79

3.13

ug/l

0.22

1403

13453

Other diseases of liver

2434

23274

1.06

1.84

5.1

5.2

2.06

2.78

ug/l

2.39

2191

21246

Keratoconus

328

2905

1.19

1.84

3.8

4.3

1.48

1.89

ug/l

1.78

302

2685

Secondary right heart disease

471

5200

0.87

1.84

4.5

6.1

2.46

4.37

ug/l

1.51

402

4626

Hypertrophic scar

350

3074

1.16

1.84

5.2

4.8

2.32

2.41

ug/l

0.07

326

2791

Agoraphobia

199

1671

1.22

1.83

3.4

1.24

1.40

ug/l

0.70

170

1549

Childhood allergy (age < 16)

327

2336

1.16

1.83

1.5

0.86

0.84

ug/l

0.10

287

2075

Benign neoplasm: Scrotum

107

910

1.58

1.83

5.0

5.3

1.83

2.30

ug/l

0.58

821

Benign thyroid growths and nodules

2251

19875

1.06

1.82

6.6

5.9

3.03

3.50

ug/l

0.47

2015

17786

Parkinson's disease, including avohilmo

2933

28270

1.06

1.82

5.6

6.3

4.48

3.89

ug/l

0.25

2625

25303

Fracture of skull and facial bones

3564

34388

1.05

1.82

4.8

4.9

4.24

2.62

ug/l

0.54

3200

31562

Thyrotropin deficiency

734

1.36

1.82

6.7

4.8

1.51

2.25

ug/l

0.97

662

Other specified/unspecified soft tissue disorders

407

3621

1.15

1.82

5.5

5.4

2.66

3.32

ug/l

0.67

377

3209

Hyperfunction of pituitary gland

320

2796

1.17

1.82

5.4

4.9

1.49

2.21

ug/l

3.26

296

2525

Malignant neoplasm of bone and articular cartilage, including Hilmo

252

2198

1.22

1.81

4.9

4.1

4.53

1.90

ug/l

0.76

230

1977

Pervasive developmental disorders excl. Autism + Asperger

326

1.50

1.81

2.1

2.6

0.78

1.19

ug/l

1.32

293

Microscopic polyangiitis

643

1.44

1.80

4.8

5.8

2.42

2.48

ug/l

0.03

570

Chronic viral hepatitis

549

6024

0.88

1.79

3.4

3.7

2.04

1.68

ug/l

0.22

474

5582

Pigmented purpuric dermatosis

139

1155

1.31

1.78

5.8

5.3

2.30

2.67

ug/l

0.33

128

1046

Other anxiety disorders

4396

38720

0.96

1.78

4.3

2.76

2.16

ug/l

0.41

3944

35701

Other pulmonary heart/vessel disease

538

5890

0.88

1.78

4.6

6.1

2.55

4.38

ug/l

1.65

462

5240

Fasciculation

151

1262

1.29

1.78

5.9

5.1

1.79

2.26

ug/l

0.73

144

1149

Peroneal tendinitis

142

1164

1.27

1.78

6.0

4.6

2.55

2.19

ug/l

0.19

131

1058

Event of undetermined intent

863

8019

1.11

1.78

4.5

4.8

1.74

2.23

ug/l

1.98

782

7339

Other mycoses, not elsewhere classified/unspecified, including avohilmo

220

1896

1.23

1.78

5.9

5.3

2.49

2.23

ug/l

0.20

200

1732

Toxic effect of contact with venomous animals

448

4032

1.15

1.78

5.8

5.2

2.14

2.19

ug/l

0.09

418

3669

Disorder of the sleep-wake schedule

185

1564

1.24

1.77

4.3

4.6

2.02

2.05

ug/l

0.02

167

1423

Emotional disorders starting during childhood or adolescence

120

943

1.27

1.77

2.3

0.81

1.01

ug/l

1.71

102

866

Benign neoplasm of meninges

801

7382

1.10

1.77

6.7

5.9

2.50

3.68

ug/l

1.24

723

6584

Other infestations, including avohilmo

224

1938

1.23

1.77

6.1

5.4

10.70

2.41

ug/l

0.73

206

1738

Adenocarcinoma and papilloma adenocarcinoma of rectum

1832

17500

1.08

1.77

5.2

4.4

2.58

2.07

ug/l

1.97

1611

15842

Other melanin hyperpigmentation

224

1927

1.22

1.76

6.9

5.9

2.62

3.08

ug/l

0.32

197

1722

Endocrine disorders, other/unspecified

174

1462

1.25

1.76

5.6

5.0

1.70

2.27

ug/l

1.35

149

1325

Vascular dementia (other)

103

832

1.37

1.76

5.8

6.3

2.18

4.34

ug/l

1.53

730

Benign neoplasm: Tongue

342

3046

1.18

1.75

5.3

5.4

1.78

2.31

ug/l

2.02

311

2742

Malignant neoplasm of digestive organs, including Hilmo

7891

56648

1.04

1.75

5.2

4.2

2.72

1.97

ug/l

7.02

6950

51505

Amblyopia ex anopsia

341

3011

1.16

1.74

5.3

5.1

1.88

2.74

ug/l

1.40

296

2732

Nail disorders

935

8701

1.10

1.74

5.0

4.8

1.87

2.37

ug/l

1.78

864

7941

Other congenital malformations of the digestive system

384

3394

1.16

1.74

5.2

5.3

2.25

2.64

ug/l

0.54

354

3048

Convalescence

491

4435

1.14

1.73

5.5

5.4

2.04

2.21

ug/l

0.60

443

4012

Melanocytic naevi of upper limb, including shoulder

236

2040

1.21

1.73

6.7

5.6

2.07

3.04

ug/l

1.15

216

1834

Injury of muscle and tendon at ankle and foot level

342

3051

1.18

1.73

5.5

5.0

2.26

2.23

ug/l

0.03

320

2785

Acute generalized exanthematous pustulosis

417

3737

1.15

1.73

5.7

5.6

2.41

2.90

ug/l

0.52

372

3344

Other misadventures during surgical and medical care

321

2856

1.19

1.72

6.4

5.6

5.85

2.52

ug/l

0.54

290

2567

Isolated growth hormone deficiency

181

1.68

1.72

6.0

3.8

1.14

1.36

ug/l

0.58

157

Congenital malformations and deformations of the musculoskeletal system

521

4673

1.12

1.72

4.5

4.3

2.00

1.91

ug/l

0.08

477

4260

Tularaemia

181

1549

1.26

1.72

5.9

5.2

2.37

2.32

ug/l

0.04

175

1407

Emotionally unstable personality disorder

765

7030

1.10

1.72

3.8

1.28

1.72

ug/l

5.51

680

6524

Other bursitis of hip

169

1416

1.24

1.71

5.7

5.6

3.92

2.77

ug/l

0.37

151

1252

Need for immunization against other single viral diseases

231

2633

0.82

1.71

4.4

4.9

15.13

2.11

ug/l

0.48

213

2406

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

124

0.32

1.71

4.0

5.8

3.20

2.40

ug/l

—

109

Speech disturbances, not elsewhere classified

1297

12251

1.09

1.70

5.6

5.9

3.66

3.76

ug/l

0.04

1138

10987

Other and unspecified mood [affective] disorders

521

4711

1.12

1.69

3.8

4.1

1.38

1.87

ug/l

2.95

475

4361

Malignant neoplasm of other and ill-defined sites, including Hilmo

145

1728

0.79

1.69

5.9

4.3

4.55

2.19

ug/l

1.34

129

1519

Respiratory tuberculosis, confirmed, including avohilmo

222

2540

0.82

1.68

5.1

5.8

6.21

5.02

ug/l

0.12

198

2244

Benign neoplasm: Skin of lip

152

1277

1.27

1.67

5.7

5.6

2.28

2.35

ug/l

0.06

140

1144

Wide developmental disorders, excluding more controls

154

1240

1.24

1.67

2.5

2.8

1.05

1.44

ug/l

0.81

131

1140

Benign neoplasm: Skin of scalp and neck

312

2769

1.18

1.67

5.9

5.7

2.22

2.91

ug/l

0.99

286

2477

Shoulder region

193

1661

1.24

1.67

4.9

5.3

1.59

2.30

ug/l

2.03

180

1498

Endometriosis

120

1.60

1.66

1.2

1.1

—

0.03

—

Graves disease, strict definition

477

4288

1.13

1.66

5.2

4.8

2.03

2.21

ug/l

0.25

413

3890

Temporal arteritis

416

3754

1.15

1.66

6.2

4.76

3.15

ug/l

0.33

367

3340

Benign neoplasm: Skin of trunk

478

4339

1.14

1.66

6.2

5.4

2.68

2.55

ug/l

0.10

438

3917

Wide developmental disorders

154

1267

1.23

1.66

2.5

2.7

1.05

1.12

ug/l

0.23

131

1156

Malignant neoplasm of lip, including Hilmo

185

1601

1.27

1.65

5.6

4.6

2.76

2.28

ug/l

0.47

167

1422

L04AX Other immunosuppressants

7453

72665

1.03

1.65

4.7

5.3

2.26

2.87

ug/l

2.85

6764

66259

Cardiomyopathy, other and unspecified

1225

12934

0.92

1.65

4.7

5.8

2.48

3.39

ug/l

1.59

1092

11765

Chondrocostal junction syndrome [Tietze]

259

2250

1.18

1.65

5.3

5.1

1.72

2.23

ug/l

1.50

239

2043

Epiphora

192

1636

1.22

1.65

6.3

5.8

2.39

2.86

ug/l

0.46

176

1446

Other diseases of pericardium

760

7087

1.12

1.65

5.2

5.9

2.01

3.43

ug/l

1.80

688

6456

Gout due to impairment of renal function

224

1993

1.28

1.65

5.1

5.9

2.24

2.63

ug/l

0.62

212

1792

Tularaemia, including avohilmo

254

2233

1.21

1.64

5.7

5.2

2.18

2.40

ug/l

0.21

245

2031

Paget disease

697

1.44

1.64

6.6

6.0

2.29

2.64

ug/l

0.30

623

Encephalopathy

122

1451

0.77

1.64

3.4

5.5

1.46

3.09

ug/l

2.44

109

1299

Contusion of toe(s) without damage to nail

226

1949

1.20

1.64

4.7

4.8

1.62

2.15

ug/l

1.36

213

1774

324

3599

0.85

1.64

5.4

6.3

2.45

4.77

ug/l

1.12

275

3173

Other and unspecified mononeuropathies of lower limb

256

2235

1.19

1.64

5.6

5.1

2.08

2.39

ug/l

0.44

231

2030

Diastasis of muscle

785

1.34

1.64

6.1

5.3

1.77

2.56

ug/l

0.90

709

Inhalation and ingestion of food causing obstruction of respiratory tract

100

1222

0.75

1.63

4.7

5.4

2.85

3.07

ug/l

0.07

1094

Lactose intolerance, other/unspecified

217

1865

1.20

1.63

5.2

4.9

1.53

2.87

ug/l

1.81

201

1682

Ingrowing nail

596

5467

1.12

1.63

4.5

1.72

2.13

ug/l

1.14

545

4999

Benign neoplasm: Lip

281

2491

1.20

1.63

6.1

5.7

3.99

2.73

ug/l

0.40

246

2231

Hypersomnia

170

1448

1.25

1.63

5.2

5.1

1.87

2.27

ug/l

0.61

155

1311

Coagulation defects, purpura and other haemorrhagic conditions

2610

25072

1.06

1.62

5.2

5.6

2.87

3.14

ug/l

0.36

2330

22698

Inflammation of lacrimal passages (acute and unspecified)

134

1104

1.26

1.62

4.4

5.1

5.34

2.45

ug/l

0.61

122

989

Infection of intervertebral disc (pyogenic)

258

2305

1.23

1.62

5.8

5.4

1.87

2.58

ug/l

2.34

229

2059

Diabetic maculopathy, excluding more controls

1628

17079

0.93

1.61

4.0

5.5

1.75

3.23

ug/l

6.46

1457

15565

Other and unspecified injuries of abdomen, lower back and pelvis

169

1434

1.24

1.61

5.3

5.0

2.07

2.15

ug/l

0.05

158

1289

Unspecified visual impairment (binocular)

165

1398

1.25

1.61

5.2

5.3

2.29

2.53

ug/l

0.16

155

1251

Bursitis of shoulder

279

2460

1.18

1.61

5.8

5.1

6.40

2.75

ug/l

0.41

259

2217

Unknown and unspecified causes of morbidity

863

8042

1.10

1.60

5.6

5.5

2.91

2.88

ug/l

0.02

816

7231

Amyloidosis, other/unspecified

295

2639

1.20

1.60

5.5

6.1

2.13

3.13

ug/l

1.73

264

2332

Dissocial personality disorder

226

2554

0.82

1.60

3.7

3.8

5.34

1.72

ug/l

0.47

194

2376

Carcinoma in situ of colon

490

4512

1.16

1.60

6.0

5.8

2.90

2.70

ug/l

0.10

443

4071

Emphysema

1387

14540

0.92

1.59

5.1

6.1

2.76

3.86

ug/l

1.62

1205

13045

Other abnormalities of plasma proteins

226

1983

1.22

1.59

6.8

5.2

3.45

2.33

ug/l

1.42

202

1761

Hereditary corneal dystrophies

332

2958

1.16

1.59

5.9

2.49

2.94

ug/l

0.38

301

2638

Other superficial mycoses

282

2496

1.18

1.59

5.1

4.8

1.85

2.10

ug/l

0.43

258

2283

Congenital malformations of the nervous system

124

1011

1.26

1.59

3.9

4.1

1.31

1.93

ug/l

1.15

114

916

Mental and behavioural disorders due to sedatives or hypnotics

799

7431

1.10

1.59

3.9

4.2

1.53

2.04

ug/l

1.71

691

6834

Chronic lymphocytic leukaemia, helper endpoint

509

4692

1.15

1.58

5.5

4.4

8.41

2.10

ug/l

0.51

457

4221

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

509

4692

1.15

1.58

5.5

4.4

8.41

2.10

ug/l

0.51

457

4221

Chronic lymphocytic leukaemia

509

4692

1.15

1.58

5.5

4.4

8.41

2.10

ug/l

0.51

457

4221

Other bursitis of elbow

181

1590

1.30

1.58

6.1

5.4

2.20

2.76

ug/l

0.68

169

1418

Viral meningitis, including avohilmo

304

2686

1.16

1.57

3.9

4.1

1.51

1.88

ug/l

0.84

275

2465

Psychotic depression

636

5851

1.11

1.57

4.9

5.1

1.88

3.20

ug/l

1.17

558

5375

Benign neoplasm: Cranial nerves

355

3194

1.16

1.57

6.6

5.6

5.58

2.62

ug/l

0.63

324

2876

Allergic asthma (mode)

2221

20703

1.06

1.57

4.4

4.8

2.92

2.61

ug/l

0.18

2027

19006

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

340

3036

1.16

1.56

5.8

5.2

1.92

2.21

ug/l

0.58

321

2759

Pyogenic granuloma

211

1833

1.21

1.56

5.2

5.3

2.03

2.38

ug/l

0.48

192

1660

Bacterial intestinal infections, IBD co-morbidities

2585

24863

1.06

1.55

5.6

5.7

3.26

3.47

ug/l

0.15

2350

22398

Hypocalcemia

277

2455

1.18

1.55

6.1

5.5

7.28

2.38

ug/l

2.26

248

2218

Asthma, hospital admissions 3, pneumonia

5432

52681

1.04

1.55

5.2

5.7

3.07

3.96

ug/l

1.45

4877

47280

Asthma-related pneumonia or sepsis

5432

52681

1.04

1.55

5.2

5.7

3.07

3.96

ug/l

1.45

4877

47280

Asthma-related pneumonia

5424

52605

1.04

1.55

5.1

5.7

3.07

3.96

ug/l

1.45

4870

47216

Other and unspecified coagulation defects

444

4017

1.13

1.55

4.9

5.1

2.33

2.41

ug/l

0.07

407

3646

Generalized epilepsy

295

3333

0.86

1.55

3.9

4.7

1.67

2.13

ug/l

1.57

268

3035

Other abnormal auditory perceptions

705

1.32

1.55

5.6

4.9

1.46

2.08

ug/l

1.29

634

Iron deficiency anaemia secondary to blood loss (chronic)

2117

20274

1.06

1.54

5.6

6.0

3.64

3.73

ug/l

0.06

1885

18184

Glomerulonephritis

1499

14277

1.08

1.54

4.6

5.4

2.80

3.00

ug/l

0.18

1365

12964

Benign neoplasm: Long bones of lower limb

369

3321

1.15

1.54

5.4

4.7

1.82

1.99

ug/l

0.45

334

3046

Disorders of brain, other and unspecified

1128

0.76

1.54

4.4

5.3

1.82

2.57

ug/l

1.15

1007

Allergic asthma (mode), excluding more controls

2221

20712

1.05

1.54

4.4

4.9

2.92

2.77

ug/l

0.08

2027

19025

Sarcoidosis

1761

16812

1.07

1.53

5.1

5.2

2.42

2.54

ug/l

0.19

1605

15351

Adhesive middle ear disease

162

1376

1.24

1.53

5.6

5.1

2.11

2.33

ug/l

0.27

142

1234

Flatulence and related conditions

119

985

1.29

1.52

6.2

5.7

1.65

2.74

ug/l

1.53

110

866

Other blood glucose lowering drugs, excl. Insulins

2543

24509

1.06

1.52

5.4

6.1

2.87

3.68

ug/l

0.57

2266

22211

Causalgia

145

1218

1.25

1.51

4.8

4.5

1.89

2.38

ug/l

0.61

137

1117

Other bursal cyst

187

1616

1.23

1.51

7.1

5.5

1.96

3.08

ug/l

1.12

177

1437

Cardiomyopathy in other diseases

109

919

1.37

1.51

5.8

6.0

2.47

2.96

ug/l

0.45

823

Other orthopaedic follow-up care

674

6243

1.11

1.51

5.1

5.2

1.79

2.34

ug/l

2.06

616

5676

Polycystic ovarian syndrome, consortium definition

304

1.34

1.50

1.1

0.01

0.68

ug/l

—

Hyphaema and other vascular disorders of iris and ciliary body

310

2787

1.18

1.50

5.2

5.7

2.27

2.96

ug/l

0.94

270

2500

Other salmonella infections, including avohilmo

496

4536

1.13

1.50

5.5

5.1

2.03

3.45

ug/l

0.90

446

4114

Benign neoplasm: Anus and anal canal

361

3262

1.16

1.50

6.4

5.9

4.58

2.85

ug/l

0.48

326

2903

Other specified disorders of muscle

388

3517

1.15

1.50

4.6

2.09

2.72

ug/l

0.64

354

3176

Giant cell arteritis with polymyalgia rheumatica

416

3780

1.14

1.49

6.2

4.76

2.99

ug/l

0.37

367

3365

Second line medication for Crohn's disease

7683

75022

1.03

1.48

4.7

5.3

2.25

2.83

ug/l

2.83

6972

68455

Osteomyelitis

1059

11170

0.92

1.48

5.0

5.7

7.44

3.33

ug/l

0.37

923

10119

Spasmodic torticollis

215

1862

1.19

1.47

5.3

5.2

1.98

2.30

ug/l

0.57

194

1700

Other disorders of binocular movement

169

1438

1.21

1.47

5.0

5.1

19.36

2.29

ug/l

0.95

155

1302

Periodontal disease, other/unspecified

276

2446

1.17

1.47

6.1

5.3

3.83

2.11

ug/l

0.51

250

2220

Malignant neoplasm of penis, including Hilmo

159

1418

1.37

1.46

8.1

4.2

26.48

1.97

ug/l

0.65

148

1262

Horner syndrome

154

1318

1.25

1.46

4.7

5.1

1.93

2.34

ug/l

0.66

140

1197

Erectile dysfunction, exclusion

706

0.67

1.46

4.6

5.6

2.97

2.81

ug/l

0.05

634

Papilloedema, unspecified

222

1939

1.19

1.46

5.9

5.3

8.36

2.33

ug/l

0.67

200

1751

Multiple system atrophy (rare forms of Parkinsonism)

384

0.60

1.46

4.0

6.3

3.39

2.59

ug/l

0.23

344

Severe visual impairment, monocular

121

1012

1.28

1.45

6.6

5.5

3.17

2.96

ug/l

0.08

110

903

Overjet

629

1.30

1.45

5.9

4.0

1.35

1.53

ug/l

0.50

559

Other lesions of median nerve

251

2211

1.18

1.44

5.2

5.5

1.71

3.06

ug/l

3.11

232

1990

Disseminated intravascular coagulation [defibrination syndrome]

343

0.59

1.44

5.6

4.9

1.41

2.76

ug/l

0.75

302

Effects of other external causes

346

3117

1.15

1.44

4.1

4.2

1.54

1.76

ug/l

0.71

320

2874

Desensitization to allergens

292

2579

1.15

1.44

4.1

3.5

1.31

1.59

ug/l

0.98

268

2371

Burns and corrosions

2081

19984

1.06

1.44

4.8

2.63

2.57

ug/l

0.04

1902

18319

Viral meningitis

292

2592

1.16

1.44

3.9

4.1

1.54

1.88

ug/l

0.76

265

2378

Mental and behavioural disorders due to opioids

392

3547

1.14

1.44

3.4

1.30

1.54

ug/l

0.42

324

3279

Personal history of medical treatment

131

1105

1.27

1.43

5.7

5.5

3.01

3.29

ug/l

0.09

120

979

Corneal scars and opacities

365

3310

1.15

1.43

5.6

5.4

2.01

2.61

ug/l

1.15

334

3002

Tibial collateral bursitis [Pellegrini-Stieda]

806

1.29

1.42

4.5

4.8

1.34

2.12

ug/l

2.36

738

Vertical strabismus

364

3288

1.14

1.42

5.5

4.61

2.65

ug/l

0.33

334

2969

Injuries involving multiple body regions

424

3860

1.13

1.42

5.2

5.0

1.79

2.58

ug/l

1.78

378

3509

Blindness, monocular

121

1017

1.28

1.41

5.6

1.65

2.92

ug/l

2.16

107

901

Viral infections of the central nervous system, including avohilmo

780

7275

1.09

1.41

4.7

4.8

2.10

2.60

ug/l

0.91

702

6635

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

250

2214

1.18

1.40

6.1

5.5

1.79

2.60

ug/l

2.43

218

1989

Emotional disorders and disorders of social functioning with onset specific to childhood

116

926

1.24

1.40

2.2

2.1

0.78

0.94

ug/l

1.16

834

Parkinson's disease

2793

27051

1.05

1.40

5.6

6.3

4.59

3.88

ug/l

0.30

2502

24227

Pneumoconiosis due to other inorganic dusts

485

0.65

1.40

5.6

5.7

1.99

2.56

ug/l

0.60

419

Evidence of alcohol involvement determined by blood alcohol level

174

1992

0.82

1.40

4.6

2.34

2.02

ug/l

0.27

159

1827

Generalized skin eruption due to drugs and medicaments

353

3180

1.14

1.39

5.7

5.6

2.42

3.01

ug/l

0.56

313

2840

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

122

1028

1.28

1.39

4.9

4.0

1.88

ug/l

0.00

113

913

Other salmonella infections

430

3928

1.13

1.39

5.8

5.3

2.09

3.63

ug/l

0.82

382

3550

Malignant neoplasm of bone and articular cartilage

139

1191

1.27

1.39

4.6

4.2

2.97

1.90

ug/l

0.63

127

1060

Sixth [abducent] nerve palsy

469

4319

1.13

1.38

6.0

5.8

2.92

2.94

ug/l

0.01

420

3888

Heart failure and bmi 25plus

6715

45695

0.97

1.38

5.2

5.9

2.82

3.56

ug/l

2.16

5850

41168

Other appendicitis

1005

9476

1.08

1.38

5.8

5.0

2.30

2.52

ug/l

0.27

899

8654

Parapsoriasis

233

2062

1.19

1.37

5.7

5.4

1.73

2.42

ug/l

2.17

209

1862

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

409

3632

1.12

1.37

4.0

3.9

1.43

1.76

ug/l

1.62

376

3331

L02BA Anti-estrogens

120

983

1.22

1.37

6.4

5.0

1.94

2.33

ug/l

0.44

765

Hypertrophy of breast

121

0.41

1.37

1.0

1.1

—

1.16

—

D07AA Corticosteroids, weak (group I)

1372

12993

1.07

1.37

4.9

2.39

2.89

ug/l

0.41

1235

11771

Other articular cartilage disorders

342

3107

1.16

1.37

5.4

5.1

1.99

2.93

ug/l

1.90

322

2822

Other injuries of upper limb, level unspecified

167

1449

1.23

1.36

5.2

5.1

2.78

2.17

ug/l

0.41

155

1300

Autonomic disorders

287

2571

1.16

1.36

4.9

5.3

2.17

2.79

ug/l

0.79

257

2323

Nosocomial condition (hospital)

631

1.36

5.7

5.4

1.84

2.24

ug/l

0.60

566

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

290

2631

1.19

1.35

4.6

4.3

2.17

1.89

ug/l

0.32

276

2429

Diseases of the myoneural junction and muscle

1898

18237

1.06

1.35

4.9

5.6

3.18

3.28

ug/l

0.08

1677

16489

Superficial injuries involving multiple body regions

286

2558

1.16

1.35

5.3

5.0

1.84

2.75

ug/l

1.23

254

2316

Gastric ulcer

2893

29864

0.95

1.34

5.5

5.9

2.72

3.91

ug/l

3.07

2600

26699

Malignant neoplasm of other connective and soft tissue, including Hilmo

575

5342

1.12

1.34

5.5

4.3

2.69

2.00

ug/l

1.33

518

4839

Benign neoplasm: Small intestine

511

4726

1.12

1.34

6.1

5.9

2.34

2.90

ug/l

0.94

457

4247

Undescended testicle

756

1.29

1.34

4.8

4.5

1.76

1.75

ug/l

0.01

674

Streptococcal septicaemia, including avohilmo

1638

15718

1.07

1.33

5.6

5.9

6.39

3.17

ug/l

0.48

1451

14187

Chromophobe cell carcinoma of kidney

100

849

1.36

1.33

5.9

4.4

4.16

1.93

ug/l

0.57

761

Asthma (mode)

12277

63361

1.02

1.33

5.2

5.3

2.54

3.24

ug/l

2.03

11253

58112

Otosclerosis

796

7460

1.09

1.32

6.0

5.6

2.20

2.96

ug/l

2.29

710

6741

Other coagulation defects

736

6869

1.09

1.32

5.1

5.4

2.88

3.66

ug/l

0.46

662

6212

Migraine

3296

26537

0.96

1.32

4.8

4.6

1.80

2.42

ug/l

7.39

3040

24305

Melanoma in situ of upper limb, including shoulder

796

1.31

1.32

7.2

5.8

8.37

2.40

ug/l

0.45

712

Heart failure and coronary heart disease

8547

60898

0.97

1.32

5.1

6.1

2.86

3.84

ug/l

4.21

7510

54941

Intestinal malabsorption

546

5052

1.11

1.32

4.9

5.3

1.76

2.55

ug/l

2.52

483

4601

Otorrhagia

103

864

1.31

1.32

5.3

5.2

1.92

2.39

ug/l

0.55

765

Pedal cyclist injured in other and unspecified transport accidents

1459

13920

1.07

1.32

4.9

2.21

2.36

ug/l

0.26

1323

12726

Chondromalacia

317

2863

1.15

1.32

6.3

5.1

2.26

2.16

ug/l

0.14

280

2608

Other congenital malformations of skin

310

2779

1.14

1.31

4.3

5.0

1.73

2.12

ug/l

0.97

293

2518

Malignant neoplasm of trachea, including Hilmo

131

0.43

1.31

3.6

4.7

3.32

2.35

ug/l

—

110

Dementia in Alzheimer disease

2891

23391

1.05

1.31

5.1

6.6

4.13

5.25

ug/l

1.40

2398

20537

Isolated proteinuria

412

3788

1.14

1.31

4.7

5.5

2.00

2.37

ug/l

1.23

374

3411

Intestinal infectious diseases

15181

111123

1.02

1.30

4.9

5.3

2.54

3.24

ug/l

2.56

13823

100884

Papillary adenocarcinoma of thyroid gland

365

3299

1.13

1.30

5.9

4.0

2.33

1.77

ug/l

1.20

329

2977

Central retinal artery occlusion

373

3427

1.15

1.30

5.4

6.2

4.76

4.78

ug/l

0.00

329

3032

Calcaneal spur

107

887

1.26

1.30

5.1

2.48

2.31

ug/l

0.08

100

787

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1979

18419

1.06

1.30

4.9

5.0

1.94

2.44

ug/l

3.95

1782

16835

Alcohol-induced acute pancreatitis

703

7423

0.90

1.30

4.7

4.9

1.91

2.19

ug/l

0.85

625

6821

Other acquired deformities of musculoskeletal system and connective tissue

590

5491

1.11

1.30

5.1

4.9

2.09

2.30

ug/l

0.35

540

5018

Severe visual impairment, binocular

553

1.37

1.29

6.8

5.5

1.90

2.30

ug/l

0.52

484

Other congenital malformations of face and neck

267

2381

1.16

1.29

5.1

4.7

2.09

1.96

ug/l

0.18

240

2175

Drug-induced adrenocortical insufficiency

167

1444

1.20

1.29

6.0

5.4

9.83

2.42

ug/l

0.50

150

1307

Benign neoplasm: Pancreas

359

3277

1.15

1.29

6.5

6.1

2.44

2.84

ug/l

0.49

331

2945

Background retinopathy and retinal vascular changes

298

2697

1.16

1.29

4.7

5.6

7.67

2.39

ug/l

0.71

269

2420

Thyrotoxicosis with toxic multinodular goitre

343

3088

1.13

1.28

6.6

5.9

3.46

3.21

ug/l

0.10

298

2712

Communicating hydrocephalus

201

2276

0.85

1.28

4.6

5.8

2.82

2.77

ug/l

0.02

184

2034

Hereditary ataxia

147

1690

0.82

1.28

5.7

2.41

2.91

ug/l

0.42

124

1530

Benign neoplasm: Cerebral meninges

704

6558

1.09

1.28

6.6

5.9

2.43

3.78

ug/l

1.27

636

5859

Recurrent and persistent haematuria

119

1013

1.27

1.28

5.6

5.7

3.53

2.67

ug/l

0.42

108

920

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

749

1.36

1.27

5.2

4.5

2.48

2.05

ug/l

0.45

672

Dislocation, sprain and strain of joints and ligaments of elbow

550

5078

1.10

1.27

4.5

4.4

2.00

1.89

ug/l

0.23

504

4648

Scabies

663

6203

1.10

1.27

4.5

4.6

1.66

1.99

ug/l

1.27

597

5721

Congenital deformities of feet, including avohilmo

295

2641

1.14

1.27

4.7

4.4

2.19

1.88

ug/l

0.19

274

2417

Collapsed vertebra, not elsewhere classified

658

1.31

1.27

6.3

5.4

3.92

2.79

ug/l

0.61

585

ILD-related respiratory insufficiency

521

5575

0.89

1.27

4.6

6.2

2.04

3.42

ug/l

2.71

458

4990

Hyperkinetic disorders (excl. ADHD)

102

825

1.25

1.27

2.4

2.3

0.83

1.08

ug/l

2.60

757

Malignant neoplasm of oral cavity, including Hilmo

633

6749

0.90

1.27

5.0

4.1

3.50

1.93

ug/l

1.14

562

6140

Crohn disease

1530

14619

1.06

1.26

4.6

4.7

2.15

2.34

ug/l

0.37

1410

13364

Hypertrophy of tongue papillae

149

1284

1.22

1.26

5.9

5.5

1.80

2.55

ug/l

1.07

140

1163

Respiratory conditions due to other external agents

178

2032

0.84

1.26

5.4

6.1

3.35

3.12

ug/l

0.08

153

1806

Streptococcal septicaemia

1601

15379

1.07

1.26

5.6

5.9

6.43

3.19

ug/l

0.47

1419

13878

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

484

4464

1.11

1.26

5.5

5.2

2.10

2.26

ug/l

0.39

450

4045

Other retinal artery occlusion

374

3439

1.15

1.26

6.1

6.0

2.40

4.35

ug/l

0.93

330

3065

Benign neoplasm: salivary glands, exclude unknown (D119)

1218

11608

1.07

1.26

5.6

5.7

2.22

3.27

ug/l

2.10

1088

10494

Multiple myeloma, including Hilmo

679

6375

1.10

1.25

5.3

4.4

2.98

2.12

ug/l

2.01

610

5728

Eustachian salpingitis and obstruction

745

6967

1.09

1.25

3.9

3.5

2.00

1.57

ug/l

0.73

660

6429

Hypothermia

273

3000

0.86

1.24

5.0

5.7

5.52

2.78

ug/l

0.60

234

2701

Pedal cyclist injured in transport accident

3015

29212

1.04

1.24

4.9

2.21

2.56

ug/l

1.06

2738

26740

Other degenerative diseases of the basal ganglia

323

2967

1.17

1.24

5.0

6.4

4.06

3.10

ug/l

0.25

289

2646

Malignant neoplasm of ureter, including Hilmo

163

1448

1.26

1.24

5.3

4.6

2.34

2.13

ug/l

0.22

139

1286

Mental and behavioural disorders due to tobacco

1153

12108

0.93

1.24

4.5

5.2

2.89

2.49

ug/l

0.21

992

11099

Impacted maxillary molar

229

2010

1.15

1.24

4.0

3.4

1.34

1.40

ug/l

0.19

212

1839

Appendectomy

8468

79014

1.03

1.24

4.9

2.50

2.69

ug/l

0.38

7734

72285

Undescended testis, unilateral

567

1.32

1.24

4.5

4.3

1.64

1.77

ug/l

0.12

508

Ulcer of oesophagus

1282

12285

1.08

1.24

5.7

5.8

3.54

3.71

ug/l

0.06

1145

11076

Smoking dependency

1153

12107

0.93

1.24

4.5

5.2

2.89

2.46

ug/l

0.24

992

11090

Autism spe, excluding more controls

121

1010

1.22

1.24

2.6

2.7

1.11

1.15

ug/l

0.11

102

930

Acquired stenosis of external ear canal

208

1882

1.23

6.1

5.5

1.89

2.17

ug/l

0.63

189

1706

Nondiabetic hypoglycaemic coma

368

0.64

1.22

3.4

4.7

1.43

1.69

ug/l

0.51

324

Helminthiases, including avohilmo

278

2485

1.14

1.22

5.3

4.8

1.80

2.19

ug/l

0.70

254

2253

Other and unspecified injuries of wrist and hand

360

3273

1.13

1.22

5.6

4.8

1.86

2.13

ug/l

0.65

325

3003

Thiamine deficiency

959

0.75

1.22

3.9

5.2

2.01

2.30

ug/l

0.24

860

Unspecified protein-energy malnutrition

510

1.36

1.21

4.1

5.4

2.29

3.10

ug/l

0.43

431

Hemiplegia

495

5348

0.90

1.21

5.0

5.6

3.21

3.91

ug/l

0.23

443

4787

Rhinophyma

154

1389

1.33

1.21

6.2

5.9

2.82

2.81

ug/l

0.01

135

1239

Sequelae of tuberculosis

173

1972

0.84

1.21

5.3

6.1

3.28

6.38

ug/l

0.70

154

1703

Dislocation, sprain and strain of joints and ligaments of head

314

2831

1.13

1.21

4.3

4.6

1.72

1.98

ug/l

0.80

282

2606

Autism

125

1051

1.21

1.20

2.6

1.09

1.08

ug/l

0.03

106

955

Inflammatory bowel disease

4430

43189

1.03

1.20

5.0

2.44

2.68

ug/l

0.40

4062

39446

Benign neoplasm: Parotid gland

1103

10503

1.08

1.20

5.6

5.7

2.25

3.00

ug/l

3.34

983

9493

Cysts of oral region, not elsewhere classified

846

8000

1.09

1.20

5.8

5.2

4.79

2.68

ug/l

0.73

770

7288

Mental retardation, excluding more controls

292

3124

0.88

1.20

3.5

4.6

1.43

2.33

ug/l

2.10

262

2867

Osteitis due to dental implant

796

1.29

1.20

6.2

5.5

2.27

2.62

ug/l

0.30

709

Sequelae of tuberculosis, including avohilmo

175

1992

0.84

1.20

5.3

6.1

3.25

6.34

ug/l

0.71

156

1719

Extracorporeal dialysis

1082

10341

1.08

1.19

3.9

5.5

2.34

2.88

ug/l

0.62

1013

9376

Other problems related to primary support group, including family circumstances

560

5030

1.09

1.19

4.3

1.62

1.81

ug/l

0.66

514

4598

Iridocyclitis in diseases classified elsewhere

229

2047

1.17

1.19

5.7

5.3

2.99

2.35

ug/l

0.39

205

1866

Diabetes insipidus

792

1.27

1.18

5.5

4.9

2.79

2.17

ug/l

0.26

716

Foreign body or object entering through skin

947

8991

1.08

1.18

5.0

4.8

2.62

2.17

ug/l

0.26

869

8244

Agranulocytosis

1111

11688

0.94

1.18

5.7

4.57

2.79

ug/l

2.03

979

10536

Patent foramen ovale

254

2284

1.16

1.18

5.4

4.6

1.68

1.96

ug/l

0.61

211

2104

Frostbite

137

1567

0.82

1.18

4.0

5.0

1.80

2.24

ug/l

0.61

124

1440

Other arterial embolism and thrombosis

381

4128

0.89

1.17

5.0

6.0

4.15

4.23

ug/l

0.01

335

3687

Mental retardation, wide definition

315

3444

0.89

1.17

3.7

4.5

1.55

2.03

ug/l

1.39

281

3146

Lower leg

456

1.35

1.17

5.4

2.87

2.31

ug/l

0.31

398

Inflammatory diseases of the central nervous system

1020

9683

1.07

1.16

5.0

5.1

2.26

2.55

ug/l

0.42

934

8819

Congenital deformities of feet

191

1676

1.17

1.16

4.0

4.3

2.60

1.81

ug/l

0.37

178

1537

Viral pneumonia (unknown virus, not influenza)

963

9142

1.08

1.16

4.6

5.1

2.82

2.67

ug/l

0.06

891

8335

Other abnormal findings of blood chemistry

610

5708

1.10

1.16

5.4

5.0

2.62

2.30

ug/l

0.53

558

5160

Third [oculomotor] nerve palsy

245

2209

1.17

1.16

5.9

5.8

8.62

2.63

ug/l

0.45

220

1971

Vascular diseases of the intestine

484

5202

0.90

1.16

5.3

6.2

3.34

4.22

ug/l

0.39

419

4633

Purpura and other haemorrhagic conditions

1880

18107

1.05

1.16

5.2

5.7

2.84

3.27

ug/l

0.49

1667

16392

Abnormal findings in nipple discharge synovial fluid wound secretions

137

1179

1.21

1.16

5.4

4.9

4.40

1.84

ug/l

0.51

124

1063

Other and unspecified myopathies

1427

13701

1.07

1.15

4.9

5.7

3.44

3.50

ug/l

0.03

1251

12356

Other and/or unspecified nontoxic goitre

425

3891

1.11

1.15

6.2

5.8

2.13

3.18

ug/l

2.25

388

3474

Other diseases of spinal cord

399

3681

1.13

1.15

5.6

5.5

3.60

2.61

ug/l

0.48

365

3335

Hypokalaemia

1462

13998

1.06

1.14

5.4

5.7

3.30

3.58

ug/l

0.17

1299

12629

Other/unspecified reactive arthropathies

740

6964

1.09

1.14

5.1

2.41

2.51

ug/l

0.10

681

6352

Malignant neoplasm of rectosigmoid junction, including Hilmo

454

4227

1.12

1.14

5.6

4.3

3.74

2.11

ug/l

1.12

410

3807

Cerebral amyloid angiopathy

826

1.33

1.13

5.6

6.6

2.12

2.65

ug/l

0.58

736

Unspecified dementia

1521

14229

0.95

1.13

4.5

6.4

4.93

5.96

ug/l

0.28

1318

12472

Symptoms and signs involving emotional state

252

2257

1.14

1.13

4.8

4.7

3.43

2.21

ug/l

0.45

226

2046

Later onset COPD, excluding more controls

4294

31991

1.04

1.13

5.7

6.8

3.24

4.50

ug/l

1.76

3767

28676

Malignant neoplasm of bone and articular cartilage of limbs

475

1.38

1.13

4.4

4.2

2.05

2.01

ug/l

0.05

422

Crohn's disease of small intestine

744

7000

1.08

1.12

4.8

4.7

1.92

2.23

ug/l

0.97

686

6390

Ulcerative rectosigmoiditis

1081

10296

1.07

1.12

4.9

2.30

2.31

ug/l

0.01

999

9403

Polyarthritis, unspecified

411

3789

1.12

5.4

5.3

2.09

2.92

ug/l

1.95

369

3419

Malnutrition

214

1907

1.16

1.12

4.6

5.6

2.92

2.76

ug/l

0.07

184

1696

Personal history of certain other diseases

704

1.25

1.12

4.6

4.3

1.52

1.66

ug/l

0.19

633

Other secondary coxarthrosis

403

3719

1.12

1.11

5.2

5.3

1.96

2.67

ug/l

1.20

360

3336

Valgus deformity, not elsewhere classified

449

1.33

1.11

5.9

5.0

2.11

2.16

ug/l

0.04

405

Malignant neoplasm of digestive organs

7231

54285

1.03

1.11

5.1

4.2

2.85

1.99

ug/l

6.33

6341

49275

Contact with other sharp object(s)

850

8043

1.08

1.11

5.1

4.4

2.21

1.95

ug/l

0.26

768

7402

Myelodysplastic syndrome, including Hilmo

475

4434

1.12

1.10

5.7

4.5

2.06

2.21

ug/l

0.43

415

3956

Disorders of adult personality and behaviour

2932

28429

1.04

1.10

4.1

4.4

2.02

2.08

ug/l

0.07

2625

26240

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

143

1270

1.25

1.10

5.8

4.5

4.47

2.15

ug/l

0.86

120

1118

Dacryoadenitis

532

1.31

1.10

5.9

5.0

2.45

2.77

ug/l

0.17

474

Ankylosing spondylitis, strict definition

556

5200

1.10

4.3

4.2

2.05

1.80

ug/l

0.74

509

4818

Fracture of shoulder and upper arm

4714

45971

1.03

1.10

5.2

2.81

3.06

ug/l

0.38

4234

41758

Other respiratory diseases principally affecting the interstitium

3121

32030

0.96

1.10

5.3

6.1

3.14

3.70

ug/l

0.50

2749

28681

Other specified and unspecified disorders of eyelid

179

1589

1.19

1.09

6.0

5.6

1.76

2.71

ug/l

2.15

165

1416

Malignant neoplasm of oral cavity

497

5303

0.90

1.09

5.1

4.1

3.35

1.93

ug/l

0.80

441

4819

Essential (haemorrhagic) thrombocythaemia

429

3971

1.11

1.09

4.9

4.3

3.67

1.96

ug/l

0.64

374

3587

Optic atrophy, wide definition

207

1850

1.17

1.09

5.0

5.3

1.71

2.36

ug/l

1.60

184

1675

Benign neoplasm of middle ear and respiratory system

1256

12048

1.07

1.09

5.6

2.68

3.42

ug/l

0.92

1135

10901

Autism spe

121

1027

1.20

1.08

2.6

1.11

1.06

ug/l

0.19

102

933

Primary Sclerosing Cholangitis, IBD and UDCA required

190

2136

0.86

1.08

4.0

4.5

1.51

2.11

ug/l

1.73

173

1948

Disorders of tooth development and eruption

1763

13780

1.05

1.08

5.0

4.5

1.79

2.23

ug/l

3.29

1638

12638

Post-traumatic wound infection, not elsewhere classified

405

3757

1.12

1.08

4.9

5.0

1.85

2.23

ug/l

1.34

359

3423

Other disorders of adrenal gland

412

3798

1.11

1.07

5.6

5.4

5.73

2.80

ug/l

0.48

372

3425

Folate deficiency anaemia

165

1469

1.21

1.07

5.5

5.8

2.31

3.10

ug/l

0.75

149

1314

Lichen simplex chronicus and prurigo

769

7266

1.08

1.07

5.2

5.4

2.25

2.80

ug/l

1.17

694

6590

Malignant neoplasm of rectum

1817

17571

1.06

1.07

5.1

4.4

2.43

2.03

ug/l

1.54

1597

15907

Colitis, primary sclerosing

120

1389

0.83

1.07

3.4

4.3

1.49

2.03

ug/l

1.02

109

1282

Allergic urticaria

587

5473

1.09

1.07

5.4

5.0

2.20

2.34

ug/l

0.14

533

4937

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

134

1184

1.25

1.07

5.3

4.5

2.24

2.01

ug/l

0.32

121

1052

Other and unspecified pemphigoid

117

1012

1.24

1.07

6.0

6.1

11.53

2.77

ug/l

0.48

109

893

Benign neoplasm: Other and unspecified parts of mouth

405

3750

1.12

1.07

5.8

5.5

1.86

2.43

ug/l

2.12

364

3392

Lesion of radial nerve

494

4609

1.11

1.07

4.9

5.0

1.57

2.54

ug/l

5.57

445

4196

Aggressive periodontitis

291

2660

1.14

1.06

6.0

5.5

2.41

2.44

ug/l

0.03

269

2420

Burns and corrosions of external body surface, specified by site

1578

15189

1.06

4.8

4.9

2.24

2.72

ug/l

0.75

1444

13878

Secondary and unspecified malignant neoplasm of lymph nodes

1307

12549

1.06

5.3

4.3

3.83

1.97

ug/l

1.78

1176

11375

Diagnoses used for exclusion with ILD

4193

42887

0.97

1.05

5.1

5.7

3.10

3.49

ug/l

0.59

3692

38675

Congenital deformities of hip, including avohilmo

455

1.29

1.05

4.1

4.0

1.59

1.49

ug/l

0.12

406

Depression or dysthymia

12265

66008

1.02

1.05

5.2

5.4

2.23

3.27

ug/l

6.52

10971

60516

Decubitus ulcer and pressure area

924

9691

0.93

1.05

4.6

6.0

2.47

3.94

ug/l

2.23

811

8669

Nonalcoholic steatohepatitis

106

908

1.24

1.04

5.1

4.6

1.16

2.09

ug/l

1.92

833

Respiratory distress of newborn

2.11

1.04

1.1

1.2

0.59

0.67

ug/l

—

Polycythaemia vera

464

4331

1.11

1.04

5.0

4.3

2.03

ug/l

0.01

420

3897

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

354

3252

1.12

1.04

5.5

5.6

2.10

2.74

ug/l

1.15

332

2916

Generalized epilepsy, strict definition

134

1545

0.85

1.04

3.4

4.3

1.67

1.89

ug/l

0.31

121

1420

5-aminosalicylic acid

2884

28026

1.04

1.03

4.9

4.8

2.60

2.48

ug/l

0.10

2647

25695

Other and unspecified mononeuropathies, also in other diseases

348

3205

1.12

1.03

5.3

5.4

1.69

3.00

ug/l

2.99

308

2906

Pure hyperglyceridaemia

388

3613

1.13

1.03

5.0

5.3

2.13

2.80

ug/l

0.84

342

3273

Disorders of continuity of bone

937

8892

1.07

1.03

5.2

4.8

2.27

2.32

ug/l

0.08

854

8129

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

237

2074

1.13

1.03

2.9

1.13

1.25

ug/l

0.73

219

1903

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

801

0.77

1.02

5.1

5.4

2.78

2.35

ug/l

0.11

720

Disorders of optic nerve, not elsewhere classified

278

2544

1.14

1.02

5.4

5.9

2.29

3.04

ug/l

0.95

248

2269

Hypoplasia of dental enamel

1.75

1.02

3.1

2.7

1.02

1.17

ug/l

0.22

Other congenital malformations of male genital organs

456

1.32

1.02

4.2

1.41

1.49

ug/l

0.12

409

Benign leiomyoma with endometriosis

122

1.56

1.02

1.2

1.1

—

0.52

—

Transient acantholytic dermatosis [Grover]

380

1.57

1.02

7.0

6.1

1.90

2.06

ug/l

0.25

332

Benign neoplasm: Appendix

142

1251

1.21

1.02

6.5

5.7

2.29

2.83

ug/l

0.46

128

1119

Other conjunctival vascular disorders and cysts

236

2131

1.15

1.02

5.9

5.6

2.17

2.57

ug/l

0.73

218

1909

Alopecia areata

144

1250

1.17

1.01

4.9

4.6

7.47

2.04

ug/l

0.54

131

1129

Other specified disorders of kidney and ureter

400

3712

1.11

1.01

5.2

5.5

2.64

2.66

ug/l

0.01

360

3342

Adrenocortical insufficiency

332

3044

1.12

1.01

5.7

5.4

6.46

2.87

ug/l

0.48

301

2737

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

145

1272

1.19

1.00

5.5

5.2

2.26

2.35

ug/l

0.09

133

1147

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

131

1140

1.20

1.00

4.7

4.5

1.79

2.02

ug/l

0.29

119

1035

Perforation of oesophagus

752

0.76

1.00

5.4

5.6

2.01

2.39

ug/l

0.34

680

Dermatitis herpetiformis

204

1834

1.16

1.00

4.8

5.4

1.77

2.47

ug/l

1.83

185

1656

Hypercalcemia

484

4518

1.10

1.00

5.4

5.9

4.54

2.95

ug/l

0.93

437

4058

Chronic iridocyclitis

498

4646

1.09

1.00

5.6

5.3

3.96

2.52

ug/l

0.64

450

4219

Special screening examination for infectious and parasitic diseases

3155

23657

0.97

1.00

4.1

3.9

1.60

2.06

ug/l

5.16

2838

21885

Disorders of porphyrin and bilirubin metabolism

156

1385

1.19

1.00

5.7

5.0

2.23

2.31

ug/l

0.07

141

1246

Dialysis

640

6061

1.09

1.00

3.8

5.4

1.89

2.68

ug/l

2.37

616

5494

Somnolence

1157

0.82

0.99

4.9

5.2

1.96

2.49

ug/l

0.68

1030

Thrombocytopenia, unspecified

1076

10303

1.07

0.99

5.4

5.8

3.36

3.48

ug/l

0.06

942

9296

Other and unspecified corneal deformities and disorders

350

3226

1.12

0.99

5.5

4.9

2.27

2.15

ug/l

0.13

326

2950

Glaucoma secondary to eye trauma

110

964

1.26

0.99

6.2

5.7

2.61

2.82

ug/l

0.16

858

Anomalies of pupillary function

150

1313

1.17

0.99

6.4

4.7

2.72

2.26

ug/l

0.29

130

1196

Malignant neoplasm of rectosigmoid junction

271

2492

1.15

0.99

5.5

4.4

3.34

2.02

ug/l

1.69

242

2240

Lymphoid leukaemia

878

8382

1.08

0.99

5.5

6.0

6.18

3.73

ug/l

0.30

788

7519

Nonsuppurative otitis media

1841

16570

0.96

0.99

5.1

4.8

2.45

2.67

ug/l

0.23

1637

15002

Carcinoid syndrome

110

1257

0.82

0.98

5.2

5.8

1.87

2.58

ug/l

1.29

1128

Fracture of lower leg, including ankle

7829

75534

1.02

0.98

5.1

3.16

2.85

ug/l

0.19

7081

68923

Effects of heat and light

103

889

1.24

0.98

4.5

5.3

1.72

2.30

ug/l

0.78

793

Alzheimer’s disease (Late onset)

3796

30505

1.03

0.98

5.4

6.6

7.13

4.94

ug/l

0.64

3308

26793

Benign neoplasm of major salivary glands

1343

12918

1.06

0.98

5.6

5.7

2.31

3.32

ug/l

2.16

1201

11669

Contact with lifting and transmission devices, not elsewhere classified

343

3203

1.14

0.98

5.1

5.0

1.77

2.09

ug/l

1.29

326

2932

Other deformity of hallux (acquired)

467

1.30

0.97

6.4

5.1

2.28

3.10

ug/l

0.39

413

Visual field defects

1171

11232

1.06

0.97

5.4

5.8

3.53

3.46

ug/l

0.03

1055

10133

Other specific arthropathies, wide

219

1975

1.15

0.97

5.1

5.0

2.00

2.49

ug/l

0.95

206

1780

Psoriasis

4315

42222

1.03

0.97

5.0

5.3

2.04

2.93

ug/l

4.36

3901

38495

Deformity of finger(s)

667

1.28

0.97

5.9

5.7

1.92

3.59

ug/l

1.64

603

Benign neoplasm: Skin of lower limb, including hip

285

2606

1.13

0.97

5.6

5.5

2.08

2.36

ug/l

0.51

258

2352

Organ-limited amyloidosis

673

1.30

0.96

5.1

6.1

3.56

5.18

ug/l

0.44

581

Other disorders of amniotic fluid and membranes

1.86

0.96

1.0

1.1

—

0.02

—

Seropositive rheumatoid arthritis, strict definition

1324

13801

0.95

0.96

4.9

5.7

2.38

3.18

ug/l

1.60

1201

12468

Shock, not elsewhere classified

124

1404

0.83

0.96

4.4

5.8

3.04

2.46

ug/l

0.26

113

1246

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

146

1286

1.18

0.96

4.9

4.5

2.27

2.03

ug/l

0.12

131

1167

Benign neoplasm: Short bones of upper limb

153

1352

1.18

0.96

5.0

1.93

2.18

ug/l

0.34

141

1225

Other psoriatic arthropathies

1303

12521

1.06

0.96

4.8

5.0

1.92

2.37

ug/l

1.81

1175

11454

Lumbosacral root disorders, not elsewhere classified

144

1274

1.19

0.95

4.8

5.5

1.71

2.57

ug/l

1.92

133

1143

Malignant neoplasm of floor of mouth, including Hilmo

115

1301

0.82

0.95

5.0

4.2

5.44

1.97

ug/l

0.81

1167

Chronic myeloproliferative disease

165

1835

0.85

0.95

4.8

6.0

3.17

2.68

ug/l

0.26

155

1644

Viral infections of the central nervous system

716

6770

1.07

0.95

4.7

4.8

2.01

2.36

ug/l

0.74

649

6172

Cardiomyopathy, Hypertrophic obstructive

245

2671

0.88

0.95

5.5

5.7

2.35

2.60

ug/l

0.28

213

2421

Artificial opening status

820

7818

1.08

0.95

5.3

5.7

2.94

3.02

ug/l

0.07

701

7090

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

704

1.26

0.94

6.1

5.5

1.59

2.39

ug/l

1.02

631

Sequelae of other and unspecified infectious and parasitic diseases

660

6241

1.08

0.94

4.5

4.3

1.63

1.99

ug/l

1.66

610

5757

Acute gastritis

996

9522

1.07

0.94

5.3

5.5

3.14

3.58

ug/l

0.13

895

8607

Paralytic ileus

605

5726

1.09

0.94

4.9

5.5

3.63

3.55

ug/l

0.02

525

5150

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

665

6290

1.08

0.94

4.5

4.3

1.64

2.00

ug/l

1.69

615

5804

Benign neoplasm: Skin, unspecified

445

4153

1.10

0.94

6.0

5.5

2.67

2.60

ug/l

0.06

409

3755

Pericarditis

588

5564

1.09

0.94

5.2

5.6

2.09

3.43

ug/l

1.14

535

5072

Congenital malformations of genital organs

194

1710

1.13

0.94

4.8

4.4

1.70

2.00

ug/l

0.50

169

1514

Optic atrophy

194

1746

1.16

0.94

4.9

5.3

1.63

2.23

ug/l

1.69

172

1586

Malignant neoplasm of floor of mouth

870

0.78

0.94

4.9

4.2

3.68

1.90

ug/l

0.56

778

Brain meningioma

344

3164

1.10

0.93

6.3

4.3

2.59

1.98

ug/l

1.41

309

2841

Motorcycle rider injured in other and unspecified transport accidents

886

8460

1.07

0.93

4.6

4.2

1.65

1.84

ug/l

1.18

818

7823

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

229

2063

1.13

0.93

3.9

1.55

1.88

ug/l

0.78

210

1892

Anomalies of dental arch relationship, including avohilmo

1604

13952

1.05

0.93

5.0

4.6

2.29

2.19

ug/l

0.05

1433

12798

Pulmonary heart disease, diseases of pulmonary circulation

5077

49781

1.03

0.93

5.6

5.8

3.32

3.63

ug/l

0.51

4505

44824

Acquired absence of organs, not elsewhere classified

173

1556

1.17

0.93

4.6

5.4

3.81

3.17

ug/l

0.16

160

1383

Persistent delusional disorders

772

8128

0.93

0.92

4.3

4.9

3.57

3.02

ug/l

0.11

687

7415

Other/unspecified cytomegaloviral diseases

260

2386

1.14

0.92

4.3

5.1

1.98

2.12

ug/l

0.28

247

2159

Persistent mood disorders

2059

19934

1.04

0.92

4.8

5.1

2.14

2.80

ug/l

1.81

1831

18214

Intestinal stricture

5098

50017

1.03

0.92

5.4

5.9

2.98

3.59

ug/l

1.35

4515

45078

Other disorders of skin and subcutaneous tissue

11534

96013

1.02

0.92

5.7

5.6

2.73

3.45

ug/l

3.29

10432

86725

Kyphosis

134

1178

1.18

0.92

5.3

1.81

2.61

ug/l

1.32

121

1058

Foreign body in alimentary tract

738

7015

1.08

0.92

5.3

5.5

2.17

2.91

ug/l

1.92

655

6348

Other disorders of bone density and structure

231

2093

1.13

0.92

5.7

5.0

2.11

2.38

ug/l

0.24

213

1912

Infliximab

146

1653

0.86

0.91

3.6

3.3

1.46

1.31

ug/l

0.38

138

1529

Rare circulating lymphoid malignancy

800

0.78

0.91

4.2

4.5

1.95

2.18

ug/l

0.44

698

Other surgical follow-up care

363

3363

1.10

0.91

5.0

5.3

2.02

2.10

ug/l

0.09

340

3040

Helminthiases

164

1461

1.16

0.91

5.5

5.1

1.76

2.37

ug/l

1.24

149

1321

Chorioretinal inflammation

310

2858

1.12

0.90

5.3

5.1

2.36

2.15

ug/l

0.31

281

2590

Oral lichen planus and hypothyroidism or thyroxine medication

431

1.27

0.90

7.5

5.5

1.87

2.82

ug/l

0.59

380

Molar incisor enamel hypoplasia, with caries

1.68

0.90

10.4

3.2

2.80

1.48

ug/l

0.32

Familial chondrocalcinosis

181

1.68

0.90

7.0

6.2

3.08

2.94

ug/l

0.04

162

Myeloid leukaemia

324

3490

0.90

4.7

5.8

3.57

3.02

ug/l

0.12

294

3123

Osteoporosis with pathological fracture (FG)

135

1173

1.16

0.90

5.8

5.4

2.11

3.15

ug/l

0.84

110

999

Other viral hepatitis

675

7122

0.93

0.90

3.6

3.9

1.99

1.72

ug/l

0.20

589

6578

Specific development disorders of speech and language

393

3506

1.09

0.89

4.5

4.6

2.83

2.34

ug/l

0.30

350

3132

Psoriatic arthropathies, ICD10

1329

12800

1.05

0.89

4.8

5.0

1.91

2.36

ug/l

1.86

1195

11712

Psoriasis vulgaris

2917

28463

1.04

0.89

5.0

5.2

2.09

2.77

ug/l

2.16

2633

26002

Injury of nerves at forearm level

185

1674

1.16

0.89

5.5

4.8

1.94

2.04

ug/l

0.14

171

1534

Glomerular diseases

3156

30853

1.04

0.89

4.4

5.6

2.42

3.02

ug/l

1.77

2873

27967

Autoimmune hyperthyroidism

321

2946

1.10

0.88

5.1

2.14

2.34

ug/l

0.30

280

2652

Hypertrophic cardiomyopathy

605

6368

0.92

0.88

5.0

5.6

2.26

2.63

ug/l

0.91

537

5763

Other and unspecified primary disorders of muscles

690

1.25

0.88

4.8

1.71

1.74

ug/l

0.03

618

Other and unspecified acne

105

905

1.19

0.88

4.5

4.1

1.62

1.90

ug/l

0.29

820

Open bite

210

1885

1.12

0.88

4.4

4.0

1.71

1.76

ug/l

0.08

197

1724

Osteoporosis

2039

18124

1.04

0.88

5.8

2.59

3.60

ug/l

2.79

1758

16184

Osteomyelitis of vertebra

498

1.35

0.88

5.1

5.5

1.58

3.08

ug/l

1.37

449

Burn and corrosion of trunk

417

3907

1.10

0.88

4.5

5.2

2.04

2.24

ug/l

0.35

388

3558

Burn and corrosion confined to eye and adnexa

317

2940

1.12

0.88

4.8

4.4

4.82

1.89

ug/l

0.46

288

2700

Other diseases of biliary tract

1042

10866

0.94

0.88

5.1

5.8

2.37

3.46

ug/l

1.77

931

9774

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

123

0.48

0.88

4.4

3.9

0.82

1.50

ug/l

—

107

Spinal instabilities

282

2591

1.12

0.88

5.2

4.8

1.87

2.20

ug/l

0.36

259

2360

Disorders of iron metabolism

238

2185

1.14

0.87

4.5

5.1

1.89

2.28

ug/l

0.73

216

1993

Benign neoplasm: Duodenum

353

3293

1.11

0.87

5.8

6.0

2.19

2.82

ug/l

1.10

314

2954

Scar conditions and fibrosis of skin

249

2263

1.12

0.87

5.6

5.1

2.22

2.20

ug/l

0.02

229

2047

Other congenital malformations of intestine, including avohilmo

109

949

1.20

0.87

5.3

5.2

1.81

2.32

ug/l

0.57

851

Implicit fungal Sepsis

549

5189

1.09

0.87

5.4

5.9

2.73

3.15

ug/l

0.47

493

4683

Embedded teeth, including avohilmo

548

5139

1.08

0.87

4.2

4.0

2.11

1.77

ug/l

0.29

509

4692

Other bullous disorders

306

2828

1.11

0.87

5.0

5.6

1.88

2.50

ug/l

1.41

282

2537

Encephalitis

317

2931

1.11

0.87

4.1

5.2

2.31

2.58

ug/l

0.26

292

2648

Other bursitis of knee

238

2192

1.15

0.87

5.5

4.9

1.98

2.40

ug/l

0.77

222

1988

Vulvovaginal ulceration/inflammation in other diseases

2.00

0.87

1.2

1.1

—

0.52

—

Attention to artificial openings

719

6866

1.08

0.87

6.0

5.9

5.13

2.66

ug/l

2.35

634

6137

Abscess of anal and rectal regions

1412

13646

1.05

0.86

4.8

4.7

2.34

2.49

ug/l

0.16

1291

12516

Other, unspecified and serous retinal detachments

478

4508

1.10

0.86

5.9

5.4

2.27

2.92

ug/l

1.31

435

4087

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

336

1.37

0.86

7.3

4.0

2.24

1.89

ug/l

0.25

300

Localized skin eruption due to drugs and medicaments

123

1083

1.19

0.86

6.5

5.4

2.29

2.39

ug/l

0.07

105

976

Burns and corrosions confined to eye and internal organs

366

3416

1.11

0.86

4.7

4.4

4.51

1.87

ug/l

0.47

329

3141

Malignant neoplasm of accessory sinuses, including Hilmo

603

0.76

0.86

5.3

4.2

1.74

1.98

ug/l

0.52

533

Dystonia

429

4002

1.09

0.86

5.2

5.3

1.85

2.30

ug/l

1.76

389

3613

Nontoxic diffuse goitre

148

1306

1.15

0.86

6.5

5.7

3.05

2.66

ug/l

0.26

132

1158

Carcinoma in situ of penis

455

1.61

0.85

6.1

5.4

3.08

3.02

ug/l

0.01

411

LeFortI or BSSO operation

271

2479

1.11

0.85

5.0

4.0

1.61

1.69

ug/l

0.19

260

2293

Congenital malformations, deformations and chromosomal abnormalities

7003

65250

1.02

0.85

4.7

4.8

2.01

2.64

ug/l

4.22

6370

59738

Benign neoplasm of thyroid gland

217

1965

1.13

0.85

6.3

5.7

2.63

2.54

ug/l

0.07

200

1758

Melanoma in situ of lower limb, including hip

459

1.28

0.85

7.3

5.9

2.72

2.80

ug/l

0.04

408

Nephrotic syndrome

431

4051

1.10

0.85

4.2

5.3

2.90

2.58

ug/l

0.19

386

3672

Asymptomatic human immunodeficiency virus [HIV] infection status

1008

0.80

0.84

3.5

3.6

1.55

1.43

ug/l

0.30

941

Sequelae of injuries of neck and trunk

426

4003

1.10

0.84

5.0

5.1

1.98

2.45

ug/l

0.70

387

3668

Mixed hyperlipidaemia

727

6955

1.08

0.84

5.2

5.6

2.41

2.98

ug/l

0.94

648

6293

Mixed specific developmental disorders

343

1.28

0.84

1.7

1.8

0.82

0.89

ug/l

0.36

310

Other osteochondrodysplasias, including avohilmo

724

1.21

0.84

5.0

4.6

1.74

2.11

ug/l

0.30

648

Benign neoplasm: Spinal cord

179

1621

1.16

0.84

6.3

5.3

2.16

2.27

ug/l

0.14

163

1470

Other histiocytosis syndromes

1.73

0.84

5.8

5.0

1.05

1.69

ug/l

0.92

Other and unspecified injuries of thorax

239

2194

1.13

0.84

4.9

5.1

1.57

2.39

ug/l

2.83

217

1993

Injury of other and unspecified intrathoracic organs

1182

11420

1.06

0.83

5.2

5.4

3.09

3.16

ug/l

0.04

1045

10407

Contusion of toe(s) with damage to nail

131

1162

1.18

0.83

5.4

4.8

1.81

2.36

ug/l

0.44

115

1052

Malignant neoplasm of other connective and soft tissue

342

3191

1.11

0.83

5.6

4.3

2.59

2.00

ug/l

1.64

307

2876

Follicular adenocarcinoma of thyroid gland, including Hilmo

812

1.21

0.83

5.7

4.1

2.30

1.87

ug/l

0.66

737

Disorders in reading

611

1.22

0.82

2.6

2.7

1.08

1.17

ug/l

0.26

561

Benign neoplasm of ovary

140

0.57

0.82

1.0

1.1

—

0.04

—

Brain meningioma, including Hilmo

362

3360

1.09

0.82

6.2

4.3

2.54

2.00

ug/l

1.29

324

3010

Other chronic obstructive pulmonary disease, including avohilmo

10897

90460

0.98

0.82

5.3

5.9

2.98

3.67

ug/l

1.17

9508

81902

MS-disease / Multiple Sclerosis

460

4303

1.08

0.82

4.0

4.5

1.57

1.88

ug/l

1.48

418

3948

Other viral hepatitis, including avohilmo

710

7460

0.94

0.82

3.6

3.9

1.94

1.72

ug/l

0.17

621

6901

Malignant neoplasm of nasopharynx, including Hilmo

693

0.78

0.82

6.0

4.2

2.46

1.87

ug/l

0.73

619

Other acquired deformities of ankle and foot

552

1.25

0.82

5.4

4.6

2.46

2.60

ug/l

0.07

503

Sicca syndrome [Sjögren]

349

3226

1.09

0.82

5.3

5.5

1.83

2.46

ug/l

2.39

309

2849

Other injuries of lower limb, level unspecified

116

1024

1.19

0.82

4.6

5.1

4.98

2.46

ug/l

0.32

106

925

Follow-up care involving plastic surgery

228

2072

1.12

0.82

6.3

5.7

1.99

2.26

ug/l

0.72

174

1837

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

920

8811

1.06

0.82

5.6

5.4

4.27

3.53

ug/l

0.21

809

7807

Personality disorders, excluding more controls

2768

26906

1.03

0.82

4.1

4.5

1.98

2.18

ug/l

0.27

2485

25017

Viral hepatitis

818

8560

0.94

0.82

3.9

4.2

2.32

1.93

ug/l

0.33

719

7886

Achalasia of cardia

235

2161

1.13

0.82

5.7

5.5

2.31

3.32

ug/l

0.77

210

1942

Benign neoplasm: Parathyroid gland

851

1.20

0.81

6.8

6.0

2.11

2.79

ug/l

0.65

756

Use of benzatropine

109

0.52

0.81

4.0

5.2

1.24

2.08

ug/l

—

Leukaemia of unspecified cell type

1126

0.83

0.81

5.0

5.6

2.46

3.02

ug/l

0.27

996

Use of biperiden

632

6644

0.93

0.81

3.5

4.9

2.57

2.42

ug/l

0.05

577

6085

Other sexually transmitted chlamydial diseases

379

3521

1.09

0.81

3.2

2.9

1.58

1.22

ug/l

1.07

342

3274

Methotrexate

1195

12428

0.95

0.81

4.7

5.4

2.16

3.12

ug/l

1.80

1090

11218

Injury of nerves and spinal cord at neck level

351

3292

1.11

0.81

4.7

5.4

1.87

2.29

ug/l

1.41

319

2981

All-cause Heart Failure

11717

82352

0.98

0.80

5.3

6.0

3.25

3.67

ug/l

0.79

10339

74511

Bronchiectasis

1011

9716

1.06

0.80

6.1

6.2

3.13

4.07

ug/l

0.63

887

8689

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

165

1495

1.16

0.80

4.7

4.2

6.01

1.92

ug/l

0.77

149

1341

Ductal carcinoma of pancreas

100

1128

0.83

0.80

4.0

4.4

2.18

1.93

ug/l

0.44

1007

Myasthenia gravis

235

2167

1.13

0.80

5.2

5.9

2.93

2.55

ug/l

0.23

214

1946

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

695

7306

0.94

0.80

3.2

3.5

1.34

1.58

ug/l

0.69

601

6753

Pneumoconiosis due to dust containing silica

720

0.76

0.80

5.6

6.0

1.88

2.67

ug/l

0.86

625

Benign neoplasm: Liver/bile ducts

216

1967

1.12

0.80

6.1

5.4

2.53

2.35

ug/l

0.21

205

1768

Chronic mastoiditis

349

3266

1.11

0.80

5.7

5.8

1.93

3.20

ug/l

2.74

296

2916

Other congenital malformations, not elsewhere classified

415

1.27

0.80

4.0

4.6

2.01

1.70

ug/l

0.38

369

Other infections specific to the perinatal period

0.00

0.79

0.0

1.1

—

0.70

—

Malignant neoplasm of tongue, including Hilmo

384

4076

0.91

0.79

5.0

4.1

2.26

1.90

ug/l

0.92

345

3708

Oesophagitis

848

8136

1.07

0.79

5.3

5.5

5.92

3.14

ug/l

0.33

774

7357

Pneumonia due to Streptococcus pneumoniae

582

6121

0.93

0.79

4.7

5.5

2.24

3.56

ug/l

1.12

523

5556

Contact with sharp object, undetermined intent

363

3404

1.10

0.79

4.6

1.60

2.03

ug/l

1.63

332

3127

Other congenital malformations of upper alimentary tract

853

1.22

0.79

5.7

5.9

2.44

2.67

ug/l

0.15

763

Other and unspecified nonorganic psychotic disorders

1919

19776

0.96

0.79

3.4

4.0

1.65

1.85

ug/l

0.53

1708

18237

Injury of muscle and tendon at forearm level

285

2653

1.12

0.79

5.1

4.6

1.86

1.98

ug/l

0.23

268

2433

Coronary artery bypass grafting

6496

48760

0.97

0.78

5.6

6.4

3.44

4.05

ug/l

0.56

5774

43844

Charcot foot

280

2996

0.89

0.78

4.2

5.8

1.58

2.66

ug/l

4.25

252

2725

Mental retardation

292

3128

0.91

0.78

3.5

4.4

1.43

1.98

ug/l

2.35

262

2858

Early complications of trauma

651

6208

1.07

0.78

5.0

5.1

2.06

2.42

ug/l

0.82

591

5646

!Aliquae complicationes praecoces traumatis

651

6208

1.07

0.78

5.0

5.1

2.06

2.42

ug/l

0.82

591

5646

Choroidal haemorrhage and rupture

418

1.33

0.78

6.2

5.5

4.02

2.64

ug/l

0.51

358

Other and unspecified hypertrophic disorders of skin

492

1.26

0.78

6.5

5.2

1.93

2.42

ug/l

0.30

443

Other encephalitis

300

2785

1.11

0.77

4.2

5.3

2.35

2.48

ug/l

0.11

276

2516

Foreign body in ear

186

1688

1.13

0.77

6.1

5.3

1.79

2.48

ug/l

1.48

167

1518

Somnolence, stupor and coma

510

5387

0.93

0.77

4.5

5.5

2.28

3.73

ug/l

1.07

468

4864

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

113

990

1.16

0.77

5.5

4.9

2.08

2.07

ug/l

0.01

106

886

Explicit bacterial Sepsis, including avohilmo

1848

17977

1.04

0.77

5.6

5.9

5.90

3.39

ug/l

0.41

1644

16233

Malignant neoplasm of other and unspecified urinary organs

517

1.32

0.76

5.0

4.6

5.23

2.18

ug/l

0.50

457

Benign neoplasm: Other and unspecified parts of small intestine

171

1551

1.14

0.76

6.8

5.8

2.62

3.20

ug/l

0.32

154

1377

SLE, ICD10

165

1480

1.13

0.76

4.5

5.1

1.67

2.21

ug/l

1.10

145

1329

SLE, strict definition

165

1480

1.13

0.76

4.5

5.1

1.67

2.21

ug/l

1.10

145

1329

Panniculitis, unspecified

105

923

1.18

0.76

4.8

5.2

1.57

2.38

ug/l

1.39

826

Impacted teeth

1072

9592

0.95

0.76

3.9

3.6

2.12

1.60

ug/l

0.38

989

8753

severe traumatic brain injury, does not include concussion

4401

43264

1.03

0.76

5.6

5.8

4.25

3.63

ug/l

0.44

3917

38922

Left hemicolectomy

283

3035

0.90

0.76

5.3

6.0

3.04

3.28

ug/l

0.15

248

2698

Corneal degeneration

168

1520

1.14

0.76

5.9

5.7

2.09

2.43

ug/l

0.49

153

1365

Other aneurysm

1011

9766

1.06

0.76

5.4

6.0

3.17

3.95

ug/l

0.39

893

8761

Congenital malformations of anterior segment of eye

539

1.24

0.76

6.3

5.5

1.90

2.01

ug/l

0.17

473

Follicular adenocarcinoma of thyroid gland

551

1.24

0.76

5.8

4.0

2.44

1.90

ug/l

0.59

499

Other specified/unspecified deforming dorsopathies

132

1173

1.15

0.75

5.7

4.7

3.31

2.32

ug/l

0.39

114

1066

Polyglandular dysfunction

127

1.52

0.75

4.5

4.7

1.03

1.82

ug/l

1.89

116

SLE (Finngen)

181

1634

1.12

0.75

4.5

5.2

1.79

2.44

ug/l

1.40

159

1468

Benign neoplasm: Spinal meninges

735

1.20

0.75

5.7

5.8

2.62

2.48

ug/l

0.09

660

Melanocytic naevi of ear and external auricular canal

459

1.26

0.74

6.2

5.9

1.76

3.00

ug/l

0.96

399

Malignant neoplasm of tonsil and base of tongue, including Hilmo

420

4418

0.91

0.74

4.7

4.1

2.15

1.88

ug/l

1.12

373

4034

Paranoid personality disorder

177

1942

0.88

0.74

4.8

5.0

2.68

2.22

ug/l

0.23

157

1761

Anisometropia and aniseikonia

294

2729

1.10

0.74

5.5

2.73

2.85

ug/l

0.06

257

2472

Procedures for purposes other than remedying health state

832

1.17

0.74

5.4

4.9

2.07

1.86

ug/l

0.35

758

Other specified/unspecified disorders of bone/cartilage

415

3923

1.09

0.73

5.4

4.8

1.85

2.20

ug/l

1.16

380

3601

Other intracranial haemorrhages

569

5436

1.08

0.73

6.5

6.4

7.39

4.32

ug/l

0.39

512

4825

Other osteochondropathies

933

8976

1.06

0.73

4.8

1.84

2.19

ug/l

1.73

851

8252

Benign neoplasm: Bladder

153

1395

1.17

0.73

6.9

6.2

2.28

3.04

ug/l

1.00

140

1233

Ulcer of lower limb, not elsewhere classified

2609

25529

1.04

0.73

4.7

5.9

2.66

3.42

ug/l

1.52

2288

22988

Certain conditions originating in the perinatal period

168

1660

0.89

0.73

3.0

3.2

1.14

1.36

ug/l

0.87

155

1480

COPD/asthma related infections

15394

76283

1.01

0.73

5.1

5.6

2.88

3.30

ug/l

1.09

13886

69396

COPD/asthma/ILD related infections

15394

76283

1.01

0.73

5.1

5.6

2.88

3.30

ug/l

1.09

13886

69396

Other infectious diseases

1000

10375

0.95

0.73

5.2

5.7

3.96

3.62

ug/l

0.15

901

9315

Certain zoonotic bacterial diseases, including avohilmo

349

3270

1.09

0.73

5.5

5.4

2.23

2.46

ug/l

0.31

329

2954

L04AC Interleukin inhibitors

706

6740

1.06

0.73

4.0

4.4

1.67

1.95

ug/l

1.15

655

6220

Malignant neoplasm of tongue

288

3073

0.90

0.73

5.0

4.2

2.09

1.89

ug/l

0.66

262

2799

Glaucoma secondary to other eye disorders

569

5418

1.07

0.73

5.4

5.6

2.82

4.02

ug/l

0.73

511

4862

Motorcycle rider injured in noncollision transport accidents

443

4192

1.09

0.72

4.6

4.2

2.65

1.79

ug/l

0.56

416

3868

Thyroiditis

376

3511

1.08

0.72

6.1

5.3

2.71

2.35

ug/l

0.19

349

3159

Open wound of abdomen, lower back and pelvis

414

3906

1.09

0.72

4.7

4.8

3.85

2.06

ug/l

0.44

370

3570

Poisoning by medicine

2206

21482

1.03

0.72

3.8

4.4

2.41

2.30

ug/l

0.07

1924

19757

Viral hepatitis, including avohilmo

855

8907

0.95

0.72

3.9

4.2

2.26

1.93

ug/l

0.28

753

8209

Disorders of orbit

350

3269

1.09

0.72

5.0

5.1

3.09

2.34

ug/l

0.43

312

2941

Dissociative [conversion] disorders

175

1580

1.12

0.72

4.3

4.6

3.60

2.07

ug/l

0.32

154

1437

Bicuspidal aortic valve syndrome

615

5886

1.08

0.72

4.8

4.9

2.20

2.23

ug/l

0.05

555

5396

Pedestrian injured in collision with car, pick-up truck or van

205

2234

0.90

0.71

5.2

4.9

3.32

2.15

ug/l

0.47

176

2040

Other/unspecified crystal arthropathies

757

1.21

0.71

7.6

6.1

3.39

2.68

ug/l

0.21

669

Burns and corrosions of multiple and unspecified body regions

325

3051

1.10

0.71

4.9

5.0

2.25

2.14

ug/l

0.16

297

2795

Bus occupant injured in other and unspecified transport accidents

377

1.27

0.71

5.0

5.1

1.71

1.73

ug/l

0.02

341

0.50

0.70

2.8

4.0

3.18

1.34

ug/l

—

Corns and callosities

833

8000

1.06

0.70

5.0

5.5

1.99

2.62

ug/l

2.26

764

7241

Septal defects

510

4724

1.07

0.70

5.2

4.9

1.66

2.28

ug/l

1.98

442

4309

Exfoliative dermatitis

158

1721

0.87

0.70

4.9

5.6

2.93

2.82

ug/l

0.05

139

1532

Benign neoplasm: Larynx

532

5081

1.08

0.70

5.7

5.6

3.20

3.57

ug/l

0.14

479

4577

Cholesteatoma of external ear

122

1103

1.18

0.70

6.0

5.8

1.90

2.74

ug/l

1.14

114

995

Systemic lupus erythematosus, unspecified

136

1214

1.14

0.70

4.5

5.1

1.46

2.26

ug/l

1.78

117

1093

Cholesteatoma of middle ear

731

7016

1.07

0.70

6.0

5.8

2.99

3.83

ug/l

0.47

644

6328

Melanoma in situ, other sites/unspecified

423

1.30

0.70

6.7

5.8

3.24

1.99

ug/l

0.56

373

Lagophthalmos

160

1459

1.14

0.70

6.6

6.0

3.35

3.59

ug/l

0.08

140

1287

Non-allergic asthma (mode), excluding more controls

2421

23410

1.03

0.70

5.1

5.9

2.82

4.21

ug/l

1.28

2196

21342

Congenital deformities of hip

346

1.25

0.69

4.0

1.87

1.53

ug/l

0.37

307

Unequal limb length (acquired)

376

1.25

0.69

4.7

4.3

1.40

1.88

ug/l

1.00

341

Gonarthrosis, primary, with knee surgery

9971

78438

0.98

0.69

6.2

5.9

2.79

3.58

ug/l

1.10

9001

70734

Other/unspecified mastoiditis and related conditions

541

1.25

0.69

6.6

5.2

1.89

2.01

ug/l

0.07

478

Other and unspecified injuries of forearm

667

1.20

0.69

4.4

1.95

1.81

ug/l

0.16

602

Bullous keratopathy

782

1.19

0.69

6.1

5.9

2.47

2.82

ug/l

0.23

694

Other and unspecified types of non-Hodgkin lymphoma, hilmo

548

5742

0.93

0.69

4.8

5.9

3.55

3.03

ug/l

0.21

489

5140

Other diseases of the digestive system

6177

60924

1.02

0.69

5.6

5.9

3.97

3.88

ug/l

0.04

5454

54761

Asymmetry of jaw

662

1.19

0.69

4.3

1.59

2.04

ug/l

0.44

600

Carrier of infectious disease

230

2122

1.11

0.69

4.3

5.4

1.78

2.39

ug/l

1.39

196

1907

Nonspecific lymphadenitis

551

5233

1.07

0.69

4.5

2.71

2.07

ug/l

0.43

510

4815

Vascular syndromes of brain in cerebrovascular disorders

659

6316

1.07

0.68

5.4

6.2

2.91

4.36

ug/l

1.06

612

5664

Biological medicines for asthma

201

1844

1.12

0.68

4.8

4.3

1.51

1.92

ug/l

1.11

186

1700

Optic neuritis

259

2394

1.10

0.68

5.2

4.8

2.17

2.29

ug/l

0.15

232

2178

Use of selegiline

640

6676

0.94

0.68

5.2

6.0

2.16

3.93

ug/l

2.09

564

5961

Disease of thymus, other/unspecified

105

1.57

0.68

3.3

4.8

1.06

1.71

ug/l

1.69

100

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

183

1990

0.89

0.68

4.8

4.3

2.86

2.16

ug/l

1.12

160

1782

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms, including avohilmo

126

0.55

0.68

4.0

3.9

0.75

1.48

ug/l

—

110

IBD (strict) with PSC

915

0.84

0.68

3.2

4.1

1.60

1.76

ug/l

0.22

849

Open wound of thorax

206

2222

0.89

0.68

4.1

4.6

2.00

1.99

ug/l

0.00

177

2057

Protozoal diseases, including avohilmo

415

3931

1.09

0.68

4.8

5.7

3.16

2.43

ug/l

0.57

374

3545

Malignant neoplasm of oropharynx, including Hilmo

350

3689

0.91

0.68

4.7

4.2

2.27

1.88

ug/l

0.71

306

3361

Heart failure, strict

11908

83511

0.98

0.67

5.3

6.0

3.23

3.66

ug/l

0.86

10508

75585

Perioral dermatitis

531

1.20

0.67

4.9

4.7

1.32

2.39

ug/l

1.06

469

Malignant neoplasm of lip

130

1181

1.17

0.67

5.4

4.6

3.16

2.32

ug/l

0.63

117

1043

Bronchitis, not specified as acute or chronic

1266

12272

1.05

0.67

5.0

5.1

3.02

3.14

ug/l

0.05

1157

11173

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

279

1.38

0.67

3.9

4.7

2.65

2.84

ug/l

0.04

250

Drug-induced hypoglycaemia without coma

199

2151

0.89

0.67

4.7

5.4

2.31

2.90

ug/l

0.38

164

1921

Granulomatous disorders of skin and subcutaneous tissue

174

1583

1.12

0.67

5.2

5.3

1.87

2.30

ug/l

0.86

160

1424

Exposure to uncontrolled fire in building or structure

104

1154

0.85

0.66

4.1

4.9

9.00

2.17

ug/l

0.84

1051

Other and unspecified abdominal hernia

475

4509

1.07

0.66

5.7

5.6

2.06

2.94

ug/l

2.85

419

4057

Lifestyle-related condition

138

1251

1.15

0.66

5.3

5.2

2.07

2.38

ug/l

0.32

120

1129

Explicit bacterial Sepsis

1806

17610

1.04

0.66

5.6

5.9

5.94

3.39

ug/l

0.41

1608

15903

Cerebral palsy and other paralytic syndromes

1284

13250

0.96

0.66

5.0

5.3

4.13

3.27

ug/l

0.41

1163

11954

Non-Hodgkin lymphoma, all

690

7177

0.94

0.66

5.0

4.4

3.36

2.15

ug/l

1.85

601

6426

Degenerative conditions of globe

672

0.81

0.66

5.3

5.7

6.28

2.72

ug/l

0.38

585

Non-allergic asthma (mode)

2421

23431

1.03

0.66

5.1

5.8

2.82

3.79

ug/l

0.84

2196

21334

Thyroiditis, unspecified

646

1.18

0.66

5.9

5.2

5.85

2.54

ug/l

0.42

578

Open wound of shoulder and upper arm

259

2415

1.10

0.66

4.9

4.8

1.93

2.41

ug/l

0.69

232

2205

Enterobiasis, including avohilmo

616

1.18

0.66

3.9

3.4

1.16

1.86

ug/l

0.76

563

Personality disorders

2768

27072

1.03

0.66

4.1

4.4

1.98

2.08

ug/l

0.12

2485

24983

L01XX Other antineoplastic agents

757

7868

0.94

0.66

5.5

6.0

4.58

3.73

ug/l

0.30

668

7046

Fungal Sepsis

611

5850

1.07

0.66

5.4

5.9

3.32

3.11

ug/l

0.12

551

5277

Inhalation and ingestion of other objects causing obstruction of respiratory tract

589

1.22

0.65

6.5

5.3

1.96

2.02

ug/l

0.06

526

Blood alcohol or alcohol intoxication level

281

3000

0.91

0.65

4.1

4.5

2.13

1.99

ug/l

0.17

260

2758

ILD, hospital admissions

2710

26582

1.03

0.65

5.4

6.1

3.21

3.63

ug/l

0.29

2393

23848

Systemic lupus erythematosus

181

1650

1.11

0.65

4.5

5.1

1.79

2.22

ug/l

0.87

159

1479

Use of trihexyphenidyl

170

0.64

0.65

4.8

5.7

1.43

2.05

ug/l

—

141

Malignant neoplasm of penis

901

1.27

0.65

6.1

4.1

2.06

1.92

ug/l

0.25

807

Drug-induced gout

675

0.80

0.65

5.2

6.2

3.62

3.18

ug/l

0.14

597

Assault by unspecified means

210

2269

0.90

0.64

3.8

3.7

1.48

ug/l

0.01

181

2107

Other operation for atrial fibrillation

106

972

1.23

0.64

5.4

6.0

1.87

2.63

ug/l

1.06

873

Malignant neoplasm of ureter

430

1.30

0.64

4.6

4.5

1.96

2.11

ug/l

0.10

378

Viral agents as the cause of diseases classified to other chapters

228

2115

1.11

0.64

5.5

5.3

5.13

2.38

ug/l

0.71

205

1922

Bilateral sagittal split ramus osteotomy operation

220

2028

1.10

0.64

5.0

4.1

1.60

1.73

ug/l

0.29

212

1878

Benign neoplasm: Connective and other soft tissue of head, face and neck

184

1693

1.12

0.64

5.6

5.3

2.01

2.55

ug/l

0.89

166

1525

Frontotemporal dementia

793

0.82

0.63

5.4

5.9

2.30

2.73

ug/l

0.28

697

Arthropathic psoriasis

1458

14175

1.04

0.63

4.9

5.1

2.25

2.46

ug/l

0.28

1316

12963

Cytomegaloviral disease

301

2829

1.09

0.63

4.3

5.1

2.00

2.10

ug/l

0.23

287

2569

Pedal cyclist injured in noncollision transport accidents

1454

14130

1.04

0.63

4.7

4.8

1.99

2.32

ug/l

1.41

1321

12930

Other protozoal intestinal diseases, including avohilmo

197

1813

1.11

0.63

5.3

5.1

1.54

2.42

ug/l

2.62

184

1645

Alcohol abuse counselling and surveillance

236

2520

0.90

0.63

4.2

4.5

2.13

1.89

ug/l

0.47

214

2325

Drug-induced autoimmune haemolytic anaemia

133

0.60

0.63

3.6

4.9

1.25

1.89

ug/l

—

120

Benign neoplasm: Connective and other soft tissue, unspecified

120

1081

1.15

0.63

6.0

5.5

2.21

2.52

ug/l

0.29

109

978

Exposure to noise

250

0.67

0.63

5.3

1.49

2.19

ug/l

1.15

223

Other factor of the environment

147

1341

1.14

0.63

5.4

5.3

2.21

2.42

ug/l

0.19

129

1216

Intussusception

116

1035

1.14

0.63

5.8

5.1

2.01

2.84

ug/l

0.94

106

929

Other diseases of pancreas

1336

12998

1.04

0.62

5.8

5.7

2.13

3.21

ug/l

2.51

1214

11767

Guillain-Barre syndrome

230

2148

1.11

0.62

6.0

5.5

2.17

2.80

ug/l

0.54

209

1949

Hypoparathyroidism

191

1751

1.10

0.62

5.5

5.4

3.07

2.43

ug/l

0.44

165

1563

Use of cabergoline

144

1311

1.13

0.62

5.4

5.0

1.55

2.47

ug/l

1.99

128

1191

Anorexia (incl.atypical)

272

2922

0.92

0.62

4.5

4.7

2.22

2.20

ug/l

0.03

251

2654

Complications of cardiac and vascular prosthetic devices, implants and grafts

361

3431

1.09

0.62

4.8

5.9

2.10

3.17

ug/l

2.11

320

3061

Idiopathic hypercalciuria

642

1.21

0.62

5.4

4.9

1.87

2.53

ug/l

0.56

576

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

128

1168

1.16

0.62

5.0

5.1

3.10

2.47

ug/l

0.29

119

1073

Other congenital musculoskeletal deformities, including avohilmo

1.49

0.61

3.3

2.9

1.76

1.36

ug/l

0.19

Erythema nodosum

167

1523

1.11

0.61

5.3

5.2

2.72

2.24

ug/l

0.38

148

1375

Corticotropin deficiency

780

1.18

0.61

5.3

5.5

2.62

2.57

ug/l

0.02

699

Thyrotoxicosis with toxic single thyroid nodule

420

1.22

0.61

6.4

5.5

3.56

2.74

ug/l

0.26

376

Benign neoplasm: Liver

178

1632

1.11

0.61

6.4

5.3

2.61

2.41

ug/l

0.20

167

1462

Other disorders of breast

1.46

0.61

1.1

1.2

—

0.33

—

Other congenital malformations of peripheral vascular system

102

908

1.15

0.61

4.2

4.6

1.56

2.15

ug/l

0.93

829

Neuroendocrine tumor and carcinoma of small intestine

203

1890

1.12

0.61

5.4

4.4

2.33

1.99

ug/l

0.80

177

1702

Cytomegalovirus infection, IBD co-morbidity

293

2757

1.09

0.61

4.3

5.1

2.00

2.13

ug/l

0.27

279

2507

Other and unspecified acquired haemolytic anaemias

105

1163

0.86

0.61

5.2

5.6

2.67

2.50

ug/l

0.10

1047

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

286

3033

0.91

0.61

5.2

4.2

2.16

1.93

ug/l

0.36

254

2754

Coarctation of the aorta

947

0.86

0.61

3.4

4.3

1.65

1.97

ug/l

0.36

859

Nezelof syndrome

401

0.77

0.61

6.0

5.6

4.80

2.91

ug/l

0.26

364

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

777

0.84

0.60

4.8

3.9

3.70

1.86

ug/l

0.56

696

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

183

1691

1.12

0.60

4.7

4.5

2.02

2.04

ug/l

0.02

163

1552

Idiopathic urticaria

130

1172

1.13

0.60

5.0

4.7

1.73

2.15

ug/l

0.39

123

1064

Poor fetal growth

1.57

0.60

1.0

1.2

—

1.03

—

Fibrothorax

316

0.72

0.60

5.5

5.8

2.26

2.49

ug/l

0.16

278

Prolapse and hernia of ovary and fallopian tube

0.00

0.60

0.0

1.0

—

Other and unspecified trigeminal disorders

117

1052

1.14

0.60

5.5

5.1

2.13

2.40

ug/l

0.27

100

952

Viral conjunctivitis, including avohilmo

277

2587

1.08

0.60

4.7

2.09

2.01

ug/l

0.07

259

2357

Mature T/NK-cell lymphomas, hilmo

196

2098

0.89

0.60

4.8

5.9

2.30

2.71

ug/l

0.33

180

1874

Other congenital musculoskeletal deformities

1.54

0.60

3.0

2.4

0.94

1.16

ug/l

—

Calcific tendinitis

108

973

1.15

0.59

5.2

5.3

14.77

2.65

ug/l

0.48

874

Portal vein thrombosis

219

2340

0.90

0.59

4.6

5.4

1.91

2.69

ug/l

0.95

191

2119

Idiopathic pulmonary fibrosis

1338

13721

0.96

0.59

5.0

6.3

3.36

4.04

ug/l

0.29

1155

12255

Etanercept

530

5051

1.06

0.59

3.9

4.6

1.72

1.97

ug/l

1.07

487

4636

Azathioprine

1635

16783

0.97

0.59

4.2

4.8

2.63

2.53

ug/l

0.06

1497

15299

Dementia in other diseases classified elsewhere

626

6513

0.94

0.59

4.7

6.4

2.82

4.24

ug/l

1.26

525

5806

Burn and corrosion, body region unspecified

692

1.20

0.59

5.2

4.8

1.68

1.88

ug/l

0.38

626

Endometriosis of ovary

1.45

0.59

1.1

—

0.03

—

Protozoal diseases

402

3825

1.08

0.59

4.8

5.7

3.19

2.44

ug/l

0.58

363

3446

ILD medications: immunosuppressive drugs

9632

88107

0.99

0.59

4.6

5.1

2.17

2.54

ug/l

1.88

8795

80501

Any dementia, excluding more controls

6685

45326

1.02

0.59

5.3

6.7

4.11

4.27

ug/l

0.12

5831

40422

Ulcerative colitis

3389

33297

1.02

0.59

5.1

5.0

2.56

2.66

ug/l

0.11

3110

30429

Crohn disease (strict definition, all UC cases excluded)

519

4952

1.06

0.59

4.6

2.23

2.00

ug/l

0.21

491

4520

Major anomalies of jaw size

259

2422

1.09

0.59

4.8

4.3

1.79

ug/l

0.01

237

2224

Drug-induced osteoporosis with pathological fracture

129

1169

1.13

0.59

6.0

5.8

2.11

2.41

ug/l

0.20

110

1042

Esophageal diverticulum (pouch), including avohilmo

403

1.27

0.59

6.8

6.1

2.96

2.11

ug/l

0.62

353

Poisoning by drugs, medicaments and biological substances

2477

24242

1.03

0.59

3.9

4.4

2.32

2.29

ug/l

0.02

2151

22294

Other and unspecified epidermal thickening

302

2843

1.09

0.59

5.0

5.6

4.37

2.86

ug/l

0.26

276

2551

Delayed milestone in childhood

1.45

0.58

2.1

1.4

0.54

0.75

ug/l

1.83

Tick-borne viral encephalitis

561

1.22

0.58

6.8

5.3

2.93

1.82

ug/l

0.50

505

Viral agents as the cause of diseases classified to other chapters, including avohilmo

255

2385

1.09

0.58

5.4

5.2

4.68

2.30

ug/l

0.68

230

2166

Venous thromboembolism

8961

85351

1.02

0.58

5.7

3.35

3.58

ug/l

0.29

8045

77006

Abnormality of white blood cells, not elsewhere classified

102

918

1.16

0.58

5.0

1.62

2.21

ug/l

0.97

823

Sulfasalazine

3677

36147

1.02

0.58

4.8

5.3

2.60

2.80

ug/l

0.24

3317

32943

Acute poliomyelitis

1010

0.87

0.58

4.3

4.8

1.48

2.42

ug/l

1.51

908

Cytomegaloviral disease, including avohilmo

302

2849

1.09

0.58

4.3

5.1

2.00

2.09

ug/l

0.21

288

2589

Ankle and foot

697

1.17

0.58

4.9

5.4

2.27

2.04

ug/l

0.19

625

Handgun discharge

100

0.56

0.58

7.1

4.2

0.83

1.47

ug/l

—

Multifocal fibrosclerosis

482

1.21

0.58

5.9

6.1

1.99

2.82

ug/l

0.57

420

Neovascular glaucoma

567

5439

1.06

0.58

5.4

5.7

2.83

3.97

ug/l

0.69

509

4880

Congenital iodine-deficiency syndrome/hypothyroidism

147

1337

1.11

0.58

5.8

5.7

2.39

3.35

ug/l

0.70

127

1174

Exposure to other and unspecified animate mechanical forces

248

2313

1.09

0.57

5.0

4.4

1.31

1.95

ug/l

2.86

232

2132

Hodgkin lymphoma, hilmo

320

3384

0.92

0.57

4.6

5.3

1.80

2.33

ug/l

2.12

287

3066

Acute myeloid leukaemia, including Hilmo

143

1556

0.89

0.57

4.4

1.88

2.08

ug/l

0.50

131

1386

Acute myeloid leukaemia, helper endpoint

143

1556

0.89

0.57

4.4

1.88

2.08

ug/l

0.50

131

1386

Acute myeloid leukaemia

143

1556

0.89

0.57

4.4

1.88

2.08

ug/l

0.50

131

1386

Epidural haemorrhage

139

1507

0.88

0.57

4.4

5.0

6.86

2.23

ug/l

0.44

119

1379

Obstructive hydrocephalus

140

1528

0.89

0.57

4.9

5.2

1.74

2.33

ug/l

1.23

131

1376

Mild mental retardation

198

2135

0.91

0.57

3.3

4.6

1.46

1.95

ug/l

1.44

176

1963

Other specified and unspecified disorders of eye and adnexa

343

3240

1.08

0.56

5.6

5.4

2.01

2.69

ug/l

1.16

309

2907

Acute suppurative otitis media

2268

20658

1.03

0.56

3.9

3.8

1.58

1.81

ug/l

1.51

2057

18999

Hypertrophy of (infrapatellar) fat pad

105

947

1.15

0.56

5.2

4.7

2.07

2.31

ug/l

0.15

870

Malignant neoplasm of other and unspecified parts of tongue

183

1965

0.90

0.56

5.2

4.2

1.95

1.87

ug/l

0.17

165

1763

Superficial frostbite

935

0.85

0.56

3.8

4.9

1.72

2.16

ug/l

0.55

852

Osteomalacia

690

1.17

0.56

4.2

4.8

1.61

2.48

ug/l

0.96

632

Acute myringitis

548

1.19

0.56

5.6

5.0

1.44

1.92

ug/l

1.13

494

ILD, hospital admissions 1, main diag only

2383

23395

1.03

0.56

5.4

6.2

3.26

3.52

ug/l

0.15

2121

20999

Specific personality disorders

2258

22090

1.03

0.56

4.1

4.4

2.19

2.06

ug/l

0.14

2023

20359

Acute poliomyelitis, including avohilmo

1017

0.87

0.56

4.4

4.8

1.47

2.42

ug/l

1.57

915

Dyshidrosis [pompholyx]

126

1144

1.13

0.55

4.4

4.8

1.53

2.12

ug/l

1.14

109

1033

Other disorders of optic disc

137

1253

1.12

0.55

5.4

5.2

1.82

2.26

ug/l

0.55

126

1134

Open wound of neck

101

1112

0.87

0.55

4.9

4.4

1.44

1.99

ug/l

0.90

1022

Chronic myringitis

573

1.20

0.55

6.8

5.5

2.19

1.80

ug/l

0.44

514

Childhood asthma (age<16), excluding more controls

711

5786

0.96

0.55

2.3

1.09

1.13

ug/l

0.22

648

5387

Use of rotigotine

136

1250

1.13

0.54

5.1

5.5

1.98

2.23

ug/l

0.36

126

1115

Other specified and unspecified disorders of conjunctiva

118

1075

1.14

0.54

4.4

5.1

1.49

2.21

ug/l

1.60

109

973

Congenital malformations of the respiratory system, including avohilmo

143

1307

1.12

0.54

5.3

5.0

4.25

2.09

ug/l

0.37

133

1173

Sequelae of injuries of head

828

8020

1.05

0.54

4.6

4.9

2.14

2.35

ug/l

0.39

727

7349

Universal erythroderma, KELA reimbursement

192

2051

0.90

0.54

4.2

5.1

1.67

2.33

ug/l

1.97

172

1861

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

550

5285

1.06

0.54

5.6

5.4

2.27

2.62

ug/l

0.59

495

4778

Extreme obesity with alveolar hypoventilation

473

4942

0.94

0.54

4.5

5.4

1.93

2.58

ug/l

0.94

407

4497

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

904

0.86

0.54

5.1

5.2

2.59

2.23

ug/l

0.11

814

Degenerative macular diseases, drug-induced

377

1.26

0.54

6.1

5.8

2.51

2.12

ug/l

0.45

330

Spondylopathies in diseases classified elsewhere

181

1688

1.12

0.54

9.7

5.8

23.23

2.82

ug/l

1.21

167

1505

Habit and impulse disorders

173

1601

1.11

0.54

3.6

1.27

1.64

ug/l

0.87

159

1484

Obesity, other/unspecified

3422

33630

1.02

0.54

4.6

5.1

1.61

2.58

ug/l

9.01

3064

30796

Tooth agenesis EXCLUDE clefts and syndromes

134

1214

1.11

0.54

4.6

3.7

1.34

1.81

ug/l

0.81

124

1099

Liposarcoma

124

1143

1.15

0.54

5.4

4.2

2.14

1.96

ug/l

0.25

112

1026

Congenital malformations of the respiratory system

132

1203

1.12

0.54

5.3

5.1

4.48

2.13

ug/l

0.37

123

1079

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

319

3012

1.08

0.54

4.5

4.6

1.74

1.98

ug/l

0.48

292

2766

Other pleural conditions

1809

18463

0.97

0.53

5.5

6.1

4.91

3.84

ug/l

0.24

1559

16562

Assault by bodily force

923

8937

1.04

0.53

3.7

3.8

1.81

1.67

ug/l

0.37

800

8268

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

613

5884

1.05

0.53

4.3

4.6

2.17

2.97

ug/l

0.51

542

5358

Certain zoonotic bacterial diseases

224

2100

1.10

0.53

5.6

5.3

2.37

2.47

ug/l

0.07

210

1894

Dermatopolymyositis (FG)

137

1256

1.12

0.53

5.0

5.5

3.72

2.79

ug/l

0.40

123

1132

Infective dermatitis

1643

16059

1.03

0.53

5.1

5.6

1.98

3.18

ug/l

4.12

1477

14563

Malignant immunoproliferative diseases

162

1511

1.13

0.53

5.4

6.2

1.94

2.67

ug/l

1.36

144

1351

Monoplegia

151

1634

0.90

0.53

4.6

5.4

2.06

2.60

ug/l

0.86

138

1466

Injury of cranial nerves

707

1.17

0.52

4.2

4.8

1.79

2.04

ug/l

0.29

635

Defect, injury or illness of neck

458

1.20

0.52

6.2

5.1

3.20

1.87

ug/l

1.16

407

Unspecified transport accident

537

1.20

0.52

4.1

1.82

1.62

ug/l

0.23

491

Intentional self-harm by jumping from a high place

461

0.81

0.52

2.2

3.7

0.95

1.46

ug/l

2.60

415

Cysticercosis

2.11

0.52

5.8

6.6

1.58

2.06

ug/l

—

Cysticercosis, including avohilmo

2.11

0.52

5.8

6.6

1.58

2.06

ug/l

—

Monosomies and deletions from the autosomes, not elsewhere classified

1.42

0.52

2.8

3.3

0.82

1.52

ug/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

1656

16911

0.97

0.52

4.3

4.7

1.78

2.11

ug/l

2.96

1515

15624

Myelodysplastic syndrome

192

1798

1.11

0.52

5.6

4.6

1.98

2.22

ug/l

0.61

166

1599

ILD medications: azathioprine

1635

16742

0.97

0.52

4.2

4.8

2.63

2.61

ug/l

0.01

1497

15282

Other specified/unspecified diseases of inner ear

508

1.20

0.52

8.0

5.6

27.69

2.07

ug/l

0.68

449

Discontinuity and dislocation of ear ossicles

575

1.19

0.52

5.4

5.1

1.65

1.88

ug/l

0.46

517

Congenital malformations of aortic and mitral valves

639

6171

1.06

0.51

4.8

4.9

2.16

2.22

ug/l

0.10

576

5659

Malignant neoplasm of oropharynx, including Hilmo

827

0.84

0.51

3.9

4.3

2.77

1.91

ug/l

0.31

741

Disorders of magnesium metabolism

128

1184

1.14

0.51

4.9

5.9

1.89

2.67

ug/l

1.18

106

1066

Beningn neoplasm: Meninges, unspecified

112

1016

1.13

0.51

6.4

5.6

3.12

2.78

ug/l

0.24

902

Pyoderma

209

2229

0.91

0.51

5.3

5.5

1.90

2.61

ug/l

1.64

179

2032

Lichen simplex chronicus

416

3975

1.07

0.51

5.1

5.3

2.18

2.64

ug/l

0.61

374

3600

Other injuries of spine and trunk, level unspecified

100

1098

0.88

0.51

5.2

5.1

8.66

2.24

ug/l

0.48

988

Other and unspecified hydrocephalus

168

1809

0.91

0.51

4.3

5.5

3.39

2.61

ug/l

0.31

146

1616

Circumscribed brain atrophy

272

2872

0.92

0.51

5.2

6.3

2.90

3.37

ug/l

0.27

235

2561

Secondary thrombocytopenia

140

1513

0.89

0.51

5.1

5.3

2.25

2.27

ug/l

0.01

129

1373

Demyelinating diseases of the central nervous system

580

5563

1.05

0.51

4.3

4.6

1.60

1.95

ug/l

2.29

522

5090

Blepharospasm

743

1.15

0.51

5.1

5.3

1.64

2.47

ug/l

1.03

659

Chronic conjunctivitis

217

2027

1.09

0.50

5.7

5.1

1.87

2.38

ug/l

1.20

197

1831

Myotonic disorders

716

1.16

0.50

4.7

4.5

1.47

1.73

ug/l

0.56

649

Glomerular disorders in diseases classified elsewhere

2066

20286

1.03

0.50

4.2

5.6

2.05

3.10

ug/l

3.97

1885

18404

Open wound of hip and thigh

458

4391

1.06

0.50

4.7

1.68

2.03

ug/l

1.59

417

4019

Burn and corrosion of wrist and hand

463

4436

1.06

0.50

4.6

2.17

1.94

ug/l

0.27

420

4064

Combined immunodeficiencies

903

0.87

0.50

5.9

5.5

4.74

3.09

ug/l

0.42

807

Hair colour and hair shaft abnormalities

638

0.82

0.50

4.7

6.1

2.21

2.52

ug/l

0.22

563

Frontotemporal dementia, wide, incl. Pick's disease

915

0.86

0.50

5.4

6.1

2.83

2.64

ug/l

0.09

803

Congenital malformations of posterior segment of eye

491

1.20

0.50

4.7

5.3

2.44

2.84

ug/l

0.19

441

Infection due to other mycobacteria

156

1681

0.90

0.49

6.0

2.65

2.74

ug/l

0.06

140

1491

Enteropathic arthropathies

214

2003

1.09

0.49

5.1

4.7

2.44

2.47

ug/l

0.02

198

1825

Spotted fever [tick-borne rickettsioses], including avohilmo

1.67

0.49

5.4

4.6

2.04

1.74

ug/l

0.14

Childhood asthma (age<16)

712

5778

0.96

0.49

2.3

1.09

1.13

ug/l

0.26

649

5379

Spotted fever [tick-borne rickettsioses]

1.78

0.49

5.7

4.7

2.19

1.74

ug/l

—

Other superficial injuries of ankle and foot

584

1.17

0.49

4.3

4.8

1.74

1.86

ug/l

0.11

533

Psoriasis (vulgaris), strict definition

509

4898

1.06

0.49

4.0

4.7

1.46

2.08

ug/l

4.79

460

4510

Iliotibial band syndrome

618

1.16

0.49

5.6

4.5

2.24

2.37

ug/l

0.07

563

Isolated proteinuria with specified morphological lesion

148

1374

1.12

0.49

4.6

5.5

2.14

2.48

ug/l

0.45

137

1250

Fatigue fracture of vertebra

377

1.22

0.49

5.9

5.3

2.21

2.97

ug/l

0.34

344

Maze procedure for atrial fibrillation

771

0.84

0.49

5.2

5.7

2.28

2.66

ug/l

0.26

688

Multiple congenital exostoses, including avohilmo

268

1.28

0.49

5.2

4.1

2.29

1.53

ug/l

0.58

247

Contact with heat and hot substances

671

6481

1.05

0.49

4.9

5.0

1.76

2.45

ug/l

2.86

604

5920

Rubella [German measles], including avohilmo

899

8811

1.07

0.49

3.8

4.1

1.70

1.82

ug/l

0.64

843

8282

Rare circulating lymphoid malignancy, including Hilmo

417

3996

1.07

0.49

5.5

4.2

2.53

2.01

ug/l

0.45

374

3590

Gastrointestinal stromal tumor and sarcoma

174

1630

1.11

0.48

7.1

4.4

2.92

1.99

ug/l

1.81

152

1469

Cauda equina syndrome

131

1206

1.12

0.48

5.5

5.0

8.41

2.10

ug/l

0.70

122

1089

Congenital malformations of gallbladder, bile ducts and liver

659

1.15

0.48

5.1

5.3

2.07

2.43

ug/l

0.30

598

Injury of blood vessels at wrist and hand level

110

1014

1.15

0.48

6.7

5.0

2.06

2.35

ug/l

0.28

102

931

Rubella [German measles]

898

8803

1.07

0.48

3.8

4.1

1.70

1.82

ug/l

0.65

842

8275

Malignant neoplasm of base of tongue, including Hilmo

146

1557

0.89

0.48

4.4

4.1

2.30

1.83

ug/l

1.02

133

1406

Necrotizing fasciitis

756

0.85

0.48

4.7

5.3

2.21

2.68

ug/l

0.26

680

Heart failure and hypertrophic cardiomyopathy

273

2867

0.92

0.48

4.4

5.9

2.16

2.95

ug/l

1.20

237

2566

Postdysenteric arthropathy

111

1017

1.13

0.48

5.0

4.8

1.59

1.96

ug/l

0.88

102

923

Other prurigo

112

1024

1.13

0.48

4.9

5.5

3.18

3.07

ug/l

0.04

908

Increased muscle tone

547

1.17

0.48

6.4

5.3

2.17

1.93

ug/l

0.26

483

Other and unspecified parapsoriasis

700

1.19

0.48

7.2

5.8

2.06

2.59

ug/l

0.44

628

Disorders of gallbladder, biliary tract and pancreas

16809

103811

1.01

0.47

5.7

5.4

2.79

3.35

ug/l

2.35

15142

94324

Benign neoplasm of other and unspecified sites

352

3356

1.07

0.47

5.8

5.3

1.95

2.36

ug/l

1.54

319

3035

Dependent personality disorder

158

1465

1.10

0.47

5.2

4.8

1.71

1.92

ug/l

0.32

144

1349

Bacterial, viral and other infectious agents, including avohilmo

1282

12519

1.03

0.47

4.4

4.2

3.18

2.02

ug/l

0.88

1182

11548

Suppurative otitis media, unspecified

226

2122

1.08

0.47

5.5

5.4

2.03

2.53

ug/l

1.03

206

1898

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

393

3766

1.07

0.47

5.0

4.4

2.54

2.11

ug/l

1.33

342

3363

Multiple myeloma

393

3766

1.07

0.47

5.0

4.4

2.54

2.11

ug/l

1.33

342

3363

Tic disorders

563

1.15

0.47

3.8

3.5

1.58

1.39

ug/l

0.20

507

Polyglandular dysfunction, other/unspecified

1.54

0.47

2.1

4.7

1.25

1.83

ug/l

—

Sequelae of other and unspecified effects of external causes

608

1.17

0.47

6.2

5.1

2.24

1.99

ug/l

0.32

548

Fitting and adjustment of external prosthetic device

316

1.24

0.47

4.6

5.7

1.33

1.94

ug/l

1.30

283

Torticollis

147

1360

1.10

0.47

4.1

4.3

1.72

2.09

ug/l

0.55

136

1237

Other bursitis, not elsewhere classified

124

1145

1.12

0.46

5.6

5.3

1.98

2.76

ug/l

1.01

114

1032

Other and unspecified disorders of adult personality and behaviour

369

1.20

0.46

4.2

3.6

0.84

1.44

ug/l

3.74

340

Acute inflammation of orbit

626

1.16

0.46

4.2

4.9

5.87

2.41

ug/l

0.37

567

Eating disorders

378

3968

0.95

0.46

4.3

4.6

1.98

2.06

ug/l

0.14

338

3598

Unspecified nephritic syndrome

310

2957

1.08

0.46

4.9

5.3

2.30

2.37

ug/l

0.06

291

2673

Mental and behavioural disorders due to use of other stimulants, including caffeine

242

2566

0.93

0.46

2.5

2.7

0.81

1.19

ug/l

6.53

204

2395

Congenital malformations of cardiac chambers and connections

208

0.75

0.46

1.8

2.8

0.50

1.13

ug/l

6.02

193

Congenital lactase deficiency

104

1.40

0.46

7.4

5.2

1.82

1.64

ug/l

0.13

Clubfoot

738

1.14

0.46

4.4

4.3

1.57

ug/l

0.00

662

Tetralogy of Fallot, a congenital heart defect.

250

0.77

0.46

2.9

3.3

1.04

1.51

ug/l

1.45

230

Peptic ulcer

107

1164

0.89

0.46

6.5

5.4

2.85

3.65

ug/l

0.39

1036

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

358

1.19

0.46

4.8

1.47

1.65

ug/l

0.20

311

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

244

1.29

0.45

4.8

1.65

2.02

ug/l

0.35

222

Liposarcoma, including Hilmo

158

1482

1.11

0.45

5.3

4.3

2.15

1.95

ug/l

0.31

143

1328

Poisoning by medicine, drug-induced

109

1188

0.89

0.45

3.8

4.2

1.19

1.89

ug/l

1.67

101

1089

Oral leukoplakia, including avohilmo

361

3455

1.07

0.45

5.0

5.2

1.77

2.19

ug/l

1.26

321

3147

Benign neoplasm: Ciliary body

356

1.23

0.45

4.9

5.3

1.53

1.94

ug/l

1.00

316

Otitis media, unspecified

715

6814

0.96

0.45

5.2

4.7

1.84

2.23

ug/l

1.32

658

6186

Hereditary motor and sensory neuropathy

896

1.13

0.45

5.0

5.4

2.12

2.51

ug/l

0.38

812

Subacute thyroiditis

191

1783

1.08

0.45

6.4

5.4

3.53

2.26

ug/l

0.40

177

1601

Other specified transport accidents

621

0.85

0.45

3.9

4.7

1.59

2.16

ug/l

0.53

563

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

882

0.88

0.45

6.4

5.9

2.27

2.85

ug/l

0.50

778

Mucinous and mucinous cystic tumor of rectum

781

1.17

0.44

4.6

4.4

2.26

2.02

ug/l

0.32

689

Other (seronegative) rheumatoid arthritis, wide

1838

18012

1.03

0.44

5.2

5.8

2.50

3.38

ug/l

2.37

1650

16220

Infection due to other mycobacteria, including avohilmo

167

1785

0.91

0.44

5.9

2.59

2.70

ug/l

0.08

151

1580

Yellow nail syndrome

1.64

0.44

5.0

6.6

3.31

1.59

ug/l

—

Total colectomy

490

5085

0.95

0.44

4.7

5.1

2.79

2.23

ug/l

0.71

446

4618

Total colectomy operation

490

5085

0.95

0.44

4.7

5.1

2.79

2.23

ug/l

0.71

446

4618

Ulcerative colitis, NAS

1717

16827

1.03

0.44

4.9

2.53

2.73

ug/l

0.14

1574

15358

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

367

3837

0.94

0.44

3.0

3.5

1.14

1.53

ug/l

4.76

338

3610

Asthma and opportunity respiratory infection

495

4766

1.05

0.44

5.7

6.0

2.25

4.41

ug/l

1.52

438

4257

Disorders of pituitary gland, other and/or unspecified

505

1.17

0.44

6.6

4.6

1.88

2.39

ug/l

0.31

449

Juvenile osteochondrosis

288

2734

1.07

0.44

4.0

4.3

1.73

1.89

ug/l

0.23

261

2509

Oher contracture of tendon (sheath)

414

1.21

0.44

6.4

5.7

1.86

3.66

ug/l

1.18

369

Malignant neoplasm of nasopharynx

455

0.81

0.44

5.5

4.2

2.32

1.89

ug/l

0.45

408

Exophthalmic conditions

905

1.12

0.43

5.2

4.9

2.33

2.25

ug/l

0.03

812

Melanocytic naevi of eyelid, including canthus

742

1.14

0.43

5.3

5.5

2.62

2.46

ug/l

0.08

659

Colectomy operation

2589

25497

1.02

0.43

5.6

5.8

3.06

3.24

ug/l

0.20

2339

22969

Adalimumab

938

9120

1.04

0.43

3.8

4.2

1.74

1.85

ug/l

0.41

873

8415

Melanoma in situ of scalp and neck

469

1.24

0.43

7.0

6.3

2.19

2.85

ug/l

0.40

404

Chronic nephritic syndrome

570

5519

1.05

0.43

4.5

5.4

2.45

2.56

ug/l

0.10

526

5005

Aortic valve malfunction, age under 60 years

1594

16235

0.97

0.43

4.3

4.7

1.78

2.08

ug/l

2.53

1456

15009

Ophthalmic devices associated with adverse incidents

154

1.38

0.43

4.6

5.8

1.47

4.23

ug/l

0.72

136

Traumatic amputation of ankle and foot

451

0.81

0.43

4.3

5.2

1.91

1.90

ug/l

0.01

405

Viral infections of central nervous system, not elsewhere classified/unspecified

111

1022

1.12

0.43

4.7

4.4

1.62

1.69

ug/l

0.08

103

925

Protein-energy malnutrition of moderate and mild degree

830

1.13

0.42

5.5

6.0

2.59

2.29

ug/l

0.28

728

Secondary parkinsonism, excluding more controls

365

3501

1.06

0.42

4.7

6.1

2.37

3.91

ug/l

2.18

319

3164

Benign neoplasm: Scapula and long bones of upper limb

113

1043

1.12

0.42

5.9

5.0

2.06

2.57

ug/l

0.46

107

952

Choroidal detachment

245

1.27

0.42

6.4

5.0

1.38

2.60

ug/l

1.35

212

Primary gonarthrosis, bilateral

8553

72177

0.99

0.42

6.2

5.9

2.80

3.57

ug/l

1.36

7771

65037

Exposure to smoke, fire and flames

360

3747

0.94

0.42

4.8

5.24

2.17

ug/l

1.03

326

3415

Other congenital malformations of spinal cord

107

1.41

0.42

2.9

5.2

1.83

1.98

ug/l

0.10

conjunctival degenerations and deposits

206

1942

1.08

0.42

5.6

5.5

1.69

3.00

ug/l

1.87

193

1733

Intentional self-harm by unspecified means

856

1.12

0.42

3.9

3.8

2.00

1.61

ug/l

0.44

779

Mesial bite

418

1.17

0.42

4.8

4.5

1.45

1.78

ug/l

0.44

371

Benign neoplasm: Endocrine pancreas

877

1.14

0.42

6.8

5.9

2.08

2.85

ug/l

0.79

789

Hereditary lymphedema

114

0.66

0.42

3.3

5.0

2.92

1.42

ug/l

—

101

Colon adenocarcinoma, helper endpoint

2103

20691

1.03

0.42

5.7

6.1

3.50

3.81

ug/l

0.25

1875

18543

Crohn's disease NAS

680

6588

1.04

0.42

4.6

4.8

2.20

2.28

ug/l

0.09

617

6004

Malignant neoplasm of tonsil, including Hilmo

294

3062

0.93

0.42

4.9

4.1

2.06

1.86

ug/l

0.62

257

2791

Perichondritis of external ear

203

1917

1.08

0.42

5.7

2.94

2.78

ug/l

0.13

178

1714

Other osteochondrodysplasias

552

1.15

0.42

4.9

4.6

1.65

2.30

ug/l

0.47

496

Mumps

364

3496

1.06

0.42

4.7

4.3

1.89

1.83

ug/l

0.07

339

3230

Allergic bronchopulmonary aspergillosis (ABPA)

658

1.17

0.42

5.2

6.0

1.59

4.09

ug/l

1.13

594

Any mental disorder

18505

93199

0.99

0.41

4.9

5.4

3.04

3.08

ug/l

0.06

16556

85251

Other papulosquamous disorders

120

1111

1.11

0.41

5.3

5.5

3.72

2.82

ug/l

0.30

110

984

Other nonthrombocytopenic purpura

104

958

1.12

0.41

5.6

5.7

2.23

2.65

ug/l

0.39

845

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.41

0.0

1.0

—

0.53

—

Acute drug-induced interstitial lung disorder

886

0.88

0.41

5.8

6.1

2.26

2.73

ug/l

0.35

783

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

241

1.22

0.41

6.0

4.8

4.06

1.85

ug/l

0.55

208

Bacterial, viral and other infectious agents

1221

11947

1.03

0.41

4.3

4.2

3.27

2.02

ug/l

0.92

1126

11036

Intestinal infectious diseases, including avohilmo, including avohilmo

19021

106478

0.99

0.41

5.1

5.4

2.73

3.28

ug/l

1.39

17332

96569

Scissor bite

106

960

1.10

0.40

4.2

4.0

1.46

1.79

ug/l

0.74

878

Other conditions related to polyarteritis nodosa

218

1.27

0.40

5.6

5.4

2.82

1.92

ug/l

0.62

192

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

733

1.15

0.40

4.7

4.1

3.65

1.84

ug/l

0.61

654

Exposure to excessive natural heat

242

0.77

0.40

4.3

5.3

1.15

1.76

ug/l

0.82

214

Hypersensitivity pneumonitis due to organic dust

194

1834

1.09

0.40

5.9

5.5

2.81

2.59

ug/l

0.12

182

1659

Hereditary hypogammaglobulinemia

298

0.80

0.40

6.3

5.1

2.38

2.71

ug/l

0.11

267

Arthropathies in other diseases classified elsewhere

450

4339

1.05

0.40

4.3

5.3

1.69

2.94

ug/l

4.59

403

3918

Abscess of external ear

150

1404

1.09

0.40

5.3

4.8

2.49

2.09

ug/l

0.26

137

1278

Moderate visual impairment, monocular

511

1.17

0.40

6.4

5.5

2.94

2.66

ug/l

0.10

458

Other disorders of fluid, electrolyte and acid-base balance

4973

47318

0.98

0.40

5.3

5.8

3.41

3.67

ug/l

0.36

4404

42537

Postprocedural disorders of digestive system, not elsewhere classified

385

3699

1.06

0.40

5.2

5.8

2.09

2.90

ug/l

1.45

342

3337

Other nutritional anaemias

1072

0.90

0.40

6.0

5.9

2.24

3.50

ug/l

1.02

945

Cutaneous lupus erythematosus

155

1447

1.09

0.40

5.4

5.3

2.50

2.36

ug/l

0.07

140

1299

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

125

1338

0.90

0.40

4.5

4.1

2.69

1.94

ug/l

0.42

115

1186

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

643

1.12

0.39

4.9

4.5

1.55

1.72

ug/l

0.36

575

Other congenital malformations of circulatory system

285

2721

1.07

0.39

5.6

5.3

1.86

2.34

ug/l

1.35

261

2476

Other disorders of white blood cells

682

6626

1.04

0.39

5.5

5.6

3.89

2.73

ug/l

0.28

615

5989

Atypical mycobacterium lung infection

106

1146

0.90

0.39

6.0

5.8

2.77

3.13

ug/l

0.18

1015

Malignant neoplasm of eye and adnexa

1028

0.89

0.39

5.3

4.4

2.77

2.03

ug/l

1.32

917

Interstitial lung disease endpoints

2747

27111

1.02

0.39

5.4

6.1

3.20

3.65

ug/l

0.32

2423

24305

Interstitial lung disease

2747

27111

1.02

0.39

5.4

6.1

3.20

3.65

ug/l

0.32

2423

24305

Carpal tunnel syndrome

8441

73709

0.99

0.39

5.5

5.4

2.12

3.04

ug/l

9.27

7755

67141

Acute posthaemorrhagic anaemia

412

4277

0.95

0.39

5.3

6.0

3.14

4.20

ug/l

0.48

365

3809

Contact with sharp glass

424

4082

1.05

0.39

4.2

4.3

1.69

1.83

ug/l

0.40

381

3761

Rheumatoid lung disease

578

0.85

0.39

4.8

6.1

2.10

2.84

ug/l

0.59

508

Actinomycosis

433

0.83

0.39

6.3

5.3

1.31

1.97

ug/l

2.22

382

Routine general health check-up of defined subpopulation

609

1.13

0.39

3.4

3.8

1.62

1.51

ug/l

0.19

547

Malignant neoplasm of base of tongue

107

1139

0.88

0.38

4.6

4.1

2.34

1.82

ug/l

0.96

1022

Prurigo nodularis

262

2498

1.07

0.38

5.0

5.6

2.00

2.52

ug/l

1.15

239

2240

Benign neoplasm: Peripheral nerves and autonomic nervous system

179

1690

1.08

0.38

5.9

5.3

2.15

2.38

ug/l

0.33

169

1525

Non-ischemic cardiomyopathy

5524

44207

0.99

0.38

5.5

6.2

3.94

3.90

ug/l

0.03

4867

39909

Anxious personality disorder

133

1237

1.09

0.38

3.4

3.6

1.21

1.67

ug/l

0.99

121

1149

Contusion of ankle

387

3718

1.05

0.38

4.7

4.8

3.56

2.02

ug/l

0.41

354

3398

Tic and related disorders

602

1.13

0.38

3.9

3.5

1.56

1.46

ug/l

0.10

540

Autoimmune polyglandular failure

1.41

0.38

5.6

4.9

0.97

1.88

ug/l

1.47

Algoneurodystrophy

206

1945

1.07

0.38

4.6

4.4

1.56

1.92

ug/l

0.74

187

1782

Acute epiglottitis

202

1917

1.08

0.38

5.0

4.9

2.02

2.17

ug/l

0.19

181

1745

Other diseases of arteries and capillaries

1187

12122

0.97

0.38

5.5

5.9

7.15

3.74

ug/l

0.35

1069

10921

Disorders of globe

276

2636

1.06

0.38

5.4

5.7

5.54

2.74

ug/l

0.87

249

2354

Foreign body in genitourinary tract

681

1.13

0.38

6.1

5.5

2.40

2.67

ug/l

0.12

605

Assault by sharp object

233

2442

0.93

0.38

3.1

3.7

5.93

1.64

ug/l

0.59

194

2272

Benign neoplasm: Urethra

119

1.38

0.38

7.1

5.9

2.68

2.09

ug/l

0.39

105

Crossbite

424

3749

1.05

0.38

5.0

4.5

1.69

1.97

ug/l

0.95

380

3433

Allergic contact dermatitis due to drugs in contact with skin

171

1608

1.08

0.37

5.3

5.7

2.29

2.45

ug/l

0.17

155

1445

IBD patients in KELA-register

3041

30006

1.02

0.37

4.7

4.8

2.26

2.47

ug/l

0.37

2797

27517

Lymphocyte function antigen-1 [LFA-1] defect

0.66

0.37

3.0

6.2

1.04

2.33

ug/l

—

Other meningitis

141

1318

1.09

0.37

5.1

5.0

3.75

2.19

ug/l

0.41

134

1192

Superficial injury of neck

185

1746

1.08

0.37

4.6

4.3

2.79

1.97

ug/l

0.30

168

1602

Viral conjunctivitis

166

1560

1.08

0.37

4.7

4.6

2.29

2.00

ug/l

0.18

152

1428

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

666

6467

1.04

0.37

4.6

4.5

1.82

1.98

ug/l

0.59

620

5919

Prophylactic surgery

135

0.73

0.37

5.9

5.1

3.24

1.93

ug/l

—

122

Impetigo

406

3906

1.05

0.37

4.1

4.7

2.19

2.08

ug/l

0.16

367

3578

Other female pelvic inflammatory diseases

107

1.31

0.37

1.3

1.1

—

0.33

—

Alzheimer’s disease, strict definition

4093

32654

1.02

0.37

5.3

6.5

6.83

4.98

ug/l

0.56

3565

28755

Maxillary retrognathism

119

1104

1.09

0.37

4.9

4.2

1.59

1.89

ug/l

0.44

107

1008

Marginal zone B-cell lymphoma, including Hilmo

214

2038

1.08

0.37

5.4

4.4

2.14

1.97

ug/l

0.38

192

1826

Renal tubulo-interstitial disorders in diseases classified elsewhere

132

1240

1.10

0.36

5.0

5.7

2.17

2.52

ug/l

0.37

123

1103

Listeriosis

536

0.86

0.36

5.5

6.1

2.38

3.05

ug/l

0.36

468

Pain in joint

9909

61292

0.99

0.36

5.2

5.1

2.57

3.11

ug/l

0.87

9084

55815

Benign neoplasm: Other/unspecified site

162

1527

1.08

0.36

5.7

5.5

1.75

2.45

ug/l

1.48

142

1379

Left ventricular outflow tract obstruction, narrow definition

716

6978

1.04

0.36

4.8

4.9

2.10

2.25

ug/l

0.32

645

6398

Cholangitis (primary sclerosing, PSC), with reimbursement 202

151

1607

0.92

0.36

4.5

4.7

1.67

1.97

ug/l

0.67

139

1471

Café au lait spots

1.42

0.36

2.2

3.8

0.83

1.37

ug/l

—

Pulmonary eosinophilia, not elsewhere classified

114

1222

0.91

0.36

5.4

5.6

1.63

2.51

ug/l

2.08

104

1085

Autoimmune thyroiditis

594

1.12

0.36

6.5

5.2

1.71

2.22

ug/l

0.61

527

Tooth eruption problems

700

6556

1.03

0.36

4.0

3.9

2.05

1.71

ug/l

0.37

648

5974

Malignant neoplasm of tonsil and base of tongue

369

3809

0.94

0.36

4.9

4.1

2.17

1.86

ug/l

1.30

328

3466

Chloasma

172

1.25

0.36

7.2

5.4

1.94

1.67

ug/l

0.14

151

Femoral hernia, bilateral

258

1.22

0.36

4.9

5.4

2.26

2.16

ug/l

0.07

225

Acute and transient psychotic disorders

1202

12275

0.97

0.36

3.8

4.3

1.54

2.03

ug/l

3.79

1081

11297

Other congenital malformations of integument, including avohilmo

325

1.20

0.36

3.5

5.7

8.83

2.06

ug/l

0.41

287

Other acantholytic disorders

464

1.20

0.36

6.9

5.9

2.09

2.17

ug/l

0.11

407

Atopic dermatitis, strict definition

2081

20003

1.02

0.35

4.2

2.11

2.02

ug/l

0.13

1898

18357

Other and unspecified nail disorders

212

2013

1.07

0.35

6.0

5.3

2.14

2.36

ug/l

0.25

196

1820

Gastrojejunal ulcer

187

1778

1.08

0.35

4.1

5.6

2.05

2.85

ug/l

1.62

168

1565

Mumps, including avohilmo

367

3542

1.06

0.35

4.6

4.3

1.88

1.83

ug/l

0.06

341

3270

Malignant neoplasm of gallbladder, including Hilmo

600

0.88

0.35

5.1

4.3

2.38

1.98

ug/l

0.51

527

Glaucoma secondary to eye inflammation

880

1.11

0.35

6.3

5.3

3.82

2.53

ug/l

0.58

789

Neuroendocrine tumor and carcinoma of lung

694

0.88

0.35

4.4

1.56

1.98

ug/l

1.24

613

Laparoscopic left hemicolectomy

257

2466

1.07

0.35

5.3

5.7

2.57

2.81

ug/l

0.21

231

2224

Recurrent cholesteatoma of postmastoidectomy cavity

365

1.20

0.35

5.4

5.9

1.88

1.94

ug/l

0.05

319

147

1557

0.92

0.35

3.3

4.8

11.46

2.27

ug/l

0.54

127

1406

Chronic suppurative otitis media, including avohilmo

858

8374

1.03

0.35

5.3

5.4

2.59

3.43

ug/l

0.58

761

7566

Granuloma annulare

779

1.11

0.35

5.7

5.5

2.07

2.68

ug/l

0.59

701

Hypermobility syndrome

699

1.11

0.35

4.4

3.6

1.73

1.86

ug/l

0.06

637

Intracranial and intraspinal abscess and granuloma

172

1634

1.09

0.35

5.4

1.74

2.31

ug/l

1.43

149

1478

Multiple superficial injuries of ankle and foot

0.68

0.35

4.4

4.6

2.05

1.78

ug/l

—

Use of ropinirole

532

5175

1.05

0.35

5.3

6.0

2.41

2.73

ug/l

0.45

469

4656

GI-bleeding

6216

61640

1.01

0.35

5.6

5.9

3.97

3.88

ug/l

0.04

5495

55395

Synovial hypertrophy, not elsewhere classified

860

1.11

0.34

4.4

4.5

1.24

2.24

ug/l

1.63

781

Sequelae of poliomyelitis

958

0.90

0.34

5.4

5.9

4.92

2.93

ug/l

0.30

847

Other corneal oedema

843

1.11

0.34

6.0

5.8

1.73

2.64

ug/l

1.17

748

Family history of other specific disorders

607

1.12

0.34

5.4

4.8

1.64

1.80

ug/l

0.24

549

Acute mastoiditis

100

930

1.11

0.34

4.1

4.3

1.45

1.76

ug/l

0.97

858

Agent resistant to multiple antibiotics

0.64

0.34

3.2

7.0

1.31

1.73

ug/l

—

Disorders of purine and pyrimidine metabolism

829

1.12

0.34

4.7

5.8

2.51

2.77

ug/l

0.16

740

Other congenital malformations of intestine

775

1.11

0.34

5.3

1.91

2.03

ug/l

0.12

687

Cerebral palsy

112

1042

1.09

0.34

3.0

3.9

9.10

2.10

ug/l

0.45

958

Other renal tubulo-interstitial diseases

153

1439

1.07

0.33

5.6

5.5

2.08

2.51

ug/l

0.61

134

1284

Benign neoplasm: Extrahepatic bile ducts

356

1.19

0.33

5.0

5.2

2.20

2.06

ug/l

0.12

314

Crohn disease (strict definition, require KELA)

617

5998

1.04

0.33

4.6

4.5

1.82

1.96

ug/l

0.47

576

5496

Late syphilis

192

2010

0.93

0.33

4.3

5.1

1.78

2.18

ug/l

0.77

163

1832

Biliary cirrhosis, secondary

1.36

0.33

3.4

5.2

1.54

2.18

ug/l

—

Varicella [chickenpox], including avohilmo

810

7914

1.03

0.33

4.2

4.1

1.73

1.84

ug/l

0.33

751

7365

Malignant neoplasm of palate, including Hilmo

668

0.88

0.33

6.0

4.2

2.03

1.83

ug/l

0.18

595

Tic and related disorders

607

1.12

0.33

3.9

3.6

1.56

2.12

ug/l

0.41

549

Seropositive rheumatoid arthritis

2435

24556

0.98

0.33

5.0

5.7

2.48

3.61

ug/l

2.87

2181

22110

Previous suicide attempt

832

1.10

0.33

3.8

4.3

1.13

1.62

ug/l

2.31

763

Hydrocephalus

948

9683

0.97

0.33

5.1

6.1

3.63

4.02

ug/l

0.15

845

8630

Hidradenitis suppurativa

273

2612

1.05

0.33

3.6

4.2

1.22

1.85

ug/l

3.75

252

2402

Other interstitial pulmonary diseases

2747

27158

1.02

0.33

5.4

6.1

3.20

3.64

ug/l

0.32

2423

24346

Other and unspecified intracranial injuries

406

4192

0.95

0.33

5.0

5.4

5.64

2.97

ug/l

0.42

365

3780

Abscess of tendon sheath

652

1.12

0.33

5.1

5.3

1.37

2.65

ug/l

1.56

585

Heart failure,strict

10824

75928

0.99

0.32

5.2

6.0

3.24

3.57

ug/l

0.52

9576

68895

Chronic myeloid leukaemia

646

1.14

0.32

4.5

4.1

1.47

1.79

ug/l

0.88

578

Adenocarcinoma of small intestine

393

0.84

0.32

5.0

4.5

1.89

2.03

ug/l

0.16

346

Nephropathy related operations

2218

21907

1.02

0.32

3.9

5.5

2.34

2.99

ug/l

1.24

2057

19908

Chondrosarcoma, including Hilmo

529

1.14

0.32

4.3

4.1

2.73

1.92

ug/l

0.77

475

Poisoning by narcotics and psychodysleptics [hallucinogens]

142

1337

1.08

0.32

3.3

3.4

1.31

1.59

ug/l

0.40

117

1237

Listeriosis, including avohilmo

552

0.87

0.32

5.6

6.1

2.46

3.36

ug/l

0.50

483

Other noninfective disorders of lymphatic vessels and lymph nodes

323

3107

1.05

0.32

6.4

5.2

8.21

2.35

ug/l

0.78

289

2818

Congenital malformations of the circulatory system

1677

16020

1.02

0.32

5.0

4.9

1.88

2.35

ug/l

3.44

1495

14667

Use of rasagiline

378

3664

1.05

0.32

5.3

6.1

2.54

2.86

ug/l

0.36

342

3305

Crohn disease (strict definition, require KELA, min 2 HDR)

606

5894

1.04

0.32

4.5

4.6

1.81

1.96

ug/l

0.54

567

5404

Deaf mutism, not elsewhere classified

480

1.14

0.32

4.3

5.2

2.03

2.24

ug/l

0.12

429

Tick-borne viral encephalitis, including avohilmo

625

1.13

0.32

6.6

5.1

2.85

1.80

ug/l

0.49

566

Other diseases of blood and blood-forming organs, wide

2971

29364

1.02

0.32

5.5

5.6

3.74

2.98

ug/l

0.75

2643

26624

Senile degeneration of the brain, not elsewhere classified

519

0.87

0.32

7.0

6.4

3.11

3.03

ug/l

0.03

449

Malignant neoplasm of breast, HER2-negative

207

1.15

0.32

1.1

—

1.33

—

Soft tissue disorders in diseases classified elsewhere

1.38

0.32

6.8

5.5

2.14

1.67

ug/l

—

Explicit fungal Sepsis, including avohilmo

106

1125

0.90

0.32

5.5

5.6

6.69

2.66

ug/l

0.58

1002

Congenital edentulism

1.42

0.32

8.1

4.0

7.04

1.51

ug/l

—

Malignant neoplasm of breast

207

1.15

0.32

1.1

—

1.33

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

417

1.18

0.31

6.0

5.2

2.23

2.71

ug/l

0.24

368

Disorders of aromatic amino-acid metabolism

300

0.83

0.31

5.2

5.5

1.71

2.78

ug/l

0.79

274

Hypothyroidism due to medicaments and other exogenous substances

101

941

1.09

0.31

4.5

5.6

2.02

2.85

ug/l

0.92

843

Other secondary gout

525

0.86

0.31

4.5

5.9

1.43

3.12

ug/l

1.36

464

Other disorders of choroid

169

1606

1.07

0.31

6.0

5.5

2.37

2.57

ug/l

0.17

151

1446

Hereditary retinal dystrophy

152

1439

1.08

0.31

4.9

4.7

2.58

1.95

ug/l

0.81

140

1299

Syphilis, including avohilmo

386

3979

0.95

0.31

4.6

4.8

2.36

2.06

ug/l

0.28

346

3641

Syphilis

386

3979

0.95

0.31

4.6

4.8

2.36

2.06

ug/l

0.28

346

3641

Actinomycosis, including avohilmo

447

0.86

0.31

7.4

5.2

1.42

1.97

ug/l

1.52

394

Marginal zone B-cell lymphoma

128

1209

1.09

0.31

5.6

4.4

2.39

1.95

ug/l

0.86

117

1090

Other disorders of central nervous system

110

1029

1.09

0.31

4.9

5.3

2.17

2.43

ug/l

0.30

933

Idiopathic thrombocytopenic purpura

348

3362

1.05

0.31

5.3

5.6

2.33

2.75

ug/l

0.50

316

3010

Contact with other hot fluids

320

3084

1.05

0.31

5.2

4.8

1.83

2.20

ug/l

0.68

292

2814

Other sideroblastic anaemias

404

0.85

0.31

4.8

5.7

2.61

2.83

ug/l

0.08

355

Tuberculosis of other organs

211

2016

1.06

0.31

5.4

6.0

3.39

3.43

ug/l

0.01

187

1780

Malignant neoplasm of gum

601

0.88

0.31

4.6

4.1

1.70

2.05

ug/l

0.62

539

Ulcer of oesophagus, drug-induced

742

0.88

0.30

7.2

6.0

5.25

2.56

ug/l

0.39

650

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1505

14796

1.02

0.30

3.7

4.2

2.67

1.87

ug/l

0.44

1302

13655

Explicit fungal Sepsis

106

1123

0.91

0.30

5.5

5.6

6.69

2.66

ug/l

0.58

1001

Disorders of sexual preference

428

0.83

0.30

3.7

4.8

1.44

2.39

ug/l

0.65

388

ILD medications: nintedanib

110

1045

1.12

0.30

4.0

6.3

1.63

2.68

ug/l

2.27

925

Other congenital malformations of posterior segment of eye (coloboma)

1.33

0.30

4.8

1.76

1.58

ug/l

—

Bulimia nervosa (incl. atypical)

249

1.17

0.30

2.9

3.4

0.93

1.44

ug/l

2.41

229

Nonsuppurative otitis media, including avohilmo

2801

24513

0.99

0.30

5.0

4.7

2.26

2.59

ug/l

0.56

2546

22314

Dementia due to Parkinsons disease, excluding more controls

392

3806

1.05

0.30

4.5

6.8

2.88

4.92

ug/l

2.98

326

3384

Meningitis

542

5274

1.04

0.30

5.4

5.0

2.42

2.21

ug/l

0.16

501

4797

Benign neoplasm: Brain, supratentorial

156

1480

1.07

0.30

5.5

5.4

3.84

2.43

ug/l

0.55

141

1332

Dermatopolymyositis

139

1314

1.08

0.30

5.0

5.5

3.67

2.34

ug/l

0.69

125

1188

Burn and corrosion of shoulder and upper limb, except wrist and hand

280

2699

1.06

0.30

4.5

4.9

1.93

2.19

ug/l

0.47

253

2465

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

1027

0.90

0.30

4.7

4.3

2.07

2.00

ug/l

0.05

932

ILD, hospital admissions 3, with pneumonia sepsis

1465

14865

0.98

0.30

5.2

6.4

4.23

3.97

ug/l

0.08

1280

13323

Conotruncal defects

606

0.90

0.29

3.2

3.7

1.02

1.44

ug/l

2.41

554

Mandibular retrognathia AND surgery (BSSO)

162

1535

1.07

0.29

5.1

4.1

1.57

1.60

ug/l

0.07

156

1414

Eosinophilic disease (BM)

192

1836

1.07

0.29

5.8

8.55

2.59

ug/l

0.48

179

1657

Hereditary angioödema type 1

0.65

0.29

8.4

4.8

0.53

1.71

ug/l

—

Disorders of other and unspecified cranial nerves

580

1.12

0.29

6.5

5.4

7.31

2.82

ug/l

0.78

530

Unspecified severe protein-energy malnutrition

160

1.25

0.29

3.2

5.2

9.96

1.76

ug/l

0.61

142

Dementia due to Parkinson's disease

392

4032

0.95

0.29

4.5

6.5

2.88

5.05

ug/l

1.21

326

3556

Contracture of joint

147

1395

1.08

0.29

4.7

5.3

1.99

3.46

ug/l

1.22

126

1256

Mandibular prognathia

116

1089

1.08

0.29

5.0

4.8

1.58

1.73

ug/l

0.40

106

985

Benign neoplasm: Nasopharynx

106

997

1.09

0.29

5.8

5.5

3.65

2.59

ug/l

0.40

893

Personal history of allergy to drugs, medicaments and biological substances

760

0.91

0.29

5.0

4.8

1.60

2.08

ug/l

0.87

681

Congenital ptosis, including avohilmo

272

1.18

0.29

5.0

1.64

1.76

ug/l

0.10

239

Malignant neoplasm of oropharynx

291

3001

0.94

0.29

4.8

4.1

2.03

1.87

ug/l

0.46

253

2735

Congenital malformation of optic disc

1.25

0.28

2.5

4.5

1.26

1.60

ug/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

804

1.10

0.28

4.4

5.2

1.74

2.57

ug/l

0.75

732

Primary_lymphoid and hematopoietic malignant neoplasms

4187

41517

1.01

0.28

5.2

6.0

3.56

3.62

ug/l

0.03

3764

37359

Labyrinthine dysfunction

0.67

0.28

6.2

4.8

1.27

1.88

ug/l

—

Other hypertrophic osteoarthropathy

0.70

0.28

3.8

5.4

0.93

2.31

ug/l

—

Other infectious diseases, including avohilmo

1220

12400

0.98

0.28

5.3

5.7

4.06

3.64

ug/l

0.22

1104

11153

Other/unspecified rheumatoid arthritis

1046

10659

0.98

0.28

5.1

5.9

2.65

3.70

ug/l

1.54

939

9515

Cleft hard palate NOS

139

0.78

0.28

3.9

3.1

1.61

1.41

ug/l

0.20

128

Diaper [napkin] dermatitis

0.69

0.28

2.4

6.8

3.38

2.26

ug/l

—

Shigellosis, including avohilmo

677

1.11

0.28

4.6

4.9

2.38

1.75

ug/l

0.73

614

Dermatitis due to ingested food

504

1.10

0.28

2.5

2.9

1.32

1.36

ug/l

0.07

447

Schistosomiasis [bilharziasis], including avohilmo

351

1.16

0.28

7.5

5.3

2.53

1.87

ug/l

0.73

314

Chronic hepatitis NAS

1055

0.92

0.27

5.5

5.0

2.12

2.40

ug/l

0.25

948

Eosinophilia

192

1840

1.06

0.27

5.8

5.6

8.55

2.59

ug/l

0.48

179

1667

Unspecified event, undetermined intent

274

2643

1.05

0.27

4.2

4.8

1.69

2.07

ug/l

1.00

243

2403

Gangrene, not elsewhere classified

108

1140

0.92

0.27

3.6

5.9

2.78

3.09

ug/l

0.20

1010

Contact with blunt object, undetermined intent

718

1.10

0.27

4.9

4.8

1.58

2.02

ug/l

0.67

652

Purulent endophthalmitis

777

1.10

0.27

5.7

5.8

3.69

2.61

ug/l

0.51

696

Benign neoplasm: Ill-defined sites within the digestive system

543

1.12

0.27

6.0

5.8

2.04

2.62

ug/l

0.38

482

Other and unspecified disorders of white blood cells

488

4756

1.04

0.27

5.4

5.6

2.08

2.64

ug/l

1.29

436

4280

Acquired absence of limb

154

1608

0.93

0.27

4.7

5.4

1.78

2.55

ug/l

1.91

138

1428

Diffuse brain injury

521

5338

0.97

0.27

4.7

5.1

4.22

3.43

ug/l

0.20

468

4879

Other and unspecified paralytic syndromes

139

1462

0.93

0.27

4.6

4.9

2.19

2.43

ug/l

0.13

128

1324

Other disorders following mastoidectomy

449

1.14

0.27

4.3

6.1

11.92

2.29

ug/l

0.50

392

Exposure to other and unspecified forces of nature

719

1.10

0.26

5.2

5.3

1.76

2.37

ug/l

0.68

646

Other drug-induced osteomalacia in adults

117

1.34

0.26

2.5

3.0

1.07

1.30

ug/l

0.35

110

Congenital glaucoma

1.33

0.26

4.4

5.5

1.22

2.09

ug/l

0.73

Interstitial myositis

0.70

0.26

4.9

5.5

1.21

2.10

ug/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

118

1112

1.07

0.26

5.3

5.0

2.39

2.26

ug/l

0.09

107

994

Malaria

565

1.12

0.26

5.4

5.3

2.45

2.47

ug/l

0.01

508

Disorders of glycoprotein metabolism, other/unspecified

1.51

0.26

9.0

5.7

26.32

2.34

ug/l

—

Acute nephritic syndrome

288

2971

0.95

0.26

5.0

5.4

4.09

2.29

ug/l

0.69

259

2696

Findings of drugs and other substances, not normally found in blood

547

1.12

0.26

6.5

4.8

4.75

1.80

ug/l

1.26

484

Other congenital malformations of eye

1.31

0.26

4.4

5.5

1.22

2.09

ug/l

0.73

Inflammatory bowel disease, strict (require KELA)

3041

30110

1.01

0.26

4.7

4.8

2.26

2.48

ug/l

0.38

2797

27591

Stroke, including SAH

12020

85799

1.01

0.26

5.5

5.8

3.51

3.41

ug/l

0.11

10725

77639

Acrodermatitis chronica atrophicans

146

0.78

0.25

4.8

6.1

3.45

2.20

ug/l

0.31

124

Molar incisor enamel hypoplasia

672

1.08

0.25

4.8

3.2

1.53

1.34

ug/l

0.23

607

Traumatic ischaemia of muscle

169

1762

0.94

0.25

4.8

2.07

2.06

ug/l

0.02

161

1605

Deep bite

849

7303

1.02

0.25

5.1

4.8

2.76

2.24

ug/l

0.18

753

6692

Proteinuria and renal glomerular damage; focal glomerulonephritis

134

0.76

0.25

5.9

5.4

2.32

1.86

ug/l

0.23

118

Other birth injuries

1.40

0.25

5.0

0.54

2.21

ug/l

—

Idiopathic hypoparathyroidism

200

0.82

0.25

5.2

5.3

2.79

1.64

ug/l

1.08

176

Refsum disease

0.65

0.25

6.3

5.7

1.65

2.61

ug/l

—

Fibrosis of liver

104

986

1.09

0.25

4.8

5.4

1.82

1.96

ug/l

0.18

882

Granuloma faciale [eosinophilic granuloma of skin]

1.39

0.25

3.4

4.7

3.40

2.08

ug/l

—

Atopic dermatitis, strict definition with reimbursement

2344

22245

1.01

0.25

4.2

4.3

2.06

2.13

ug/l

0.12

2137

20430

Cholangitis (primary sclerosing, PSC)

842

8269

1.03

0.25

5.1

5.7

2.53

3.63

ug/l

0.96

748

7442

Burn and corrosion of head and neck

310

3010

1.05

0.25

5.2

4.7

2.78

2.12

ug/l

0.49

285

2752

Glaucoma in diseases classified elsewhere

1.46

0.25

7.7

4.1

15.69

1.73

ug/l

—

Malignant neoplasm of adrenal gland

479

1.12

0.25

5.5

4.1

3.36

1.85

ug/l

0.62

430

Whooping cough

332

1.13

0.25

3.0

4.1

1.34

1.43

ug/l

0.09

296

Stroke, excluding SAH

11563

83016

1.01

0.25

5.5

5.8

3.58

3.51

ug/l

0.08

10301

75016

Iodine-deficiency-related thyroid disorders and allied conditions

1.41

0.25

5.2

5.6

67.22

1.63

ug/l

—

Atopic conjunctivitis

268

2585

1.04

0.24

4.7

4.6

1.46

1.91

ug/l

1.83

246

2339

Tetraplegia

1003

0.92

0.24

6.0

5.4

1.62

2.39

ug/l

2.11

896

Other specified congenital malformation syndromes affecting multiple systems

103

970

1.07

0.24

3.5

4.0

1.45

1.49

ug/l

0.08

882

Cytomegaloviral pneumonitis

269

0.83

0.24

4.0

6.2

1.93

ug/l

0.00

240

Congenital malformations of cardiac septa

549

5191

1.03

0.24

5.1

4.8

1.65

2.28

ug/l

2.33

477

4747

Other and unspecified degenerative diseases of nervous system

386

3959

0.96

0.24

5.6

6.4

2.77

4.82

ug/l

1.14

341

3535

Secondary lactase deficiency

101

0.75

0.24

3.5

5.4

1.82

1.98

ug/l

—

Disorders of phosphorus metabolism and phosphatases

538

1.11

0.24

5.7

5.2

2.39

2.95

ug/l

0.30

482

Hypotony of eye

155

1.24

0.24

7.0

5.8

2.70

2.23

ug/l

0.28

136

Mental disorders, not otherwise specified

599

5854

1.03

0.24

4.1

4.4

1.81

1.92

ug/l

0.19

557

5378

Palindromic rheumatism

925

1.08

0.24

5.4

5.1

2.36

3.05

ug/l

0.62

832

Injury of blood vessels at lower leg level

588

1.11

0.24

5.0

5.1

1.44

2.27

ug/l

1.48

530

Ischaemic Stroke, excluding all haemorrhages

10901

79814

1.01

0.24

5.5

5.9

3.58

3.67

ug/l

0.11

9689

71984

Varicella [chickenpox]

772

7589

1.03

0.24

4.2

4.1

1.73

1.81

ug/l

0.23

719

7075

Poikiloderma of Civatte

124

0.78

0.24

7.4

4.2

1.81

1.67

ug/l

—

110

Toxic liver disease

143

1497

0.94

0.24

5.0

5.2

1.96

2.29

ug/l

0.49

133

1358

Vitamin D deficiency

148

1412

1.06

0.24

4.0

5.0

1.66

2.41

ug/l

1.46

133

1281

Drug-induced hypopituitarism

1.32

0.24

6.3

4.7

1.71

1.75

ug/l

0.03

Benign neoplasm: Retina

538

1.11

0.23

5.3

5.9

2.27

2.83

ug/l

0.38

480

Other mosquito-borne viral fevers, including avohilmo

683

1.09

0.23

5.4

4.9

1.83

1.76

ug/l

0.12

619

Enterocolitis due to Clostridium difficile

1342

13605

0.98

0.23

5.6

5.8

4.11

3.74

ug/l

0.15

1207

12168

Mild or no visual impairment, binocular

315

1.14

0.23

5.8

5.5

1.85

3.01

ug/l

0.56

286

Drug-induced osteoporosis

1017

0.93

0.23

5.9

5.3

1.43

2.28

ug/l

1.82

906

Burn and corrosion of hip and lower limb, except ankle and foot

300

2913

1.04

0.23

5.1

5.0

2.79

2.20

ug/l

0.32

267

2647

Interstitial cystitis (chronic), drug-induced

0.74

0.23

3.4

6.3

2.09

2.71

ug/l

—

Pseudomembranous colitis

605

0.91

0.23

4.1

4.8

3.64

2.20

ug/l

0.60

539

Other inherited muscular atrophy

217

0.83

0.23

7.6

5.2

2.00

1.87

ug/l

0.08

190

Nanophthalmos, microphthalmos and macrophthalmos

1.35

0.23

5.8

4.6

4.73

1.97

ug/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

195

1867

1.05

0.23

3.9

4.1

1.49

1.75

ug/l

0.53

182

1713

Contact with other specified venomous animals

655

1.09

0.23

5.7

5.0

2.59

2.28

ug/l

0.16

588

Malignant neoplasm of gum, including Hilmo

106

1115

0.93

0.23

5.3

4.2

1.71

1.98

ug/l

0.66

987

Use of metixene

0.00

0.23

0.0

6.2

—

5.10

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

930

0.92

0.23

5.0

4.2

2.02

1.95

ug/l

0.12

817

Malignant neoplasm of nasal cavity and sinuses

959

0.92

0.23

4.4

4.0

3.07

1.83

ug/l

0.54

849

Unspecified parasitic disease, including avohilmo

112

1068

1.08

0.23

4.6

5.6

1.84

2.76

ug/l

1.46

101

968

Non-neuropathic heredofamilial amyloidosis

143

0.78

0.23

2.4

5.7

0.91

1.85

ug/l

3.09

126

Late syphilis, including avohilmo

227

2343

0.95

0.22

4.3

5.3

1.75

2.33

ug/l

1.35

193

2126

Other parasitologically confirmed or unspecified malaria, including avohilmo

308

1.15

0.22

5.5

4.7

2.36

1.71

ug/l

1.19

281

Meretoja disease

376

1.13

0.22

5.5

5.6

2.27

2.05

ug/l

0.22

332

Normal-pressure hydrocephalus

668

6560

1.03

0.22

5.1

6.4

4.51

4.49

ug/l

0.01

584

5802

Malignant neoplasm of anus and anal canal, including Hilmo

133

1271

1.06

0.22

4.5

4.3

2.35

2.05

ug/l

0.23

111

1125

Surgical ablation of atrial fibrillation

106

1104

0.91

0.22

4.8

5.6

1.86

2.46

ug/l

0.90

1003

Malignant neoplasm of anus and anal canal

491

1.11

0.22

3.4

4.3

1.48

1.96

ug/l

0.72

438

Neurological devices associated with adverse incidents

1.45

0.22

4.7

5.3

1.47

1.69

ug/l

—

Other acute viral hepatitis

143

1370

1.06

0.22

4.7

4.4

1.71

1.80

ug/l

0.15

127

1256

Endometriosis of pelvic peritoneum

1.25

0.22

1.2

1.1

—

0.03

—

Constitutional tall stature

1.23

0.22

2.8

2.1

1.55

0.88

ug/l

—

Divergent concomitant strabismus

672

6590

1.02

0.22

5.0

4.8

2.53

2.25

ug/l

0.32

610

6005

Air embolism (traumatic)

0.72

0.22

6.3

4.0

15.89

2.16

ug/l

—

Arthropathy in ulcerative colitis

111

1055

1.07

0.22

5.5

4.8

3.22

2.15

ug/l

0.64

103

954

Chylothorax

299

0.86

0.22

4.4

6.0

1.63

3.05

ug/l

0.71

269

Allergic purpura

281

2726

1.04

0.22

4.6

5.0

1.73

2.33

ug/l

1.90

252

2477

Erythema multiforme

196

2033

0.95

0.22

6.2

5.3

2.63

2.31

ug/l

0.17

178

1835

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

928

1.07

0.22

4.7

4.8

1.88

2.18

ug/l

0.26

842

Wegener granulomatosis

167

1734

0.95

0.21

4.5

5.4

2.40

2.42

ug/l

0.02

151

1570

Drug-induced polyneuropathy

104

991

1.07

0.21

6.5

5.5

2.69

2.54

ug/l

0.06

898

Myopathy due to other toxic agents

0.69

0.21

6.6

4.6

1.31

1.91

ug/l

—

Haemorrhagic disorder due to circulating anticoagulants

207

2006

1.05

0.21

5.2

6.1

4.68

5.32

ug/l

0.09

181

1774

Crushing injury of lower leg

301

1.15

0.21

4.8

5.0

13.14

1.84

ug/l

0.46

271

Other disorders of electrolyte and fluid balance, not elsewhere classified

837

0.93

0.21

5.7

5.3

3.70

4.13

ug/l

0.09

741

Excessive vomiting in pregnancy

1.16

0.21

1.0

1.2

—

0.52

—

Blindness or visual impairment, binocular

493

1.10

0.21

5.2

5.4

2.23

2.08

ug/l

0.14

435

Deficiency of other B group vitamins

221

2139

1.04

0.21

5.9

5.8

2.22

2.89

ug/l

1.23

191

1898

Gastric ulcer - Acute with haemorrhage, drug-induced

266

0.85

0.21

5.2

6.1

1.78

2.50

ug/l

0.75

229

Vasculitis limited to skin, not elsewhere classified

288

2801

1.04

0.20

4.9

5.5

2.19

2.73

ug/l

0.63

261

2521

Exclusion endpoint for clefts

128

1220

1.06

0.20

4.1

4.3

1.79

1.65

ug/l

0.21

119

1106

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

0.73

0.20

4.4

3.9

3.58

2.53

ug/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

288

1.12

0.20

5.2

4.7

1.61

1.65

ug/l

0.03

254

Cushing syndrome

817

0.93

0.20

6.6

5.7

2.27

2.48

ug/l

0.14

724

Amoebiasis, including avohilmo

687

1.08

0.20

6.0

4.8

1.38

1.73

ug/l

0.99

608

Non-allergic asthma

955

9401

1.02

0.20

5.3

5.5

3.92

3.41

ug/l

0.14

873

8483

Volvulus

333

3247

1.04

0.20

5.3

5.6

3.18

3.81

ug/l

0.22

298

2901

Colorectal neuroendocrine tumor and carcinoma

129

1235

1.06

0.20

5.6

4.0

1.79

1.82

ug/l

0.06

114

1107

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

842

1.07

0.20

4.4

4.5

1.54

2.03

ug/l

0.60

758

Disorders of breast

331

0.90

0.20

1.0

1.1

—

0.53

—

Internuclear ophthalmoplegia

388

1.12

0.20

4.9

5.5

5.63

2.83

ug/l

0.42

348

Chronic ulcer of skin, not elsewhere classified

1021

10074

1.02

0.20

4.9

5.8

3.49

3.51

ug/l

0.01

907

9083

Lordosis

288

0.87

0.20

4.2

4.6

1.30

3.02

ug/l

0.93

259

Degeneration of iris and ciliary body

1.26

0.20

2.7

3.9

1.00

1.99

ug/l

—

Myeloproliferative diseases (CML excluded)

971

9577

1.02

0.20

5.2

5.8

2.39

3.49

ug/l

1.53

862

8597

Hypertension, portal

462

0.89

0.20

3.1

5.1

1.16

1.80

ug/l

1.06

412

Other specified/unspecified nutritional deficiencies

589

0.92

0.20

4.0

5.0

1.70

2.75

ug/l

1.03

530

Posteruptive colour changes of dental hard tissues

165

1.17

0.20

4.9

4.3

1.83

1.78

ug/l

0.03

155

Benign mammary dysplasia

115

0.78

0.20

1.0

1.2

—

0.44

—

Pneumonia due to Haemophilus influenzae

433

0.90

0.20

6.5

5.3

2.78

2.75

ug/l

0.01

393

Other hereditary haemolytic anaemias

572

1.09

0.19

4.7

4.8

1.50

1.81

ug/l

0.63

520

Malignant neoplasm of eye and adnexa, including Hilmo

208

2017

1.05

0.19

6.0

4.3

3.32

2.01

ug/l

0.69

184

1809

Other disorders of kidney and ureter in diseases classified elsewhere

1.29

0.19

4.7

5.7

1.85

1.90

ug/l

—

Malignant neoplasm of pyriform sinus, including Hilmo

283

0.83

0.19

6.7

4.2

5.04

1.92

ug/l

0.49

255

Other and unspecified acute skin changes due to ultraviolet radiation

307

3147

0.96

0.19

5.5

5.49

3.25

ug/l

0.52

274

2826

Immunodeficiency associated with other specified major defects, or unspecified

1.28

0.19

4.5

4.6

2.64

1.84

ug/l

—

Other eating disorders

908

1.06

0.19

3.8

3.9

1.26

2.03

ug/l

1.20

809

Gender identity disorders

488

0.92

0.19

2.4

3.4

0.91

1.35

ug/l

2.15

446

Myeloproliferative diseases

1092

10782

1.02

0.19

5.1

5.8

2.82

3.39

ug/l

0.39

973

9694

Tetanus, other/unspecified, including avohilmo

0.74

0.19

4.5

5.1

1.11

2.51

ug/l

—

Paraplegia, diplegia of upper limbs

272

2792

0.96

0.19

5.1

5.4

5.95

2.60

ug/l

0.67

243

2501

Secondary malignant neoplasm of respiratory and digestive organs

234

2406

0.96

0.19

5.1

4.4

6.04

2.05

ug/l

1.43

206

2160

Meckel's diverticulum

750

1.08

0.19

5.1

5.2

2.00

1.88

ug/l

0.12

676

Anuria and oliguria

907

1.07

0.19

5.3

5.6

4.27

2.64

ug/l

0.61

790

Malignant neoplasm of gallbladder

382

0.90

0.19

5.1

4.5

2.08

1.94

ug/l

0.14

336

Use of levodopa decarbox-comt-inhibitor

516

5248

0.97

0.19

4.8

6.1

3.32

3.18

ug/l

0.08

461

4694

Benign neoplasm: Skin of upper limb, including shoulder

198

1917

1.04

0.19

5.9

5.3

5.96

2.37

ug/l

0.61

177

1721

Other disorders of peripheral nervous system

760

1.08

0.19

5.6

5.4

2.25

2.62

ug/l

0.20

675

Pneumocystosis, including avohilmo

281

2743

1.04

0.19

4.9

5.9

3.70

2.54

ug/l

0.65

255

2453

Pneumocystosis

281

2743

1.04

0.19

4.9

5.9

3.70

2.54

ug/l

0.65

255

2453

Hypertension, Pulmonary Arterial

660

0.93

0.19

4.3

5.7

2.98

3.54

ug/l

0.21

580

Distal bite

118

1117

1.05

0.19

5.1

4.3

1.74

1.66

ug/l

0.14

109

1008

KRA_PSY_EATING, excluding more controls

148

1405

1.04

0.19

3.9

4.1

1.30

1.88

ug/l

1.47

127

1274

Pelvic region

0.77

0.19

4.7

5.7

4.34

2.25

ug/l

—

Benign neoplasm of other and unspecified intrathoracic organs

124

1191

1.06

0.19

5.6

5.5

2.29

2.59

ug/l

0.26

113

1070

All dysplastic lesions of the cervix uteri, vagina or vulva

161

1.15

0.19

1.1

—

0.77

—

Indeterminate sex and pseudohermaphroditism

0.75

0.19

4.8

5.5

1.89

1.79

ug/l

—

Sequelae of poliomyelitis, including avohilmo

109

1136

0.94

0.18

5.6

6.0

4.60

2.97

ug/l

0.29

1002

Disorders of synovium and tendon

7831

66073

1.01

0.18

5.4

5.2

2.44

3.17

ug/l

2.31

7133

60165

Other and unspecified psoriasis

938

9257

1.02

0.18

4.9

5.5

2.27

2.71

ug/l

0.60

843

8411

Cutis laxa senilis

185

1.15

0.18

7.0

5.2

1.14

1.85

ug/l

0.91

158

Dextrocardia

1.23

0.18

2.9

3.7

1.18

1.64

ug/l

—

Flatback syndrome

1.21

0.18

6.8

5.1

0.49

1.99

ug/l

—

LSIL lesion of the cervix uteri

1.21

0.18

1.0

1.2

—

0.44

—

Prolonged pregnancy

1.19

0.18

1.0

1.1

—

0.02

—

Pedal cyclist injured in collision with motor vehicle

317

3094

1.03

0.18

5.5

4.8

2.84

2.18

ug/l

0.62

280

2802

Use of interferon beta-1a

102

972

1.06

0.18

3.0

3.6

1.31

1.40

ug/l

0.29

896

Congenital malformations of oesophagus, including avohilmo

575

1.09

0.18

6.1

5.6

2.63

2.02

ug/l

0.55

512

Unspecified parasitic disease

111

1067

1.06

0.18

4.7

5.6

1.85

2.76

ug/l

1.43

100

967

Other endophthalmitis

526

1.09

0.18

4.9

5.6

5.06

2.66

ug/l

0.39

468

Keratosis punctata

0.73

0.18

4.0

4.9

1.27

1.69

ug/l

—

Other and unspecified haemorrhagic conditions

156

1506

1.05

0.18

5.1

5.4

2.15

2.46

ug/l

0.40

142

1359

Need for immunization against other single infectious diseases

1.25

0.18

3.5

4.6

1.76

1.71

ug/l

0.02

Other and unspecified bullous disorders

105

1005

1.06

0.18

5.6

2.11

2.76

ug/l

0.42

904

Family history of mental and behavioural disorders

1.14

0.18

3.4

5.5

1.90

1.70

ug/l

—

Hydroxyapatite deposition disease

0.75

0.18

7.8

6.3

1.08

2.17

ug/l

—

Mental and behavioural disorders due to cannabinoids

250

2570

0.97

0.17

2.7

1.08

1.19

ug/l

0.41

201

2385

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

115

1198

0.95

0.17

5.6

5.7

11.09

2.45

ug/l

0.57

100

1075

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

735

1.08

0.17

4.5

5.7

2.44

2.78

ug/l

0.19

655

Follicular lymphoma, hilmo

542

5510

0.98

0.17

5.1

5.8

2.35

2.86

ug/l

0.97

480

4958

Benign neoplasm of breast

1.21

0.17

1.2

1.1

—

0.44

—

Deep endometriosis

1.15

0.17

1.0

1.1

—

0.44

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

109

1138

0.95

0.17

4.7

4.2

1.98

2.02

ug/l

0.05

1001

Abscess of spleen

0.77

0.17

10.0

5.3

1.65

2.12

ug/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.13

0.17

1.0

1.2

—

1.32

—

Disorders of amino-acid transport

208

1.16

0.17

4.6

5.0

1.68

2.36

ug/l

0.54

184

Other specified/unspecified systemic involvement of connective tissue

313

3053

1.03

0.17

5.0

5.4

2.15

2.57

ug/l

0.52

280

2729

Pedestrian injured in other and unspecified transport accidents

100

1045

0.95

0.17

5.0

1.84

2.05

ug/l

0.44

944

Intercostal neuropathy

900

1.06

0.17

5.1

5.5

1.37

2.53

ug/l

2.06

805

Secondary parkinsonism

365

3723

0.97

0.17

4.7

5.9

2.37

3.04

ug/l

0.82

319

3337

Pedestrian injured in collision with railway train or railway vehicle

122

1.23

0.17

6.9

5.4

2.73

2.16

ug/l

0.18

111

Benign neoplasm: other/unspecified salivary gland

295

2883

1.03

0.16

5.8

2.54

3.31

ug/l

0.67

262

2567

Filariasis, including avohilmo

1.16

0.16

5.6

5.3

1.11

1.90

ug/l

—

Filariasis

1.16

0.16

5.6

5.3

1.11

1.90

ug/l

—

Congenital retinoschisis

364

1.12

0.16

4.8

5.5

2.51

3.28

ug/l

0.29

325

Burns classified according to extent of body surface involved

137

1325

1.05

0.16

4.0

4.8

2.29

2.23

ug/l

0.04

127

1207

Other immunodeficiencies

708

0.94

0.16

4.4

5.1

1.53

2.27

ug/l

0.69

634

Pedestrian injured in collision with pedal cycle

342

3348

1.03

0.16

4.4

4.9

1.99

2.53

ug/l

0.85

317

3048

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.77

0.16

4.7

3.9

2.75

1.29

ug/l

—

Congenital malformations of great arteries

120

1225

0.95

0.16

4.4

1.80

1.97

ug/l

0.21

108

1113

Labyrinthine fistula

443

1.11

0.16

6.1

5.7

1.94

2.77

ug/l

0.54

397

Autoimmune hepatitis, wide definition

467

4586

1.02

0.16

4.8

5.0

6.36

2.30

ug/l

0.62

425

4174

Other or unspecified paralytic strabismus

736

0.93

0.16

5.0

5.4

2.34

2.45

ug/l

0.07

657

Bacterial meningoencephalitis and meningomyelitis

0.79

0.16

3.4

5.1

2.21

2.48

ug/l

—

Benign neoplasm: Oesophagus

133

1376

0.95

0.16

5.3

5.6

1.39

2.62

ug/l

3.48

117

1227

Preterm labour and delivery

162

0.86

0.16

1.1

—

0.02

—

Motor- or nonmotor-vehicle accident in traffic area

736

0.94

0.16

4.8

4.6

1.68

2.16

ug/l

0.46

667

Diabetic nephropathy, excluding more controls

2604

21063

1.01

0.16

4.4

5.6

2.24

2.82

ug/l

1.81

2393

18945

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

958

0.94

0.16

4.5

4.2

3.04

1.91

ug/l

0.48

845

Malignant neoplasm of small intestine

323

3166

1.03

0.16

5.5

4.4

2.31

1.99

ug/l

1.09

282

2858

Disorders of glycoprotein metabolism

103

1.23

0.16

9.8

5.5

14.13

1.98

ug/l

0.48

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

811

1.06

0.16

4.2

4.9

1.52

2.35

ug/l

0.89

730

Secondary parkinsonism+Parkinsonism in other disease

375

3820

0.97

0.16

4.8

5.9

2.34

3.06

ug/l

0.96

327

3425

Morphin

336

3426

0.97

0.16

5.3

6.0

2.28

3.12

ug/l

1.24

280

3045

Non-selective monoamine reuptake inhibitors

4527

43660

0.99

0.16

5.4

5.5

2.14

3.31

ug/l

4.93

4005

39780

Fibrosarcoma

814

1.06

0.16

5.2

4.2

2.36

2.01

ug/l

0.36

719

Other disorders of amino-acid metabolism

520

0.92

0.15

5.2

5.4

2.18

2.78

ug/l

0.30

463

Other and unspecified thalassaemias

0.77

0.15

3.3

4.3

1.39

1.87

ug/l

—

Injury of nerves at ankle and foot level

725

1.07

0.15

5.6

4.9

5.53

1.94

ug/l

0.50

650

Congenital malformations of lung, including avohilmo

208

1.13

0.15

4.1

4.4

1.38

1.64

ug/l

0.49

185

Huntington disease

0.82

0.15

4.3

4.9

1.10

2.14

ug/l

—

Pneumonia derived septicemia

435

4425

0.98

0.15

5.1

5.6

2.61

2.66

ug/l

0.03

385

3989

Other drug-induced secondary parkinsonism

122

1179

1.05

0.15

4.8

5.2

2.05

2.38

ug/l

0.28

104

1061

Disorders of adrenal gland, other and/or unspecified

461

1.08

0.15

6.1

5.5

3.01

2.61

ug/l

0.10

418

Symptoms and signs involving appearance and behaviour

646

1.07

0.15

4.2

5.0

13.45

2.42

ug/l

0.47

584

Acidosis

363

3692

0.97

0.15

5.2

5.6

2.89

2.90

ug/l

0.01

322

3330

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

237

1.12

0.15

5.0

5.4

2.14

3.51

ug/l

0.47

210

Other contact dermatitis

748

7379

1.02

0.15

5.0

5.1

2.61

2.83

ug/l

0.17

673

6681

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

305

1.10

0.15

4.5

5.3

2.40

2.35

ug/l

0.02

263

Other demyelinating diseases of the central nervous system

236

2300

1.03

0.15

4.7

4.4

1.57

1.87

ug/l

0.83

206

2110

Aortic aneurysm

6151

60086

1.01

0.15

5.8

6.2

2.66

3.98

ug/l

5.87

5403

54073

Endometriosis ASRM stages 3,4

159

1.13

0.15

1.1

—

1.03

—

Complications following infusion, transfusion and therapeutic injection

144

1486

0.96

0.15

5.6

5.4

4.32

2.57

ug/l

0.51

132

1329

Other primary thrombocytopenia

325

1.10

0.15

5.2

5.8

1.92

3.06

ug/l

0.53

286

Injury of blood vessels of thorax

345

0.91

0.15

5.2

5.0

2.11

2.72

ug/l

0.25

311

Other parasitologically confirmed or unspecified malaria

258

1.12

0.15

5.4

4.7

2.27

1.70

ug/l

0.86

235

Malignant neoplasm of tonsil

266

2711

0.96

0.15

5.0

4.1

2.10

1.84

ug/l

0.83

232

2471

Other and unspecified water transport accidents

497

0.92

0.15

5.1

5.2

2.06

1.77

ug/l

0.35

447

Atypical virus infections of central nervous system

927

0.95

0.15

4.1

4.8

1.65

2.24

ug/l

0.67

830

Schizoid personality disorder

236

2413

0.97

0.14

3.5

4.4

2.58

1.87

ug/l

0.30

212

2223

Eating disorder

148

1427

1.04

0.14

3.9

3.8

1.30

1.79

ug/l

1.13

127

1288

Graves ophthalmopathy, strict

104

999

1.05

0.14

5.4

5.1

2.53

2.30

ug/l

0.14

889

Injuries to the hip and thigh

8253

73696

1.01

0.14

5.5

5.7

3.43

3.64

ug/l

0.19

7362

66385

Autoimmune hepatitis

549

1.07

0.14

4.2

5.3

1.12

2.99

ug/l

2.25

495

Occupant of pick-up truck or van injured in other and unspecified transport accidents

751

0.94

0.14

4.7

4.5

1.48

1.74

ug/l

0.60

680

Use of amantadine

137

1414

0.96

0.14

5.6

5.5

2.34

2.39

ug/l

0.04

118

1260

Sequelae of infectious and parasitic diseases, including avohilmo

947

9369

1.01

0.14

4.8

4.9

2.26

3.05

ug/l

0.80

864

8505

Atrial septal defect

273

2652

1.03

0.14

4.5

4.7

1.61

2.05

ug/l

1.56

241

2430

Benign neoplasm: Other parts of oropharynx

954

1.05

0.14

5.8

5.1

1.71

2.12

ug/l

0.65

859

Endocarditis

659

6666

0.98

0.14

5.2

5.9

2.64

3.58

ug/l

0.73

582

6084

Restrictive cardiomyopathy

445

0.92

0.14

4.8

5.6

2.34

2.72

ug/l

0.17

396

Polyarteritis nodosa

661

0.94

0.14

4.5

5.6

1.88

2.42

ug/l

0.61

595

Injury of nerves at lower leg level

117

1132

1.05

0.14

5.4

4.8

4.24

2.31

ug/l

0.36

107

1033

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

393

1.08

0.14

3.6

3.8

2.09

1.48

ug/l

0.79

358

LSIL lesion of the cervix uteri, vagina or vulva

1.19

0.14

1.0

1.2

—

1.32

—

General autosomal fish scale disease

116

0.82

0.13

4.7

3.4

1.63

1.51

ug/l

—

102

Chronic tubulo-interstitial nephritis

255

2492

1.03

0.13

4.8

5.6

3.04

2.62

ug/l

0.17

233

2204

Pityriasis rosea

472

1.07

0.13

4.4

4.6

1.38

1.82

ug/l

1.19

423

Pityriasis lichenoides chronica

425

1.08

0.13

5.1

5.5

1.45

2.09

ug/l

1.49

382

Congenital malformations of oesophagus

523

1.07

0.13

6.2

5.6

2.65

2.04

ug/l

0.50

464

Embolic stroke with flimmer

384

3899

0.98

0.13

5.1

6.5

3.15

4.78

ug/l

0.73

337

3464

Neuroendocrine tumor and carcinoma of pancreas

908

1.06

0.13

5.4

4.1

2.09

1.87

ug/l

0.43

819

Other and unspecified vasculitis limited to skin

262

2567

1.03

0.13

5.0

5.6

2.25

2.80

ug/l

0.56

235

2318

Graves ophthalmopathy

115

1110

1.04

0.13

5.3

5.1

2.42

2.27

ug/l

0.10

104

988

Hereditary lymphedema, including avohilmo

137

0.85

0.13

4.9

5.0

3.52

1.83

ug/l

0.84

122

Congenital malformations of lung

191

1.13

0.13

4.0

4.2

1.34

1.67

ug/l

0.61

170

Conduct disorder

136

1403

0.96

0.13

2.8

3.2

7.33

1.34

ug/l

0.50

123

1287

Acute appendicitis, with complications

3035

30190

1.01

0.13

5.1

5.3

2.98

2.92

ug/l

0.06

2731

27505

Renal agenesis and other reduction defects of kidney

514

1.07

0.13

4.4

5.4

2.19

2.52

ug/l

0.15

461

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

197

2016

0.97

0.13

5.9

6.2

4.42

2.91

ug/l

0.55

183

1783

Mucosal proctocolitis

1586

15981

0.99

0.13

4.6

2.46

2.24

ug/l

0.23

1466

14630

Disorder of mineral metabolism, other/unspecified

178

0.88

0.13

4.1

5.1

0.89

1.79

ug/l

2.82

159

Knuckle pads

212

1.13

0.12

4.1

5.2

1.87

1.86

ug/l

0.01

185

Immunodeficiency associated with other major defects

211

1.12

0.12

4.4

4.8

1.92

1.78

ug/l

0.16

185

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

925

1.04

0.12

5.4

5.0

1.49

2.44

ug/l

1.60

829

Convergent concomitant strabismus

420

4133

1.02

0.12

3.8

4.2

1.88

1.94

ug/l

0.05

388

3787

Chronic Coagulation defects

122

1260

0.96

0.12

5.0

4.9

1.88

2.11

ug/l

0.24

109

1141

Generalized pustular psoriasis

403

0.92

0.12

6.1

5.7

1.88

2.26

ug/l

0.29

353

Vitamin deficiency

500

4931

1.02

0.12

4.9

5.5

2.08

3.03

ug/l

2.51

442

4436

Vitamin deficiency, wide

500

4931

1.02

0.12

4.9

5.5

2.08

3.03

ug/l

2.51

442

4436

Injury of nerves and spinal cord at thorax level

643

1.06

0.12

5.3

4.8

1.91

2.18

ug/l

0.20

584

Sequelae of burns, corrosions and frostbite

566

0.94

0.12

4.7

1.65

1.85

ug/l

0.38

514

Chronic myeloid leukaemia, including Hilmo

121

1176

1.04

0.12

4.9

4.1

6.14

1.89

ug/l

0.44

111

1056

Other mycoses, not elsewhere classified/unspecified

496

1.07

0.12

4.2

5.7

3.18

2.35

ug/l

0.41

443

Pneumonia due to other infectious organisms, not elsewhere classified

474

4678

1.02

0.12

4.9

5.8

5.52

3.03

ug/l

0.46

425

4226

Insulin, combination of fast acting with intermediate-acting or long-acting

11867

107301

1.00

0.12

4.8

5.5

2.66

3.36

ug/l

2.37

10566

97485

Varus deformity, not elsewhere classified

513

1.06

0.12

4.4

5.1

1.87

2.55

ug/l

0.66

464

Assault by drugs, medicaments and biological substances

146

0.86

0.12

5.5

3.5

1.45

1.48

ug/l

0.04

133

Macular hole, drug-induced

1.35

0.12

8.7

6.5

0.53

2.86

ug/l

—

Malignant neoplasm of small intestine, including Hilmo

414

4198

0.98

0.12

5.4

4.3

2.22

2.01

ug/l

0.81

362

3790

Secondary malignant neoplasm of other and unspecified sites

274

2694

1.03

0.12

9.6

4.5

19.36

2.09

ug/l

8.38

256

2406

Intentional self-harm by sharp object

175

1794

0.97

0.12

3.5

4.0

1.86

1.88

ug/l

0.01

156

1643

Drug-induced myopathy

381

0.92

0.12

4.6

5.7

1.85

2.53

ug/l

0.62

339

Abnormality of red blood cells

604

1.06

0.12

5.7

4.6

1.40

2.03

ug/l

1.40

535

Maltreatment syndromes

402

4083

0.98

0.12

3.7

1.82

1.61

ug/l

0.28

348

3764

Contact with hot air and gases

881

1.05

0.11

4.2

4.7

1.69

2.17

ug/l

0.58

795

Other juvenile arthritis

149

1449

1.03

0.11

3.4

3.9

1.69

2.04

ug/l

0.57

138

1298

Cachexia

646

0.94

0.11

5.2

6.2

1.91

3.00

ug/l

1.22

570

Anorexia

671

1.05

0.11

5.6

5.4

2.33

2.62

ug/l

0.15

593

Immunodeficiency with predominantly antibody defects

203

1986

1.03

0.11

4.7

5.0

1.72

2.29

ug/l

1.42

194

1818

Hypospadias

428

1.07

0.11

5.2

4.7

1.80

2.46

ug/l

0.35

387

Hyperosmolality and hypernatraemia

174

1702

1.03

0.11

4.3

6.0

2.11

3.04

ug/l

1.85

158

1502

Acute pancreatitis (for exclusion)

3573

35875

0.99

0.11

5.1

5.5

2.87

3.08

ug/l

0.17

3208

32610

Mosquito-borne viral encephalitis, including avohilmo

1.16

0.11

4.2

4.9

0.94

2.08

ug/l

—

Diseases of spleen

217

2212

0.97

0.11

5.4

5.5

3.58

2.77

ug/l

0.32

195

2004

Thromboangiitis obliterans

482

0.93

0.11

4.4

5.6

2.52

3.15

ug/l

0.29

420

Polymyositis

772

1.05

0.11

5.0

5.3

3.95

2.61

ug/l

0.40

697

Other early complications of trauma

1.18

0.11

8.2

4.8

1.22

1.63

ug/l

—

Other maltreatment syndromes

364

3587

1.02

0.11

3.5

3.6

2.82

1.59

ug/l

0.59

332

3332

Traction detachment of retina

1020

0.96

0.11

5.2

4.9

1.95

1.94

ug/l

0.01

918

Atypical virus infections of central nervous system, including avohilmo

950

0.96

0.11

4.0

4.8

1.64

2.22

ug/l

0.69

850

Increased secretion of glucagon

0.79

0.11

4.4

3.8

1.38

2.20

ug/l

—

Donors of organs and tissues

133

1295

1.03

0.11

4.6

4.5

1.85

1.69

ug/l

0.43

128

1191

Deficiency of other/unspecified vitamins

106

1.17

0.11

3.0

5.2

2.35

1.91

ug/l

0.23

Other peripheral vascular diseases

796

8038

0.99

0.11

5.1

5.8

2.27

3.50

ug/l

1.44

718

7233

Abscess of mediastinum

257

0.90

0.11

4.2

5.4

1.51

2.97

ug/l

0.60

227

Dissection of cerebral arteries, nonruptured

862

1.05

0.11

5.0

4.9

11.83

2.13

ug/l

0.52

777

Muscular dystrophy

743

1.05

0.11

5.8

5.2

2.09

2.61

ug/l

0.43

665

Contact with other hot metals

211

2071

1.03

0.10

4.6

5.0

1.70

2.24

ug/l

1.54

183

1871

Immunodeficiencies

388

3936

0.98

0.10

4.8

5.2

2.35

2.74

ug/l

0.39

357

3547

Ependymoma

106

1.16

0.10

3.5

4.0

0.94

2.47

ug/l

2.38

Other endocrine disorders

323

3042

1.02

0.10

5.2

5.1

1.69

2.59

ug/l

1.95

281

2732

Fracture of lower limb, level unspecified

1.23

0.10

4.7

4.2

6.76

2.32

ug/l

—

Defects in post-translational modification of lysosomal enzymes

1.26

0.10

11.7

5.9

1.41

2.13

ug/l

—

Lesion of sciatic nerve

521

5270

0.98

0.10

6.1

6.0

3.29

4.87

ug/l

0.97

476

4672

Dysplasia of cervi uteri

1.12

0.10

1.1

—

0.03

—

Rat-bite fevers

1.11

0.10

4.6

6.0

1.85

2.27

ug/l

—

Malignant neoplasm of parotid gland, including Hilmo

126

1229

1.04

0.10

5.3

4.2

2.22

1.90

ug/l

0.52

111

1101

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

967

9573

1.01

0.10

5.3

6.2

2.77

4.15

ug/l

1.68

875

8525

Other and unspecified localized connective tissue disorders

164

1.12

0.10

5.1

5.3

1.99

1.73

ug/l

0.19

143

Oesophageal obstruction

550

5557

0.98

0.10

5.7

5.8

2.16

4.09

ug/l

1.74

481

4982

Benign neoplasm: Connective and other soft tissue of thorax

488

1.06

0.10

5.7

5.5

3.21

2.50

ug/l

0.22

431

Car occupant injured in noncollision transport accident

367

3722

0.98

0.10

4.5

4.8

1.82

2.14

ug/l

0.97

329

3389

Respiratory disorders in diseases classified elsewhere

139

1357

1.03

0.10

4.5

5.8

2.01

2.50

ug/l

0.83

117

1225

Mantle cell lymphoma

169

1721

0.96

0.10

5.8

4.4

3.47

2.04

ug/l

0.55

153

1536

Hereditary deficiency of other clotting factors

615

1.05

0.10

5.2

5.1

1.42

2.40

ug/l

1.14

556

Acute pancreatitis

3573

35595

1.01

0.10

5.1

5.5

2.87

3.22

ug/l

0.29

3208

32323

Tetanus, other/unspecified

0.81

0.10

5.0

5.9

0.94

2.80

ug/l

—

Tetanus, including avohilmo

0.81

0.10

5.0

5.9

0.94

2.80

ug/l

—

Tetanus

0.81

0.10

5.0

5.9

0.94

2.80

ug/l

—

Diving or jumping into water causing injury other than drowning or submersion

623

0.95

0.10

5.5

4.2

3.46

2.08

ug/l

0.42

563

Vitamin B12 deficiency anaemia

1361

13519

1.01

0.10

5.5

6.1

3.41

4.01

ug/l

0.50

1198

12076

Problems related to lifestyle

1500

14908

1.01

0.10

4.2

4.8

2.44

2.31

ug/l

0.08

1332

13658

Other bacterial agents as the cause of diseases classified to other chapters

978

0.96

0.10

5.4

5.9

13.20

2.59

ug/l

0.58

872

Other acute lower respiratory infections

8503

81142

1.00

0.10

4.9

5.3

2.94

3.42

ug/l

0.95

7646

73457

Carcinoma in situ of cervix uteri

1.11

0.09

1.2

1.1

—

0.38

—

Hyperalimentation, other specified

1.12

0.09

5.0

5.3

4.89

2.32

ug/l

—

Other and unspecified firearm discharge, undetermined intent

176

1.14

0.09

6.7

4.3

5.15

1.53

ug/l

0.38

165

Unspecified contracted kidney

663

0.95

0.09

4.5

5.4

1.37

2.42

ug/l

1.42

595

Other ulcerative colitis

651

6572

0.99

0.09

4.9

4.8

4.47

2.13

ug/l

0.84

606

5988

Contact with other and unspecified heat and hot substances

865

1.04

0.09

5.0

4.7

2.01

2.50

ug/l

0.38

778

All dysplastic lesions of the cervix uteri

133

1.11

0.09

1.1

—

0.77

—

Drug-induced obesity

502

0.95

0.09

4.4

5.0

1.47

2.46

ug/l

0.82

441

Pituitary-dependent Cushing's disease

165

1.11

0.09

6.3

5.2

2.08

1.88

ug/l

0.14

145

Assault by blunt object

190

1934

0.97

0.09

4.1

3.9

1.63

1.78

ug/l

0.27

168

1783

Relapsing polychondritis

185

0.90

0.09

7.0

5.9

1.53

1.86

ug/l

0.31

169

Hepatomegaly and splenomegaly, not elsewhere classified

123

1202

1.03

0.09

5.1

5.2

1.93

2.33

ug/l

0.56

113

1073

Oesophagitis, drug-induced

266

0.91

0.09

6.6

5.8

2.96

2.02

ug/l

0.68

235

Mental and behavioural disorders due to hallucinogens

440

1.06

0.09

2.3

2.9

0.89

1.24

ug/l

1.47

402

Malignant neoplasm of meninges

0.83

0.09

7.7

4.8

2.04

1.88

ug/l

—

Scarlet fever, including avohilmo

623

0.96

0.09

2.8

3.2

1.09

1.38

ug/l

0.49

583

Neuromyelitis optica

107

1.14

0.09

3.3

4.7

1.04

1.58

ug/l

0.67

Juvenile dermatomyositis

0.81

0.09

2.8

5.2

0.60

1.85

ug/l

—

Substance abuse, excluding more controls

11148

92927

1.00

0.09

4.5

5.5

2.70

3.06

ug/l

0.89

9847

85107

Myiasis

1.12

0.09

5.0

5.8

0.99

1.94

ug/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2359

23485

1.01

0.09

4.8

2.38

2.30

ug/l

0.10

2159

21523

Early syphilis, including avohilmo

197

1938

1.03

0.09

4.6

4.1

2.82

1.76

ug/l

0.66

184

1784

Nonhereditary hypogammaglobulinemia

835

0.96

0.09

4.5

4.7

2.16

2.07

ug/l

0.07

751

Nystagmus and other irregular eye movements

122

1191

1.03

0.09

5.0

1.54

2.31

ug/l

1.60

112

1072

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.84

0.09

3.9

5.1

0.57

1.68

ug/l

—

Exposure to unspecified smoke, fire and flames

126

1233

1.03

0.09

5.0

4.7

6.51

2.03

ug/l

0.62

111

1113

Other and unspecified diseases of blood and blood-forming organs

306

3020

1.02

0.09

5.0

5.6

2.06

2.50

ug/l

0.75

270

2708

Selective deficiency of immunoglobulin G [IgG] subclasses

391

1.06

0.08

3.9

4.7

1.44

1.72

ug/l

0.59

353

Benign lipomatous neoplasm of intrathoracic organs

137

1.13

0.08

3.7

5.7

1.32

2.14

ug/l

0.96

120

Congenital malformations of trachea and bronchus

697

1.04

0.08

6.3

5.6

6.91

1.91

ug/l

0.45

616

Exposure to other specified electric current

224

2204

1.02

0.08

3.4

4.0

1.63

1.69

ug/l

0.10

219

2022

Leishmaniasis

1.08

0.08

2.3

4.6

2.32

1.49

ug/l

—

Night blindness

1.13

0.08

3.9

4.5

1.64

1.55

ug/l

—

Chronic suppurative otitis media

729

7228

1.01

0.08

5.3

5.4

2.71

3.62

ug/l

0.53

638

6516

Leishmaniasis, including avohilmo

1.08

0.08

2.3

4.6

2.32

1.49

ug/l

—

Assault

1723

17142

1.01

0.08

3.8

2.49

1.71

ug/l

0.82

1510

15882

Biological medication for rheuma

1719

17099

1.01

0.08

3.9

4.3

1.75

1.89

ug/l

0.74

1599

15767

Benign neoplasm: Bronchus and lung

179

1760

1.03

0.08

5.1

5.7

2.03

3.17

ug/l

1.64

163

1582

Muscle wasting and atrophy, not elsewhere classified

792

0.96

0.08

4.7

5.5

2.23

2.28

ug/l

0.05

713

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2090

20805

1.01

0.08

4.8

4.7

2.35

2.33

ug/l

0.02

1914

19060

Nutritional marasmus

133

0.88

0.08

3.0

5.9

2.02

1.97

ug/l

0.03

120

Viral encephalitis, not elsewhere classified/unspecified

218

2214

0.98

0.08

5.4

2.52

2.47

ug/l

0.03

201

1991

Systemic sclerosis (FG)

104

1013

1.03

0.08

5.4

5.1

2.35

2.62

ug/l

0.18

909

Cellulitis of external ear

118

1207

0.97

0.08

5.4

5.1

1.72

2.08

ug/l

0.60

111

1102

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

1.09

0.08

6.9

5.5

3.41

1.84

ug/l

—

Other and unspecified disorders of refraction

1.12

0.08

8.3

4.7

1.74

1.67

ug/l

—

Other autoimmune haemolytic anaemias

137

1343

1.03

0.08

4.9

5.9

2.45

2.53

ug/l

0.07

124

1192

Carcinoma in situ of oral cavity, oesophagus and stomach

869

1.04

0.08

6.3

5.7

1.68

2.61

ug/l

1.36

777

Ventricular septal defect, a heart condition

922

1.03

0.08

4.5

4.6

1.34

2.29

ug/l

1.65

830

Acute bronchitis

6003

58711

1.00

0.08

5.1

5.5

3.19

3.75

ug/l

0.79

5329

52877

Dermatopolymyositis, unspecified

551

1.05

0.08

5.3

5.8

3.02

2.82

ug/l

0.05

493

631

0.96

0.08

4.1

4.4

1.71

1.70

ug/l

0.01

563

Secondary uncertain malignant neoplasm

2120

21285

0.99

0.08

5.7

4.4

5.85

2.12

ug/l

7.74

1911

19226

Cleft lip

194

0.91

0.08

4.6

3.3

1.14

1.55

ug/l

0.80

177

Malignant neoplasm of mesothelium and soft tissue

548

5526

0.99

0.08

5.2

4.4

2.49

2.09

ug/l

1.52

480

4982

Other disorders of carbohydrate metabolism

492

1.05

0.07

3.7

4.7

1.58

2.47

ug/l

0.70

439

Phakomatoses, not elsewhere classified

867

1.03

0.07

4.7

4.6

2.17

1.65

ug/l

1.01

784

Lipodystrophy, not elsewhere classified

1.04

0.07

6.6

5.5

1.85

1.93

ug/l

—

ILD, hospital admission 2, with pulmonary infections

1735

17424

0.99

0.07

5.2

6.3

3.86

3.96

ug/l

0.04

1518

15658

Reiter disease

101

989

1.04

0.07

4.3

4.7

1.66

2.10

ug/l

0.64

897

Perineal laceration during delivery

1.08

0.07

1.0

1.1

—

0.02

—

Other acute skin changes due to ultraviolet radiation

364

3679

0.99

0.07

5.4

4.86

3.11

ug/l

0.46

323

3313

Sequelae of infectious and parasitic diseases

920

9142

1.01

0.07

4.7

4.9

2.24

3.06

ug/l

0.81

840

8300

Other diseases of peritoneum

335

3311

1.01

0.07

5.8

2.35

2.85

ug/l

0.86

303

2956

Drug-induced Cushing's syndrome

1.16

0.07

5.2

1.25

1.96

ug/l

—

Juvenile arthritis (FINNGEN)

185

1882

0.98

0.07

3.6

4.0

1.75

1.85

ug/l

0.17

172

1707

Benign neoplasm: Pharynx, unspecified

789

1.04

0.07

5.1

2.01

2.47

ug/l

0.38

708

Benign neoplasm: Floor of mouth

384

1.06

0.07

6.0

5.1

1.98

1.88

ug/l

0.11

340

Primary biliary cholangitis, wide definition

135

1377

0.98

0.07

4.8

5.5

1.62

2.52

ug/l

2.13

125

1235

Arteriovenous malformation of cerebral vessels

123

1254

0.97

0.07

5.7

5.2

1.57

2.10

ug/l

1.11

114

1142

Lichen planopilaris

118

1.11

0.07

2.2

4.9

3.70

2.00

ug/l

0.35

103

Other cestode infections, including avohilmo

315

0.94

0.07

5.4

5.6

2.35

2.21

ug/l

0.08

276

Polyarteritis nodosa and related conditions

122

1196

1.03

0.07

5.0

5.4

2.24

2.39

ug/l

0.13

110

1082

Fibrosarcoma, including Hilmo

939

1.03

0.07

5.3

4.1

2.32

1.95

ug/l

0.43

834

Osteopathy in diseases classified elsewhere

830

0.97

0.07

7.2

5.4

5.35

2.52

ug/l

0.92

751

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

872

8669

1.01

0.07

5.4

4.4

2.66

2.05

ug/l

1.89

769

7794

Tuberculosis of other organs, strict, including avohilmo

237

2340

1.02

0.07

5.4

6.0

3.25

5.13

ug/l

0.47

209

2055

Other and unspecified aplastic anaemias

129

1313

0.98

0.06

5.3

5.6

3.48

2.99

ug/l

0.14

116

1169

Polyclonal hypergammaglobulinaemia

151

0.88

0.06

4.4

6.2

1.68

4.09

ug/l

0.54

127

466

0.95

0.06

5.5

4.2

1.43

1.63

ug/l

0.37

429

Non-follicular lymphoma

1547

15409

1.01

0.06

5.4

6.0

2.90

3.50

ug/l

0.77

1384

13893

Exposure to other and unspecified man-made environmental factors

195

1923

1.02

0.06

4.6

4.8

1.72

1.85

ug/l

0.27

188

1760

Juvenile Open Angle Glaucoma

587

0.96

0.06

4.3

4.4

1.55

2.04

ug/l

0.64

529

Defects in the complement system

335

0.95

0.06

4.1

5.0

2.12

1.66

ug/l

0.24

300

Impaction of intestines

662

1.04

0.06

5.6

5.0

1.97

3.53

ug/l

1.42

592

Acute hepatitis B

516

0.96

0.06

3.9

4.7

1.55

2.29

ug/l

0.57

469

Other and unspecified neuropathies

534

1.05

0.06

5.9

5.7

2.44

2.66

ug/l

0.11

477

Tobacco use

714

7184

0.99

0.06

4.1

5.1

2.74

2.29

ug/l

0.16

629

6583

Acute otitis externa, noninfective

171

1685

1.02

0.06

5.5

5.2

1.85

2.66

ug/l

1.06

156

1533

Malignant neoplasm of parotid gland

106

1040

1.03

0.06

5.3

4.2

2.33

1.93

ug/l

0.58

922

Whooping cough, including avohilmo

939

1.03

0.06

4.0

4.2

1.65

1.67

ug/l

0.04

853

Schizoaffective disorder

718

7134

1.01

0.06

3.7

4.5

1.47

1.95

ug/l

3.24

644

6564

Congenital musculoskeletal deformities of head, face, spine and chest

741

1.03

0.06

4.6

4.3

1.65

1.99

ug/l

0.32

662

Systemic sclerosis

104

1062

0.98

0.06

5.4

5.2

2.35

2.22

ug/l

0.08

949

Tumor necrosis factor alpha inhibitors

1471

14646

1.01

0.06

3.8

4.2

1.72

1.81

ug/l

0.49

1372

13492

Cerebral aneurysm, nonruptured

909

9140

0.99

0.06

5.1

5.5

2.13

2.73

ug/l

2.75

846

8297

Rheumatoid arthritis, including avohilmo

4004

40141

1.00

0.06

5.1

5.7

2.59

3.34

ug/l

2.26

3608

36231

Gonococcal infection, including avohilmo

236

2331

1.01

0.06

3.2

3.6

1.62

1.46

ug/l

0.67

220

2149

Unspecified threat to breathing

682

1.03

0.06

4.9

2.51

2.05

ug/l

0.34

615

Other retinal disorders in diseases classified elsewhere

343

0.94

0.06

4.5

5.4

29.37

2.26

ug/l

0.47

304

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

118

1160

1.03

0.06

5.7

5.9

3.81

2.34

ug/l

0.45

111

1037

Burn and corrosion of ankle and foot

188

1904

0.98

0.06

5.0

2.03

2.21

ug/l

0.27

176

1733

Tarsal tunnel syndrome

593

1.03

0.06

5.3

5.0

1.55

2.50

ug/l

1.04

541

Other Crohn's disease

695

6907

1.01

0.06

4.2

4.5

2.27

1.99

ug/l

0.37

652

6320

Malignant neoplasm of breast, HER2-negative, including Hilmo

208

1.05

0.06

1.1

—

1.33

—

Malignant neoplasm of breast, including Hilmo

208

1.05

0.06

1.1

—

1.33

—

Malignant neoplasm of retroperitoneum and peritoneum

544

1.04

0.06

4.0

4.2

1.56

2.03

ug/l

1.13

492

Toxic effect of carbon monoxide

224

2265

0.98

0.06

5.4

5.1

2.85

2.29

ug/l

0.28

208

2055

Melanoma of uvea

127

1290

0.98

0.06

6.1

5.8

3.89

2.68

ug/l

0.32

112

1147

Obesity and other hyperalimentation

8376

78818

1.00

0.05

5.0

5.3

2.14

2.78

ug/l

2.13

7508

72133

Asthma mixed form (mode), excluding more controls

518

5141

1.01

0.05

5.2

5.8

2.92

4.23

ug/l

0.78

474

4649

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

7876

71818

1.00

0.05

4.8

2.04

2.65

ug/l

4.45

7158

65739

Behavioural disorders

131

1332

0.98

0.05

2.7

3.1

7.52

1.32

ug/l

0.49

118

1223

Congenital malformations of heart and great arteries

1463

14243

0.99

0.05

4.9

4.8

1.88

2.26

ug/l

2.58

1311

13043

Pedestrian injured in transport accident

738

7338

1.01

0.05

4.8

5.0

2.31

2.49

ug/l

0.20

668

6675

Toxic effects of substances chiefly nonmedicinal as to source

1425

14304

0.99

0.05

4.8

2.84

2.61

ug/l

0.11

1296

13102

Injury of nerves at shoulder and upper arm level

139

1370

1.02

0.05

4.1

4.8

1.61

2.19

ug/l

1.03

129

1255

Malignant neoplasm of other and ill-defined digestive organs

1007

0.97

0.05

4.5

4.4

2.76

2.17

ug/l

0.85

887

Disorders of vagus nerve

130

1.11

0.05

6.4

5.1

1.56

4.45

ug/l

0.61

113

Early syphilis

186

1839

1.02

0.05

4.7

4.1

2.91

1.75

ug/l

0.69

173

1695

Tuberculosis of other organs, strict

234

2315

1.01

0.05

5.4

6.0

3.26

5.18

ug/l

0.47

207

2031

Mantle cell lymphoma, including Hilmo

241

2432

0.98

0.05

5.7

4.3

3.13

2.04

ug/l

0.60

218

2179

Injury of intra-abdominal organs

294

2966

0.99

0.05

4.8

4.6

3.44

2.07

ug/l

0.47

258

2707

Acute myeloid leukaemia and myelodysplastic syndromes

317

3196

0.99

0.05

5.1

4.4

1.93

2.16

ug/l

0.93

281

2845

Pneumoconiosis due to asbestos and other mineral fibres

441

4436

0.99

0.05

6.6

6.4

5.89

5.05

ug/l

0.14

366

3905

Focal brain injury

1164

11680

0.99

0.05

5.2

5.4

2.35

3.61

ug/l

3.20

1019

10628

Other inflammatory liver diseases

755

7512

1.01

0.05

5.1

5.3

4.80

2.55

ug/l

0.53

688

6823

Nonpyogenic thrombosis of intracranial venous system

774

1.03

0.05

5.2

5.0

2.45

2.24

ug/l

0.10

700

Drug-induced systemic lupus erythematosus

268

1.05

0.05

3.2

5.1

0.85

2.00

ug/l

2.90

244

Evidence of alcohol involvement determined by level of intoxication

113

1113

1.02

0.04

3.4

4.4

1.79

1.86

ug/l

0.09

107

1020

Problems related to social environment

247

2446

1.01

0.04

5.4

5.3

3.48

3.14

ug/l

0.10

220

2186

Birth trauma

209

1.06

0.04

3.6

4.4

1.25

1.83

ug/l

0.95

187

Drug-induced cataract

243

2408

1.01

0.04

4.5

5.3

1.90

2.23

ug/l

0.73

216

2194

Assault by other specified means

956

0.98

0.04

4.9

3.6

1.51

1.46

ug/l

0.10

882

1.10

0.04

2.0

1.8

0.86

0.74

ug/l

—

Personal history of risk-factors, not elsewhere classified

113

1113

1.02

0.04

3.9

4.4

1.27

2.11

ug/l

1.98

100

998

ILD and respiratory illness in diseases classified elsewhere

537

1.03

0.04

4.1

5.8

1.71

2.71

ug/l

0.91

477

Contact with venomous snakes and lizards

107

1054

1.02

0.04

5.6

5.4

2.08

2.42

ug/l

0.26

949

Haemolytic-uraemic syndrome

180

1.07

0.04

3.4

5.1

1.76

2.07

ug/l

0.26

164

Golimumab

269

2667

1.01

0.04

3.5

3.9

1.55

1.68

ug/l

0.32

253

2475

Operations for atrial fibrillation

277

2789

0.99

0.04

5.1

5.8

1.95

2.69

ug/l

1.27

248

2533

Pemphigus

764

0.97

0.04

5.1

5.5

1.97

2.66

ug/l

0.59

679

Occupant of special vehicle mainly used on industrial premises injured in transport accident

973

0.97

0.04

4.8

5.1

2.04

2.38

ug/l

0.32

871

Erythema in diseases classified elsewhere

210

1.07

0.04

5.1

5.7

3.67

1.64

ug/l

1.08

188

Dislocations, sprains and strains involving multiple body regions

129

0.91

0.04

8.2

5.9

1.05

1.91

ug/l

1.42

114

Lack of expected normal physiological development

235

1.04

0.04

2.7

2.6

0.87

2.53

ug/l

0.63

201

Haemolytic anaemias

383

3806

1.01

0.04

4.8

5.6

2.26

2.59

ug/l

0.56

348

3426

Calcium deposit in bursa

240

0.94

0.04

5.8

5.4

1.33

3.23

ug/l

0.80

211

Other specified and unspecified personality disorders

862

8586

1.01

0.04

4.1

4.5

1.76

1.97

ug/l

0.42

773

7889

Other and unspecified pemphigus

409

1.04

0.04

5.5

5.4

1.92

2.74

ug/l

0.42

360

Neuroendocrine tumor and carcinoma of stomach

542

0.97

0.04

5.5

4.5

5.53

2.03

ug/l

0.60

482

Toxic effect of other gases, fumes and vapours

773

0.97

0.04

3.8

4.2

1.29

1.63

ug/l

0.96

698

Magnesium deficiency

441

0.96

0.04

3.9

5.2

1.38

2.38

ug/l

1.43

394

Other other unspecified disorders of the circulatory system

402

3997

1.01

0.04

5.7

5.9

3.83

2.78

ug/l

0.43

365

3583

Pustular psoriasis

355

3573

0.99

0.04

5.0

5.3

1.88

2.46

ug/l

1.45

315

3240

Bacterial meningitis

397

3948

1.01

0.03

5.6

5.1

1.98

2.13

ug/l

0.20

362

3603

Disorders of parathyroid gland, other and/or unspecified

369

1.03

0.03

7.2

5.8

2.59

3.03

ug/l

0.16

325

Schizotypal disorder

220

2218

0.99

0.03

3.2

3.7

1.22

1.63

ug/l

1.72

191

2058

Renal cell carcinoma of kidney

459

4568

1.01

0.03

6.0

4.3

5.25

2.17

ug/l

1.29

412

4083

Crowding of teeth, including avohilmo

306

2515

1.01

0.03

3.9

3.8

1.50

1.66

ug/l

0.44

275

2286

Mixed connective tissue disease

103

1016

1.02

0.03

4.4

5.5

1.27

2.34

ug/l

2.45

910

Acute lymphadenitis

530

5276

1.01

0.03

4.3

4.7

8.64

2.21

ug/l

0.63

474

4825

Manic episode

306

3041

1.01

0.03

3.9

4.7

1.61

2.04

ug/l

1.60

269

2793

Other lack of coordination

208

2064

1.01

0.03

5.8

5.7

2.62

2.59

ug/l

0.02

192

1840

Acne, including avohilmo

1099

8917

1.00

0.03

4.1

3.8

1.83

1.81

ug/l

0.02

990

8125

Cerebral atherosclerosis

173

1740

0.99

0.03

5.6

6.0

2.50

3.94

ug/l

1.13

155

1530

Acute bronchiolitis

219

1992

0.99

0.03

4.3

4.6

2.19

2.22

ug/l

0.02

197

1759

Renal agenesis and other reduction defects of kidney, including avohilmo

579

1.03

0.03

4.4

5.4

2.11

2.41

ug/l

0.14

518

Burns and corrosions of multiple body regions

135

1337

1.02

0.03

5.4

4.9

2.46

2.37

ug/l

0.07

122

1209

Postprocedural disorders of ear and mastoid process, not elsewhere classified

948

1.02

0.03

5.1

5.9

6.83

2.42

ug/l

0.46

829

Crohn's disease of large intestine

503

5009

1.01

0.03

4.3

4.6

2.21

2.05

ug/l

0.18

463

4572

Other disorders of thyroid

549

1.02

0.03

6.8

5.4

8.51

2.58

ug/l

0.44

479

Systemic sclerosis, icd10

103

1043

0.99

0.03

5.5

5.0

2.36

2.21

ug/l

0.10

932

Other cestode infections

289

0.96

0.03

4.7

5.5

2.41

2.17

ug/l

0.13

253

Acute hepatitis B, including avohilmo

540

0.97

0.03

4.2

4.7

1.55

2.26

ug/l

0.58

492

Degenerative diseases of the nervous system

6486

46593

1.00

0.02

5.3

6.5

5.72

4.49

ug/l

0.57

5610

41380

Unspecified lump in breast

122

1.07

0.02

1.0

1.1

—

0.44

—

Other and unspecified disorders of pigmentation

490

1.02

0.02

4.6

5.2

1.36

2.56

ug/l

1.05

444

Thrombotic microangiopathy

590

0.98

0.02

3.9

5.5

1.69

2.48

ug/l

0.75

528

ILD medications: pirfenidone

214

2128

1.01

0.02

4.8

6.4

1.80

3.01

ug/l

1.76

194

1892

Disorder of thyroid, unspecified

540

1.02

0.02

6.7

5.4

8.62

2.64

ug/l

0.43

470

Acquired pure red cell aplasia [erythroblastopenia]

429

0.97

0.02

6.0

5.7

2.09

2.62

ug/l

0.40

378

Pneumococcal septicemia

421

4226

0.99

0.02

5.1

5.7

2.65

2.59

ug/l

0.04

372

3797

Malignant neoplasm of pyriform sinus

157

0.89

0.02

4.6

4.3

1.20

1.68

ug/l

1.08

146

Multiple myeloma and malignant plasma cell neoplasms

709

7072

1.00

0.02

5.2

6.1

2.91

3.91

ug/l

0.80

639

6325

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

226

2273

0.99

0.02

5.3

5.4

2.51

2.85

ug/l

0.24

209

2046

UC patients in KELA-register (code 208), prior to 1994

573

5746

1.00

0.02

5.4

2.63

2.64

ug/l

0.01

516

5212

Ulcerative enterocolitis

337

3384

0.99

0.02

5.0

2.25

2.28

ug/l

0.04

310

3066

Syndrome of inappropriate secretion of antidiuretic hormone

609

0.98

0.02

4.6

5.7

1.93

2.53

ug/l

0.68

539

Reimbursement for rheumatic diseases

6789

67402

1.00

0.02

4.9

5.4

2.36

3.11

ug/l

3.43

6121

61139

Retained (old) intraocular foreign body

173

1.09

0.02

6.8

5.3

24.05

2.04

ug/l

0.52

152

Atrial septal defect, secundum type

152

1526

0.99

0.02

4.7

4.5

1.61

2.11

ug/l

1.03

133

1402

Other dermatomyositis

318

0.97

0.02

3.8

5.6

2.34

1.97

ug/l

0.20

284

Medullary cystic kidney disease, nephronophthisis

123

1.07

0.02

4.7

5.1

1.90

1.89

ug/l

0.01

110

Infarction of spleen

881

1.02

0.02

5.0

5.6

4.75

2.62

ug/l

0.44

787

Crushing injury of ankle and foot

608

0.98

0.01

4.7

5.1

1.51

2.59

ug/l

1.21

552

508

0.98

0.01

4.2

5.9

1.74

2.78

ug/l

0.89

454

Abnormal reflex

502

1.02

0.01

4.8

5.1

1.96

1.91

ug/l

0.05

447

Disorders of glossopharyngeal nerve

183

1.05

0.01

8.8

5.4

1.27

3.00

ug/l

1.07

164

Measles

112

1129

0.99

0.01

3.0

3.2

1.56

1.36

ug/l

0.50

105

1050

Measles, including avohilmo

112

1129

0.99

0.01

3.0

3.2

1.56

1.36

ug/l

0.50

105

1050

Primary biliary cholangitis (PBC)

106

1051

1.01

0.01

4.8

5.7

1.67

2.74

ug/l

1.62

937

Cerebral arteritis

227

0.96

0.01

4.5

5.2

2.55

1.69

ug/l

0.56

206

Fracture of spine, level unspecified

293

1.04

0.01

5.3

6.0

1.56

2.09

ug/l

1.16

251

Benign neoplasm: Thymus

293

1.04

0.01

7.2

5.2

3.29

1.99

ug/l

0.66

256

Dialysis, with operation codes

2334

23324

1.00

0.01

4.0

5.6

2.37

2.96

ug/l

1.20

2165

21181

Amoebiasis

503

1.02

0.01

6.4

4.9

1.44

1.76

ug/l

0.53

438

Other specified/unspecified necrotizing vasculopathies

155

1542

1.01

0.01

4.7

5.7

2.46

2.59

ug/l

0.10

135

1366

Asthma, including avohilmo

19686

108310

1.00

0.01

5.2

5.3

2.45

3.28

ug/l

5.42

17930

98313

Ulcerative colitis (strict definition, all Crohn cases excluded)

1839

18377

1.00

0.01

4.8

2.39

ug/l

0.00

1681

16790

Congenital syphilis, including avohilmo

1.09

0.01

5.5

4.9

2.00

2.41

ug/l

—

Spinal enthesopathy

289

2893

1.00

0.01

5.4

5.6

5.23

6.53

ug/l

0.23

255

2507

Aspergillosis, including avohilmo

137

1377

0.99

0.01

5.2

5.7

1.84

2.50

ug/l

1.33

121

1238

Female infertility, cervical, vaginal, other or unspecified origin

100

0.96

0.01

1.2

1.1

—

0.03

—

Hyperfunction of pituitary gland, other and/or unspecified

154

1.05

0.00

6.0

5.6

2.79

2.04

ug/l

0.56

136

Ulcerative ileocolitis

447

4462

1.00

0.00

4.5

4.6

1.95

2.11

ug/l

0.32

414

4088

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

226

0.97

0.00

5.6

5.2

1.70

2.60

ug/l

0.70

196

Benign neoplasm: Respiratory system, unspecified

266

0.97

0.00

6.7

5.2

3.60

1.80

ug/l

1.25

238

Ankyloglossia

365

0.98

0.00

3.5

2.8

1.48

1.17

ug/l

0.49

328

Ulcerative colitis (strict definition, require KELA)

2159

21580

1.00

0.00

4.8

2.34

2.33

ug/l

0.01

1976

19766

Mental and behavioural disorders due to use of volatile solvents

264

1.03

0.00

2.5

3.0

1.10

1.41

ug/l

0.56

246

Lipomatosis, not elsewhere classified

296

0.97

0.00

4.8

5.2

1.00

3.02

ug/l

1.25

268

Monocytic leukaemia

466

0.98

0.00

4.6

6.1

1.84

2.78

ug/l

0.67

412

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

424

1.02

0.00

5.2

4.4

1.35

2.41

ug/l

0.71

374

Malignant neoplasm of nasal cavity and middle ear

674

1.01

0.00

4.4

4.1

3.55

1.81

ug/l

0.58

597

Other neurotic disorders

572

5727

1.00

0.00

5.5

5.3

5.37

2.49

ug/l

0.68

515

5209

Haemorrhage in early pregnancy

167

0.99

0.00

1.0

1.1

—

0.25

—

Obesity

8342

78493

1.00

0.00

5.0

5.3

2.15

2.78

ug/l

2.11

7475

71839

Endometriosis ASRM stages 1,2

108

1.02

0.00

1.2

1.1

—

1.16

—

Behavioural disorders, excluding more controls

131

1311

1.00

0.00

2.7

3.2

7.52

1.39

ug/l

0.48

118

1208

CR(E)ST syndrome

487

1.01

0.00

6.2

5.1

2.74

2.63

ug/l

0.03

431

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

5047

39171

1.00

0.00

11.6

5.7

8.03

3.33

ug/l

6.87

4703

35209

Retrobulbar neuritis in diseases classified elsewhere

144

0.97

0.00

3.5

4.0

1.31

1.70

ug/l

0.67

134

Amiodarone users

1921

19211

1.00

0.00

5.0

6.0

3.70

3.34

ug/l

0.11

1703

17352

6-mercaptopurine

298

2978

1.00

0.00

4.3

4.1

1.82

1.68

ug/l

0.44

269

2729

Disorders of oesophagus in diseases classified elsewhere

281

2806

1.00

0.00

5.6

5.7

2.40

3.18

ug/l

0.89

255

2516

Toxic effect of other and unspecified substances

112

1123

1.00

0.00

3.9

3.8

11.52

1.52

ug/l

0.50

1034

Benign neoplasm: Rectum/anal canal icd-9

778

1.00

0.00

8.1

6.2

3.00

4.09

ug/l

0.42

677

Acquired haemolytic anaemia

275

2753

1.00

0.00

5.1

5.8

2.60

2.61

ug/l

0.01

251

2457

Other and unspecified disorders of orbit

566

1.01

0.00

4.8

5.1

2.20

2.42

ug/l

0.12

509

Acrodermatitis continua

172

0.99

0.00

5.7

5.9

2.16

1.80

ug/l

0.22

151

Other and unspecified diseases of spleen

471

1.00

0.00

4.8

5.2

2.54

2.82

ug/l

0.13

428

Gonococcal infection

208

2082

1.00

0.00

3.3

3.7

1.66

1.47

ug/l

0.77

195

1912

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

103

1034

0.99

0.00

4.7

4.3

6.54

2.00

ug/l

0.50

921

Asthma mixed form (mode)

518

5182

1.00

0.00

5.2

5.7

2.92

4.30

ug/l

0.83

474

4666

Malignant neoplasm of adrenal gland, including Hilmo

719

1.00

0.00

5.0

3.9

2.86

1.83

ug/l

0.56

642

Drug-induced tremor

759

1.00

0.00

4.8

5.4

1.88

2.32

ug/l

0.39

682

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

102

1019

1.00

0.00

5.2

6.5

2.55

3.25

ug/l

0.64

899

HSIL lesion of the cervix uteri, vagina or vulva

109

1.01

0.00

1.2

1.1

—

0.84

—

Malignant neoplasm of other and unspecified major salivary glands

432

0.99

0.00

4.5

4.3

1.93

2.00

ug/l

0.08

376

Disorders of muscle in diseases classified elsewhere

101

0.99

0.00

4.8

5.9

82.05

1.99

ug/l

—

Corrosions classified according to extent of body surface involved

1.01

0.00

5.9

5.5

2.95

1.62

ug/l

—

Follicular keratosis (Darier-White), including avohilmo

109

1.01

0.00

3.2

4.8

1.05

2.12

ug/l

1.08

102

Transepidermal elimination disorders

121

0.99

0.00

3.4

4.8

0.82

1.73

ug/l

3.58

107

Other protozoal intestinal diseases

121

1211

1.00

0.00

5.6

5.2

1.60

2.57

ug/l

1.78

112

1089

Guttate psoriasis

124

1241

1.00

0.00

5.0

1.53

2.03

ug/l

0.90

111

1118

Chronic hepatitis, not elsewhere classified

299

2987

1.00

0.00

4.9

5.1

1.65

2.16

ug/l

2.07

278

2725

Disorders of copper metabolism

123

0.97

0.00

4.2

4.9

2.31

1.61

ug/l

0.38

109

Exposure to high and low air pressure and changes in air pressure

177

1.03

0.00

6.3

4.7

1.69

1.70

ug/l

0.00

160

Disorder of carbohydrate metabolism, other/unspecified

371

1.00

0.00

3.5

4.5

1.40

1.75

ug/l

0.78

337

Contact urticaria

167

1.02

0.00

3.8

4.7

0.91

1.74

ug/l

4.27

152

100

1.05

0.00

1.9

1.7

0.81

0.73

ug/l

0.19

Chromomycosis and phaeomycotic abscess

105

1.06

0.00

6.8

5.2

223.40

1.87

ug/l

0.47

Other helminthiases

105

0.94

0.00

4.0

5.0

1.95

2.27

ug/l

—

Other adrenocortical overactivity

217

1.02

0.00

6.5

5.7

4.32

1.98

ug/l

0.46

192

Benign neoplasm: Tonsil

127

1273

1.00

0.00

4.8

5.3

1.79

2.34

ug/l

0.81

111

1157

Benign neoplasm: Heart

345

0.98

0.00

5.4

5.7

2.45

2.04

ug/l

0.15

302

Changes in corneal membranes

275

0.98

0.00

4.8

4.9

1.34

1.70

ug/l

0.91

248

Toxic encephalopathy

435

0.97

0.00

5.5

1.78

2.95

ug/l

0.85

392

Pediculosis and phthiriasis, including avohilmo

646

1.01

0.00

3.5

4.0

1.49

1.59

ug/l

0.15

589

Scarlet fever

566

1.01

0.00

2.7

3.3

1.11

1.37

ug/l

0.39

532

Rheumatic fever with heart involvement

515

1.01

0.00

5.8

5.4

1.95

2.13

ug/l

0.18

462

Other diseases of appendix

925

0.99

0.00

6.3

5.2

3.19

2.46

ug/l

0.53

840

Carcinoma in situ of middle ear and respiratory system

703

0.99

0.00

6.7

6.1

3.26

2.75

ug/l

0.23

611

Absence of one kidney, including avohilmo

336

1.02

0.00

4.4

5.6

2.84

2.04

ug/l

0.31

302

Sphingolipidosis, other/unspecified

104

0.96

0.00

3.9

5.4

1.40

2.01

ug/l

—

Glaucoma secondary to drugs

416

1.01

0.00

5.0

5.5

1.52

2.77

ug/l

0.94

373

Airway disease due to specific organic dust

284

0.98

0.00

5.3

5.0

4.54

1.87

ug/l

0.42

259

Burkitt lymphoma, including Hilmo

105

1.08

0.00

4.5

1.68

1.83

ug/l

0.08

Burkitt lymphoma

105

1.08

0.00

4.5

1.68

1.83

ug/l

0.08

Hyposplenism

144

0.96

0.00

5.1

5.5

2.04

1.81

ug/l

0.16

127

Myiasis, including avohilmo

1.07

0.00

5.0

5.2

1.06

1.79

ug/l

—

Benign muscular dystrophy (Becker)

118

1.02

0.00

3.7

4.9

1.25

1.72

ug/l

0.55

105

Thoracic root disorders

158

1.02

0.00

4.5

5.1

1.45

4.02

ug/l

0.74

150

Benign neoplasm: Hypopharynx

694

0.99

0.00

4.7

5.6

2.04

2.78

ug/l

0.67

631

Injury of blood vessels at ankle and foot level

138

1.02

0.00

8.2

5.0

2.80

3.95

ug/l

0.19

127

Burkitt lymphoma, helper endpoint

111

0.99

0.00

4.5

5.5

1.68

1.76

ug/l

0.04

Traumatic subcutaneous emphysema

212

0.98

0.00

6.1

5.3

2.18

2.08

ug/l

0.06

192

Rat-bite fevers, including avohilmo

0.98

0.00

4.3

5.4

2.13

2.03

ug/l

—

Infections of genitourinary tract in pregnancy

0.91

0.00

1.0

1.1

—

0.43

—

Brucellosis

0.96

0.00

4.3

5.4

2.92

1.49

ug/l

—

Carcinoma in situ of other/unspecified digestive organs

0.94

-0.00

8.0

6.3

3.01

2.03

ug/l

—

Benign neoplasm: Ureter

0.93

-0.00

5.7

5.9

3.65

1.92

ug/l

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.93

-0.00

3.7

5.6

2.17

2.15

ug/l

—

Traumatic anuria

1.11

-0.00

5.1

5.8

2.62

2.35

ug/l

—

Pityriasis alba

0.91

-0.00

4.3

0.86

1.89

ug/l

—

R07AX Other respiratory system products

0.00

-0.00

0.0

2.3

—

0.99

—

Hereditary factor IX deficiency

0.84

-0.00

2.2

4.4

3.33

1.52

ug/l

—

Congenital mitral valve regurgitation

0.89

-0.00

4.5

4.3

2.04

1.46

ug/l

—

Pyoderma gangrenosum

630

1.00

-0.00

4.3

5.2

1.57

1.98

ug/l

0.60

557

Exposure to high-pressure jet

120

1.00

-0.00

3.2

4.3

2.38

1.61

ug/l

0.50

108

Pedal cyclist injured in collision with pedestrian or animal

880

1.00

-0.00

5.8

5.0

2.02

1.82

ug/l

0.35

786

Forearm

1.02

-0.00

3.1

5.3

1.26

1.80

ug/l

—

Kernicterus

0.96

-0.00

4.7

5.8

1.43

1.68

ug/l

—

Short stature starting before birth

0.99

-0.00

2.9

1.6

0.89

0.87

ug/l

—

Other assisted single delivery

0.00

-0.00

0.0

1.5

—

Lethal midline granuloma

0.86

-0.00

4.6

0.53

1.57

ug/l

—

Vitiligo

102

1020

1.00

-0.00

4.3

4.6

1.70

2.35

ug/l

0.85

922

Cyst of spleen

130

1.00

-0.00

5.5

4.5

2.45

1.82

ug/l

0.43

118

Right hemicolectomy

780

7800

1.00

-0.00

5.4

5.9

2.69

3.85

ug/l

1.22

697

6971

HSIL lesion of the cervix uteri

0.95

-0.00

1.1

—

0.92

—

Malignant neoplasm of other and unspecified parts of mouth

680

1.00

-0.00

4.3

9.22

2.08

ug/l

0.51

606

Pinta [carate], including avohilmo

0.91

-0.00

5.2

4.5

1.99

1.56

ug/l

—

Brucellosis, including avohilmo

0.94

-0.00

4.3

5.4

2.92

1.47

ug/l

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.88

-0.00

4.1

4.3

2.19

2.24

ug/l

—

Aspergillosis

134

1340

1.00

-0.00

5.2

5.7

1.86

2.52

ug/l

1.26

119

1205

Serous carcinoma of ovary

0.00

-0.00

0.0

1.2

—

Ascorbic acid deficiency

0.98

-0.00

4.3

5.0

3.36

1.78

ug/l

—

Follicular keratosis (Darier-White)

0.94

-0.00

4.0

5.3

1.09

2.32

ug/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.93

-0.00

1.4

2.9

0.94

1.44

ug/l

—

Environmental-pollution-related condition

0.92

-0.00

7.0

5.7

4.08

1.90

ug/l

—

Alpha thalassaemia

0.93

-0.00

5.3

1.28

1.42

ug/l

—

Explicit viral Sepsis

0.90

-0.00

5.3

5.2

2.27

1.88

ug/l

—

Reduction defects of lower limb, including avohilmo

240

1.00

-0.00

4.7

4.6

1.89

1.79

ug/l

0.08

210

Eosinophilic cellulitis [Wells]

0.96

-0.00

3.3

6.3

0.86

1.72

ug/l

—

Chronic thyroiditis

0.98

-0.00

4.0

5.8

2.08

1.93

ug/l

—

Explicit viral Sepsis, including avohilmo

0.95

-0.00

5.4

5.2

2.21

1.79

ug/l

—

Hypothyroidism, autoimmune, DX-based

0.99

-0.00

4.0

4.7

2.25

1.64

ug/l

—

Kidney diseases associated to Fabry's disease

0.95

-0.00

4.5

5.8

1.42

2.23

ug/l

—

Pustulosis palmaris et plantaris

307

3070

1.00

-0.00

4.8

5.3

1.85

2.48

ug/l

1.39

272

2788